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Abstract   IX
ABSTRACT 
 
 This Ph.D. thesis describes the first collective total synthesis of the leucosceptroid  
family of natural products, as well as a divergent approach to the marine diterpenes (+)-dictyoxetane  
and (+)-dolabellane V. 
 
PART I: Leucosceptrum canum Smith is a shrub endemic to southwest China and Nepal that 
harbors sesterterpenoids, designated leucosceptroids A‒Q and norleucosceptroids A‒H. These 
compounds were found to act as a potent biological defense against plant-feeding insects. The 
antifeedant properties together with the novel molecular scaffolds of the leucosceptroids, comprising a 
5,6,5-framework with a fully functionalized tetrahydrofuran ring and eight contiguous stereogenic 
centers, make these natural products highly attractive targets for total synthesis. 
Part I of this thesis presents the evolution of a strategy for the collective synthesis of this family 
of antifeedant natural products. The elaborated synthetic route commenced with the convergent 
assembly of the two similarly complex building blocks I and II (Scheme A). Next, an unprecedented 
intramolecular dilactol aldol-type condensation of III was devised to produce the 5,6,5-framework that 
is common in all leucosceptroids. Elaboration of the core structure IV gave access to gram quantities of 
the highly functionalized tricycle V, which served as the pivotal intermediate for the asymmetric total 
synthesis of 18 complex leucosceptroid members. The development of a model system helped revealing 
biogenetic relationships between individual leucosceptroids and could shed light on their biosynthesis. 
Finally, the biomimetic transformation of leucosceptroid A to leucosceptroids C, K, O and P using 
singlet oxygen was investigated. Results of these studies corroborated the hypothesis that 
leucosceptroids A and B are most likely the parent members of the leucosceptroid family of natural 




Scheme A. Total synthesis of the leucosceptroid family of natural products.  
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PART II: The second project of this Ph.D. thesis deals with the oxetane-containing natural 
product (+)-dictyoxetane and the macrocyclic diterpenoid (+)-dolabellane V, for both of which 
biological activities were unknown and total syntheses had yet to be reported. While only relatively few 
natural products feature an oxetane, intriguing and strong biological activities are often observed for 
compounds containing such a structural subunit. 
The synthetic efforts towards (+)-dictyoxetane were guided by bioinspired, classical and 
nonconventional strategies to construct the oxetane, which is embedded in an intricate and 
unprecedented 2,7-dioxatricyclo[4.2.1.03,8]nonane ring system. At the outset of the bioinspired route, a 
scalable synthetic approach to key tricycle VII was developed starting from known trans-hydrindane 
VI. While attempts to prepare (+)-dictyoxetane via epoxides VIII and X were met with failure, a crucial 
modification of the originally proposed biosynthesis, involving formation of the oxetane prior to the 
strained trans-tetrahydrofuran ring, eventually enabled construction of the dioxatricyclic substructure. 
In this respect, use of a highly selective photo-oxidation converted tricycle VII into allylic alcohol XII, 
which underwent smooth 4-exo-tet cyclization to form oxetane XIII. Based on the modified biosynthetic 
proposal, construction of the synthetically challenging dioxatricyclic framework of (+)-dictyoxetane 
was then finalized via a 5-exo cyclization. Furthermore, the elaborated synthetic route to the full 
diterpenoid carbon skeleton VII emerged as a valuable point of divergence and also allowed disclosing 
the first total synthesis of (+)-dolabellane V. Notably, a wealth of fascinating reactivity was discovered 
during the synthetic investigations with putative biogenetic precursors of the dioxatricyclic substructure, 
and these results culminated in the development of the first strain-releasing type I dyotropic 












































+ highly diastereoselective carbonyl addition reactions
+ bioinspired 4-exo-tet, 5-exo-trig cyclization sequence
+ Grob fragmentation to construct 11-membered macrocycle
+ first dyotropic rearrangement of an epoxideoxetane substrate
i. NIS
ii. H2, Pd/C
R = Bn, X










R = Bn, VIII






Scheme B. Divergent total synthesis of the marine diterpenoids (+)-dictyoxetane and (+)-dolabellane V. 
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1 BIOINSPIRED SYNTHESIS 
 
1.1 General Introduction 
In the field of organic chemistry, a biomimetic synthesis or reaction sequence constitutes a 
transformation that mimics a hypothetical or proven biosynthetic pathway of a natural product.1 In 
general, the imitated biosynthetic proposal needs to have a firm basis in known chemical pathways, such 
as the biosynthesis of terpenoids or polyketides. It is preferable to use the term bioinspired rather than 
biomimetic synthesis, when the mimicking transformations are conducted with reagents and conditions 
that are not representative of natural systems. By inducing a specific reaction on a putative biosynthetic 
intermediate, the transformation might serve as an approach to corroborate a biosynthetic proposal. 
Alternatively, if the reaction would not succeed, the suggested biosynthesis would remain unsupported 
and might need to be revised.2 
The concept of biomimetic synthesis was first introduced in 1917 by Sir Robert Robinson who 
described the one-pot synthesis of the natural product tropinone (3) from glutaraldehyde (1), methyl 
amine and acetone dicarboxylic acid 2 by a Mannich reaction cascade (Scheme 1a).3 Following this 
seminal report, numerous other syntheses have been inspired by nature, such as the polyene cyclization 
cascade to form allopregnanolone (5) (Scheme 1b).4 Heathcock and co-workers realized an impressive 
cascade of biomimetic steps in total syntheses of several homosecodaphniphyllate congeners starting 
from simple squalene-type precursors, such as 6 (Scheme 1c).5 The ‘endiandric acid cascade’ constitutes 
a further classic contribution to the field and highlights the beauty of electrocyclizations, which nature 
uses to build complex natural products.6 In Nicolaou’s bioinspired study, diyne 8 was subjected to 
Lindlar hydrogenation, whereupon the product underwent sequential, spontaneous 8π conrotatory and 
6π disrotatory electrocyclizations and, after a thermally induced intramolecular Diels–Alder reaction, 
yielded endiandric acid A methyl ester (9) (Scheme 1d).7  
                                                     
1 M. C. de la Torre, M. A. Sierra, Angew. Chem. Int. Ed. 2004, 43, 160–181. 
2 a) E. Gravel, E. Poupon, Eur. J. Org. Chem. 2008, 1, 27–42; b) M. Razzak, J. K. de Brabander, Nat. Chem. Biol. 2011, 7, 
865–875. 
3 a) R. Robinson, J. Chem. Soc. Trans. 1917, 111, 762–768; b) A. J. Humphrey, D. O’Hagan, Nat. Prod. Rep. 2001, 18, 
494–502. 
4 a) W. S. Johnson, M. B. Gravestock, B. E. McCarry, J. Am. Chem. Soc. 1971, 93, 4332–4334; b) S. K. Taylor, Org. Prep. 
Proced. Int. 1992, 24, 245–284. c) R. A. Yoder, J. N. Johnston, Chem. Rev. 2005, 105, 4730–4756. 
5 a) C. H. Heathcock, S. K. Davidsen, S. Mills, M. A. Sanner, J. Am. Chem. Soc. 1986, 108, 5650–5651; b) R. B. Ruggeri, M. 
M. Hansen, C. H. Heathcock, J. Am. Chem Soc. 1988, 110, 8734–8736; c) J. A. Stafford, C. H. Heathcock, J. Org. Chem. 1990, 
55, 5433–5434; d) C. H. Heathcock, J. A. Stafford, D. L. Clark, J. Org. Chem. 1992, 57, 2575–2585; e) C. H. Heathcock, R. 
B. Ruggeri, K. F. McClure, J. Org. Chem. 1992, 57, 2585–2594; e) C. H. Heathcock, J. A. Stafford, D. L. Clark, J. Org. Chem. 
1992, 57, 2566–2574; f) C. H. Heathcock, J. C. Kath, R. B. Ruggeri, J. Org. Chem. 1995, 60, 1120–1130.  
6 C. M. Beaudry, J. P. Malerich, D. Trauner, Chem. Rev. 2005, 105, 4757–4778 
7 K. C. Nicolau, N. A. Petasis, R. E. Zipkin, J. Am. Chem. Soc. 1982, 104, 5560–5562. 

















































Scheme 1. Seminal biomimetic syntheses of a) tropinone (3), b) allopregnanolone (5), c) methyl 
homosecodaphniphylate precursor 7 and d) endiandric acid A methyl ester (9) 
As highlighted by these four examples, nature uses relatively small and simple building blocks 
as precursors for the synthesis of complex molecules. In these processes, cascade reactions frequently 
occur,8 where products of one transformation serve as the starting material for a subsequent reaction 
sequence, thus leading to a rapid increase in structural complexity. Striving to match nature’s ingenuity 
for achieving the total synthesis of natural products is often an intractable ambition in a chemical 
laboratory. However, it can be advantageous to design synthetic routes bearing biosynthetic 
considerations in mind, or to devise strategies that feature an individual bioinspired step.9 Besides 
providing the recognition and understanding of how nature generates molecular complexity, bioinspired 
syntheses also stimulate the development of new reactions or result in alternative methods for the 
preparation of a desired target.10 Furthermore, employing step-economic cascade reactions can 
favorably minimize the amount of labor and a general entry to a whole family of natural products might 
be feasible, if a common biosynthetic precursor can be identified. 
  
                                                     
8 a) K. C. Nicolau, D. J. Edmonds, P. G. Bulger, Angew. Chem. Int. Ed. 2006, 45, 7134–7186; b) R. Ardkhean, D. F. J. Caputo, 
S. M. Morrow, H. Shi, Y. Xiong and E. A. Anderson, Chem. Soc. Rev. 2016, 45, 1557–1569. 
9 P. G. Bulger, S. K. Bagal, R. Marquez, Nat. Prod. Rep. 2008, 25, 254–297. 
10 A. M. Armaly, Y. C. DePorre, E. J. Groso, P. S. Riehl, C. S. Schindler, Chem. Rev. 2015, 115, 9232–9276. 
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A wealth of fascinating discoveries have been made and elegant routes to daunting natural 
products were rendered possible in the pursuit of biomimetic and bioinspired syntheses. In the following 
section, compelling examples from the recent literature are presented, which highlight conceptually 
different bioinspired syntheses in the field of terpenoids. 
 
1.2 Bioinspired Syntheses of Terpenoids 
1.2.1 Polycyclizations 
Arguably, one of the most vibrant areas of bioinspired syntheses of terpene-derived molecules, 
involve orchestrated, cascade cyclizations of linear precursors to form polycyclic cores of natural 
products.11 This strategy is similar to the way nature operates in the biosynthesis of terpenoids  
(cf. Chapter 2.1.1) and stands in stark contrast to traditional syntheses. In the latter case, structural 
complexity is built up in a stepwise fashion and the idea prevails that each chemical step should 
introduce a new stereocenter. 
Using a strategy that mimics nature, researchers have reported the total synthesis of the 
meroterpenoid–hybrid hongoquercin B (10) from the acyclic precursor 11 (Scheme 2a).12 In the dual 
bioinspired route, cyclo-aromatization formed the resorcylate substructure and was directly followed by 
a stereocontrolled diene epoxide cyclization, which generated the tetracyclic core of the natural product. 
As opposed to classical terpenoid biosynthesis, where after cyclization the product then is 
sequentially oxidized, the order is reversed in the case of ladder polyether metabolites. In the proposed 
biosynthesis of polyethers, such as the non-traditional polyketide brevetoxin B (12), a linear polyene is 
first oxidized to a polyepoxide (e.g. 13), which then undergoes a cascade of regio- and stereoselective 
epoxide-opening events (Scheme 2b).13 Such dramatic epoxide-opening cascades have enticed many 
researchers to translate nature’s elegant method to the laboratory and develop bioinspired syntheses of 
challenging polyethers.14 
The group of McDonald reported an elegant total synthesis of the marine triterpenoid abudinol B 
(18), which features an intriguing structure with cyclic ethers fused to carbacyclic rings (Scheme 2c).15 
In their strategy, the proposed biosynthetic pathway was mimicked starting from a linear squalene-like 
precursor and by employing a hybrid cascade of epoxide openings and carbacyclizations. Diepoxide 14 
was prepared in a short reaction sequence and incorporates an enolsilane for efficient nucleophilic 
termination of the cascade reaction. In the first stage of the bioinspired tricyclization, the combination 
                                                     
11 a) G. Stork, A. W. Burgstahler, J. Am. Chem. Soc. 1955, 77, 5068–5077; b) P. A. Stadler, A. Eschenmoser, H. Schinz, G. 
Stork, Helv. Chim. Acta 1957, 40, 2191–2198; c) W. S. Johnson, K. Wiedhaup, S. F. Brady, G. L. Olson, J. Am. Chem. Soc. 
1968, 90, 5277–5279. 
12 T. N. Barrett, A. G. M. Barrett, J. Am. Chem. Soc. 2014, 136, 17013–17015. 
13 a) M. S. Lee, G.-W. Qin, K. Nakanishi, M. G. Zagorski, J. Am. Chem. Soc. 1989, 111, 6234–6241; b) I. Vilotijevic, T. F. 
Jamison, Mar. Drugs 2010, 8, 763–809. 
14 a) I. Vilotijevic, T. F. Jamison, Science 2007, 317, 1189–1192; b) I. Vilotijevic, T. F. Jamison, Angew. Chem. Int. Ed. 2009, 
48, 5250–5281. 
15 R. Tong, F. E. McDonald, Angew. Chem. Int. Ed. 2008, 47, 4377–4379. 
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of trimethylsilyl triflate and 2,6-di-tert-butyl-4-methylpyridine led to selective activation of the terminal 
epoxide and promoted tandem cyclizations to provide tricyclic ketone 16, after desylation with 
tetrabutylammonium fluoride. The stereochemical outcome for this major product was found to be 
consistent with the chair-like conformation shown in 15. The cascade product 16 was then elaborated to 
diepoxide 17 in a reaction sequence involving Wittig methylenation and Shi epoxidation. Employing 
the same activation conditions as before, 17 underwent the hybrid cyclization cascade and afforded ent-
abudinol B (18), albeit accompanied by a partially cyclized by-product arising due to the relatively poor 
nucleophilicity of the terminating alkene. Despite being a linear synthetic route, the rapid generation of 
structural complexity using the bioinspired tandem oxa- and carbacyclizations proved highly 
advantageous and resulted in a concise synthesis of 18. 
 
 
Scheme 2. a) Concept of polyolefin carbocyclizations, b) cascade epoxide-opening reactions and c) application to 
the bioinspired synthesis of abudinol B (18). 
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While bioinspired cationic polyene cyclizations constitute a well-studied and powerful approach 
to access the carbocyclic framework of many terpenoids in a laboratory setting,4c this method is often 
problematic or unsuitable for the synthesis of medium or larger ring frameworks. Alternatively, radical-
based bioinspired syntheses of terpenoids have been developed and in some cases these methods can 
nicely complement the previous cationic approach.16 Maimone and co-workers recently described a 
strategy to forge a 5-8-5 fused ring system, as is common in ophiobolin sesterterpenoids, by radical-
based cyclization of polyprenyl-derived chains.17 As outlined in Scheme 3a, the tricyclic framework of 
19 was envisioned to be constructed by a cascade 8-endo/5-exo radical cyclization of 20, and to this end 
linalool (21) and farnesol (22) were identified as suitable starting materials. Thus, the key principle of 
this strategy involved a bioinspired building block choice, while bond formation was envisioned to take 
place in a disparate fashion. 
The synthesis of the 5-8-5 fused ring system initiated with preparation of iodide 24 via 
asymmetric cyclopropanation of farnesol (22), followed by an Apple reaction (Scheme 3b). Treatment 
of 24 with tert-butyllithium induced lithium-halogen exchange and cyclopropane fragmentation,18 
affording organocopper species 25, after transmetallation. Addition of the latter species to 
cyclopentenone 26 (itself prepared in two steps from 21) occurred diastereoselectively and the 
intermediate enolate was trapped with trichloroacetyl chloride, yielding trichloroketone 27. After 
conversion to acetate 28, the envisioned key radical cyclization was investigated. A survey of a variety 
of reaction conditions revealed that the impressive reductive cyclization of 28 to 30 could be effected 
using triethylborane/air-mediated initiation and employing tris(trimethylsilyl)silane together with a thiol 
additive. Chiral thiol 29 exerted its influence during the termination of the radical cascade, and was 
found to improve the diastereoselectivity at C-15 (d.r. = 3.4:1). The remarkably short total synthesis of 





A conceptually different approach for the total synthesis of natural products was adopted by researchers 
who hypothesized that a strategy that holistically mimics nature’s two-phase terpenoid synthesis would 
prove advantageous.19 Following the first phase (cyclase phase), where the carbon framework is 
constructed from linear hydrocarbon building blocks, such as by polyene cyclizations, the second phase 
(oxidase phase) involves divergent oxidation of C=C and C–H bonds to generate structural diversity. 
Inspired by nature’s efficiency in creating a myriad of complex terpenoids, Baran and co-workers 
                                                     
16 J. Justicia, L. A. de Cienfuegos, A. G. Campaña, D. Miguel, V. Jakoby, A. Gansäuer, J. M. Cuerva, Chem. Soc. Rev. 2011, 
40, 3525–3537. 
17 Z. G. Brill, H. K. Grover, T. J. Maimone, Science 2016, 352, 1078–1082. 
18 A. B. Charette, J. Naud, Tetrahedron Lett. 1998, 39, 7259–7262. 
19 K. Chen, P. S. Baran, Nature 2009, 459, 824–828. 
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Scheme 3. a) Strategic radical cascade to forge the 5-8-5 tricyclic structure and b) nine-step synthesis of 6-epi-
ophiobolin N (31). 
 
initiated a research program aimed at replicating the biosynthesis of taxanes (Scheme 4a).20 In 2012, the 
artificial first phase synthesis of the taxane family of terpenoids was outlined,21 and taxadienone (37) 
was introduced as the laboratory’s synthetic cyclase phase endpoint (Scheme 4b). Since this prelude to 
an ultimate total synthesis of taxol (32), considerable advances have been reported regarding translation 
of the oxidase phase to the laboratory and in the ‘oxidative ascent’ of the taxane pyramid (Scheme 4c).22 
In this ‘oxidase phase pyramid’, the target natural product (32) is placed at the apex and the number of 
C–O bonds decreases upon moving down the pyramid, forming descending levels of oxidation. 
In this regard, the successful synthesis of ‘level 7’ taxabaccatin III (44), featuring five oxidized 
carbon atoms and two degrees of unsaturation, was recently reported starting from taxadienone (37).23 
As outlined in Scheme 4b, C–O bonds were sequentially introduced into the carbon framework of 37 
using a carefully choreographed sequence of reactions involving epoxidation (37→38), chromium(V)-
mediated allylic oxidation (38→40), radical-based C–H functionalization (40→41) and α-hydroxylation 
(42→43). These sequential, regio- and stereoselective C–H oxidations highlight that a creative 
bioinspired synthesis may constitute a huge driving force for the development of novel methods, such 
as the C–H oxidation with chromium(V)-based reagent 39, and can stimulate considerable advances in 
                                                     
20 Y. Ishihara, P. S. Baran, Synlett 2010, 1733–1745. 
21 A. Mendoza, Y. Ishihara, P. S. Baran, Nat. Chem. 2012, 4, 21–25. 
22 N. C. Wilde, M. Isomura, A. Mendoza, P. S. Baran, J. Am. Chem. Soc. 2014, 136, 4909–4912. 
23 C. Yuan, Y. Jin, N. C. Wild, P. S. Baran, Angew. Chem. Int. Ed. 2016, 55, 8280–8284. 
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a field of chemistry.24 While further ascension of the ‘oxidase phase pyramid’, to eventually reach taxol 
(32), certainly remains a significant challenge, the completion of this short total synthesis of 




Scheme 4. a) Terpenoid biosynthesis, b) bioinspired two-phase terpene total synthesis of taxabaccatin III (44) and 
c) oxidase phase pyramid. 
 
A quite different total synthesis, but also guided by biosynthetic logic regarding oxidation of a 
carbon framework, was recently reported of cardamom peroxide (45) (Scheme 5a).25 This natural 
product features an oxidized, dimeric monoterpene framework and incorporates a bridging seven-
membered endoperoxide. While the biosynthetic origin of 45 was unknown at the outset of the studies, 
it was hypothesized that two monoterpene units and three units of molecular oxygen might be the 
building blocks. Moreover, the endoperoxide motif was considered to arise from an unusual 7-endo 
cyclization of a peroxy radical (as shown in 52). To investigate these hypotheses, myrtenal (47) was first 
                                                     
24 a) M. S. Chen, M. C. White, Science 2007, 318, 783–787; b) T. Newhouse, P. S. Baran, Angew. Chem. Int. Ed. 2011, 50, 
3362–3374. 
25 X. Hu, T. J. Maimone, J. Am. Chem. Soc. 2014, 136, 5287–5290. 
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dimerized to triene 48 which underwent smooth [4+2] cycloaddition with singlet oxygen. The 
intermediate endoperoxide 49 was then converted to dienone 51 via Kornblum–DeLaMare 
rearrangement26 to 50 and subsequent oxidation. Exposure of 51 to molecular oxygen and a manganese 
catalyst led to an impressive tandem hydroperoxidation process, which presumably involved the 
postulated biosynthetic intermediate 52, and gave diperoxide 53. A final reduction with 
triphenylphosphine completed the four-step synthesis of cardamom peroxide (45) which corroborated 
the biosynthetic proposal involving a 7-endo cyclization of a peroxy radical. 
 
 
Scheme 5. a) Oxygen stitching blueprint and b) concise total synthesis of cardamom peroxide (45). 
 
One of the most widespread applications of singlet oxygen in laboratory syntheses is its use for 
bioinspired furan oxidations.27 In this regard, She and co-workers recently reported a short total 
synthesis of the tetracyclic diterpenoid kravanhin A (54) based on retrosynthetic disconnections outlined 
in Scheme 6a.28 In their successful plan, 54 was derived from γ-hydroxybutenolide 55 through sequential 
aldol reaction and lactone formation. In turn, 55 was traced back to furan 56 via a bioinspired photo-
oxidation. 
A further compelling example involving a bioinspired oxidation concerns the synthesis of the 
natural product intricarene (63), which is a furanocembranoid isolated from Caribbean corals.29 
Diterpenoid 63 was isolated from one of the most irradiated regions of the earth and it thus appears 
conceivable that photochemical reactions are involved in its biosynthesis. It was hypothesized that 
intricarene (63) might biosynthetically be derived from bipinnatin J (57) via intermediate 
                                                     
26 N. Kornblum, H. E. DeLaMare, J. Am. Chem. Soc. 1951, 73, 880–881. 
27 a) I. Margaros, T. Montagnon, M. Tofi, E. Pavlakos, G. Vassilikogiannakis, Tetrahedron 2006, 62, 5308–5317; b) T. 
Montagnon, M. Tofi, G. Vassilikogiannakis, Acc. Chem. Res. 2008, 41, 1001−1011. 
28 Z. Zhong, G. Zhao, D. Xu, B. Dong, D. Song, X. Xie, X. She, Chem. Asian J. 2016, 11, 1542–1547. 
29 J. Marrero, A. D. Rodríguez, C. L. Barnes, Org. Lett. 2005, 7, 1877–1880. 
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hydroxypyranone 61.30 Elimination of water from the latter species would produce oxidopyrylium 
species 62 which is well-disposed to undergo a transannular 1,3-dipolar cycloaddition to form 63. In 
their seminal work, Trauner and co-workers showed that conversion of bipinnatin J (57) to 
hydroxypyranone 61 could be achieved using either meta-chloroperoxybenzoic acid or the biomimetic 
oxidant singlet oxygen. However, the final cycloaddition to form 63 was found to require temperatures 
beyond 150 °C, which are conditions that cannot be deemed ‘biomimetic’.30a In more recent work by 
the same group,31 an intriguing discovery was made: Oxidation of the methyl ether derived from 
bipinnatin J (58) with singlet oxygen afforded dione 60, which upon irradiation with light (mimicking 
Caribbean sunlight) yielded intricarene (63). This surprising outcome was thoroughly investigated with 
a combination of experiments and theory, and eventually revealed that the oxidopyrylium intermediate 
can also form under photochemical conditions. Thus, the existence of 63 can be rationalized by invoking 
a photochemical rather than a thermal, ‘non-biomimetic’ 1,3-dipolar cycloaddition. 
 
Scheme 6. a) Retrosynthetic analysis of kravanhin A (54) based on furan oxidation and b) bioinspired synthesis 
of intricarene (63). 
 
 
1.2.3 Biosynthetic Relationships 
The development of bioinspired syntheses based on a formulated biosynthetic proposal can also 
help unveil links between apparently related natural products, especially if these coexist in an organism. 
In some cases, a postulated biosynthetic relationship can invoke a viable intermediate, which might be 
a natural product in its own right. Alternatively, identification of a common biosynthetic precursor can 
enable a general entry to a family of natural products. 
                                                     
30 a) P. A. Roethle, P. T. Hernandez, D. Trauner, Org. Lett. 2006, 8, 5901–5904; b) Tang, B.; Bray, C. D.; Pattenden, G. 
Tetrahedron Lett. 2006, 47, 6401–6404; c) Huang, Q.; Rawal, V. H. Org. Lett. 2006, 8, 543–545. 
31 D. Stichnoth, P. Kölle, T. J. Kimbrough, E. Riedle, R. de Vivie-Riedle, D. Trauner, Nat. Commun. 2014, 5, 5597. 
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Bolivianine (64) is a complex sesterterpenoid featuring a daunting heptacyclic skeleton with 
nine stereogenic centers, which makes it an alluring target for chemical synthesis. Attracted by this 
challenge, Liu and co-workers established a biosynthetic hypothesis for the formation of bolvianine (64) 
involving a Diels–Alder cascade of onoseriolide (65) and β-E-ocimene (66) (Scheme 7a).32 This 
proposal was particularly motivated by the discovery, that the terpenoids 65 and 66 are also present in 
Hedyosmum angustifolium, the small tree from which 64 had been isolated. 
Inspired by this hypothesis, a concise synthesis of onoseriolide (65) was first developed which 
started from verbenone (67) and included allylic metal carbene species 69 for achieving an 
intramolecular cyclopropanation (Scheme 7b). After oxidation of 65 to aldehyde 71, the feasibility of 
the bioinspired cascade reaction for the preparation of bolvianine (64) was investigated. Gratifyingly, it 
was discovered that heating a mixture of 71 and β-E-ocimene (66) led to the envisioned Diels–
Alder/intramolecular hetero-Diels–Alder cascade, and furnished 64 as the only isolable isomer. 
Impressively, three cycles, four C–C bonds and five stereogenic centers were generated in this one-pot 
transformation. While it was put forth that the first cycloaddition reaction (72→73) might be catalyzed 
by a Diels–Alderase in nature,33 investigations on a related system showed, that the intramolecular 
hetero-Diels–Alder reaction (73→64) spontaneously took place under ambient conditions. 
 
Scheme 7. a) Proposed biogenesis of bolivianine (64) and b) bioinspired Diels–Alder cascade in the synthesis  
of 64. 
  
                                                     
32 a) C. Yuan, B. Du, L. Yang, B. Liu, J. Am. Chem Soc. 2013, 135, 9291–9294; b) A different hypothesis for the biogenesis 
of 64 was also reported by the Jullian group, see: L. Acebey, M. Sauvain, S. Beck, C. Moulis, A. Gimenez, V. Jullian, Org. 
Lett. 2007, 9, 4693–4696. 
33 a) H. J. Kim, M. W. Ruszczycky, S. Choi, Y. Liu, H. Liu, Nature 2011, 473, 109–112; b) E. M. Stocking, R. M. Williams, 
Angew. Chem. Int. Ed. 2003, 42, 3078−3115; c) M. J. Byrne, N. R. Lees, L.-C. Han, M. W. van der Kamp, A. J. Mulholland, 
J. E. M. Stach, C. L. Willis, P.R. Race, J. Am. Chem. Soc. 2016, 138, 6095–6098. 
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The rare indole sesquiterpenoid sespenine A (74) constitutes a further enthralling example, in 
which identification of a relationship between two natural products proved invaluable for the 
development of a successful bioinspired total synthesis. It was hypothesized that 74 might 
biosynthetically originate from indosespene (76), which features a similar decalin system as the target 
natural product (Scheme 8a).34 After oxidation of the indole C3-position in 76, a cationic cascade could 
take place, which would initiate with an aza-Prins cyclization to form the cationic species 75. 
Subsequently a Friedel−Crafts annulation followed by retro-Friedel−Crafts fragmentation would form 
the spiro-tetrahydroquinoline scaffold of 74. 
As outlined in Scheme 8b, Li and co-workers approach to the indosespene-type intermediate 81 
commenced with a titanium-catalyzed radical cyclization of epoxide 78 (prepared in seven steps from 
77). After conversion to enone 79, conjugate addition of indole 80 was promoted by bismuth(III) 
trifluoromethanesulfonate, and the resulting ketone was treated with Nysted reagent35 to furnish 81. The 
C2-substituent on the indole represents a slight detour from the biosynthetic proposal (cf. 76), but was 
found to be essential for stabilizing the following synthetic intermediates. Treatment of 81 with oxone 
led to formation of 82, which upon exposure to acid cleanly underwent the anticipated cationic cascade 
reaction and efficiently furnished aniline 83. Finally, demethoxycarbonylation and subsequent global 
hydrolysis completed the bioinspired total synthesis of sespenine (74). 
 
 
Scheme 8. a) Proposed biosynthetic relationship of sespenine (74) and indosespene (76) and b) bioinspired total 




                                                     
34 Y. Sun, P. Chen, D. Zhang, M. Baunach, C. Hertweck, A. Li, Angew. Chem. Int. Ed. 2014, 53, 9012–9016. 
35 S. Matsubara, M. Sugihara, K. Utimoto, Synlett 1998, 313–315. 
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2.1.1 trans-Fused Cyclopentane Terpenoids 
Terpenoids constitute the largest class of natural products and play essential roles in mediating 
a variety of antagonistic and beneficial interactions among organisms in nature.36 Isopentenyl 
diphosphate (IPP) stands at the biosynthetic origin of all higher terpenoids, and by isomerization to 
dimethylallyl diphosphate (DMAPP) is sequentially elongated by prenyltransferases to geranyl 
diphosphate (GPP, C10), farnesyl diphosphate (FPP, C15), geranylgeranyl diphosphate (GGPP, C20) or 
geranylfarnesyl diphosphate (GFPP, C25) (Scheme 9).37 The myriad terpenoid skeletons then arise from 
these linear precursors by enzyme catalyzed cascade reactions,38 involving cyclizations, rearrangements, 
























































Scheme 9. Biosynthesis of higher terpenoids. 
                                                     
36 J. Gershenzon, N. Dudareva, Nat. Chem. Biol. 2007, 3, 408–414. 
37 P. M. Dewick, Nat. Prod. Rep. 2002, 19, 181−222. 
38 D. W. Christianson, Chem. Rev. 2006, 106, 3412–3442. 
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Based on the great diversity and large number of naturally occurring terpenoids they may be classified 
according to their number of basic C5 building blocks. Thus, the exemplary natural products carvone 
(84),39 artemisinin (85),40 intricarene (63)41 and ophiobolin A (86) 42 belong to the subclasses of  
mono-, sesqui-, di- and sesterterpenoids, respectively. 
Within the large family of terpenoid natural products, various members have been discovered 
that feature a trans-fused cyclopentane moiety. Based on the different substitution patterns of the 
cyclopentane, further distinctions can be made depending on the presence of an iso-propyl (or 
isopropenyl) substituent (type I),43 both an iso-propyl and a tertiary hydroxyl group (type II), or cases 
where a methyl substitutes the iso-propyl substituent and the angular (quaternary) methyl group is 
missing (type III). The archetypal example of trans-fused cyclopentane terpenoid featuring an iso-propyl 
group (type I) is retigeranic acid A (87), which was also synthesized in the laboratory by various groups 
(Figure 1a).44 Further, natural products with a comparable carbon framework  
are the sesterterpenoids variecolin (88),45 asperterpenoid (89)46 and recently discovered  
aspterpenacid A (90).47  
 
 
Figure 1. Selected trans-fused cyclopentane terpenoids (some members are drawn as the unnatural enantiomer to 
facilitate comparison). 
  
                                                     
39 R. Croteau, Chem. Rev. 1987, 87, 929–954. 
40 N. J. White, Science 2008, 320, 330–334. 
41 J. Marrero, A. D. Rodríguez, C. L. Barnes, Org. Lett. 2005, 7, 1877–1880. 
42 K. Ishibashi, R. Nakamura, J. Agric. Chem. Soc. Jpn. 1958, 32, 739–744. 
43 For a detailed classification of different subtypes of trans-hydrindane iso-propyl sesterterpenoids, see: D. T. Hog, 
Dissertation, LMU Munich, 2013. 
44 a) M. Kaneda, R. Takahashi, Y. Iiataka, S. Shibata, Tetrahedron Lett. 1972, 13, 4609–4611; b) M. Kaneda, R. Takahashi, S. 
Shibata, Acta Crystallogr. B 1974, 30, 358–364; for total syntheses of retigeranic acid, see: c) E. J. Corey, M. C. Desai, T. A. 
Engler, J. Am. Chem. Soc. 1985, 107, 4339–4341; d) L. A. Paquette, J. Wright, G. J. Drtina, R. A. Roberts, J. Org. Chem. 1987, 
52, 2960–2962; e) T. Hudlicky, L. Radesca-Kwart, L.-q. Li, T. Bryant, Tetrahedron Lett. 1988, 29, 3283–3286; f) P. A. Wender, 
S. K. Singh, Tetrahedron Lett. 1990, 31, 2517–2520. 
45 O. D. Hensens, D. Zink, J. M. Williamson, V. J. Lotti, R. S. L. Chang, M. A. Goetz, J. Org. Chem. 1991, 56, 3399–3403. 
46 X. Huang, H. Huang, H. Li, X. Sun, H. Huang, Y. Lu, Y. Lin, Y. Long, Z. She, Org. Lett. 2013, 15, 721–723. 
47 Z. Liu, Y. Chen, S. Chen, Y. Liu, Y. Lu, D. Chen, Y. Lin, X. Huang, Z. She, Org. Lett. 2016, 18, 1406–1409. 
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The marine natural products dictyoxetane (91) and dolabellane V (92) were isolated from 
Dictyota dichotoma and an additional tertiary hydroxyl group was found to decorate the cyclopentane 
with the iso-propyl moiety (Figure 1b).48 A similar oxidation state of this type II trans-fused 
cyclopentane is also present in many other dolabellane diterpenoids,49 and in ophiobolin A (86) 
(vide supra). While the trans-ring junction in dolabellane V (92) is comparable to the other presented 
trans-fused cyclopentane terpenoids, it differs in the missing C1–C9 bond (dolabellane numbering).50 
Finally, leucosceptroid B (93)51 and ircinianin (94)52 are examples of terpenoids belonging to the third 
category of trans-fused cyclopentane terpenoids (Figure 1c). 
 
The intriguing scaffolds of trans-fused cyclopentane terpenoids pose a formidable challenge for 
synthetic endeavors, and together with their oftentimes promising biological activities, make these 
natural products highly attractive targets for chemical synthesis. In the first part of this Ph.D. thesis we 
focused our efforts on developing a collective total synthesis of the leucosceptroids. Amongst other 
factors, this family of antifeedant sesterterpenoids is intriguing since all members share a common  
5,6,5-tricyclic framework, but only a few feature a type III trans-ring junction in the hydrindane portion. 
Subtle differences in the substitution pattern of the leucosceptroid skeleton seemingly lead to a 





                                                     
48 a) K. C. Pullaiah, R. K. Surapaneni, C. B. Rao, K. F. Albizati, B. W. Sullivan, D. J. Faulkner, H. Cun-heng, J. Clardy, J. 
Org. Chem. 1985, 50, 3666–3667; b) C. B. Rao, K. C. Pullaiah, R. K. Surapaneni, B. W. Sullivan, K. F. Albizati, D. J. Faulkner, 
H. Cun-heng, J. Clardy, J. Org. Chem. 1986, 51, 2736–2742. 
49 a) A. D. Rodríguez, E. González, C. Ramírez, Tetrahedron 1998, 54, 11683–11729; b) M. Hiersemann, H. Helmboldt, Top. 
Curr. Chem. 2005, 243, 73–136. 
50 The sesterterpenoids nitiol lacks a similar C–C bond, see: N. Kawahara, M. Nozawa, A. Kurata, T. Hakamatsuka, S. Sekita, 
M. Satake, Chem. Pharm. Bull. 1999, 47, 1344–1345 
51 S.-H. Luo, Q. Luo, X.-M. Niu, M.-J. Xie, X. Zhao, B. Schneider, J. Gershenzon, S.-H. Li, Angew. Chem. Int. Ed. 2010, 49, 
4471–4475 
52 W. Hofheinz, P. Schönholzer, Helv. Chim. Acta, 1977 60, 1367–1370. 
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2.2 Results and Discussion 
2.2.1. A General Entry to Antifeedant Sesterterpenoids: Total Synthesis of  
(+)-Norleucosceptroid A, (–)-Norleucosceptroid B, and (–)-Leucosceptroid K 
 
 
Reprinted with permission from C. L. Hugelshofer, T. Magauer, Angew. Chem. Int. Ed. 2014, 53, 










AGeneral Entry to Antifeedant Sesterterpenoids: Total Synthesis
of (+)-Norleucosceptroid A, ()-Norleucosceptroid B,
and ()-Leucosceptroid K**
Cedric L. Hugelshofer and Thomas Magauer*
Dedicated to Professor Johann Mulzer and Professor Andrew G. Myers
Abstract: The first asymmetric total synthesis of the antifeed-
ant terpenoids (+)-norleucosceptroid A, ()-norleucoscep-
troid B, and ()-leucosceptroid K has been accomplished.
This highly concise synthetic route was guided by our efforts to
develop a platform for the collective synthesis of a whole
family of antifeedant natural products. The synthesis features
a Hauser–Kraus-type annulation followed by an unprece-
dented, highly efficient intramolecular dilactol aldol-type
condensation reaction to produce the 5,6,5 skeleton. The
developed synthetic route proceeds for norleucosceptroid A
and B in 16 steps (longest linear sequence) from known
compounds.
The cotton bollworm (Helicoverpa armigera) and the beet
armyworm (Spodoptera exigua) are among the most destruc-
tive agricultural pests in nature and they affect vegetables and
other crops worldwide.[1] Protection against them has been
achieved by the use of sex-pheromone traps, insecticides, and
transgenic crops. However, resistance to insecticides has
developed over the last decade and new chemical agents are
necessary to prevent further crop damage from these pests.
Leucosceptrum canum Smith (“Birds Coca Cola tree”)[2] and
Colquhounia coccinea var.mollisa, plants found in China and
Nepal, are remarkably resistant to herbivores and pathogens.
Extraction and isolation of the trichomes, flowers, and whole
leaves recently led to the discovery of novel sesterterpenoids,
designated leucosesterterpenone and leucosesterlactone,[3]
leucosceptroids A–O,[4] colquhounoids A–C,[5] and norleuco-
sceptroids A–C, which are classified as pentanor-sesterterpe-
noids.[6] In general, these compounds display potent antifeed-
ant activity against the cotton bollworm and the beet army-
worm and are the first natural sesterterpenoids with biolog-
ical activity against plant-feeding insects and pathogens. The
concept of employing nontoxic antifeedant compounds to
protect plants from insect herbivores could emerge as an
alternative to conventional synthetic pesticides since the
former exhibit high specificity, quick degradation, and lack of
impact on nontarget organisms.[7]
The biological properties and novel chemical scaffolds of
leucosceptroids and many other sesterterpenoids[8] make
these natural products highly attractive targets for chemical
synthesis. Recently, Liu and co-workers[9] disclosed the first
total synthesis of leucosceptroid B, and Horne and co-work-
ers[10] reported an approach to the core of the leucosceptroids.
To date, a general and modifiable strategy that would allow
the collective synthesis of this natural product class (compris-
ing 23 members) is not yet available. Structurally, all members
of the leucosceptroid family of natural products share a highly
functionalized, synthetically challenging 5,6,5 framework that
differs in the oxidation state at C11 (OH, H) and the
substitution of the C14 ethyl linkage. These attributes were an
essential consideration in our initial retrosynthetic analysis of
the common ABC core structure and led us to focus on
disconnection of the central six-membered ring.
Herein, we describe an enantioselective synthetic route to
(+)-norleucosceptroid A (1), ()-norleucosceptroid B (2),
and ()-leucosceptroid K (3) that proceeds through the
convergent assembly of two building blocks of similar
complexity (Scheme 1). Our initial synthetic target was
fragment 4, which could be traced back to 5 through
disconnection of the substituents at C4, C5 and C6. The
ABC tricycle 5 contains the full retron for a simplifying
formal Diels–Alder reaction of the AB dienolate 6 and the C-
ring butenolide 7. We envisaged that both coupling partners
could be accessed from simple, readily available building
blocks.
In the forward sense, the absolute configuration of
fragment 7 was set through a Sharpless asymmetric dihy-
droxylation reaction starting from 8 (Scheme 2).[11] As shown
by Corey, the p-methoxyphenyl directing group determined
the enantiofacial selectivity and was essential to provide 9 in
high enantiomeric excess (> 97% ee).[12] Oxidation of diol 9
using Parikh–Doering conditions[13] and homologation with
Bestmanns ylide (Ph3P=C=C=O)
[14] formed the butenolide 7
in good overall yield.
The sequence for the preparation of 6 was initiated with
the degradation of inexpensive (R)-pulegone (10)[15] accord-
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ing to a reported procedure.[16] A combination of lithium
diisopropylamide and triflic anhydride was superior to all
other investigated conditions (KHMDS/Tf2O; NEt3/Tf2O;
DIPEA/Tf2O; LDA/PhNTf2; LDA/Comins reagent) for the
triflation of the known b-keto ester 11. Selective reduction of
the ester group was readily accomplished with diisobutylalu-
minium hydride to afford the allyl alcohol in 57% yield over
two steps. Palladium(0)-catalyzed insertion of carbon mon-
oxide,[17] generated in situ from the reaction of formic acid
with sulfuric acid,[18] gave the AB bicycle 12 in 98% yield.
Having developed scalable routes to both ring fragments,
we concentrated our efforts on uniting 7 and the AB compo-
nent 12-derived lithium isofuran-1-olate 6, through a Hauser–
Kraus-type annulation (Scheme 3).[19,20] Predicting that the
reaction would proceed via the transition state shown in
Scheme 3, we expected the stereochemical outcome depicted
for the ABC tricycle 13. Although the stereodiscriminating
effect of the quaternary center at C14 in 7 was highly
uncertain at this stage, we hypothesized that the methyl group
at C10 of the AB segment 6 could reinforce the stereofacial
selectivity by approaching 7 with its sterically less-hindered
bottom face. Indeed, treatment of a solution of 6 in
tetrahydrofuran, prepared from 12 using lithium hexamethyl-
disilazane (2.2 equiv), with equimolar amounts of 7 (78 8C to
30 8C) led to the formation of enone 13 as a 3:1 mixture of
diastereomers. The proposed structure and relative stereo-
chemistry of 13was unambiguously validated by single-crystal
X-ray diffraction. It was necessary to employ excess base to
trap 13 as the enolate in order to prevent a retro-Claisen
reaction from occurring. The formation of the minor diaste-
reomer can be rationalized by an exo approach of 6 from the
Scheme 1. Selected members of the leucosceptroids family of natural
products: (+)-norleucosceptroid A (1), ()-norleucosceptroid B (2),
and ()-leucosceptroid K (3); and retrosynthetic analysis. PMP=
p-methoxyphenyl.
Scheme 2. 1) Preparation of C-ring butenolide 7. Reagents and con-
ditions: a) SO3·pyridine, DMSO, NEt3, CH2Cl2, 23 8C, 87%; b) Ph3P=C=
C=O, THF, 60 8C, 56%. 2) Preparation of AB segment 12. Reagents
and conditions: c) Tf2O, LDA, THF, 78 8C to 0 8C; d) DIBAL-H,
CH2Cl2, 78 8C to 23 8C, 58% over two steps; e) H2SO4/HCO2H,
Pd(PPh3)4, LiCl, (nBu)3N, MeCN, 70 8C, 98%. DIBAL-H=diisobutylalu-
minium hydride, DMSO=dimethyl sulfoxide, LDA= lithium diisopro-
pylamide.
Scheme 3. Fragment coupling to give the ABC tricycle 5. Reagents and
conditions: a) LHMDS, THF, then 7, 78 8C to 30 8C, d.r.=3:1;
b) Pd/C, H2, MeOH, 57% over two steps; c) DIBAL-H, CH2Cl2, 78 8C;
d) TFA, CH2Cl2, 4  molecular sieves, 23 8C, then PDC, 23 8C; e) LDA,
THF, 78 8C, 69% over three steps. LHMDS= lithium hexamethyldisil-
azane, PDC=pyridinium dichromate, TFA= trifluoroacetic acid.
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lower face of 7 to give the corresponding enone, which
possesses the inverse stereochemistry at C5, C12, and C13
compared to 13, as shown by NMR analysis. We also found
that the use of degassed tetrahydrofuran for this transforma-
tion suppressed the formation of a p-hydroquinone byproduct
(see the Supporting Information) and increased the yield of
the reaction by approximately 20%.
Initial attempts to directly hydroxylate C5 and introduce
the methyl group at C6 were unsuccessful since overoxidation
prevailed. However, prior reduction of the enone allowed us
to develop an alternative approach that avoided the afore-
mentioned problem. Hydrogenation of 13[21] using palladium
on charcoal under 1 atm of hydrogen occurred exclusively
from the convex side of the molecule. After prolonged
reaction times or exposure of the crude reaction mixture to
triethylamine, we isolated a product with 13C NMR and IR
spectra that did not correspond to the expected ketone 14a.
From a molecular model, we concluded that the free hydroxyl
group at C12 was well disposed to form hemiacetal 14b, which
could in turn undergo a retro-Claisen condensation to give
dilactone 15. This reaction pathway was also supported by
data obtained from density functional theory (DFT) calcu-
lations at the B3LYP/6-31G(d) level of theory with the
Gaussian09 software suite.[22] Although ketone 14a was never
observed experimentally, the intermediate 14b could be
obtained as a single compound and fully characterized. As
above, upon exposure of hemiacetal 14b to mildly basic
(NEt3) or acidic (silica gel) conditions, clean transformation
to 15 was observed. To date, more than 4.7 g of dilactone 15
have been prepared in a single batch.
This rather unexpected reaction outcome was taken as
a chance to reform the 5,6,5 framework by developing an
unprecedented intramolecular dilactol aldol-type condensa-
tion within a complex molecular setting.[23] The synthesis of
the required dilactol motif through a twofold reduction of 15
(DIBAL-H, CH2Cl2, 78 8C) was highly efficient and gave 16
as a mixture of four diastereomers. Careful screening of the
reaction parameters (solvent, temperature, reagent) was
necessary to realize the intended one-pot condensation–
oxidation sequence to give 19. The optimized procedure
involved treating a solution of dilactol 16 in dichloromethane
containing 4  molecular sieves with trifluoroacetic acid
(5 equiv) at 23 8C for 20 min, followed by the addition of
pyridinium dichromate to the intermediate 4-O-trifluoroace-
tyl acetal 18.[24] This afforded the tetracycle 19 as a single
diastereomer, the structure of which was unambiguously
confirmed by single-crystal X-ray diffraction. Excess acid was
required to prevent the reaction from stalling after the
intramolecular acetalization of 16 to 17. The most efficient
conditions for the opening of the ether bridge involved the
addition of lithium diisopropylamide (1.15 equiv) to a solution
of 19 in tetrahydrofuran at 78 8C, which afforded more than
3.0 g of a,b-unsaturated lactone 5 (69% yield over three
steps).
Conjugate addition of excess dimethyl cuprate to 5
occurred with excellent diastereoselectivity at C6 and gave
rise to 20 as an inconsequential 4:1 mixture of kinetic and
thermodynamic epimers at C5 (Scheme 4). Since direct a-
hydroxylation followed by lactone reduction proved to be
unsuccessful, we envisioned introduction of the C5 hydroxy
group via enol ether 21. The addition of triethylamine
(7.5 equiv) to a solution of the crude lactol, derived from 20
by DIBAL-H reduction, and methanesulfonyl chloride
(3.5 equiv) in dichloroethane at 75 8C provided 21 in a repro-
ducible manner. These reaction conditions reduced formation
of the acetal byproduct that resulted from attack of the C12
hydroxy group on C4 (see the Supporting Information). The
epoxide obtained from the reaction of 21 with a solution of
dimethyldioxirane in acetone, prepared by the method
developed by Taber et al.,[25] was found to be highly unstable
and was readily hydrolyzed to the corresponding lactol. We
found that the addition of the crude epoxide product as
a solution in dichloromethane to a large excess of tris-(2-
methyl-1-propenyl) aluminum[26] in tetrahydrofuran at78 8C
delivered the required vinylic appendage from the same side
as the epoxide to give the configuration at C4 and C5 depicted
in 4. The observed stereoselectivity of this transformation was
attributed to coordination of the organoaluminum reagent to
the epoxide to give the alanate and concomitant internal
Scheme 4. Functionalization of the leucosceptroids ABC core and total
synthesis of (+)-norleucosceptroid A (1), ()-norleucosceptroid B (2),
and ()-leucosceptroid K (3). Reagents and conditions: a) MeLi, CuI,
Et2O, 45 8C to 5 8C, 76%; b) DIBAL-H, CH2Cl2, 78 8C; c) MsCl,
NEt3, 1,2-dichloroethane, 75 8C, 53% over two steps; d) DMDO,
acetone, CH2Cl2, 78 8C to 30 8C, then AlCl3, 2-methyl-1-propenyl-
magnesium bromide, THF, CH2Cl2, 78 8C, 52%; e) PCC, CH2Cl2, 4 
molecular sieves, 23 8C, 87%; f) CAN, pyridine, MeCN, H2O, 0 8C,
70%; g) DMP, NaHCO3, CH2Cl2, 23 8C, 66%; h) LHMDS, O2, P(OEt)3,
78 8C to 35 8C; i) IBX, DMSO, 23 8C, 40% 1 and 10% 2 over two
steps; j) 24, KOtBu, THF, 0 8C, then 2, 0 8C to 23 8C, 70%. CAN=ceric
ammonium nitrate, DMDO=dimethyldioxirane, DMP=Dess–Martin
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delivery of the propenyl nucleophile. Introduction of the
vinylic appendage at C4 occurred with opposite stereoselec-
tivity when a combination of copper(I) iodide and 2-methyl-1-
propenylmagnesium bromide was applied in the analogous
reaction.[27]
Subsequent oxidation of the sterically hindered alcohol
produced the configurationally stable ketone 4. We found that
H11 and H13 of 4 do not epimerize under basic conditions at
23 8C, however, since the b-hydroxy ketone is perfectly
aligned for an E2 elimination, dehydration takes place
under more forcing conditions (NEt3, MeOH, 45 8C).
Although cis-hydrindanones were calculated to be thermo-
dynamically more stable,[28] and as is corroborated by the
structures of most leucosceptroid natural products, (+)-nor-
leucosceptroid A (1) features an AB-cis-BC-trans fusion in
which intramolecular hemiacetal formation preserves this
conformation from epimerization to the AB-cis-BC-cis
system.
Cleavage of the p-methoxyphenyl ether in 4 with cer-
ic(IV) ammonium nitrate followed by oxidation of the
primary alcohol 22 with Dess–Martin periodinane afforded
(+)-11-deoxynorleucosceptroid A (23), which has not yet
been isolated from natural sources.[29] Regioselective a-
hydroxylation (LHMDS, O2, P(OEt)3)
[30] of 22 afforded two
C11 hydroxylated products, which were directly oxidized
under mild conditions (IBX, DMSO)[31] without prior purifi-
cation. NMR analysis of the resulting product mixture
revealed that a-hydroxylation had occurred with high stereo-
selectivity. However, we also recognized that partial epimer-
ization of H13 to the thermodynamically more stable AB-cis-
BC-cis fusion had spontaneously taken place during the a-
hydroxylation step. Column chromatography on silica gel thus
gave (+)-norleucosceptroid A (1), as well as minor amounts
of ()-norleucosceptroid B (2). Finally, the union of 2 with
phosphonate 24[32] gave rise to ()-leucosceptroid K (3) in
70% yield. The spectroscopic data (1H and 13C NMR, HRMS,
[a]D) for 1–3, which are the unnatural enantiomers, were in
full agreement with those reported for the naturally occurring
substances.
In summary, a general enantioselective synthesis of
antifeedant (pentanor-)sesterterpenoids has been developed.
This enabled the preparation of three representative anti-
feedant leucosceptroids; (+)-norleucosceptroid A (1),
()-norleucosceptroid B (2), and ()-leucosceptroid K (3);
in a convergent manner with a high level of efficiency. The
ability to prepare the ABC tricycle 5 on a multigram scale
(3.0 g) paves the way for the synthesis of the remaining
leucosceptroids. This work also highlights the fact that the
intramolecular aldol condensation of dilactols could be
a useful method for organic synthesis. A collective synthesis
of the leucosceptroid family and unnatural derivatives thereof
is currently underway in our laboratories.
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ABSTRACT: Seven new leucosceptroid degradation products
possessing a C20, C21, or C25 framework, norleucosceptroids
D−H (1−5), leucosceptroids P (6), and Q (7), have been
isolated from Leucosceptrum canum. Their structures were
determined by comprehensive NMR, MS, and single-crystal X-
ray diﬀraction analyses. Discovery of these key intermediates,
together with the biomimetic oxidation of a model system,
supports the hypothesis that two biosynthetic pathways are operative. Antifeedant activity was observed for compounds 1−3.
Terpenoids, the largest class of natural products with highlydiversiﬁed chemical structures, have been frequently
reported to play important physiological and ecological roles
in the natural world.1 To date, degradation of sesterterpenoids
in plants is still largely unknown, while the oxidative
degradation of other terpenoids has been documented,
although the mechanism underlying these transformations is
often poorly understood. Known examples include the
apocarotenoids (nortetraterpenoids),2 antifeedant limonoids
(tetranortriterpenoids),3 schinortriterpenoids (nortriterpe-
noids),4 and volatile tetra-norterpenoid degradation products
of the diterpenoid (E,E)-geranyllinalool and the sesquiterpe-
noid (3S)-(E)-nerolidol, which were shown to attract enemies
of herbivores (indirect defense) in a variety of plant species.5
Recently, it was found that the glandular trichomes of two
Himalayan−Chinese Labiatae species6 harbor two unique
classes of defensive sesterterpenoids, leucosceptroids and
colquhounoids, respectively.7,8 Subsequently, three intriguing
antifeedant C20 terpenoids, norleucosceptroids A−C,
9 were
isolated from L. canum and tentatively classiﬁed as
pentanorsesterterpenoids. Choudhary and co-workers also
reported the isolation of three sesterterpenoids from L.
canum of Nepalese origin,10 which are structurally quite
diﬀerent from those discovered in Chinese plants.
Synthetic routes to these natural products were reported by
three groups. The core structure of leucosceptroids A−D has
been prepared by Horne’s group,11a an asymmetric total
synthesis of leucosceptroid B has been achieved by Liu and co-
workers,11b and most recently Magauer’s group reported the
total synthesis of norleucosceptroid A, norleucosceptroid B,
and leucosceptroid K.11c,d
In order to shed light on the metabolic pathways in L. canum,
the search for key biosynthetic intermediates of norleucoscept-
roids A−C has been an ongoing topic of interest. Herein, the
isolation, structure elucidation, antifeedant activity, and
biogenetic relationship of seven new biosynthetic intermediates
including two tetranorsesterterpenoids (1 and 2), three
pentanorsesterterpenoids (3−5), and two sesterterpenoids (6
and 7) are described. Additionally, the oxidative degradation of
the furan appendage using an advanced model system was
investigated. The obtained results further support the
coexistence of two metabolic pathways in leucosceptroid
biosynthesis.
For compound 1, a molecular formula of C21H30O4 was
deduced from the high-resolution (HR) EI-MS (m/z 346.2148
[M]+, calcd 346.2144) and the IR spectrum indicated the
presence of two carbonyl groups (1736 and 1709 cm−1).
Analysis of the NMR spectra (Tables S1 and S2 and Figures
S2−S7 in the Supporting Information) revealed various
similarities with those of leucosceptroids B7 (9) and E8b
(12), although the furan or lactone moieties in the C14 side
chains were absent and instead a carboxylic acid group was
present in 1. Consideration of all the spectroscopic data
suggested that 1 is a tetranorsesterterpenoid lacking C11 and
C5 oxygenation. Eventually, a single crystal of 1 was obtained
from a mixture of MeOH/water (8:1), and X-ray crystallo-
graphic analysis unambiguously established the complete
structure of 1 which was named norleucosceptroid D (Figure
1).
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In an analogous fashion, comprehensive NMR, MS, and IR
analysis together with comparison of spectroscopic data of
previously isolated parent leucosceptroids allowed compounds
2−7 to be characterized as shown in Figure 1, and they were
named norleucosceptroids E−H (2−5), leucosceptroids P (6),
and Q (7). A detailed description of the isolation and structure
elucidation of all these compounds is provided in the
Supporting Information of this report.
During the structure elucidation of the novel leucosceptroids
1−7, a biogenetic relationship between the previously isolated
C25 sesterterpenoids and C20 terpenoids from L. canum was
recognized (Scheme 1). It is likely that the carboxylic acids
norleucosceptroids D (1) and E (2) directly originate from
leucosceptroids A (8) and B (9), which both are major
sesterterpenoids in L. canum, by 5,13-dehydration and oxidative
cleavage of the furan moiety (scission of the C17/C18 bond).
Subsequent decarboxylation and oxidation12 of tetranorsester-
terpenoids 1 and 2 aﬀords the pentanorsesterterpenoids
norleucosceptroid F (3) and 22. Oxidation of the latter
compounds yields norleucosceptroid G (4) and aldehyde 24,
which then may be further oxidized to norleucosceptroid H (5)
and carboxylic acid 25.
An alternative degradation pathway of leucosceptroids A (8)
and B (9) is hypothesized to proceed through peroxides 18 and
19, which arise from the [4 + 2] cycloaddition of singlet oxygen
with the furan moiety.13 A subsequent Kornblum−DeLaMare-
type rearrangement14 of 18 and 19 yields the hydroxy lactones
leucosceptroids P (6) and Q (7), which upon 5,13- and 16,17-
dehydration are converted to leucosceptroids L (13) and M
(14) and 23. While reduction of the C16/C17 bond furnishes
leucosceptroid E (12), an oxidative cleavage of this bond
aﬀords the same aldehydes 4 and 24 as from the C25 → C21 →
C20 decarboxylative pathway. Through hydration of the C5/
C13 bond, norleucosceptroid G (4) and 24 are then converted
to a mixture of intermediates 26−29.9 While 28 and 29 with
the AB-cis-BC-trans fusion may spontaneously convert to the
thermodynamic epimers 26 and 27, respectively, intramolecular
hemiacetal formation can alternatively preserve this conforma-
tion from epimerization to the AB-cis-BC-cis system. Bio-
synthetically, norleucosceptroids B (16) and C (17) thus arise
from intermediates 26 and 27 through lactol formation
between 5-OH and 16-CHO. Similarly, lactol formation
between 5-OH and 16-CHO in intermediates 28 and 29,
followed by hemiacetal formation between 16-OH and
12-CO aﬀords norleucosceptroid A (15) and 30.
Furthermore, the existence of leucosceptroids C (10) and D
(11) also strongly suggests that photooxidation of leucoscept-
roids A (8) and B (9) initiates the partial metabolic degradation
Figure 1. Chemical structures of norleucosceptroids D−H (1−5),
leucosceptroids P (6), and Q (7).
Scheme 1. Proposed Metabolic Pathway of Leucosceptroids A (8) and B (9)a
aFor clarity, numbers in parentheses are used for isolated natural products, while numbers in square brackets correspond to intermediates or
suspected natural products.
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of these sesterterpenoids. In lieu of the proposed rearrange-
ment of peroxides 18 and 19 to 6 and 7, respectively, it is
envisaged that also nucleophilic addition of water takes place,
aﬀording keto aldehydes 20 and 21 via expulsion of
hydrogenperoxide from a hemiacetal intermediate. An intra-
molecular aldol cyclization of the enolized 17-ketone with the
aldehyde group in 20 and 21 then gives rise to leucosceptroids
C (10) and D (11).
Although further intermediates remain to be discovered, it is
likely that two parallel biosynthetic pathways exist in L. canum,
leading to the 11-hydroxylated and 11-deoxygenated sesterter-
penoids or norsesterterpenoids, respectively. The isolation of
intermediates 1−7 provides direct evidence that the C20
terpenoids, norleucosceptroids A−C (15−17), are, in fact,
sesterterpenoid degradation products and should be classiﬁed
as pentanorsesterterpenoids rather than diterpenoids which are
directly biosynthesized from the universal precursor geranylger-
anyl diphosphate (GGPP).
In order to experimentally evaluate the proposed degradation
pathway, which is initiated by photooxygenation, a model
system was developed. With this objective in mind, known
dilactone 31, available in gram quantities,11c was converted to
lactone 32 by 2-fold reduction, followed by an intramolecular
dilactol aldol-type condensation−oxidation sequence (Scheme
2). DIBAL-H reduction of 32 and acetylation of the resulting
lactol aﬀorded an intermediate acetyl acetal as a mixture of
diastereomers at C4 (dr = ∼2:1). Treatment of this crude
product with the mixed organoaluminum reagent, dimethyl-(2-
methyl-1-propenyl)aluminum (prepared from aluminum tri-
chloride, methylmagnesium bromide, and 2-methyl-1-prope-
nylmagnesium bromide; see the Supporting Information for
details), furnished alcohol 33 as a single diastereomer after
cleavage of the p-methoxyphenyl ether (62% yield over four
steps). Next, Swern oxidation15 of 33 followed by Wittig−
Levine reaction16 of the so-obtained aldehyde with
(methoxymethyl)triphenylphosphonium chloride was carried
out, yielding the corresponding C1−extended aldehyde after
acidic hydrolysis. Addition of lithiated ethyl vinyl ether to the
latter compound provided α-hydroxy ketone 34 as an
inconsequential mixture of diastereomers at C17 (dr = ∼1:1).
Alkoxide formation in 34 with sodium hydride followed by
addition of Wittig salt 3517 furnished an intermediate ethoxy
acetal, which underwent facile elimination under acidic
conditions to aﬀord furan 36, which constituted the model
system of leucosceptroids A (8) and B (9).
This system was then used to mimic the putative conversion
of leucosceptroids A (8) and B (9) to the hydroxycyclopente-
none leucosceptroids C (10) and D (11) (vide supra),
respectively, in a biomimetic manner. Thus, irradiation of an
oxygen-sparged solution of furan 36 in methanol containing
Rose Bengal as a photosensitizer with light at −78 °C led to
rapid consumption of the starting material (<5 min), aﬀording
a more polar product, as seen by thin-layer chromatographic
analysis. Addition of dimethyl sulﬁde (DMS) to the putative
hydroperoxide 38, arising from nucleophilic addition of
methanol to endo-peroxide 37,18 followed by warming of the
reaction mixture to 23 °C and addition of triethylamine to
induce the intramolecular aldol reaction in keto aldehyde 39,
cleanly furnished hydroxy cyclopentenones 40 and 41 as a 1:1
mixture of diastereomers (93% combined yield). It is proposed
that, in nature, the conversion from endo-peroxide 37 to the
hydroxy cyclopentenones would occur via nucleophilic addition
of water (instead of methanol) followed by expulsion of
hydrogen peroxide to aﬀord keto aldehyde 39 (in the
laboratory mimic, peroxide 38 is ﬁrst reduced with DMS and
methanol then serves as the leaving group). The ﬁnal
cyclization step in a natural environment could be catalyzed
by an aldolase which is capable of controlling the stereo-
chemical outcome of this aldol reaction.19 Although the model
furan 36 is certainly simpliﬁed compared to leucosceptroids A
(8) and B (9), the experimental outcome corroborates the
hypothesis that photooxidation occurs readily and might be the
ﬁrst step in the metabolic pathway of the defensive
leucosceptroid sesterterpenoids.
Finally, norleucosceptroids D−F (1−3) were evaluated for
their antifeedant activity against a generalist insect, cotton
bollworm (H. armigera), as previously described.7 Signiﬁcant
antifeedant activity for 1−3 was observed with EC50 values of
3.81, 10.86, and 7.35 μg/cm2, respectively (neem oil: EC50 =
2.63 μg/cm2), suggesting that these leucosceptrane sesterterpe-
noid degradation products could also be involved in the plant
defense against insect enemies.
■ ASSOCIATED CONTENT
*S Supporting Information
Experimental procedures, plant material, crystallographic data,
physical-chemical properties, key HMBC correlations and
NMR spectra of 1−7. Synthetic procedures, analytical data,
and NMR spectra of the biomimetic model synthesis. This
Scheme 2. Model System Synthesis and Biomimetic Furan Photooxidationa
aDIBAL-H = diisobutylaluminum hydride, TFA = triﬂuoroacetic acid, PDC = pyridinium dichromate, CAN = ceric ammonium nitrate, DMSO =
dimethyl sulfoxide, EVE = ethyl vinyl ether, DMS = dimethyl sulﬁde.
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ABSTRACT: A highly eﬃcient strategy enabled the
asymmetric total synthesis of 15 antifeedant leucosceptroid
natural products. The advanced tricyclic core, available in
gram quantity, served as the pivotal intermediate for the
preparation of norleucosceptroids B, C, F, and G and
leucosceptroids A, B, G, I, J, L, and M. Additionally, the
bioinspired oxidative transformation of leucosceptroid A to
leucosceptroids C, K, O, and P using singlet oxygen
supports the hypothesis that leucosceptroids A and B are
most likely the biogenetic precursors of all other members
of this natural product family.
Leucosceptroids A−Q and norleucosceptroids A−H aremembers of families of sesterterpenoids and pentanorses-
terterpenoids, respectively, that have been isolated from
Leucosceptrum canum Smith by Li and co-workers.1,2 The
potent antifeedant activities and novel molecular scaﬀolds of
the leucosceptroids, comprising a 5,6,5-framework with a fully
functionalized tetrahydrofuran ring and eight contiguous
stereogenic centers, have attracted the attention of several
research groups.3 Concurrent with Ma’s work,3a we became
interested in the biogenetic relationship of the leucosceptroid
natural products and hypothesized that two biosynthetic
pathways are operative in L. canum Smith.1f Building upon
the previously reported general entry to antifeedant sesterter-
penoids,4 we report the total synthesis of 15 members of the
leucosceptroid family. The synthesis of leucosceptroids K (9),
C (19), P (20), and O (23) was accomplished by the
development of experimental conditions that mimic the
biosynthetic oxidation, thus corroborating our proposal
concerning the metabolic pathway in L. canum Smith.
Beginning from the tricyclic core 1,4 we ﬁrst developed an
improved route for the synthesis of norleucosceptroid B (4),
which in the previous approach had been obtained only as a
minor byproduct of norleucosceptroid A. As outlined in
Scheme 1, we found that α-hydroxylation of 1 prior to cleavage
of the p-methoxyphenyl ether followed by puriﬁcation on
deactivated silica gel favored the epimerization of H-13 to
aﬀord triol 2 together with norleucosceptroid F (3). Oxidation
(IBX, DMSO, 23 °C)5 of 2 furnished norleucosceptroid B (4),
and exposure of 3 to the same conditions aﬀorded
norleucosceptroid G (see the Supporting Information for
details). The latter was converted to leucosceptroids L (7) and
M (8) (93%, Z:E = 2:1) by a Horner−Wadsworth−Emmons
reaction with phosphonate 6.6
Installation of the AB-trans-BC-cis ring fusion of norleuco-
sceptroid C (5) proved to be unexpectedly challenging. While
H-11 and H-13 of tricyclic core 1 were reluctant to undergo
epimerization under basic conditions and elimination of OH-5
prevailed, the attempted direct conversion of 4 to 5 failed.
Eventually, resorting to triol 2, where epimerization of H-13
had occurred with ease after the introduction of OH-11,7
allowed us to prepare the corresponding α-deoxygenated AB-
cis-BC-cis annulated ketone by exposure to samarium(II)
iodide.8 To our surprise, epimerization of H-11 to form the
AB-trans-BC-cis ring system could not be accomplished at this
stage. However, oxidation under the established conditions
aﬀorded 11-epi-norleucosceptroid C, which upon exposure to
Received: February 24, 2015
Published: March 13, 2015
Scheme 1. Synthesis of Norleucosceptroids F (3), B (4), and
C (5) and Leucosceptroids L (7) and M (8)a
aReagents and conditions: (a) LHMDS, O2, P(OEt)3, THF, −78 to
−20 °C; (b) CAN, pyridine, MeCN, H2O, 0 °C, 21% 2 and 23% 3
over two steps; (c) IBX, DMSO, 23 °C, 56%; (d) SmI2, THF, MeOH,
23 °C, ≥99%; (e) IBX, DMSO, 23 °C; (f) NEt3, MeOH, 23 °C, 42%
over two steps; (g) IBX, DMSO, 23 °C, 68%; (h) 6, KOt-Bu, 0 to 23
°C, 93%, Z:E = 2:1.
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triethylamine in methanol at 23 °C for 24 h was fully converted
to norleucosceptroid C (5) (42% yield over two steps). Only
trace amounts of the 5,13-dehydrated byproduct were formed.
Using our optimized conditions for the extension of
norleucosceptroid B,4 we were able to produce 64 mg of
leucosceptroid K (9) in a single batch. For its transformation to
leucosceptroid G (12), we needed to develop a protocol for the
selective installation of the remote C-17 stereocenter (Scheme
2). As direct hydrogenation of the C-16/C-17 double bond was
not possible, we were confronted with the challenge of ﬁnding
conditions to achieve a selective conjugate 1,6-reduction of 9 to
β,γ-unsaturated butenolide 10. Investigation of conditions
reported by Baran9 (sodium borohydride, cobalt(II) chloride)
for the reduction of a somewhat similar system revealed that
reduction of 9 under the analogous conditions was nonselective
and aﬀorded a mixture of products arising from 1,6- and 1,4-
reduction. Further investigations using a combination of
sodium borohydride with nickel(II) chloride10 in ethanol
were also unsatisfactory. Although the crude product mixture
revealed that the reduction occurred with slightly improved
selectivity for the desired 1,6-hydride addition, incomplete
conversion of the starting material was observed at low
temperatures, while partial hydrogenation of the propenyl side
chain took place at temperatures above −25 °C. These
diﬃculties prompted us to investigate the use of sodium
borohydride in conjunction with copper(II) chloride, a reagent
combination that appears to have received only little attention
in the literature to date.11 To our delight, treating an ethanolic
solution of leucosceptroid K (9) with excess CuCl2 and NaBH4
at 0 °C resulted in the formation of copper boride (Cu2B) as a
ﬁnely divided black precipitate12 and cleanly furnished β,γ-
unsaturated butenolide 10. The use of these conditions proved
to be remarkable with respect to both the essentially complete
1,6-selectivity and the tolerance of all other functional groups.
The installation of the C-17 stereocenter was then realized by
employing a methodology developed by Deng13 for asymmetric
oleﬁn isomerization via proton transfer catalysis. Treating crude
β,γ-unsaturated butenolide 10 with cinchona alkaloid-derived
catalyst 11 led to the formation of leucosceptroid G (12) with
good selectivity (7:1 d.r.) in high yield (70% over two steps).14
While α-deoxygenation of 12 gave rise to leucosceptroid I
(13) and traces of its H-11 epimer leucosceptroid J (14),
DIBAL-H reduction followed by acidic workup furnished
leucosceptroid A (15) in 75% yield.15,16 For the synthesis of
leucosceptroid B (17), 15 was α-deoxygenated to aﬀord known
ketone 16.3b Unfortunately, the epimerization conditions that
had eﬃciently converted the AB-cis-BC-cis ring system to the
AB-trans-BC-cis one in the synthesis of norleucosceptroid C (5)
(vide supra) proved to be not as successful in this case. While
for 5 the AB-trans ring fusion might prevent unfavorable
interactions between the lactol moiety and the A ring, the
absence of such transannular strain in 16 and 17 leads to a
much smaller energetic diﬀerence between the two H-11
epimers. Discontinuing the epimerization of 16 after 4.5 h
completely avoided the elimination of 5-OH and provided 16
and leucosceptroid B (17) as a 5:2 mixture (62% yield).17
Having developed an eﬃcient route for the preparation of
leucosceptroid A (15), our next challenge was its biomimetic
photo-oxidation1f to access leucosceptroids C (19), P (20), and
O (23) (Scheme 3). These studies were also guided by our
interest in ﬁnding the biosynthetic precursor of the intriguing
spirocycle 23, an issue that raised uncertainty at the outset of
our investigations since several members were considered as
potential candidates. Initial attempts to convert 15 to 19
showed that the [4 + 2] cycloaddition of singlet oxygen with
the furan moiety occurred rapidly.18 However, the reaction
appeared to stall during the ensuing eﬀorts to induce the
intramolecular aldol reaction that forms the hydroxycyclopen-
tenone ring in 19. After a detailed analysis of the reaction
mixture, it became apparent that the methoxy acetal
intermediate (resulting from nucleophilic addition of methanol
to endo-peroxide 18 followed by reduction with dimethyl
sulﬁde) was remarkably stable and did not convert to the
crucial γ-keto aldehyde under the reaction conditions. Hence,
an optimized procedure was developed in which the reaction
mixture was concentrated at the stage of the methoxy acetal
intermediate and the residue was chromatographed on silica gel
to unmask the γ-keto aldehyde functionality. The subsequent
base-induced intramolecular aldol reaction occurred smoothly
and produced leucosceptroid C (19) and its diastereomer in
78% yield (1:1 d.r.). Next, the synthesis of leucosceptroid P
(20) could be accomplished by replacing methanol with a non-
nucleophilic solvent and conducting the photo-oxidation in the
presence of base. Irradiation of a solution of leucosceptroid A
(15) in oxygen-saturated dichloromethane containing a
catalytic amount of tetraphenylporphyrin (TPP) and N,N-
diisopropylethylamine cleanly produced 20 (85% yield), the
product of a Kornblum−DeLaMare-type rearrangement19 of
endo-peroxide 18.
Finally, we turned our attention to the challenge of preparing
leucosceptroid O (23) in a biomimetic manner. The initial plan
to hydrolyze the lactone in leucosceptroid K (9) to aﬀord the
corresponding γ-keto acid and eﬀect an acid-mediated
Scheme 2. Preparation of Leucosceptroids A (15), B (17), G
(12), I (13), and J (14)a
aReagents and conditions: (a) NaBH4, CuCl2, EtOH, 0 °C; (b) 11 (20
mol %), CH2Cl2, 0 °C, 70% over two steps, 7:1 d.r.; (c) SmI2, THF,
MeOH, 23 °C, 59%, 13:14 = 7:1; (d) DIBAL-H, CH2Cl2, −78 °C,
then MeOH, aq. 2 M HCl, 23 °C, 75%; (e) SmI2, THF, MeOH, 23
°C; (f) NEt3, MeOH, 23 °C, 62%, 16:17 = 5:2.
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spiroketalization was unsuccessful in our hands.20 Although
leucosceptroid P (20) was also regarded as a promising
precursor for the synthesis of 23 by virtue of intramolecular
ketalization, the envisioned cyclization could not be accom-
plished under various conditions. After considering several
biosynthetic precursors, we hypothesized that all of the
leucosceptroid natural products are in fact derived from two
parent members, leucosceptroids A (15) and B (17). Thus, we
returned to the biomimetic photo-oxidation and monitored the
reaction after exposure of 15 to singlet oxygen by 1H NMR
spectroscopy (see the Supporting Information for details).
Under strictly anhydrous conditions we were able to observe
the clean formation of a 1:1 mixture of diastereomeric endo-
peroxides 18.
While standing in solution at 23 °C, 18 slowly (3 h)
underwent competing spirocyclization and elimination to aﬀord
hydroperoxides 21 and 22, respectively. Treating this mixture
with acetic anhydride and pyridine gave leucosceptroid O (23)
(26%) and leucosceptroid K (9) (34%) after puriﬁcation by
column chromatography on silica gel. Under the assumption
that this reaction sequence mimics the biosynthetic oxidation of
leucosceptroid A (15), it sheds light on the fact that the
corresponding E isomer of leucosceptroid K (9) is unknown.
On the basis of a series of optimized structures at the B3LYP/6-
31G(d) computational level,21 we believe that hydrogen
bonding between OH-5 and the endo-peroxide, as depicted
for 18 and 18′ (Figure 1), results in such an orientation that
elimination leads to exclusive formation of the Z double bond,
as observed for leucosceptroid K (9). In the case of the photo-
oxidation precursor of leucosceptroids L (7) and M (8),22 the
absence of such a hydrogen-bonding interaction would lead to
no preferred orientation of the endo-peroxide moiety, resulting
in the formation of both double-bond isomers in nature.
In conclusion, our general entry to the synthesis of
antifeedant sesterterpenoid natural products enabled the
synthesis of 15 complex leucosceptroid members, whose
spectroscopic data (1H and 13C NMR, HRMS, [α]D) were in
full agreement with those reported for the naturally occurring
substances. Additionally, the conducted biomimetic photo-
oxidation disclosed that leucosceptroids A and B are most likely
the parent members of all other known leucosceptroids.
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Figure 2. Family of leucosceptroid natural products. Check marks indicate all members which were prepared by 
the developed synthetic strategy. 
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Abstract The evolving pathogen resistance in agricultural pests re-
quires the development of novel chemical agents to maintain efficient
pest control. Biological screening of natural products isolated from Leu-
cosceptrum canum Smith led to the discovery of active antifeedant ses-
terterpenoids. This article highlights recent progress towards the syn-
thesis of these natural products.
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1 Introduction
Bioactive natural products constitute an essential
source for the development of new therapeutics and agri-
cultural agents. For these reasons, synthetic organic chem-
ists have been fascinated by the discovery of such com-
pounds for many years. With the advent of efficient syn-
thetic methods, total synthesis is nowadays capable of
delivering bioactive natural products in practical quanti-
ties1 whilst allowing for the preparation of structural ana-
logues with an enhanced biological profile. The develop-
ment of an efficient, modular, and practical synthetic route
is a highly creative process, which often is driven by the
motivation of developing the ‘ideal synthesis’.2–4 However,
pursuit of this ambitious aim does not usually culminate in
realizing the actual ‘ideal synthesis’. Instead, it allows for
the development of multiple approaches for the prepara-
tion of a target molecule. Thus an ‘intellectual playground’
for synthetic organic chemists is created in which everyone
strives to outrun the competition by devising a more effi-
cient and elegant synthetic route for addressing the respec-
tive molecular complexity.
Current protection measures against the cotton boll-
worm (Helicoverpa armigera) and the beet armyworm
(Spodoptera exigua), some of the most destructive and
widely distributed agricultural pests in nature, are unsatis-
factory.5 These insects have developed pathogen resistance
during the past decade, and in order to ensure efficient pest
control in the future, the discovery of novel chemical agents
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is necessary to replace existing insecticides, sex-phero-
mone traps, and transgenic crops.6 Employing antifeedant
chemicals (feeding deterrents) to protect plants from insect
herbivores is intuitively a very attractive concept and the
emergence of antifeedants as an element for safe crop pro-
tection is highly desirable due to the specificity, effective-
ness, and quick degradation of this alternative protection
measure.7 By extraction and isolation of the trichomes,
flowers, and whole leaves of Leucosceptrum canum Smith
(Labiatae) which is a native plant in China and Nepal, Li and
co-workers discovered the first sesterterpenoids which act
as a biological defense against plant-feeding insects, dis-
playing nanomolar antifeedant activity against both the
cotton bollworm and the beet armyworm. The novel sester-
terpenoids were named leucosceptroids A–Q,8 and norleu-
cosceptroids A–H,9 which are pentanorsesterterpenoids
(Figure 1).10
Characteristic for all members of the leucosceptroid
family of natural products is a common, highly functional-
ized tricyclic framework containing a tetrahydrofuran ring
(C ring) and eight contiguous stereogenic centers. Differ-
ences between the various members arise in the oxidation
state at C11 (OH, H), the substitution of the southern hemi-
sphere side chain (C14 linkage), and hydration/dehydration
of the C5–C13 bond.
The leucosceptroid natural products and other sester-
terpenoids are highly attractive targets for total synthesis11
based on their intriguing molecular structures combined
with their significant biological activity. On these grounds,
Horne’s laboratory12 reported an asymmetric approach to
the core structure of leucosceptroids in 2011. Two years lat-
er, Liu and co-workers13 accomplished the first total syn-
thesis of leucosceptroid B (2). Efforts of our own group14
have led to the development of a general strategy for the
synthesis of this natural product class, which culminated in
the total synthesis of (+)-norleucosceptroid A (ent-9), (–)-
norleucosceptroid B (ent-10) and (–)-leucosceptroid K (ent-
5). Most recently, Ma and co-workers15 disclosed an effi-
cient route for the first total synthesis of leucosceptroid A
(1) and the preparation of leucosceptroid B (2). Herein, we
highlight the recent developments toward the total synthe-
sis of antifeedant sesterterpenoids and focus on the strate-
gies used to construct the synthetically challenging 5,6,5-
framework of the leucosceptroids.
2 Synthesis of the Leucosceptroid Core 
Structure
The synthetic strategy developed by Horne and co-
workers relies on an intramolecular Diels–Alder reaction to
form the tricyclic leucosceptroid core 12 (Scheme 1). The
precursor for the [4+2] cycloaddition was envisaged to be
derived from triflate 13 by employing a Sonagashira cross-
coupling reaction. In turn, the cis-tetrahydrofuran moiety
in 13 would be prepared from diol 14 using an oxidative cy-
clization strategy.
In the forward sense, homoallylic alcohol 15 (derived
from D-mannitol diacetonide in two steps) was first con-
verted into ketone 16. This sequence included several pro-
tecting-group manipulations and an oxidative cyclization
method developed by Stark and co-workers16 for the syn-
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thesis of cis-tetrahydrofuran diols (Scheme 2). Treatment of
16 with N-phenyl-bis(trifluoromethanesulfonimide) pro-
duced the corresponding triflate which underwent Sono-
gashira cross-coupling to afford, after semihydrogenation of
the alkyne functionality, triene 17. Oxidation of the allylic
alcohol then furnished the crucial Diels–Alder substrate.
Heating a solution of this cycloaddition precursor in tolu-
ene, gratifyingly furnished the endo product 12 as a single
diastereomer in good yield. This transformation enabled the
efficient construction of the tricyclic core of the leucoscep-
troid natural products and set three key stereogenic centers
in one step. Next, a sequence consisting of aldehyde reduc-
tion followed by TBDPS protection of the resulting alcohol
and cleavage of the primary TBS ethers gave diol 18. Epoxi-
dation of the latter compound with MCPBA preferentially
occurred from the endo face of the cis-hydrindane system to
yield epoxide 19 as the major compound (dr = 2:1). Unfor-
tunately, all attempts to install the C6 methyl group in 19 by
SN2 epoxide ring opening failed. It was suggested by Horne
and co-workers that this is due to the unfavorable attack of
a methyl carbanion onto the dialkoxide which is formed
upon addition of excess organometallic reagent.
Epoxide 19 ultimately resulted in a dead end, however,
Horne showed that construction of the tricyclic leucoscep-
troid core by means of an intramolecular Diels–Alder reac-
tion is conceptually feasible. Introduction of a chiral alkyne,
already containing the C10 methyl group, might allow the
synthesis of a more functionalized leucosceptroid core
structure. Nevertheless, drawbacks of this route are the
need for many protecting-group manipulations, as well as
an inevitable C1 degradation for the installation of the C12
ketone.
3 Total Synthesis of Leucosceptroid B
A fundamentally different approach to construct the
5,6,5-framework of the leucosceptroids was employed by
Liu and co-workers in their synthesis of leucosceptroid B
(2). They envisioned a late-stage intramolecular oxa-
Michael addition to form the highly functionalized tetrahy-
drofuran (ring C) of the tricyclic core 20 (Scheme 3). The
six-membered B ring of bicycle 21 could be accessed via a
Michael–aldol cascade, and the A ring in lactone 22 was
planned to be prepared by an aldol condensation reaction.
The synthetic endeavor started with conjugate organo-
cuprate addition to ?,?-unsaturated lactone 23 (prepared in
three steps by an asymmetric Michael addition–elimination
reaction17), followed by a sequence consisting of ozonolysis,
acid-catalyzed aldol condensation, and hydrogenation to af-
ford lactone 22 (Scheme 4). Treatment of 22 with the
alkynyl lithium species derived from tert-butyldimeth-
yl(pent-4-ynyloxy)silane gave a hydroxy ketone which was
efficiently oxidized to the corresponding aldehyde. Asym-
metric Brown allylation18 of the latter compound afforded
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ynone 24 after Dess–Martin periodinane oxidation. Next,
the key sequence of a conjugate 1,4-addition of a methyl
carbanion to the ynone and attack of the so-formed allenyl-
cuprate at the ketone was investigated. Optimization of the
reaction conditions for this Michael–aldol cascade revealed
methyl magnesium bromide and copper(I) iodide to be the
best reagent combination for achieving good Z/E selectivity
(3.6:1) and excellent yield (88%) of bicycle 21. As anticipat-
ed, formation of the tetrahydrofuran C ring was then
achieved by a boron trifluoride promoted intramolecular
oxa-Michael addition. Mechanistically it is suggested that
treatment of bicycle 21 with the Lewis acid leads to SN2?
elimination of the allylic hydroxy group once attack of the
electron-deficient double bond by the MOM ether takes
place. Since direct epoxidation of the enone moiety in 25
failed under basic conditions, stereoselective reduction of
the ketone was first performed, thus enabling a hydroxy-di-
rected epoxidation. Subsequent ozonolysis of the terminal
double bond and Wittig olefination to install the propenyl
side chain furnished diol 26 in very high yield. Oxidation of
both the primary and secondary alcohols followed by addi-
tion of vinyl lithium 27 to the aldehyde moiety gave rise to
the corresponding 1,4-diol. Introduction of the C5 hydroxy
group was then achieved by epoxide opening with lithium
naphthalene, and the furan moiety was formed in a one-pot
oxidation–cyclization–dehydration sequence, affording the
H11 epimer of leucosceptroid B (2) in excellent yield over
four steps. The final epimerization of H11 was plagued by
facile elimination of the ?-hydroxy ketone under various
conditions. Finally, it was discovered that by using triethyl-
amine in methanol at 50 °C, the natural product 2 could be
isolated in 21% yield (60% based on recovered starting ma-
terial) from the thermodynamic product distribution re-
sulting from this reaction.
In conclusion, Liu and co-workers accomplished the first
asymmetric total synthesis of leucosceptroid B (2) which
proceeds in 19 steps from lactone 23. The developed ap-
proach is highly linear and for the stereoselective install-
ment of the C5 hydroxy group additional redox manipula-
tions are required. Although this added several synthetic
operations to the overall number of steps, the elegant reac-
tion cascades to forge the B and C rings of the core structure
still make this a very attractive strategy.
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4 Towards the Collective Synthesis of Leu-
cosceptroid Natural Products
With the incentive of devising a concise and practical
route for the collective synthesis of leucosceptroid natural
products, we considered a convergent assembly of the tri-
cyclic core that would allow for the preparation of large
quantities of advanced intermediates for late-stage diversi-
fication. The functionalized core structure 28 (Scheme 5)
which constituted our initial synthetic target, resembles in-
termediate 20 in Liu’s synthesis. However, the shorter C14
ethyl linkage would also allow the synthesis of the norleu-
cosceptroids. We envisaged preparing 28 by introduction of
the C4 propenyl side chain and C6 methyl group with ap-
propriate organometallic reagents in the ABC core structure
29. In turn, 29 could be formed by a convergent formal
[4+2] cycloaddition from two simple coupling partners, AB
bicycle 30 and butenolide 31.
At the outset of our studies we developed highly scal-
able routes for the synthesis of both AB bicycle 30 (derived
from inexpensive (R)-pulegone in five steps) and buteno-
lide 31 (four steps from commercially available starting ma-
terial), allowing facile preparation of decagram quantities
of these cycloaddition precursors. The p-methoxyphenyl
ether in 31 was necessary to set the absolute configuration
of this building block19 and thus serves as the sole, dual-
purpose protecting group throughout our synthesis.
Our efforts then focused on assembling tricyclic core 29
via a Hauser–Kraus-type annulation (Scheme 6).20 We
found that treatment of the lithium dienolate 32, derived
from AB bicycle 30, with the C ring precursor 31, afforded
tricyclic enone 29 as a 3:1 mixture of diastereomers. Sur-
prisingly, hydrogenation of 29 did not afford the corre-
sponding ketone, but instead furnished dilactone 33 as the
final product, in a sequence proceeding via a hemiacetal in-
termediate that then underwent retro-Claisen condensa-
tion. Although the importance and potential of this inter-
mediate was not immediately recognized,21 we later discov-
ered its hidden dialdehyde structure allowing us to develop
an intramolecular aldol-type condensation. We envisaged
that twofold reduction of dilactone 33 would afford dilactol
34, which is in equilibrium with dialdehyde 35. The latter
was envisaged to undergo an aldol condensation to reform
the 5,6,5-tricyclic system. After DIBAL-H reduction of 33, 1H
NMR analysis of the crude product showed a complex mix-
ture of four dilactol diastereomers 34, with only trace
amounts of aldehyde 35 being observable. Investigation of
the reaction parameters revealed that a one-pot condensa-
tion–oxidation sequence of dilactol 34 to tetracycle 41
could be carried out in a highly efficient manner. Treating a
solution of 34 in dichloromethane containing 4 Å molecular
sieves with excess trifluoroacetic acid (5 equiv) led to for-
mation of 4-O-trifluoroacetyl acetal 40 (its presence was
confirmed by NMR analysis) which upon addition of pyri-
dinium dichromate was oxidized to tetracycle 41. We be-
lieve that the sequence to 40 proceeds through a pair of iso-
meric oxonium ions 36a and 36b, arising from expulsion of
one equivalent of water from dilactol 34, which then both
convert into bisacetal 37 as an intermediate. The latter
compound could be isolated and characterized when dilac-
tol 34 was treated with substochiometric amounts of trifluo-
roacetic acid. Equilibration of bisacetal 37 to trace amounts
of enol-oxonium ion 38 then allowed an aldol-type reaction
to take place, affording ether 39 after lactol formation. La-
beling studies revealed that the final conversion of 39 into
4-O-trifluoroacetyl acetal 40 does not proceed via formal
addition of trifluoroacetic acid to a C4–C5 enol ether, but
rather by expulsion of one equivalent of water from 39,
leading to the corresponding oxonium ion which then gets
trapped by trifloroacetate. This intramolecular dilactol al-
dol-type condensation reaction is remarkable since the
complex mixture of dilactol diastereomers 34 is converted
into a single compound and the reaction proceeds efficient-
ly also on large scale (more than 3.4 g of 41 could be pre-
pared in a single batch). Furthermore, spectroscopically
pure tetracycle 41 can be obtained by simply removing the
excess solids by filtration.
Continuing the elaboration of the core structure, the
ether bridge of 41 was opened under basic conditions, af-
fording the corresponding ?,?-unsaturated lactone which
allowed introduction of the C6 methyl group by conjugate
addition of dimethyl cuprate. Facing the challenge of diaste-
reoselectively introducing the C4 propenyl side chain and
C5 hydroxyl group in a syn fashion, we prepared enol ether
42 by DIBAL-H reduction of the lactone moiety followed by
elimination using methanesulfonyl chloride and triethyl-
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amine. The labile ?-epoxide derived from 42 was most effi-
ciently obtained using a freshly prepared solution of di-
methyldioxirane in acetone. Immediate addition of the
crude product to excess tris(2-methyl-1-propenyl) alumi-
num afforded, after oxidation and cleavage of the PMP
ether, ketone 43. Regioselective ?-hydroxylation of 43 sur-
prisingly lead to partial epimerization of H13, so that after
subsequent oxidation of the primary alcohol both (+)-nor-
leucosceptroid A (ent-9) and (–)-norleucosceptroid B (ent-
10) were isolated. The nature of how seemingly minor
changes in the substitution pattern of the 5,6,5-leucoscep-
troid framework leads to thermodynamic preference for the
AB-cis-BC-cis or the AB-cis-BC-trans fusion, is not fully un-
derstood and remains a matter of investigation. Finally, con-
densation of ent-10 with phosphonate 44, afforded (–)-leu-
cosceptroid K (ent-5), thus demonstrating the generality of
our synthetic route which also allows preparation of fur-
ther members of the leucosceptroid family. Efforts towards
the collective synthesis of this natural product class are cur-
rently being pursued in our laboratories.
5 Total Synthesis of Leucosceptroids A and B
Most recently, Ma and co-workers reported a synthetic
route to leucosceptroid A (1) and B (2) in which the tricyclic
core was prepared in convergent manner. They envisaged
forming the 5,6,5-framework 45 using a late-stage intramo-
lecular ketyl–olefin radical cyclization of ketone 46
(Scheme 7). In turn, 46 could be assembled by an aldol reac-
Scheme 6  Total synthesis of (+)-norleucosceptroid A (ent-9), (–)-norleucosceptroid B (ent-10) and (–)-leucosceptroid K (ent-5) proceeding via an un-
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tion of aldehyde 48 and dihydrofuranone 47, a building
block that resembles Horne’s intermediate 16 but already
contains the furan moiety.
In the forward sense, assembly of dihydrofuranone 47
commenced by coupling of enynol 49 with 3-bromoprop-1-
yne, followed by gold-catalyzed 5-exo-dig cyclization to af-
ford furan 50 (Scheme 8). Addition of aldehyde 51 to the ti-
tanium acetylide complex derived from 50 gave rise to the
corresponding anti adduct (dr = 7:1) which was further
transformed into allyl alcohol 52 by an iron-catalyzed car-
bometalation with methylmagnesium bromide. After hy-
drolysis of the acetal and protection of the primary alcohol
as its silyl ether, a PhSeCl-mediated cyclization–oxidation
sequence afforded dihydrofuranone 47. The second aldol
reaction partner, aldehyde 48, was prepared in three steps
from (S)-citronellal employing MacMillan’s SOMO–organo-
catalysis allylation protocol.22 While condensation of the
lithium enolate derived from 47 with aldehyde 48 failed to
afford 53, it was found that an anti-selective boron–aldol
reaction [Et3N, (hex)2BCl] gave 53 in high yield (78%). Next,
the crucial SmI2-mediated intramolecular ketyl–olefin radi-
cal cyclization was investigated. Disappointingly, treatment
of substrates containing a ?-OTMS as found in 53 with SmI2
(THF, HMPA, t-BuOH) only led to a 7-endo-trig cyclization
to produce the undesired 5,7,5-tricyclic compound. It was
hypothesized that a repulsive interaction between the axial
?-OTMS group and the olefin moiety disfavored the 6-exo
cyclization. On these grounds, preparation of ketone 46
containing an ?-OTMS group (in equatorial position) was
envisaged. For the inversion of the C12 hydroxy group in 53,
a five-step redox sequence was required: Reduction of 53
with Me4NB(OAc)3H, regioselective acylation of the so-
obtained 5-OH group, oxidation of 12-OH, followed by re-
duction of the resulting ketone (LiBH4) furnished the sec-
ondary alcohol with the desired stereochemistry. Selective
oxidation of 5-OH and protection of 12-OH as the silyl ether
then gave ketone 46 containing the desired ?-OTMS group.
The SmI2-mediated cyclization of 46 afforded the desired
tricyclic triol 45 in excellent yield (89%) after desilylation.
Regioselective oxidation of 45 followed by Wittig olefina-
tion allowed installation of the propenyl side chain, and
Swern oxidation of 12-OH completed the total synthesis of
leucosceptroid B (2). Finally, ?-hydroxylation, employing
similar conditions as reported for the introduction of the
11-OH group of the norleucosceptroids, gave leucoscep-
troid A (1).
Ma and co-workers developed a total synthesis of leuco-
sceptroid B (2) which proceeded in 18 steps (longest linear
sequence) from commercially available enynol 49. A con-
vergent aldol reaction of two highly functionalized building
blocks gave the substrate for the intramolecular ketyl–
olefin radical cyclization. Unfortunately, as this cyclization
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turned out to be unselective for the initial aldol product,
many redox manipulations were required to correct the 12-
OH stereochemistry and conduct the SmI2-mediated cy-
clization in a highly efficient manner.
6 Summary
In conclusion, four quite different strategies for the syn-
thesis of the core structure of antifeedant leucosceptroid
natural products have been presented. While the group of
Horne employed an intramolecular Diels–Alder reaction,
Liu and co-workers developed an oxa-Michael–elimination
cascade to forge the tricyclic core. The efforts of our own
group culminated in a convergent synthetic route involving
a formal [4+2] cycloaddition (Hauser–Kraus-type annula-
tion) followed by an unprecedented intramolecular dilactol
aldol-type condensation reaction that allowed us to prepare
multigram quantities of the advanced intermediates. Final-
ly, the group of Ma used a SmI2-mediated intramolecular
ketyl–olefin radical cyclization to construct the challenging
5,6,5-leucosceptroid framework. By highlighting the attrac-
tiveness of the leucosceptroid natural products and disclos-
ing intricacies associated with their preparation, we hope
the work presented herein will stimulate and inspire fur-
ther organic chemists to develop novel synthetic methods
and efficient routes to this fascinating class of natural prod-
ucts.
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2.4 Conclusion and Outlook 
In Part I of this thesis, a general entry to antifeedant (pentanor-)sesterterpenoids was developed, 
which culminated in a collective synthesis of the leucosceptroid family of natural products. The key 
features of the established synthetic route involved convergent assembly of two similarly complex 
building blocks and the invention of an unprecedented intramolecular aldol condensation of a dilactol. 
The efficient approach allowed preparation of a highly functionalized core structure on a multigram 
scale. This pivotal intermediate paved the way for the asymmetric synthesis of 18 complex 
leucosceptroid natural products. Moreover, we reviewed recent developments toward the total synthesis 
of leucosceptroids and highlighted the different strategies which have been employed to construct the 
synthetically challenging 5,6,5-framework. 
In collaboration with the group of Prof. Sheng-Hong Li, we focused on unraveling the metabolic 
pathway in Leucosceptrum canum, formulated a biosynthetic proposal and developed a model system 
to investigate biomimetic furan oxidations. Thus, we were able to suggest links between individual 
leucosceptroid members and, importantly, identified leucosceptroids A and B as the probable parent 
members of all other known leucosceptroids. Based on this proposal, we investigated the oxidation of 
leucosceptroid A using singlet oxygen and could thereby achieve biomimetic syntheses of 
leucosceptroids C, K, O and P. The results of our studies corroborated the hypothesis that photo-
oxidation is involved in the metabolic pathway of the antifeedant leucosceptroids. 
In future work, we aim to apply the intramolecular aldol condensation of dilactols in the total 
synthesis of other complex natural products and establish it as a useful method for organic synthesis. 
Moreover, the antifeedant properties of the leucosceptroid natural products and of synthetic analogs will 
be further investigated in collaboration with the group of Prof. Sheng-Hong Li. Together with the 
research group of Prof. Alexander Adibekian (University of Geneva, Switzerland) it was recently 
discovered that certain leucosceptroid members bind highly selectively to proteins, which are primarily 
involved in cancer treatment. These collaborations are expected to provide many more fascinating 
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3 PART II: THE MARINE DITERPENOIDS  
(+)-DICTYOXETANE AND (+)-DOLABELLANE V 
 
3.1 Introduction 
3.1.1 Oxetane-containing Natural Products 
Oxetanes are highly polar, four-membered cyclic ethers occurring only in a relatively small 
number of natural products – many of them being terpenoids. The prime example is taxol (32), a complex 
compound isolated from the bark of the western yew,53 which has gained major application as a clinical 
agent in cancer chemotherapy (Figure 3).54 Notably, replacement of the oxetane in taxol with an 
azetidine, thietane or selenetane afforded structural analogs with significantly decreased bioactivity 
compared to the parent compound.55 The presence of the oxetane ring in taxol thus appears to be essential 
for the strong anticancer activity, however, the precise role of this four-membered heterocycle remains 
controversial and obscure.56 
Notably, several other oxetane-containing natural products, which are structurally distinct from 
taxol, were also found to exhibit anticancer activity. For example, maoyecrystal I (95) was isolated from 
Isodon japonicas and displayed considerable cytotoxicity.57 Interestingly, a derivative of this natural 
product in which the oxetane was cleaved methanolytically no longer showed cytotoxic effects against 
the same cell line. Saharanolide A (96), a guaianolide type sesquiterpenoid lactone, was discovered in 
the organic extract of the leaves of a shrub endemic to Morocco and showed significant cytotoxicity 
against a human cervix carcinoma cell line.58 Finally, the extraction of a soft coral of the genus 


































Figure 3. Oxetane-containing natural products exhibiting anticancer activity. 
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54 a) E. K. Rowinsky, Annu. Rev. Med. 1997, 48, 353–374; b) A. K. Singla, A. Garg, D. Aggarwal, Int. J. Pharm. 2002, 235, 
179–192. 
55 a) R. Marder‐Karsenti, J. Dubois, L. Bricard, D. Guénard, F. Guéritte‐Voegelein, J. Org. Chem. 1997, 62, 6631–6637; b) A. 
A. L. Gunatilaka, F. D. Ramdayal, M. H. Sarragiotto, D. G. I. Kingston, D. L. Sackett, E. Hamel, J. Org. Chem. 1999, 64, 
2694–2703. 
56 a) T. C. Boge, M. Hepperle, D. G. Vander Velde, C. W. Gunn, G. L. Grunewald, G. I. Georg, Bioorg. Med. Chem. Lett. 
1999, 9, 3401–3046; b) M. Wang, B. Cornett, J. Nettles, D. C. Liotta, J. P. Snyder, J. Org. Chem. 2000, 65, 1059–1068. 
57 Q. B. Han, J. X. Zhang, Y. Lu, Y. S. Wu, Q. T. Zheng, H. D. Sun, Planta Med. 2004, 70, 581–584. 
58 F. Hilmi, O. Sticher, J. Heilmann, J. Nat. Prod. 2002, 65, 523–526. 
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tumor growth by means of displaying specific inhibitory activity against cell division cycle 
phosphatases.59 
Besides anticancer activity, many further oxetane-containing natural products show a wide 
range of other intriguing pharmacological effects (Figure 4). For example, mitrephorone A (98) was 
isolated from the dried bark of Mitrephora glabra and displayed both antimicrobial effects, as well as 
cytotoxic activity against a panel of different cancer cell lines.60 Extraction of a fermentation broth of a 
Streptomyces strain allowed isolation of oxetin (99), a small molecule displaying antibacterial as well 
as herbicidal effects.61 Oxetanocin (100) was isolated from a Bacillus megaterium soil-bacterium and 
triggered considerable interest from the scientific community due to its promising anti HIV activity.62 
While thromboxane A2 (101) proved to be a potent inducer of platelet aggregation and constrictor of 
vascular smooth muscles,63 bradyoxetin (102) was found to be a unique signaling molecule in 
soybeans.64 The highly oxygenated natural product trigonothryin C (103) showed promising inhibitory 
activity against HIV and also constitutes one of the first discovered daphnane diterpenoids containing 
an oxetane.65 Laureatin (104), featuring an oxetane embedded in an eight-membered cyclic ether, was 
obtained from the extract of the dried seaweed Laurencia nipponica and has shown potent activity as a 
 
Figure 4. Selected oxetane natural products with varied biologically activities. 
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A was published in 1988, d) D. W. Norbeck, J. B. Kramer, J. Am. Chem. Soc. 1988, 110, 7217–7218. 
63 H. Arita, T. Nakano, K. Hanasaki, Prog. Lipid. Res. 1989, 28, 273–301. 
64 J. Loh, R.W. Carlson, W. S. York, G. Stacey, Proc. Natl. Acad. Sci. 2002, 99, 14446–14451. 
65 L. Zhang, R.-H. Luo, F. Wang, M.-Y. Jiang, Z.-J. Dong, L.-M. Yang, Y.-T. Zheng, J.-K. Liu, Org. Lett. 2010, 12, 152–155. 
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mosquito larvicide.66 Merrilactone A (105) represents a well-known natural product containing a four-
membered oxygen hetereocycle.67 The promising bioactivity of this natural product, namely the 
stimulation of neuron growth in rats, together with the dense, polycyclic structure has led to considerable 
synthetic efforts in recent years.68 
Finally, complex natural products incorporating a highly substituted oxetane are presented, for 
which distinct biological activities have not yet been reported (Figure 5). For instance, the marine 
diterpenoid dictyoxetane (91) features a structurally beautiful, unique polycyclic ether core that has 
eluded both total synthesis and investigation of its pharmacological activity for over three decades.48 
Sodwanone W (106) was isolated from the sponge Axinella and only a cursory examination of its 
biological effect was undertaken.69 The resveratrol dimer hopeahainanphenol (107) was isolated from 
the stem bark of Hopea hainanensis and in an initial screen showed no acetylcholinesterase inhibitory 
and antitumor activity.70 Cephaloziellin B (108) is a secondary metabolite from the Chinese liverwort 
Cephaloziella kiaeri and features a rare oxetane–acetal structural motif.71 While the oxetane and  
N,O-hemiacetal motifs embedded in the complex polycyclic structure of stemona-amine B (109) were 
confirmed by X-ray crystallographic analysis, the biological activity of this alkaloid remains 
unexplored.72 The daunting structure of the denudatine-type diterpenoid alkaloid epoxynapelline I (110), 
isolated from the roots of Aconitum nagarum, was likewise confirmed by X-ray crystallographic 
analysis.73 Lastly, asbestinane VII (111)74 and teufruintin C (112)75 have been isolated, yet no biological 
activity of these oxetane-containing natural products have been reported to date. 
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Figure 5. Complex oxetane-containing natural products with unknown biological activites. 
As disclosed in this brief overview, numerous oxetane-containing natural products exhibit 
intriguing biological activities. Although in many cases only a cursory examination of the 
pharmacological activities has been undertaken, the varied biological effects discovered thus far 
highlight that the need for more detailed investigations of such natural products is warranted. While 
bioactive natural products represent a rich source for the development of new therapeutic and 
agricultural agents,76 thorough biological studies are often severely hampered by the scarcity of these 
compounds obtained from natural sources. Thus, it is highly desirable to develop an efficient chemical 
synthesis that could deliver practical quantities of a natural product for extensive biological 
investigations. 
It is interesting to note that a majority of complex oxetane-containing natural products seem to 
have been ‘forgotten’ or ‘lost’ in the literature, and only a relatively small number of these compounds 
have attracted synthetic interest. This is unfortunate, since many of the presented natural products 
display beautiful and challenging structures which certainly constitute formidable synthetic targets. By 
having highlighted the structural diversity and attractiveness of oxetane-containing natural products, it 
is hoped that this brief overview might also stimulate and inspire other organic chemists to venture on a 
synthetic undertaking focusing on such fascinating targets. 
On these grounds, in the second part of this Ph.D. thesis we became encouraged to devise a total 
synthesis of (+)-dictyoxetane, which could finally enable exploration of the bioactivity of this 
fascinating oxetane-containing natural product. The beautiful and highly complex structure of  
(+)-dictyoxetane constituted an additional incentive to begin this synthetic endeavor. 
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3.2 Results and Discussion 
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ABSTRACT: We have developed the ﬁrst synthesis of the
unique oxetane containing diterpene (+)-dictyoxetane.
Our retrosynthetic planning was guided by the putative
biosynthesis of the unprecedented 2,7-dioxatricyclo-
[4.2.1.03,8]nonane ring system. A bioinspired 4-exo-tet, 5-
exo-trig cyclization sequence enabled the construction of
the synthetically challenging dioxatricyclic framework. The
overall synthesis proceeds in 15 linear steps from a known
and readily available trans-hydrindane fragment. In
addition, we were able to realize the ﬁrst dyotropic
rearrangement of an epoxide−oxetane substrate.
Natural products containing oxetanes often display strongand intriguing biological activities. However, their
occurrence is very rare and less than a dozen have been reported
to date (Scheme 1a).1 Until the development of taxol (4) as a
potent anticancer agent, medicinal chemistry has focused little
study toward this unique structural motif. Oxetanes are highly
polar heterocycles that have only recently been identiﬁed as
eﬃcient hydrogen bond acceptors and valuable surrogates for the
gem-dimethyl group in drug discovery.2 (+)-Dictyoxetane (1)
was ﬁrst isolated from the brown alga Dictyota dichotoma
(Krusadai Island, India) in 1985 and contains an oxetane
embedded in a synthetically challenging and unique 2,7-
dioxatricyclo[4.2.1.03,8]nonane ring system.3 As biological
studies of 1 have not been reported yet and authentic material
is currently unavailable,4 several attempts were made to access
the natural product in the chemical laboratory. Despite
considerable eﬀorts, only the syntheses of the more accessible
trans-hydrindane framework5 and simpliﬁed model systems of
the dioxatricyclic substructure6 have been accomplished so far. In
seminal work by Hoﬀmann, promising antitumor activity of the
dioxatricyclic subunit against HMO2 (human gastric carcinoma)
and HEP G2 (human heptocellular carcinoma) cell lines was
revealed, and a putative biosynthesis of 1 (Scheme 1b, path A)
was proposed.6a It was hypothesized that the cyclization of
geranylgeranyl pyrophosphate (GGPP) proceeds analogous to
the dollabelane biosynthesis7 and produces, after transannular
cyclization to the 5−6−7 ring system and oxidation, epoxide 5. A
series of consecutive exo-tet cyclizations that involve tetrahy-
drofuran 7 as the key intermediate was suggested to lead to the
formation of 1. While studying the molecular model of 7, we
realized that formation of the strained annulated trans-
tetrahydrofuran ring might be exceptionally challenging under
nonenzymatic conditions.8 Therefore, we envisioned that the
formation of the isomeric allylic alcohol 6 could be a valuable
alternative en route to 1 (Scheme 1b, path B). In this latter
scenario, oxetane 8 is ﬁrst formed via a 4-exo-tet cyclization. This
ring closure involves a conformational change that places the
methylene unit in close proximity to the tertiary alcohol at C10
and thus facilitates the ﬁnal 5-exo-trig cyclization. Herein, we
describe our eﬀorts toward (+)-1 and the ﬁrst total synthesis of
this unique natural product. In order to investigate the individual
pathways of the biosynthetic proposals, we decided to directly
target protected forms of compound 5 and its isomer 6.
We ﬁrst designed a synthetic route to the 5−6−7 ring fragment
14, which features the full carbon skeleton of 1, starting from
Grainger’s trans-hydrindane 10 (Scheme 2).5 The latter can be
readily prepared from 2-methylcyclopentenone (9), employing a
very elegant phosphorane-mediated, pinacol-like rearrangement
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to establish the trans-ring junction. As outlined below, the
sterically hindered tertiary alcohol of 10 was converted to the
corresponding benzyl ether and hydrolysis of the ketal then gave
access to multigram quantities (>6 g) of ketone 11.
Next, a remarkably selective aldol reaction of the lithium
enolate derived from 11with acetaldehyde was carried out. Based
on the stereodiscriminating eﬀect of the quaternary center at C7,
the aldol product was formed as a single diastereomer at C9 and
as an inconsequential 10:1 mixture at C10. After protection of
the β-hydroxy ketone as the corresponding silyl ether, the
product was treated with isopropenylmagnesium bromide in the
presence of the lanthanum(III) chloride bis(lithium chloride)
complex9 furnishing allylic alcohol 12 in high yield and excellent
diastereoselectivity.10 Conducting the analogous transformation
in the absence of the lanthanide salt or without prior silyl ether
formation proved to be signiﬁcantly lower yielding and less
diastereoselective. Subsequent removal of the silyl ether,
followed by Ley−Griﬃth oxidation (TPAP, NMO),11 then
gave ketone 13 in 87% yield over two steps. Initial attempts to
add 3-butenylmagnesium bromide to 13 proved unexpectedly
challenging, and very low conversion of the starting material was
observed, presumably due to facile enolization of this substrate.
Fortunately, this problem could be addressed by premixing the β-
hydroxyketone 13 again with lanthanum(III) chloride bis-
(lithium chloride) complex followed by addition of the Grignard
reagent at 0 °C. This modiﬁcation increased the conversion
beyond 70% and provided the corresponding diene as a single
diastereomer. To complete the synthesis of the 5−6−7 tricycle
14, we then investigated the ring-closing metathesis of this diene
substrate. After careful screening of the reaction parameters
(catalyst, concentration, additives, temperature), the best result
for formation of tricycle 14 was achieved using the Stewart−
Grubbs catalyst12 and 2,6-dichloro-1,4-benzoquinone as an
additive.13 The required high temperature (111 °C), high
catalyst loading (25 mol %), and prolonged reaction time (40 h)
are indicative of the challenge to form a seven-membered ring
containing a trisubstituted oleﬁn adjacent to a tertiary alcohol by
means of ring-closing metathesis.14
Exposure of 14 to an excess of dimethyldioxirane (DMDO)
cleanly gave epoxide 15 and traces of the product resulting from
α-epoxidation (Scheme 3). With access to 15 we were poised to
investigate the proposed, key exo-cyclization sequence to 1.
Numerous attempts to directly activate the epoxide with various
acids and fuse the oxygen bridge between C10 and C14 were met
with failure. While mild activation of 15 did not lead to any
conversion, more forcing conditions (BF3·OEt2; Yb(OTf)3;
HClO4; p-TsOH) led to complete decomposition of the starting
material. Eventually, it was discovered that the postulated 3-exo
rearrangement6a could be induced under basic conditions
(Cs2CO3, MeOH, 60 °C), leading to an approximate 1:2.5
thermodynamic distribution of 15 and 16, from which the latter
could be easily separated by column chromatography on silica
gel. At this point we determined that epoxide 16 was also
reluctant to undergo further 5-exo-cyclization under a variety of
acidic (KHSO4; Yb(OTf)3; aq. HCl; Ti(Oi-Pr)4; MgBr2·OEt2),
basic (NaH; aq. LiOH), and neutral (CF3CH2OH; H2O
15)
reaction conditions.
These results conﬁrmed our hypothesis that the seemingly
simple intramolecular epoxide opening reaction to form the
trans-tetrahydrofuran of 1 is indeed exceptionally challenging. By
analyzing the X-ray structure from deprotected 16 (see
Supporting Information for details) we learned that the seven-
membered ring adopts a chairlike conformation. Since this places
C10-OH in an equatorial position, an energetically unfavorable
conformational change would be required to bring C10-OH into
close proximity of C14. This result further corroborated our
increasing skepticism that the desired 5-exo-tet cyclization of
epoxide 16 might not be feasible using common activation
methods. Finally, in an attempt to eliminate C13-OH in order to
both change the ring geometry and generate a more reactive
allylic epoxide, we observed a remarkable reaction sequence.
Treatment of 16 with Martin sulfurane16 led to rapid
consumption of the starting material and furnished dioxatricycle
17 without detectable amounts of any oleﬁnic byproducts.
Hydrogenolysis of the benzyl ether gave 1,10,13,14-tetra-epi-
Scheme 2. Synthesis of the Full Carbon Skeleton of
Dictyoxetane (1)a
aReagents and conditions: (a) BnBr, KHMDS, THF, −78 to 23 °C;
(b) aq. 4 M HCl, THF, 23 °C, 85% over three steps; (c) LDA,
CH3CHO, −78 °C; (d) TBSCl, imidazole, DMAP, DMF, 23 °C, 80%
over two steps, 10:1 d.r. at C10; (e) LaCl3·2LiCl, isopropenyl-
magnesium bromide, THF, 0 °C, 93%; (f) TBAF, THF, 0 to 23 °C;
(g) TPAP, NMO, 4 Å MS, CH2Cl2, 23 °C, 87% over two steps; (h)
LaCl3·2LiCl, 3-butenylmagnesium bromide, THF, 0 °C, 69%, 27% 13;
(i) Stewart−Grubbs cat. (25 mol %), 2,6-dichloro-1,4-benzoquinone,
toluene, 111 °C, 55%, 25% recovered diene.
Scheme 3. Synthesis of Tetra-epi-dictyoxetane (tetra-epi-1)a
aReagents and conditions: (a) DMDO, acetone, CH2Cl2, −78 °C,
≥99%, ≥15:1 d.r.; (b) Cs2CO3, MeOH, 60 °C, 22% 15, 59% 16; (c)
Martin sulfurane, CH2Cl2, 0 °C; (d) H2, Pd/C, THF, 23 °C, 60% over
two steps.
Journal of the American Chemical Society Communication
DOI: 10.1021/jacs.6b03720
J. Am. Chem. Soc. 2016, 138, 6420−6423
6421
51
dictyoxetane (tetra-epi-1), whose structure was unambiguously
conﬁrmed by single-crystal X-ray analysis.
To rationalize this intriguing transformation, we compared
and analyzed individual reaction intermediates of possible
pathways, and the most likely proposed mechanistic scenario is
illustrated in Scheme 3. We hypothesize that upon treatment of
16 with Martin sulfurane, the cyclic sulfurane 18 is formed.
Driven by the strain release of epoxide opening and formation of
a stabilized tertiary carbocation, 18 then rearranges to
tetrahydrofuran 19. Expulsion of diphenyl sulfoxide from 19
generates an alkoxide that immediately traps the carbocation to
fuse the oxetane ring between C1 and C13 of dioxatricycle 17.
The direct generation of 17 from epoxide 15, via in situ
equilibration of 16, can be excluded, as reaction of 15withMartin
sulfurane simply led to dehydration of C10-OH to give the endo-
cyclic oleﬁn. However, we initially also speculated that epoxide−
oxetane 22 might be formed under the reaction conditions and
could play a pivotal role during the rearrangement of 16 to
dioxatricycle 17 (Scheme 4).
In this context, we discovered that activation of 15 with
magnesium bromide ethyl etherate in the presence of
tetrabutylammonium bromide (TBAB) promoted smooth
bromohydrin formation with concomitant oxetane ring closure
between C1 and C10 to furnish 20. Cleavage of the benzyl ether
aﬀorded diol 21 whose crystal structure conﬁrmed the oxetane
structural motif. Treatment of bromohydrin 20 with potassium
carbonate in methanol provided the epoxide−oxetane 22 in 94%
yield. At this stage, we found that 22 is left unreacted upon
exposure to Martin sulfurane. Although this result further
supported our mechanistic proposal and excluded any pathway
based on transient formation of 22, we were curious if a dyotropic
rearrangement to dioxatricycle 17 could be induced by means of
Lewis acid activation.17 After careful experimentation, we
discovered that treatment of epoxide−oxetane 22 with copper-
(II) tetraﬂuoroborate hydrate18 promoted a strain-releasing
dyotropic rearrangement to give the dioxatricycle 17 (36%)
together with byproducts resulting from ring contraction (37%)
and oxetane elimination (20%; see Supporting Information for
details). To the best of our knowledge, this is the ﬁrst example of
a dyotropic rearrangement involving an epoxide−oxetane
substrate.
In an attempt to apply a similar dyotropic rearrangement for
the synthesis of 1, we envisioned to extend this transformation to
epoxide−tetrahydrofuran 25 (Scheme 5). Treatment of 14 with
active halogen sources such as N-bromosuccinimide (NBS)
exclusively gave regioisomer 23.19 Activation of 23 with a panel
of silver(I) sources (AgNO3; AgBF4; AgNTf2) or under simple
thermal conditions (CF3CH2OH, 2,6-lutidine) to promote the
desired rearrangement to 27 via 25 was unsuccessful. Although
we were able to abstract the tertiary bromide using silver(I)
nitrate, exclusive formation of nitrate ester 24 occurred.
Epoxide−tetrahydrofuran 25 could be ﬁnally prepared from 16
by mesylation and consecutive double SN2 displacement.
However, evaluation of several reaction conditions revealed
that dyotropic rearrangement of 25 to 27 is not possible, owing
to a competing semipinacol-type rearrangement generating the
5−6−6 tricyclic framework of 26.20
After having failed to convert 15, 16, or 25 to the target
compound, we returned to our alternative biosynthetic proposal,
where we had envisioned constructing the dioxatricyclic
substructure by forming the oxetane prior to the strained trans-
tetrahydrofuran ring. It was found that photo-oxidation of the
silyl ether derived from 14, followed by reduction of the resulting
hydroperoxide, gave allylic alcohol 28 as a single regio- and
diastereomer in 71% yield (Scheme 6). While the subsequent 4-
exo-tet cyclization of 28 could be achieved in a single
transformation using p-toluenesulfonyl chloride and potassium
Scheme 4. Synthesis of Dioxatricycle 17 via Dyotropic
Rearrangementa
aReagents and conditions: (a) MgBr2·Et2O, TBAB, CH2Cl2, 23 °C,
51%; (b) H2, Pd/C, THF, 23 °C, 83%; (c) 20, K2CO3, MeOH, 0 °C,
94%; (d) Cu(BF4)2·xH2O, CH2Cl2, 23 °C, 36%.
Scheme 5. Attempted Dyotropic Rearrangement of 25a
aReagents and conditions: (a) NBS, CH2Cl2, 0 °C, ≥99%; (b)
AgNO3, NaHCO3, acetone, 23 °C, 60%; (c) MsCl, NEt3, CH2Cl2, −78
°C, 72%; (d) LiBr, Li2CO3, DMF, 70 °C, 80%; (e) Cu(BF4)2·xH2O,
CH2Cl2, 40 °C; (f) H2, Pd/C, THF, 23 °C, 90% over two steps.
Scheme 6. Total Synthesis of (+)-Dictyoxetane (1) via
Consecutive 4-exo-tet and 5-exo-trig Cyclizationsa
aReagents and conditions: (a) TMSI, CH2Cl2, 0 to 23 °C, 92%; (b)
O2, hv, TPP, DCE, 0 °C; PPh3, 23 °C, 71%; (c) MsCl, NEt3, CH2Cl2,
−78 °C; (d) NaH, THF, 66 °C, 88% over two steps; (e) NIS, CH2Cl2,
23 °C; (f) H2, Pd/C, THF, 23 °C, 80% over two steps.
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tert-butoxide, these conditions proved unreliable and gave
irreproducible yields of oxetane 29. Fortunately, a two-step
procedure involving formation of the allylic mesylate and
subsequent cyclization under basic conditions in reﬂuxing
tetrahydrofuran aﬀorded oxetane 29 in consistently high yields.
It was interesting to note that 29 showed severe signal
broadening in the 1H NMR spectrum at ambient temperature,
indicating that formation of the oxetane had changed the
conformation of the seven-membered ring in such a way that the
C10-OTMSmoiety had been brought into close proximity of the
exo-methylene and could no longer freely rotate. Thus, exposure
of 29 toN-iodosuccinimide (NIS) led to smooth cyclization with
concomitant silyl ether deprotection, forming the trans-
tetrahydrofuran of the dioxatricyclic substructure in 30. The
latter product was subjected to hydrogenolysis using palladium
on carbon which induced simultaneous dehalogenation of the
primary iodide and cleavage of the benzyl ether, furnishing
(+)-dictyoxetane (1) whose spectroscopic data (1H and 13C
NMR, HRMS, IR, [α]D) were in full agreement with those
reported for the naturally occurring substance. Moreover, the
positive [α]D value of our synthetic sample established the
absolute conﬁguration of the natural product to be as depicted.
In summary, we have developed the ﬁrst total synthesis of
(+)-dictyoxetane (1) that contains a unique and synthetically
challenging 2,7-dioxatricyclo[4.2.1.03,8]nonane ring system. A
crucial modiﬁcation of the proposed biosynthesis, speciﬁcally the
use of sequential 4-exo-tet and 5-exo-trig cyclizations to form the
respective oxetane and trans-tetrahydrofuran rings, enabled the
construction of the complex dioxatricyclic framework. Moreover,
we have discovered that epoxide−oxetanes are viable substrates
for strain-releasing dyotropic rearrangements. Biological studies
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A Divergent Approach to the Marine Diterpenoids
(+)-Dictyoxetane and (+)-Dolabellane V
Cedric L. Hugelshofer and Thomas Magauer*[a]
Abstract: We present a full account of the development of
a strategy that culminated in the first total syntheses of the
unique oxetane-containing natural product (+)-dictyoxetane
and the macrocyclic diterpene (+)-dolabellane V. Our retro-
synthetic planning was guided by both classical and non-
conventional strategies to construct the oxetane, which is
embedded in an unprecedented 2,7-dioxatricy-
clo[4.2.1.03,8]nonane ring system. Highlights of the successful
approach include highly diastereoselective carbonyl addition
reactions to assemble the full carbon skeleton, a Grob frag-
mentation to construct the 11-membered macrocycle of
(+)-dolabellane V, and a bioinspired 4-exo-tet, 5-exo-trig cyc-
lization sequence to form the complex dioxatricyclic frame-
work of (+)-dictyoxetane. Furthermore, an unprecedented
strain-releasing type I dyotropic rearrangement of an epox-
ide-oxetane substrate was developed.
Introduction
Terpenoids constitute the largest class of natural products and
many members display unique physical and biological activi-
ties, including anticancer, antifeedant, antiviral and antibiotic
action.[1] Among these small molecules, only relatively few fea-
ture an oxetane structural subunit,[2] as illustrated by the
marine oxocene laureatin (1) (Figure 1).[3] Taxol (2) serves as
the archetypal oxetane-containing natural product, which was
approved as a novel anticancer agent in 1992 and has spurred
medicinal chemists to focus on the unusual four-membered
heterocycle.[4] Since then, oxetanes have emerged as potential-
ly attractive structural motifs in drug discovery based on their
isosteric relationship with gem-dimethyl groups and their out-
standing capability to function as hydrogen-bond acceptors.[5]
In 1985, chemists isolated a novel natural product, (+)-dictyox-
etane (3), from a sample of the brown alga Dictyota dichotoma
collected from the Indian Ocean.[6] Structure elucidation based
on X-ray crystallography revealed that this compound features
an oxetane embedded in an intricate 2,7-dioxatricy-
clo[4.2.1.03,8]nonane ring system. From a structural perspective,
3 combines an oxetane motif with a trans-hydrindane moiety
that is found in various sesterterpenoids,[7] such as leucoscep-
troid B (4)[8] and retigeranic acid A (5).[9] A trans-fused cyclo-
pentane scaffold is also common in numerous related dolabel-
lanes,[10] as exemplified by (+)-dolabellane V (6).[11] Given the
lack of biological studies and the challenges of constructing
both the unique dioxatricyclic subunit and trans-hydrindane
moiety of (+)-dictyoxetane (3), several attempts were made to
prepare the natural product by chemical synthesis. Considera-
ble efforts led to the syntheses of a trans-hydrindane frame-
work[12] and simplified model systems of the dioxatricyclic sub-
structure.[13] Based on a crucial modification of the proposed
biosynthesis,[14] we recently reported the first total synthesis of
(+)-dictyoxetane (3).[15] Herein, we disclose a full account of
this work and describe the first total synthesis of the natural
product (+)-dolabellane V (6). Our synthetic journey led us
through several unsuccessful approaches to construct the
highly substituted oxetane, but ultimately revealed a wealth of
interesting reactivity of putative biogenetic precursors of the
dioxatricyclic substructure.
[a] C. L. Hugelshofer, Dr. T. Magauer
Department of Chemistry and Pharmacy
Ludwig-Maximilians-University Munich
Butenandtstrasse 5–13, 81377 Munich (Germany)
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Supporting information for this article, including experimental, computa-
tional, and crystallographic details, as well as compound characterization
data and copies of 1H and 13C NMR spectra, is available on the WWW
under http://dx.doi.org/10.1002/chem.201603061.
Figure 1. Representative oxetane and trans-fused natural products.





Unlike for epoxides or tetrahydrofurans,[16] there is a paucity of
synthetic methods to construct oxetanes. As outlined in
Scheme 1a, four general strategies are commonly employed
for their synthesis. The intramolecular Williamson etherification
(SN2 displacement)
[17] and the [2+2] cycloaddition of a carbonyl
and olefin (the Paternk–Bechi reaction)[18] constitute classic
synthetic routes towards the four-membered heterocycle.
Moreover, oxetanes have been efficiently prepared by ring-ex-
pansion of epoxides using sulfoxonium ylides[19] or Wagner–
Meerwein type rearrangements of substituted epoxides.[20] Our
retrosynthetic analysis of (+)-dictyoxetane (3) was primarily
guided by taking into consideration the synthetic challenge of
constructing the highly substituted oxetane that is part of the
2,7-dioxatricyclo[4.2.1.03,8]nonane ring system. Accordingly, our
synthetic plans can be divided into three conceptually different
approaches based on the method used to form the oxetane
(Scheme 1b). In an initial synthetic route, we envisioned a late-
stage Paternk–Bechi reaction of aldehyde 7 to form the dioxa-
tricyclic ring system of 3. While the [2+2] photocycloaddition
of an alkene and a carbonyl compound constitutes a powerful
method for constructing oxetanes, this strategy has enjoyed
relatively scarce application in natural product synthesis[21] and
certainly would pose a challenging transformation in such
a complex molecular setting. Aldehyde 7 was traced back to
cyclobutanone 8 or epoxide 9 by a reaction sequence that in-
volves a Baeyer–Villiger oxidation[22] and an ester enolate–ep-
oxide opening reaction, respectively. Given the high risk associ-
ated with the endgame of this approach, we also decided to
study the Paternk–Bechi reaction on a simplified model
system in parallel to our synthetic efforts towards aldehyde 7.
From an alternative retrosynthetic perspective, we consid-
ered installing the trans-hydrindane moiety at a final stage and
first focus on the challenge of constructing the dioxatricyclic
subunit. In this approach, (+)-dictyoxetane (3) was traced back
to enone 10 ; the latter could be obtained through elaboration
of the key intermediate, dioxatricycle 11. We envisaged an in-
tramolecular oxidative dearomatization of phenol 12 as
a novel method to forge the oxetane of 11.[23]
Finally, we were also interested in pursuing a synthetic ap-
proach, which is inspired by Hoffmann’s biosynthetic propos-
al.[14] Based on this, (+)-dolabellane V (6) is the biogenetic pre-
cursor of (+)-dictyoxetane (3) by means of a transannular cycli-
zation to forge the 5–6–7 ring system 14. Stereoselective epox-
idation of the C13/C14 olefin in the latter compound, followed
by 3-exo-tet cyclization would then give epoxide 15 as the key
biosynthetic intermediate. For the formation of the dioxatricy-
clic substructure of 3, consecutive 5-exo-tet and 4-exo-tet cycli-
zations of 15 were proposed. While contemplating the molecu-
lar model of 15, we realized that promotion of the suggested
5-exo-tet cyclization might be exceptionally challenging, be-
cause this would produce a highly strained trans-tetrahydrofur-
an ring. Therefore, we imagined constructing the oxetane prior
Scheme 1. a) Conventional methods for the construction of oxetanes and b) synthetic planning for (+)-dictyoxetane (3) and (+)-dolabellane V (6). R=protect-
ing group or H.
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to the trans-tetrahydrofuran, thus avoiding such a strained in-
termediate. For this purpose, we identified allylic alcohol 16 as
a valuable alternative precursor en route to (+)-dictyoxetane
(3). To investigate the biosynthetic proposal and our modifica-
tion thereof, (+)-dictyoxetane (3) was traced back to protected
forms of epoxide 15 and allylic alcohol 16, both of which
could be obtained through elaboration of tricycle 14. The
latter compound was also considered as an advantageous in-
termediate, because (+)-dolabellane (6) could be derived
therefrom through Grob fragmentation.[24] Preparation of the
macrocycle through fragmentation of the 5–6–7 ring system
thus constitutes the reverse of the biosynthetic pathway, in
which transannular cyclization of 6 is suggested to form 14.
We envisioned that tricycle 14 could be constructed from
Grainger’s trans-hydrindane 17[12] by orchestrating a series of
diastereoselective reactions and employing ring-closing meta-
thesis to form the seven-membered carbocycle.
Paternk–Bechi approach
Following the retrosynthetic analysis, we began our synthetic
endeavor with the preparation of ester 24 as the precursor for
the enolate-epoxide opening reaction (Scheme 2).[25] To this
end, the sodium enolate derived from cyclopentanedione 18
was treated with bromide 19, itself prepared from geraniol on
a multigram scale (see the Supporting Information), furnishing
the desired diketone in moderate yield (60%) due to compet-
ing O-alkylation. Subsequent lithium tri-tert-butoxyaluminium
hydride mediated reduction and Barton–McCombie deoxyge-
nation[26] of the corresponding alcohol gave ketone 20.[27]
Having prepared 20, we found the p-methoxybenzyl ether pro-
tecting group to be unstable after the subsequent epoxidation
reaction of the C9/C10 double bond due to competing intra-
molecular epoxide opening. Therefore, 20 was converted into
silyl ether 21, which was then subjected to vinyl triflate forma-
tion and subsequent regioselective epoxidation, affording ep-
oxide 22 as a mixture (1:1) of diastereomers.[28] Next, attach-
ment of the ester moiety by homoenolate coupling was ach-
ieved by Negishi coupling[29] of 22 with the organozinc species
23.[30] It is noteworthy that, whereas the use of N,N-dimethyla-
cetamide as a co-solvent proved crucial to achieve full conver-
sion of the starting material, SPhos Pd G2[31] was required to
suppress b-hydride elimination and reduction of the vinyl tri-
flate to the olefin. With 24 in hand, the intramolecular ester
enolate-epoxide opening reaction to form lactone 25 was in-
vestigated. Unfortunately, treating ester 24 with a variety of
lithium or potassium amide bases (LHMDS; KHMDS; LDA), or
alkali metal hydrides (NaH; KH) did not lead to opening of the
trisubstituted oxirane. Whereas under most investigated condi-
tions the ester enolate simply failed to react, formation of
traces of the self-condensation product (intermolecular Claisen
reaction) could be observed after prolonged reaction times.
We also attempted to increase the reactivity of the epoxide,
but found no improvement by employing various weak Lewis
acids (TMSCl; Ti(Oi-Pr)4 ; Et2AlCl), and encountered halohydrin
formation when stronger activators (AlCl3 ; TiCl4) were em-
ployed.
Failure of ester 24 to undergo the envisioned intramolecular
epoxide opening required us to develop an alternative strategy
for constructing the 5–6–5 tricyclic core of the photocycloaddi-
tion precursor 7. Hence, we were attracted to the possibility of
elaborating a trans-hydrindane building block through ketene
[2+2] cycloaddition to first give a 5–6–4 ring system that
could be ring-expanded to the 5–6–5 framework.[33] As out-
lined in Scheme 3, the synthesis started from ketone 28,[15]
which was first reported in its unprotected form by Grainger
and co-workers using an elegant phosphorane-mediated, pina-
col-like rearrangement to construct the trans-fused hydrin-
dane.[12] While this route proved highly efficient and enabled
us to readily prepare multigram quantities (>6 g) of the key
building block 28, we also wanted to determine whether an in-
tramolecular Diels–Alder reaction (IMDA) of triene 27 could be
a viable alternative to establish the trans-ring junction of 28.[32]
However, exploration of the IMDA of 27 (see the Supporting
Information for preparation of this compound) proved unfruit-
ful, and the [4+2] cycloaddition could not be induced under
either thermal or high-pressure (14 kbar) conditions.[34]
Ketone 28 was converted into the corresponding vinyl tri-
flate, which was subjected to Pd-catalyzed reduction using
a low-boiling silane to afford olefin 29 in 75% yield. This reac-
tion sequence proved far more efficient than sodium borohy-
dride mediated reduction of 28, followed by elimination of the
secondary alcohol, which gave olefin 29 in unsatisfactory yield
(15–30%). With ample quantities of 29 in hand, we then inves-
tigated the ketene-alkene [2+2] cycloaddition.[33] Given that in-
itial attempts to fuse 29 with various dialkyl ketenes were met
with failure, we became interested by Brown’s Lewis acid pro-
Scheme 2. Synthesis of ester 24 and attempted epoxide opening to prepare
lactone 25. Reagents and conditions: a) 19, NaH, DMF, 0 to 23 8C, 60%;
b) LATB, THF, @60 8C; c) p-tolylchlorothionoformate, pyridine, DMAP, CH2Cl2,
23 8C; d) Bu3SnH, AIBN, toluene, 111 8C; e) DDQ, CH2Cl2, aq. pH 7 buffer, 0 8C;
f) TBDPSCl, imidazole, CH2Cl2, 23 8C, 52% over five steps; g) PhNTf2, LDA,
THF, @78 to 23 8C, 60%; h) m-CPBA, NaHCO3, CH2Cl2, 0 8C, 65%, d.r.=1:1;
i) 23, SPhos, SPhos Pd G2, THF, DMA, 55 8C, 41%. AIBN=azobisisobutyroni-
trile, DDQ=2,3-dichloro-5,6-dicyano-para-benzoquinone, DMA=N,N-dime-
thylacetamide, DMAP=4-dimethylaminopyridine, DMF=N,N-dimethylforma-
mide, LATB= lithium tri-tert-butoxyaluminium hydride, LDA= lithium diiso-
propylamide, m-CPBA=meta-chloroperoxybenzoic acid, PMB=p-methoxy-
benzyl, SPhos=2-dicyclohexylphosphino-2’,6’-dimethoxybiphenyl,
TBDPS= tert-butyldiphenylsilyl, Tf= trifluoromethanesulfonyl, THF= tetrahy-
drofuran.
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moted ketene-alkene cycloaddition protocol.[35] Moreover, we
resorted to acid chloride 30 as the reaction partner because
generation of the corresponding ketene is known to be
facile,[36] although multiple transformations would be required
to then convert the styrene moiety into the desired alkyl side
chain. Despite extensive optimization attempts (temperature,
concentration, stochiometries, addition rate of 30) conversion
generally remained low, in the best case affording cyclobuta-
none 32 in 19% yield together with more than 70% of recov-
ered olefin 29. To make matters worse, we determined that
the [2+2] cycloaddition had furnished the undesired cyclobu-
tanone regioisomer, after a-methylation of 32 to give 33. The
outcome of this reaction was unexpected because the [2+2]
cycloaddition of dichloroketene with 29 afforded the regioiso-
meric product 35. We believe that in transition state 31, coor-
dination of trimethylaluminium to the ketene might lead to
such an orientation that steric clash of the Lewis acid with the
C4 isopropyl group is avoided, thus generating cyclobutanone
32 as the preferred regioisomer. For the formation of 35, we
reasoned that, according to transition state 34, alignment of
the dichloroketene to afford the opposite regioisomer is exclu-
sively governed by the chlorine substituents. Considering that
a rather lengthy sequence, involving several protecting group
manipulations,[37] would be required for functionalization of 35,
we decided to first investigate the Paternk–Bechi reaction on
a model system (Scheme 4).
Towards this end, exposure of lactone 36 (see the Support-
ing Information) to dimethyltitanocene[38] afforded an endocy-
clic enol ether after prolonged heating, and treatment of the
latter intermediate with tetrabutylammonium fluoride un-
masked the aldehyde functionality of 37. Compound 37
proved to be highly unstable under both acidic and basic con-
ditions and readily converted into alcohol 39, presumably
through an intramolecular carbonyl ene reaction.[39] Neverthe-
less, after a quick aqueous workup of the silyl ether cleavage
reaction, 37 was subjected to irradiation with light (254 nm;
300 nm; 250–600 nm) in a variety of solvents (CH3CN; ben-
zene; acetone). Unfortunately, the desired model dioxatricycle
38 was never observed and instead either complete decompo-
sition of the starting material or formation of alcohol 39 oc-
curred. In light of the fact that preparation of the Paternk–
Bechi reaction precursor would involve a long reaction se-
quence, and based on the results from our model system,
which raised great concern that the final [2+2] photocycload-
dition would be problematic, we decided to abandon this ap-
proach.
Oxidative dearomatization approach
At this juncture, we sought to construct the dioxatricyclic sub-
unit of (+)-dictyoxetane (3) at an early stage by intramolecular
oxidative dearomatization of phenol 12 as a largely unexplored
strategy to form an oxetane (Scheme 5). To this end, bromide
40 was converted into the corresponding benzyl ether and
coupled with potassium isopropenyltrifluoroborate to cleanly
afford styrene 41.[40] Next, a gold(I)-catalyzed cascade cycload-
dition[41] of 41 with allenamide 42 gave oxa-bridged enamide
43 in 53% yield, together with 45% recovered styrene 41. Re-
action optimization revealed that slow addition of excess alle-
namide 42 to a solution of 41 and the gold(I) catalyst im-
proved the yield. Nevertheless, incomplete conversion of 41
prevailed under these conditions because of rapid dimerization
of the allenamide. The enamine was then oxidatively cleaved[42]
and reduction of the resulting ketone together with removal
of the benzyl ether could conveniently be achieved in a single
transformation by using a combination of sodium borohydride
and nickel(II) chloride,[43] furnishing phenol 12 in excellent yield
over both steps. With key intermediate 12 in hand, we then
explored the intramolecular oxidative dearomatization.[44] Ex-
tensive screening using a variety of oxidants (PIDA; PIFA; 1O2 ;
Scheme 3. Synthesis of olefin 29 and investigation of the ketene [2+2] cy-
cloaddition. Reagents and conditions: a) PhNTf2, KHMDS, THF, @78 8C;
b) Et2MeSiH, PdCl2(dppf), DMF, 60 8C, 75% over two steps; c) 30, DIPEA,
AlMe3, CH2Cl2, @65 to @45 8C, 19% 32, 72% recovered 29 ; d) MeI, KOt-Bu,
THF, t-BuOH, @60 to 0 8C, 38%; e) Zn-Cu couple, trichloroacetyl chloride,
Et2O, 23 8C, 48%; f) SmI2, THF, MeOH, 23 8C, 87%. Bn=benzyl, DIPEA=N,N-
diisopropylethylamine, dppf=1,1’-bis(diphenylphosphino)ferrocene,
KHMDS=potassium bis(trimethylsilyl)amide.
Scheme 4. Synthesis of model aldehyde 37 and attempted Paternk–Bechi
reaction. Reagents and conditions: a) Cp2TiMe2, toluene, 75 8C, 84%; b) TBAF,
THF, @78 8C. TBAF= tetrabutylammonium fluoride.
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oxone; CAN), base additives and solvents (CH3CN; H2O; TFE;
CH3NO2 ; CH2Cl2 ; i-PrOH) unfortunately only led to decomposi-
tion of the starting material and the desired oxetane-dienone
45 was never observed. Reasoning that dearomatization at the
C1 position might become feasible by incorporating an ex-
tended O-nucleophile, phenol 12 was converted into carbon-
ate 44. Disappointingly, the attempted intramolecular oxidative
dearomatization of 44 to form cyclic carbonate 46 could also
not be promoted and decomposition again prevailed under
the conditions investigated.
To obtain crystals suitable for X-ray analysis and to gain
more insight into the conformation of the dearomatization
precursor, carbonate 44 was converted into ferrocenecarboxy-
late ester 47, according to Burns’ recently reported protocol.[45]
Analysis of this X-ray structure revealed that the tetrahydropyr-
an substructure of 47 adopts a chair-like conformation which
places the C13-O substituent in an equatorial position and
distal from C1. For the intramolecular dearomatization to take
place, the tetrahydropyran would first have to undergo an en-
ergetically unfavorable change to a boat conformation in
which C13-O would be brought in proximity to C1.
Although it was discouraging to recognize that the inherent
preference of the phenol to adopt conformer 12b rendered
the intramolecular oxidative dearomatization unfeasible
(Scheme 6A), we realized that the chair conformation of diol
48b could be a valuable alternative for ring-closure. In the
latter case, C1-OH would be well suited to form the desired ox-
etane by intramolecular SN2 displacement of a C13 leaving
group. With this idea in mind, and based on an analogous re-
action sequence as above, we prepared anisole 49 (see the
Supporting Information for details). As outlined in Scheme 6B,
49 was subjected to Birch reduction[46] and the resulting enol
ether was hydrolyzed by using aqueous oxalic acid,[47] cleanly
affording ketone 50 in 86% yield over two steps, the structure
of which was unambiguously confirmed by single-crystal X-ray
analysis. Next, we envisioned a homoallylic alcohol-directed
epoxidation[16,48] to install the C1 hydroxyl group with the de-
sired a-configuration. Whereas vanadium-catalyzed epoxida-
tion or treatment of 50 with meta-chloroperbenzoic acid led to
complex product mixtures, the use of a dinuclear peroxotung-
state catalyst[49] furnished one major epoxide. Following open-
ing of this unstable epoxide with triethylamine and hydroge-
nation of the resulting enone, NOESY NMR experiments indi-
cated that epoxidation occurred from the undesired b-face to
give diol 51 as the final product. Not surprisingly, subsequent
conversion of 51 into dioxatricycle 52 through an attempted
SN1 reaction failed using a variety of Brønsted or Lewis acids
(p-TsOH; TFA; TFAA; Yb(OTf)3 ; ZnBr2 ; Cu(BF4)2 ; BF3·OEt2), pre-
Scheme 5. Synthesis of phenol 12 and attempted oxidative dearomatization.
Reagents and conditions: a) BnBr, K2CO3, NaI, CH3CN, 45 8C, 72% b) potassi-
um isopropenyltrifluoroborate, Pd(dppf)Cl2, NEt3, n-PrOH, 100 8C, 85%; c) 42,
gold(I) catalyst (2 mol%), 4 a MS, CH2Cl2, @15 8C, 53% 43, 45% recovered
41; d) OsO4, NMO, 2,6-lutidine, acetone, H2O, 23 8C, then PIDA, 23 8C, +99%;
e) NaBH4, MeOH, @78 8C, then NiCl2·6H2O, 0 8C, +99%, d.r.=10:1; f) Boc2O,
NEt3, DMAP, CH2Cl2, 23 8C; g) K2CO3, MeOH, 23 8C, 84% over two steps; h) fer-
rocenecarboxylic acid, NEt3, DMAP, EDC, CH2Cl2, 23 8C, +99%. Boc= tert-bu-
tyloxycarbonyl, EDC=N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide,
NMO=4-methylmorpholine N-oxide, PIDA=phenyliodonium diacetate.
Scheme 6. A) Ring conformations of 12 (interatom distances of DFT-opti-
mized structures) and 48 ; B) and C) attempted synthesis of dioxatricycle 52,
55, and 56. Reagents and conditions: a) Li, NH3, THF, EtOH, @78 to @40 8C;
b) oxalic acid, MeOH, H2O, 23 8C, 86% over two steps;
c) K2[{W(=O)(O2)2(H2O)}2(m-O)]·2H2O (20 mol%), H2O2, H2O, 23 8C; d) NEt3,
MeOH, 45 8C; e) H2, Pd/C, MeOH, 23 8C, 73% over three steps.
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sumably due to a similar conformational restriction as we had
encountered in the attempted intramolecular dearomatization.
Given that a-face epoxidation of the sterically hindered C1/C9
olefin had failed using alcohol-directed methods, we envi-
sioned installing the desired epoxide via a halohydrin inter-
mediate. To this end, treatment of the enol ether resulting
from Birch reduction of 49 with ethylene glycol and a catalytic
amount of p-toluenesulfonic acid gave acetal 53, which could
be converted into carbonate 54 (Scheme 6C). Unfortunately,
halohydrin formation in 53 or 54, as well as all direct halo-
etherification attempts, met with failure. Finally, exposure of
53 or 54 to meta-chloroperbenzoic acid cleanly gave the corre-
sponding tetrasubstituted b-epoxides. However, intramolecular
opening of this moiety with the C13-O nucleophile to form 55
or 56 could likewise not be achieved.
In view of the lack of success in elaborating our oxa-bridged
6–7 ring systems, we decided to discontinue this synthetic ap-
proach. We realized that early-stage introduction of an a-con-
figured alcohol at C1, prior to formation of the right-hand 6–7
framework of (+)-dictyoxetane (3), might prove more reward-
ing and alleviate problems in constructing this fully substituted
carbon center.
Bioinspired SN2 approach
As outlined in Scheme 7, we began our bioinspired synthetic
approach from ketone 28, which underwent a highly selective
aldol reaction with 4-pentenal. Based on the Zimmerman–Trax-
ler transition-state 57,[50] the aldol product 58 was formed as
a single diastereomer at both C9 and C10, and after silyl pro-
tection furnished 59 in 72% yield. Initial attempts to add an
isopropenyl group to ketone 58 met with limited success, and
gave the corresponding tertiary alcohol 60 in both unsatisfac-
tory yields and diastereomeric ratios (Table 1, entries 1–5). For-
tunately, employing the silyl protected ketone 59 and premix-
ing it with lanthanum(III) chloride bis(lithium chloride) com-
plex[51] prior to addition of the Grignard reagent, afforded 61
with excellent diastereoselectivity (d.r.+20:1) and in high yield
(entry 6). Following removal of the silyl ether and Ley–Griffith
oxidation,[52] ketone 62 was obtained in 88% yield over two
steps (Scheme 7). We encountered low conversion of the start-
ing material in the subsequent addition of methylmagnesium
bromide to 62, presumably due to facile enolization of the
substrate. In this case, the addition of lanthanum(III) chloride
bis(lithium chloride) complex could suppress unwanted enoli-
zation with only little success. Although the configuration at
the formed C10 stereocenter could not be determined at this
stage, the intermediate was subjected to ring-closing metathe-
sis to afford tricycle 63a. The undesired C1,C10 cis-diol rela-
Scheme 7. Selective synthesis of the epimeric 5-6-7 tricycles 63a and 63b. Reagents and conditions: a) LDA, 4-pentenal, THF, @78 8C; b) TBSCl, imidazole,
DMAP, DMF, 23 8C, 72% over two steps, d.r. +20:1; c) LaCl3·2LiCl, isopropenylmagnesium bromide, THF, 0 8C, 91%, d.r.+20:1; d) TBAF, THF, 0 to 23 8C; e) TPAP,
NMO, 4 a MS, CH2Cl2, 23 8C, 88% over two steps; f) LaCl3·2LiCl, MeMgBr, THF, 0 8C, 35%, 60% recovered 62 ; g) Stewart–Grubbs cat. (20 mol%), 2,6-dichloro-
1,4-benzoquinone, toluene, 111 8C, 86% 63a ; h) LDA, CH3CHO, THF, @78 8C; i) TBSCl, imidazole, DMAP, DMF, 23 8C, 80% over two steps, d.r.=10:1 at C10;
j) LaCl3·2LiCl, isopropenylmagnesium bromide, THF, 0 8C, 93%, d.r.+20:1 at C1; k) TBAF, THF, 0 to 23 8C; l) TPAP, NMO, 4 a MS, CH2Cl2, 23 8C, 87% over two
steps; m) LaCl3·2LiCl, 3-butenylmagnesium bromide, THF, 0 8C, 69%, 27% recovered 66 ; n) Stewart–Grubbs cat. (25 mol%), 2,6-dichloro-1,4-benzoquinone, tol-
uene, 111 8C, 55% 63b, 25% recovered diene. TBS= tert-butyldimethylsilyl, TPAP= tetrapropylammonium perruthenate.
Table 1. Selected conditions for isopropenyl addition to 58 and 59.[a]
Entry Ketone [M] T [8C] Additive d.r.[b]
1 58 Li @78 – n.d.[c]
2 58 MgBr 0 – 1:2[c]
3[d] 58 MgBr 0 CeCl3 1:2
4 58 MgBr 0 LaCl3·2LiCl 1:1
5 58 MgBr @30 LaCl3·2LiCl 3:1
6[e] 59 MgBr 0 LaCl3·2LiCl +20:1
[a] Unless otherwise stated, all reactions were carried out in THF and by
premixing the additive with the ketone for 1 h at 23 8C prior to addition
of the organometallic reagent. [b] As determined by 1H NMR spectroscop-
ic analysis of the crude reaction mixture. [c] Incomplete conversion of the
starting material. [d] The Grignard reagent was premixed with CeCl3.
[e] 91% yield on gram-scale reaction.
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tionship of the latter product was confirmed by formation of
a cyclic carbonate (see the Supporting Information for details).
In an attempt to generate the desired b-C10-OH stereocenter,
as depicted for tricycle 63b, we inverted the order of the last
two reactions. However, first subjecting 62 to ring-closing
metathesis, followed by addition of various methyl organome-
tallic reagents to the resulting tricyclic ketone, again resulted
in formation of undesired tricycle 63a.[53] Eventually, we recog-
nized that the desired C10 stereochemistry of tricycle 63b
could presumably be obtained in a modified sequence that
simply involves switching the two alkyl substituents that are
sequentially introduced by means of the aldol reaction and the
second Grignard addition.
On these grounds, the aldol reaction of ketone 28 with acet-
aldehyde, followed by protection of the resulting secondary al-
cohol as the tert-butyldimethylsilyl ether, efficiently afforded
64 as a single diastereomer at C9 and as an inconsequential
10:1 mixture at C10. Exposure of 64 to isopropenylmagnesium
bromide in the presence of lanthanum(III) chloride bis(lithium
chloride) complex again furnished the product as a single dia-
stereomer at C1. The diastereoselectivity of this reaction arises
from approach of the organometallic species from the sterical-
ly less-hindered face, as shown in transition state 65.[54] Conver-
sion into ketone 66 was then achieved in an analogous fashion
as before. For the introduction of the butenyl chain, premixing
66 with the lanthanide salt prior to addition of 3-butenylmag-
nesium bromide proved to be highly beneficial and, in this
case, increased the conversion beyond 70%. Pleasingly, ring-
closing metathesis of the resulting diene gave tricycle 63b,
which possesses the desired relative stereochemistry at C10.
The final metathesis reaction for the formation of the seven-
membered ring containing a trisubstituted olefin adjacent to
a fully substituted carbon center required careful optimization
of the reaction parameters. Whereas first-generation ring-clos-
ing metathesis catalysts[55] failed to afford any tricyclic prod-
ucts, initial studies using second-generation Hoveyda–
Grubbs[56] or nitro-Grela catalyst[57] gave mixtures of 5–6–7 and
undesired 5–6–6 tricycles. Eventually, it was discovered that
using the less hindered Stewart–Grubbs catalyst (25 mol%),[58]
2,6-dichloro-1,4-benzoquinone (25 mol%) to avoid olefin iso-
merization,[59] high dilution (1 mm) and conducting the reac-
tion at elevated temperature (111 8C) gave the best results. It is
interesting to note that, under these reaction conditions, the
ring-closing metathesis to give 63b was still incomplete after
40 h (55% yield), whereas the analogous reaction that afforded
tricycle 63a reached full conversion in less than 3 h (86%
yield).
Having gained access to tricycle 63b, which features the full
carbon skeleton of (+)-dictyoxetane (3) and constitutes
a benzyl protected intermediate in the proposed biosynthe-
sis,[14] we began to investigate cyclizations to construct the di-
oxatricyclic subunit (Scheme 8). Initially, we envisioned that
direct halo-etherification would serve to construct the tetrahy-
drofuran ring between C10 and C14. However, in practice, ex-
posure of tricycle 63b to active halogen sources (NBS; NIS; KI,
PIDA) exclusively gave regioisomer 67 as a result of opening of
the intermediate halonium ion at the less hindered C13 posi-
tion. Whereas iodide 67 was useless for our purpose, we dis-
covered that treatment with potassium tert-butoxide led to
a very clean semi-pinacol rearrangement[60] and gave 68 in
90% yield. The 5–7–6 carbon framework of the latter product
has been found in various dolastane natural products.[61] We
also investigated oxymercuration of 63b,[62] but found the re-
gioselectivity of the etherification to be equally undesired, fur-
nishing diol 69 after oxidative demercuration. Hydrogenolysis
of the benzyl ether gave triol 70, the structure of which was
unambiguously confirmed by single-crystal X-ray analysis.
Failure to directly form the oxygen bridge between C10 and
C14 from tricycle 63b prompted us to pursue a strategy close-
ly mimicking the proposed biosynthetic exo-tet cyclization se-
quence (Scheme 9).[14] To this end, treatment of 63b with di-
Scheme 8. Cyclizations of tricycle 63b. Reagents and conditions: a) KI, PIDA,
CH2Cl2, 0 to 23 8C, 92%; b) KOt-Bu, THF, t-BuOH, 23 8C, 90%; c) Hg(TFA)2,
CH2Cl2, MeOH, @78 8C, then NaBH4, O2, DMF, 0 8C; d) H2, Pd/C, THF, 23 8C,
31% over two steps. TFA= trifluoroacetate.
Scheme 9. Investigation of the exo-tet cyclization sequence of epoxide 71
according to the proposed biosynthesis. Reagents and conditions: a) DMDO,
acetone, CH2Cl2, @78 8C, +99%, d.r.+15:1; b) Cs2CO3, MeOH, 60 8C, 59% 72,
22% recovered 71; c) H2, Pd/C, THF, 23 8C, 80%. DMDO=dimethyldioxirane.
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methyldioxirane afforded epoxide 71 cleanly and with high se-
lectivity (d.r. + 15:1). Attempted tetrahydrofuran formation by
activation of the epoxide in 71 with various acids (BF3·OEt2 ;
Yb(OTf)3 ; HClO4 ; p-TsOH; PPTS; aq. HCl) mostly led to decom-
position of the starting material and formation of trace
amounts of a product, which we tentatively assigned as an al-
dehyde resulting from Meinwald ring contraction.[63] Pleasingly,
it was discovered that, under basic conditions (Cs2CO3 ; NaOH;
LiOH; LiNEt2), 71 underwent the postulated 3-exo cyclization,
affording a 1:2.5 thermodynamic distribution of 71 and 72. En-
couraged by having realized the first cyclization of the pro-
posed biosynthesis, we next investigated the 5-exo cyclization
to form trans-tetrahydrofuran 73. Disappointingly, we found
this transformation to be unfeasible under a wide range of
acidic (KHSO4 ; Yb(OTf)3 ; aq. HCl; aq. CH3CO2H; Ti(Oi-Pr)4 ;
Sc(OTf)3 ; MgBr2·OEt2), basic (NaH; aq. LiOH) or neutral
(CF3CH2OH; H2O; CH3CN) reaction conditions. Eventually the
benzyl ether in epoxide 72 was cleaved and the resulting triol
74 was recrystallized from a mixture of ethyl acetate/hexanes
to provide crystals suitable for X-ray analysis. The solid-state
structure of 74 confirmed our increasing concerns that the
seven-membered ring adopts a chair-like conformation with
C10-OH being in an equatorial position. The 5-exo cyclization
would thus not only produce a highly strained trans-tetrahy-
drofuran ring, but also require an energetically unfavorable
conformational change to take place beforehand, making the
transformation exceptionally challenging under nonenzymatic
conditions.
Finally, we envisioned that elimination of C13-OH would
both change the seven-membered ring geometry and provide
a more reactive allylic epoxide. Surprisingly, dehydration was
not observed upon exposure of epoxide 72 to Martin sulfu-
rane,[64] but rather formation of dioxatricycle 77 took place
(Scheme 10). The dioxatricyclic substructure was unambiguous-
ly validated by single-crystal X-ray diffraction analysis after con-
version into the benzyl deprotected product, 1,10,13,14-tetra-
epi-dictyoxetane (tetra-epi-3). We were intrigued by this unex-
pected rearrangement that formally led to inversion of two
sterically encumbered, tertiary oxygen substituents. After con-
templating various possible mechanistic pathways and analyz-
ing individual reaction intermediates, we hypothesized that
the sequence should be initiated by the formation of cyclic sul-
furane 75. Martin sulfurane dehydration of tertiary alcohols is
known to occur through an E1-like mechanism,
[65] thus assisting
carbocation formation at C10 and ring-expansion of the epox-
ide. The latter rearrangement, which forms tetrahydrofuran 76,
is driven by the strain release of the epoxide opening and by
generation of a stabilized tertiary carbocation at C1. Finally, ex-
pulsion of diphenyl sulfoxide from 76 produces a C13 alkoxide,
which cyclizes onto the carbocation and thereby completes
the generation of dioxatricycle 77.
Although this proposed mechanism appeared reasonable in
many respects, we were undecided as to whether epoxide-oxe-
tane 78 might also be an intermediate of the unprecedented
rearrangement sequence. We initially speculated that, after for-
mation of cyclic sulfurane 75, the carbocation generated at
C10 might be trapped by the epoxide oxygen to form an oxe-
tane and C14 carbocation (instead of tetrahydrofuran 76). In
this latter scenario, diphenyl sulfoxide expulsion and cycliza-
tion would then furnish epoxide-oxetane 78. Aiming at eluci-
dating the possible involvement of 78 as an intermediate
during the rearrangement of 72 to dioxatricycle 77, we made
a serendipitous discovery. Exposure of epoxide 71 to excess
magnesium bromide ethyl etherate and tetrabutylammonium
bromide not only led to the expected bromohydrin formation,
but also promoted simultaneous oxetane ring closure between
C1 and C10. Treatment of a methanolic solution of this bromo-
hydrin with potassium carbonate then reinstalled the epoxide
and afforded epoxide-oxetane 78 in 94% yield. At this junc-
ture, it was discovered that subjecting 78 to the dehydration
Scheme 10. Synthesis of tetra-epi-dictyoxetane (tetra-epi-3) and investigation of the dyotropic rearrangement of epoxide-oxetane 78. Reagents and condi-
tions: a) Martin sulfurane, CH2Cl2, 0 8C; b) H2, Pd/C, THF, 23 8C, 60% over two steps from 72 ; c) MgBr2·Et2O, TBAB, CH2Cl2, 23 8C, 51%; d) K2CO3, MeOH, 0 8C,
94%; e) Cu(BF4)2·xH2O, CH2Cl2, 23 8C, 36% 77 and 37% 83. TBAB= tetrabutylammonium bromide.
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conditions with Martin sulfurane left the starting material un-
changed. This result led us to exclude a pathway for the for-
mation of dioxatricycle 77 involving the transient formation of
78, and rather corroborated our mechanistic proposal based
on intermediates 75 and 76.
However, fascinated by the two vicinal and highly strained
oxygen heterocycles in 78, we anticipated that a strain-releas-
ing dyotropic rearrangement could convert epoxide-oxetane
78 into dioxatricycle 77.[66] Indeed, mild Lewis acid activation
of 78 with copper(II) tetrafluoroborate hydrate[67] was found to
induce a type I dyotropic rearrangement proceeding through
79 and giving dioxatricycle 77 in 36% yield.
Whereas Mulzer has shown in seminal work that b-lactones
efficiently undergo type I dyotropic reactions to afford g-butyr-
olactones,[68] the dyotropic rearrangement of an epoxide-oxe-
tane substrate appears to be unprecedented. Moreover, we
observed that, under the reaction conditions, epoxide-oxetane
78 was converted into an olefinic byproduct resulting from ox-
etane elimination (20%, see the Supporting Information) and
the ring-contracted enol ether 83 (37% yield). We hypothe-
sized that 83 is formed through initial hydrolysis of the epox-
ide, affording anti-diol 80. Next, ionization of the C14 tertiary
alcohol, followed by a rearrangement, which is driven by the
strain release of oxetane opening, leads to tetrahydrofuran 81.
Finally, ring contraction of the latter compound generates the
5–6–6 tricycle 82, and affords enol ether 83 after elimination.
After having failed to induce the putative biomimetic 5-exo-
tet cyclization of C10-OH onto C14 in epoxide 72, and based
on the fascinating rearrangements we had observed, we re-
turned to our ring-closing metathesis product 63a with the
undesired a-configured C10 alcohol (Scheme 11). We had
learnt that ionization of tertiary alcohols occurred readily in
our system, and we thus concluded that a reverse cyclization
attempt, from C14-OH onto a C10 carbocation, might prove re-
warding to fuse the trans-tetrahydrofuran ring of (+)-dictyoxe-
tane (3). With this idea in mind, we aimed to install a C14 b-
configured hydroxyl group in tricycle 63a. Since dihydroxyla-
tion of 63a was met with failure and epoxidation occurred
nonselectively, the 1,3-cis-diol was converted into siloxane 84.
During our investigations to form a bromohydrin, we found
that exposure of 84 to N-bromosuccinimide in wet tetrahydro-
furan induced benzyl deprotection and concomitant formation
of allylic bromide 85.[69] In a small-scale experiment, we then
discovered that treatment of 85 with tetrabutylammonium
fluoride led to siloxane deprotection and spontaneous 4-exo-
tet cyclization, furnishing oxetane 86. The 4-exo-tet cyclization
was conveniently brought to completion in larger scale experi-
ments by exposure of the crude silyl deprotected product to
potassium tert-butoxide. Although we were unable to func-
tionalize the exo-cyclic olefin of 86 under various conditions
(DMDO; m-CPBA; Hg(OAc)2 ; Co(acac)2, PhSiH3
[70]), the ease with
which the 4-exo-tet cyclization had taken place was deemed
an exceedingly valuable discovery.
Having gained much knowledge concerning the structure
and unique reactivity of the oxygenated tricycles, we turned to
our alternative biosynthetic proposal. By forming the oxetane
prior to the strained trans-tetrahydrofuran, we expected to suc-
ceed in constructing the dioxatricyclic substructure of 3
(Scheme 12). To this end, it was discovered that photo-oxida-
tion[71] of the silyl ether derived from 63b afforded allylic alco-
hol 87 as a single regio- and diastereomer after reduction of
the intermediate hydroperoxide using triphenylphosphine.
Conversion of 87 into oxetane 88 could not be accomplished
under Mitsunobu conditions,[72] and proved unsatisfactory via
formation of the secondary tosylate. However, preparation of
the allylic mesylate, followed by 4-exo-tet cyclization under
basic conditions at elevated temperature, cleanly furnished ox-
etane 88 in an excellent 88% yield over two steps. The
1H NMR spectrum of 88 revealed severe signal broadening at
room temperature, but showed well-resolved resonances upon
Scheme 11. Synthesis of oxetane 86 through 4-exo-tet cyclization. Reagents
and conditions: a) Cl2Si(i-Pr)2, imidazole, DMAP, DMF, 23 8C, 97%; b) NBS, THF,
H2O, 23 8C; c) TBAF, THF, 0 to 23 8C; d) KOt-Bu, THF, 0 8C, 94% over three
steps. NBS=N-bromosuccinimide.
Scheme 12. Sequential 4-exo-tet and 5-exo-trig cyclizations leading to
(+)-dictyoxetane (3) and total synthesis of (+)-dolabellane V (6). Reagents
and conditions: a) Tf2O, 2,6-lutidine, CH2Cl2, @78 8C; b) DDQ, DCE, aq. pH 7
buffer, 40 8C, 44% over two steps; c) TMSI, CH2Cl2, 0 to 23 8C, 92%, d) O2, hv,
TPP, DCE, 0 8C, then PPh3, 23 8C, 71%; e) MsCl, NEt3, CH2Cl2, @78 8C; f) NaH,
THF, 66 8C, 88% over two steps; g) NIS, CH2Cl2, 23 8C; h) H2, Pd/C, THF, 23 8C,
80% over two steps. DCE=1,2-dichloroethane, Ms=methanesulfonyl,
NIS=N-iodosuccinimide, TMSI=1-(trimethylsilyl)imidazole, TPP=meso-tetra-
phenylporphyrin.
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heating to 65 8C (see the Supporting Information for details).
We concluded that oxetane formation had drastically changed
the seven-membered ring conformation and brought the C10-
OTMS moiety into close proximity of the exo-cyclic olefin, thus
impeding its free rotation. As anticipated, this conformational
change proved crucial to enable the 5-exo-trig cyclization to
form the trans-tetrahydrofuran. The final ring closure occurred
smoothly by using N-iodosuccinimide with concomitant trime-
thylsilyl ether deprotection. Hydrogenolysis of the latter prod-
uct using palladium on carbon led to simultaneous dehaloge-
nation of the primary iodide and cleavage of the benzyl ether,
providing (+)-dictyoxetane (3), the analytical data of which
were in excellent agreement with those of the natural prod-
uct.[6, 11]
Moreover, the unexpected reactivity of putative biogenetic
precursors of (+)-dictyoxetane (3), which had led to displace-
ment of the tertiary C14 alcohol or generated a carbocation at
that position, indicated that the envisioned Grob fragmenta-
tion to form the 11-membered carbocycle of (+)-dolabellane
(6) might be a promising endeavor (Scheme 12). Initial at-
tempts to convert the sterically hindered C10-OH of tricycle
63b into the corresponding mesylate or tosylate led to com-
plex product mixtures. Gratifyingly, careful experimentation re-
vealed that treating 63b with trifluoromethanesulfonic anhy-
dride and 2,6-lutidine at low temperature effectuated the frag-
mentation in a single step and afforded macrocycle 89.[73] Fi-
nally, cleavage of the benzyl ether under oxidative conditions
gave (+)-dolabellane (6), the spectroscopic data (1H and
13C NMR, HRMS, IR, [a]D) of which were in full agreement with
those reported for the naturally occurring substance.[11] Nota-
bly, the fragmentation of tricycle 63b also establishes a general
entry to many related dolabellane natural products containing
a 5–11 bicyclic carbon skeleton.[10,11,74]
Conclusion
We have reported the evolution of our strategies aimed at the
total syntheses of the marine diterpenes (+)-dictyoxetane (3)
and (+)-dolabellane V (6). Our initial efforts to construct the
unique 2,7-dioxatricyclo[4.2.1.03,8]nonane ring system of the
former natural product by means of a Paternk–Bechi reaction
or intramolecular oxidative dearomatization were unsuccessful.
Starting from a readily available trans-hydrindane fragment, we
finally pursued a bioinspired strategy. For this purpose, we
orchestrated a series of substrate-controlled and highly diaste-
reoselective transformations to access the advanced tricyclic
core 63b. During our attempts to form the dioxatricyclic subu-
nit by mimicking the proposed biosynthetic cyclizations, we
gained a crucial understanding of the unique reactivity of the
seven-membered ring system and discovered remarkable rear-
rangements. These studies culminated in the discovery of an
unprecedented type I dyotropic reaction of an epoxide-oxe-
tane substrate that gave access to tetra-epi-dictyoxetane
(tetra-epi-3). Eventually, a crucial modification of the originally
postulated biosynthesis, involving formation of the oxetane
prior to the strained trans-tetrahydrofuran, enabled construc-
tion of the complex dioxatricyclic substructure of (+)-dictyoxe-
tane (3). Starting from commercially available 2-methylcyclo-
pentanone (26), the asymmetric total syntheses of (+)-dictyox-
etane (3) and (+)-dolabellane V (6) proceeded in 21 (2.6%
overall yield) and 17 linear steps (2.5% overall yield), respec-
tively.
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3.3 Conclusion and Outlook 
In Part II of this thesis, the first total syntheses of the marine diterpenoids (+)-dictyoxetane  
and (+)-dolabellane V were accomplished. After unsuccessful attempts to form the  
2,7-dioxatricyclo[4.2.1.03,8]nonane ring system of (+)-dictyoxetane via a Paternò−Büchi reaction and a 
strategy involving intramolecular oxidative dearomatization, we adopted a bioinspired approach. While 
we were unable to mimic the originally postulated biosynthesis, we devised a crucial modification 
thereof, which involved formation of the oxetane prior to the strained trans-tetrahydrofuran and that 
eventually enabled us to construct the dioxatricyclic substructure of (+)-dictyoxetane. 
The ultimately successful route was designed by keeping in mind the reasons for our failed 
approaches and by perpetually gaining understanding of the unique reactivity of the oxygenated seven-
membered ring system. Moreover, we discovered a host of interesting transformations during our 
studies, including an unusual sulfur-mediated rearrangement induced by Martin's sulfurane and a strain-
releasing dyotropic rearrangement of an epoxide−oxetane substrate.  
Biological studies of (+)-dictyoxetane, tetra-epi-(−)-dictyoxetane and (+)-dolabellane V are 
currently underway and will be reported in due course. In future work, we moreover aim to explore 
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5 GENERAL EXPERIMENTAL DETAILS 
General Working Methods 





conducted  in  a  heated  oil  bath.  The  reactions  were  magnetically  stirred  and  monitored  by  NMR 
spectroscopy or analytical thin‐layer chromatography (TLC), using glass plates precoated with silica gel 
(0.25 mm, 60‐Å pore size, Merck) impregnated with a fluorescent indicator (254 nm). TLC plates were 











Tetrahydrofuran  (THF) and diethyl ether  (Et2O) were distilled  from Na/benzophenone prior  to use. 
Dichloromethane  (CH2Cl2),  triethylamine  (Et3N),  diisopropylamine  (DIPA)  and  N,N‐
diisopropylethylamine  (DIPEA)  were  distilled  under  nitrogen  atmosphere  from  CaH2  prior  to  use. 
Benzene,  dimethylformamide  (DMF),  dimethylacetamide  (DMA),  dimethyl  sulfoxide  (DMSO), 
acetonitrile (MeCN), toluene and methanol (MeOH) were purchased from Acros Organics as 'extra dry' 
reagents and used as received. All other reagents and solvents were purchased from chemical suppliers 
(Sigma‐Aldrich,  Acros  Organics,  Alfa  Aesar,  Strem  Chemicals,  ABCR)  and  were  used  as  received. 
Solvents for extraction, crystallization and flash‐column chromatography on silica gel were purchased 
in  technical  grade and distilled under  reduced pressure prior  to use.  Lithium chloride was dried at 
100 °C under vacuum (0.1 mmHg) for 12 h and stored in a drying oven at 150 °C (760 mmHg); the hot, 




of n‐butyllithium  solutions was determined by  titration  against  diphenylacetic  acid  as  an  indicator 
(average  of  three  determinations).2  The  concentration  of  freshly  prepared  dimethyldioxirane 
solutions3 was  determined  by  iodometric  titration  as  follows:  A  0.02 M  aqueous  stock  solution  of 
sodium  thiosulfate  pentahydrate  (124 mg  Na2S2O3.5H2O  in  25  mL  H2O)  was  prepared  in  a  25 mL 
graduated cylinder. A 100 mL flask was charged with water (30 mL), sodium iodide (2.00 g) and glacial 
acetic acid (1 mL), whereupon the dimethyldioxirane solution (2 mL) was added. The resulting brown 
mixture was  rapidly  titrated with  the  sodium  thiosulfate  stock  solution  until  disappearance  of  the 
yellow iodine colour occurred.  
   




74  EXPERIMENTAL SECTION 
The  concentration  of  the  dimethyldioxirane  solution  was  calculated  according  to  the  following 
equation: 





NMR  spectra  were measured  on  a Bruker  Avance  III  HD  800 MHz  spectrometer  equipped with  a 
CryoProbeTM,  Bruker  Avance  III  HD  400  MHz  spectrometer  equipped  with  a  CryoProbeTM,  Bruker 







ppm  (multiplicity,  coupling  constants  J  (Hz),  integration  intensity,  assigned  proton)  (e.g.  “5.21  (t,  
3J9/8  =  7.3 Hz,  1H,  9‐H)”).  The multiplicities  are  abbreviated with  s  (singlet),  br  s  (broad  singlet),  d 
(doublet),  t  (triplet),  q  (quartet),  p  (pentet),  se  (sextet),  h  (heptet)  and  m (multiplet).  In  case  of 




follows:  Chemical  shift  in  ppm  (assigned  carbon)  (e.g.  “159.22  (C‐21)”).  In  cases were  resonances 
overlap or cannot be unambiguously assigned to a single proton or carbon atom, multiple assignments 
are  listed  (e.g.  the  13C NMR assignment  “18.29  (C‐16, C‐17),  17.84  (C‐16, C‐17)”  indicates  that  the 
resonance at 18.29 is either C‐16 or C‐17). Additionally to 1H and 13C NMR measurements, 2D NMR 
techniques  such  as  homonuclear  correlation  spectroscopy  (COSY),  heteronuclear  single  quantum 







All mass  spectra were measured  by  the  analytic  section  of  the Department  of  Chemistry,  Ludwig‐
Maximilians‐Universität  München.  Mass  spectra  were  recorded  on  the  following  spectrometers 
(ionisation mode in brackets): MAT 95 (EI) and MAT 90 (ESI) from Thermo Finnigan GmbH. Mass spectra 

















ܿ ∙ ݀  Thereby, the wavelength λ is reported in nm and the measuring temperature ϕ in °C. α represents the 
recorded optical  rotation, c  the  concentration of  the analyte  in 10 mg/mL and d  the  length of  the 
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6 EXPERIMENTAL PROCEDURES, X-RAY 
CRYSTALLOGRAPHIC, COMPUTATIONAL AND 
SPECTROSCOPIC DATA 
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A  solution  of  this  crude  ester  triflate  in  dichloromethane  (300  mL)  was  treated  with 




the  aqueous  layer  was  extracted  with  dichloromethane  (3  x  150  mL),  and  the  combined  organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 
concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (25%  ethyl  acetate  in 
hexanes) to provide triflate 25 as a light yellow oil (22.0 g, 58%). 
TLC  (10%  ethyl  acetate  in  hexanes):  Rf  =  0.28  (UV,  KMnO4).  1H  NMR  (600 MHz,  CDCl3)  δ  4.33  (d,  
2J12A/12B = 13.2 Hz, 1H, 12‐HA), 4.13 (d, 2J12B/12A = 13.2 Hz, 1H, 12‐HB), 2.98–2.90 (m, 1H, 10‐H), 2.68–2.54 
(m,  2H,  8‐H),  2.27–2.19  (m,  1H,  9‐HA),  1.58–1.51  (m,  1H,  9‐HB),  1.15  (d,  3J23/10  =  6.9 Hz,  3H,  23‐H).  
13C NMR (150 MHz, CDCl3) δ 144.05 (C‐7), 135.25 (C‐11), 118.51 (q, 1J13/F = 320 Hz, C‐13), 55.52 (C‐12), 
36.46 (C‐10), 30.12 (C‐8), 28.94 (C‐9), 19.39 (C‐23). HRMS (EI): calcd for (C8H11F3O4S)+: 260.0330, found: 




                                                 
4 Keto ester 11 was prepared on multi‐gram scale according to: a) J. N. Marx, L. R. Norman, J. Org. Chem. 1975, 40, 1602; b) 
H. Niwa, K. Kunitani, T. Nagoya, K. Yamada, Bull. Chem. Soc. Jpn. 1994, 67, 3094. 
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Synthesis of AB‐component 12 
 




argon  and  tightly  sealed  with  a  rubber  septum  and  Teflon  tape.  A  solution  of  triflate  25  (7.35  g,  
28.2  mmol,  1  equiv)  in  degassed  acetonitrile  (270  mL)  and  tributylamine  (13.5  mL,  56.5  mmol,  
2.00 equiv) were added in sequence via syringe. A second Schlenk flask was connected to the main 
reaction chamber by a short piece of rubber tubing, enabling gas exchange between the two separated 














1H,  8‐HB),  2.05–1.98  (m,  1H,  9‐HB),  1.19  (d,  3J23/10  =  7.2  Hz,  3H,  23‐H).  13C  NMR  (150 MHz,  CDCl3)  








assembled  behind  a  blast  shield.  The  left  reaction  chamber  contains  a  suspension  of 
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Synthesis of Diol 9 
 
Based  on  a  slightly  modified  literature  procedure,5  a  mixture  of  K3Fe(CN)6  (159  g,  484  mmol,  
3.00  equiv),  K2CO3  (66.9  g,  484  mmol,  3.0  equiv),  and  hydroquinidine  1,4‐phthalazinediyl  diether  
(1.26 g, 1.61 mmol, 0.01 equiv) was ground to a fine powder and then was dissolved in a mixture of 
















1.25  (s,  3H,  24‐H).  13C NMR  (100 MHz,  CDCl3)  δ  154.40  (C‐20),  152.43  (C‐17),  115.69  (C‐18,  C‐19),  
114.87 (C‐18, C‐19), 72.50 (C‐14), 70.22 (C‐13), 65.59 (C‐16), 55.87 (C‐21), 37.74 (C‐15), 24.32 (C‐24). 
IR (Diamond‐ATR, neat) ṽmax: 3392 (br), 2935 (m) 1508 (s), 1466 (w) 1229 (s), 1038 (m) cm–1. HRMS (EI): 




                                                 
5 E. J. Corey, A. Guzman‐Perez, M. C. Noe, J. Am. Chem. Soc. 1995, 117, 10805. 






























C‐ring butenolide 7: TLC  (35% ethyl acetate  in hexanes): Rf = 0.35 (UV, KMnO4).1H NMR  (400 MHz, 
CDCl3) δ 7.52 (d, 3J13/5 = 5.6 Hz, 1H, 13‐H), 6.85–6.73 (m, 4H, 18‐H, 19‐H), 5.96 (d, 3J5/13 = 5.6 Hz, 1H,  
5‐H), 4.02–3.92 (m, 1H, 16‐HA), 3.90–3.80 (m, 1H, 16‐HB), 3.76 (s, 3H, 21‐H), 2.35–2.18 (m, 2H, 15‐H), 
1.54  (s,  3H,  24‐H).  13C NMR  (100 MHz, CDCl3)  δ  172.60  (C‐4),  160.85  (C‐13),  154.25  (C‐20),  152.41  
(C‐17), 119.65 (C‐5), 115.50 (C‐18, C‐19), 114.86 (C‐18, C‐19), 87.68 (C‐14), 63.61 (C‐16), 55.87 (C‐21), 
38.08  (C‐15),  24.55  (C‐24).  IR  (Diamond‐ATR,  neat)  ṽmax:  2934  (m),  1751  (s),  1508  (s),  1469  (w),  
1229  (s),  1119  (m)  cm–1.  HRMS  (EI):  calcd  for  (C14H16O4Na)+:  271.0946,  found:  271.0940.  
ሾࢻሿࡰ૛૙ = 96.0 (c = 1.00, CH2Cl2).  Allylic alcohol 28: TLC (30% ethyl acetate in hexanes): Rf = 0.32 (UV, KMnO4). 1H NMR (400 MHz, CDCl3) 
δ  6.86–6.79  (m,  4H,  18‐H,  19‐H),  5.93  (dd,  3J13/5A  =  17.2  Hz,  3J13/5B  =  10.7  Hz,  1H,  13‐H),  5.31  (dd,  
3J5A/13  =  17.2  Hz,  2J5A/5B  =  1.4  Hz,  1H,  5‐HA),  5.10  (dd,  3J5B/13  =  10.7  Hz,  2J5B/5A  =  1.4  Hz,  1H,  5‐HB),  
4.14–4.02  (m,  2H,  16‐H),  3.76  (s,  3H,  21‐H),  2.77  (br  s,  1H,  14‐OH),  2.12  (ddd,  2J15A/15B  =  14.3  Hz,  
3J15A/16A = 8.3 Hz,  3J15A/16B = 5.7 Hz, 1H, 15‐HA), 1.93  (app dt,  2J15B/15A = 14.3 Hz,  3J15B/16 = 5.2 Hz, 1H,  
15‐HB), 1.35 (s, 3H, 24‐H). 13C NMR  (100 MHz, CDCl3) δ 154.20 (C‐20), 152.62 (C‐17), 144.29 (C‐13), 
115.72  (C‐18,  C‐19),  114.74  (C‐18,  C‐19),  112.59  (C‐5),  73.20  (C‐14),  66.26  (C‐16),  55.82  (C‐21),  
40.41  (C‐15),  28.73  (C‐14).  IR  (Diamond‐ATR,  neat)  ṽmax:  3504  (br),  2932  (m),  1507  (s),  1466  (m),  




                                                 
6 a) H. J. Bestmann, D. Sandmeier, Angew. Chem. 1975, 87, 630; b) Angew. Chem., Int. Ed. Engl. 1975, 14, 634; the reagent 
was prepared according to c) R. Schobert, Organic Syntheses 2005, 82, 140; Coll. Vol. 2009, 11, 986. 










was  diluted  with  dichloromethane  (100  mL).  The  layers  were  separated,  the  aqueous  layer  was 




obtained by  careful  flash‐column  chromatography  (3% methanol  in dichloromethane),  followed by 
further  purification  by  normal‐phase  semi‐preparative  HPLC  using  2‐propanol‒heptane  (10:90)  as 









1H, 9‐HA),  1.63–1.57  (m,  1H, 9‐HB),  1.55  (s,  3H, 24‐H),  1.26  (d,  3J23/10  = 7.1 Hz, 3H, 23‐H).  13C NMR  










CDCl3)  δ  186.18  (C‐6),  169.88  (C‐4),  168.36  (C‐11),  154.70  (C‐20),  151.83  (C‐17),  136.80  (C‐7),  
115.51  (C‐18,  C‐19),  115.08  (C‐18,  C‐19),  87.37  (C‐14),  64.33  (C‐16),  63.67  (C‐12),  55.90  (C‐21),  
51.72  (C‐5),  46.87  (C‐13),  41.72  (C‐10),  40.17  (C‐15),  30.76  (C‐9),  28.70  (C‐8),  25.26  (C‐24),  18.65  
(C‐23). IR (Diamond‐ATR, neat) ṽmax: 3479 (br), 2934 (m), 1763 (s) 1658 (m) 1507 (s), 1230 (s), 1107 (m) 
cm–1. HRMS (ESI): calcd for (C22H26O6Na)+: 409.1627, found: 409.1620. ሾࢻሿࡰ૛૙ = –28.0 (c = 1.00, CH2Cl2).






















86  EXPERIMENTAL SECTION 
Synthesis of Hemiacetal 14b 
 












3J23/10  = 6.8 Hz, 3H, 23‐H).  13C NMR  (100 MHz, CDCl3) δ 176.61  (C‐4),  154.22  (C‐20),  152.68  (C‐17),  
115.37  (C‐18,  C‐19),  114.90  (C‐18,  C‐19),  107.97  (C‐6),  87.73  (C‐14),  73.48  (C‐12),  64.61  (C‐16),  
55.88  (C‐21),  54.88  (C‐13),  52.01  (C‐11),  50.75  (C‐5),  48.98  (C‐7),  38.41  (C‐10),  35.49  (C‐15),  34.97  




















16‐H), 3.77  (s, 3H, 21‐H), 3.10–3.02  (m, 1H, 7‐H), 2.67–2.62  (m, 2H, H‐5), 2.55–2.48  (m, 1H, 11‐H),  
2.45–2.38 (m, 1H, 13‐H), 2.29 (dt, 2J15A/15B = 15.1 Hz, 3J15A/16 = 5.6 Hz, 1H, 15‐HA), 2.25–2.19 (m, 1H,  
10‐H), 2.19–2.05 (m, 2H, 8‐HA, 15‐HB), 2.05–1.92 (m, 1H, 8‐HB), 1.88–1.79 (m, 1H, 9‐HA), 1.57 (s, 3H,  
24‐H),  1.33–1.20  (m,  1H,  9‐HB),  1.09  (d,  3J23/10  =  6.9  Hz,  3H,  23‐H).  13C  NMR  (100  MHz,  CDCl3)  δ  
179.74  (C‐6),  173.93  (C‐4),  154.14  (C‐20),  152.73  (C‐17),  115.61  (C‐18,  C‐19),  114.84  (C‐18,  C‐19),  










3H,  24‐H),  1.44–1.34  (m,  1H,  9‐HB),  1.05  (d,  3J23/10  =  6.8 Hz,  3H,  23‐H).  13C NMR  (100 MHz,  CDCl3)  
δ 179.90 (C‐6), 173.99  (C‐4), 154.37  (C‐20), 152.32 (C‐17), 115.42 (C‐18, C‐19), 114.97  (C‐18, C‐19), 





88  EXPERIMENTAL SECTION 
Synthesis of Dilactone 15 by retro‐Claisen reaction of Hemiacetal 14b 
  


































1H,  15‐HB),  2.39–2.32  (m,  1H,  11‐H),  2.32–2.24  (m,  2H,  5‐H),  2.08–1.97  (m,  2H,  13‐H,  10‐H),  
1.82–1.68  (m, 1H, 8‐HA), 1.68–1.51  (m, 2H, 8‐HB, 9‐HA), 1.33–1.14  (m, 1H, 9‐HB), 1.22  (s, 3H, 24‐H),  
1.08 (d, 3J23/10 = 6.9 Hz, 3H, 23‐H). 13C NMR (100 MHz, CDCl3) δ 153.81 (C‐20), 153.34 (C‐17), 115.29  
(C‐18, C‐19), 114.77 (C‐18, C‐19), 109.58 (C‐6), 99.59 (C‐4), 84.08 (C‐14), 79.32 (C‐12), 65.77 (C‐16), 
55.88  (C‐21),  54.62  (C‐7),  49.70  (C‐11),  49.18  (C‐13),  37.55  (C‐10),  35.56  (C‐15),  34.29  (C‐9),  32.53  
(C‐8), 32.06 (C‐5), 26.41 (C‐24), 16.29 (C‐23). IR (Diamond‐ATR, neat) ṽmax: 2956 (w), 1507 (s), 1465 (w), 
1229  (s),  1100  (w),  1034  (m), 904  (s)  cm–1. HRMS  (ESI):  calcd  for  (C22H30O5Na)+:  397.19909,  found: 
397.19816. ሾࢻሿࡰ૛૙ = +8.5 (c = 0.21, CH2Cl2).  
   









4‐O‐Trifluoroacetyl  acetal  18:  1H  NMR  (400  MHz,  CD2Cl2)  δ  6.86–6.80  (m,  4H,  18‐H,  
19‐H),  6.20  (s,  1H, 4‐H),  4.89  (s,  1H, 12‐H),  4.43  (s,  1H, 6‐H),  4.17–4.00  (m,  2H, 16‐H),  3.76  (s,  3H,  
21‐H), 2.89 (d, 3J5/13 = 7.6 Hz, 1H, 5‐H), 2.34 (d, 3J13/5 = 7.6 Hz, 1H, 13‐H), 2.33–2.21 (m, 2H, 7‐H, 15‐HA), 






























dichromate  (9.03  g,  24.0  mmol,  2.00  equiv)  was  added  in  three  large  portions  and  stirring  was 
continued at 23 °C. After 10 min, the mixture was filtered through a pad of silica gel (4 cm) and the 







154.13  (C‐20),  152.83  (C‐17),  115.42  (C‐18,  C‐19),  114.88  (C‐18,  C‐19),  86.36  (C‐14),  86.05  (C‐6),  









































78 °C, 15 min
(69% over 






sodium sulfate. The dried solution was  filtered and  the  filtrate was concentrated. The  residue was 
purified by flash‐column chromatography (40% ethyl acetate in pentane) to provide α,β‐unsaturated 
lactone 5 as a colourless foam (3.08 g, 69% over three steps from dilactone 15). 
TLC  (40%  ethyl  acetate  in  hexanes):  Rf  =  0.35  (KMnO4).  1H  NMR  (400 MHz,  CDCl3)  δ  7.05  (app  t,  







36.57  (C‐15),  33.04  (C‐9),  30.92  (C‐8),  28.21  (C‐24),  15.24  (C‐23).  IR  (Diamond‐ATR,  neat)  ṽmax:  
3500 (br), 2949 (m), 1750 (s), 1674 (w), 1508 (s), 1230 (s), 1041 (s), 826 (w) cm–1. HRMS (ESI): calcd for 
(C22H28O5Na)+: 395.18344, found: 395.18264. ሾࢻሿࡰ૛૙ = +61.2 (c = 0.29, CH2Cl2).    
94  EXPERIMENTAL SECTION 
Synthesis of Lactones 20 and 33 
 
Methyllithium  solution  (1.6 M  in  diethyl  ether,  40.8 mL,  65.3 mmol,  8.00  equiv) was  added  to  an  
ice‐cooled suspension of copper iodide (6.22 g, 32.6 mmol, 4.00 equiv) in diethyl ether (110 mL). After 
30 min, the colourless, slightly cloudy mixture was cooled to 45 °C. A solution of unsaturated lactone 




were  separated,  the  aqueous  layer  was  extracted  with  dichloromethane  (3  x  100  mL),  and  the 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered and the 
filtrate  was  concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (35%  ethyl 
acetate  in  hexanes)  to  provide  an  inconsequential mixture  of  kinetic  and  thermodynamic  lactone 
epimers 20 and 33 (20:33 = 4:1) as a yellowish foam (2.40 g, 76%).7 Analytically pure samples of both 
lactones  20  and  33  were  obtained  by  careful  purification  of  the  epimer  mixture  by  flash‐column 
chromatography (20% ethyl acetate in hexanes). 




13‐H),  1.95–1.89  (m,  1H,  7‐H),  1.89–1.82  (m,  1H,  9‐HA),  1.78–1.70  (m,  3H,  11‐H,  8‐H),  1.54  (s,  3H,  
24‐H), 1.47–1.39 (m, 1H, 9‐HB), 1.22 (d, 3J23/10 = 7.0 Hz, 3H, 23‐H), 1.03 (d, 3J22/6 = 7.1 Hz, 3H, 22‐H).  
13C NMR  (100 MHz, CDCl3) δ 177.59 (C‐4), 154.43 (C‐20), 152.19 (C‐17), 115.29 (C‐18, C‐19), 114.93  








1H,  10‐H),  2.06–2.01  (m,  1H,  13‐H),  2.01–1.92  (m,  1H,  6‐H),  1.90–1.80  (m,  2H,  7‐H,  11‐H),  
1.78–1.68  (m, 1H, 8‐HA), 1.68–1.53  (m, 2H, 8‐HB, 9‐HA), 1.41  (s, 3H, 24‐H), 1.35–1.28  (m, 1H, 9‐HB), 
1.29–1.26 (m, 1H, 12‐OH), 1.25 (d, 3J22/6 = 6.2 Hz, 3H, 22‐H), 1.17 (d, 3J23/10 = 7.1 Hz, 3H, 23‐H). 13C NMR 
(100 MHz, CDCl3) δ 179.73 (C‐4), 154.07 (C‐20), 152.81 (C‐17), 115.41 (C‐18, C‐19), 114.85 (C‐18, C‐19), 





                                                 
7 The analogous reaction conducted on smaller scale (~1.0 mmol) reproducibly afforded the mixture of lactone epimers 20 
and 33 in 92% yield. 

















extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 
concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (15%  ethyl  acetate  in 
hexanes, triethylamine pretreated silica gel) to provide enol ether 21 as a colourless oil (253 mg, 53% 
over two steps) together with some acetal 34 (not quantitatively isolated) by‐product. Note: Enol ether 
21  is  an  acid‐  and  moisture  sensitive  compound  and,  for  best  results,  should  be  freshly  prepared 
immediately prior to use in the next reaction. 








(C‐7), 45.11  (C‐11), 38.02  (C‐10), 33.23  (C‐15), 32.18  (2C, C‐8, C‐9), 30.20  (C‐6), 25.71  (C‐24), 22.29  
(C‐22), 15.35 (C‐23). IR (Diamond‐ATR, neat) ṽmax: 2951 (m), 2869 (m), 1660 (w), 1506 (s), 1464 (w), 










23.72  (C‐22),  15.81  (C‐23).  IR  (Diamond‐ATR,  neat)  ṽmax:  2949  (m),  2870  (m),  1507  (s),  1477  (m),  
1462 (m), 1375 (w), 1229 (s), 1180 (w), 1106 (w), 1041 (s) cm–1. HRMS (EI): calcd for (C23H32O4Na)+: 
395.21983, found: 395.21889. ሾࢻሿࡰ૛૙ = +41.2 (c = 0.23, CH2Cl2).  





dichloromethane  (1 mL) was  added.  The  resulting  suspension was  cooled  to 78  °C  and  then was 
treated with dimethyldioxirane solution (0.040 M in acetone, 0.75 mL, 30.1 µmol, 1.60 equiv). After  
3 min,  the mixture was warmed  to  0  °C  and  stirring was  continued  for  12 min.  The mixture was 
concentrated at 23 °C and the residue was dried in vacuo. In a separate flask, a suspension of copper 
iodide  (11.5  mg,  60.2  µmol,  3.2  equiv)  in  ether  (0.5  mL)  was  treated  with  2‐methyl‐1‐





separated,  the  aqueous  layer  was  extracted with  dichloromethane  (3  x  5 mL),  and  the  combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered and the filtrate was 











88.82  (C‐5),  87.02  (C‐4),  81.51  (C‐14),  69.89  (C‐12),  65.91  (C‐16),  55.88  (C‐21),  52.31  (C‐13),  50.60  
(C‐7), 46.09 (C‐11), 39.31 (C‐6), 37.82 (C‐15), 37.47 (C‐10), 32.42 (C‐9), 31.38 (C‐8), 28.07 (C‐24), 26.18 














The mixture was concentrated at 23 °C and the residue was dried  in vacuo.  In a separate  flask, an  
ice‐cooled suspension of aluminium trichloride (752 mg, 5.64 mmol, 8.40 equiv)  in tetrahydrofuran  
(4 mL) was treated with 2‐methyl‐1‐propenylmagnesium bromide solution (0.5 M in tetrahydrofuran,  













2H,  15‐H),  2.24–2.11  (m,  1H,  10‐H),  2.10–1.99  (m,  2H,  6‐H,  8‐HA),  1.99–1.82  (m,  2H,  7‐H,  8‐HB),  
1.82–1.66 (m, 9H, 1‐H, 9‐HA, 11‐H, 13‐H, 21‐H), 1.65–1.52 (m, 1H, 9‐HB), 1.38 (s, 3H, 24‐H), 1.22 (d, 
3J23/10 = 7.0 Hz, 3H, 23‐H), 0.97 (d, 3J22/6 = 7.3 Hz, 3H, 22‐H). 13C NMR (100 MHz, CDCl3) δ 153.89 (C‐20), 
152.93  (C‐17),  140.39  (C‐2),  118.17  (C‐3),  115.46  (C‐18,  C‐19),  114.72  (C‐18,  C‐19),  86.12  (C‐5),  



















2.57–2.39  (m,  2H,  15‐H),  2.34–2.19  (m,  2H,  7‐H,  10‐H),  2.04–1.79  (m,  3H,  6‐H,  8‐H),  1.78  (d,  
4J1/3 = 1.4 Hz, 3H, 1‐H), 1.75 (d, 4J21/3 = 1.4 Hz, 3, 21‐H), 1.68–1.55 (m, 1H, 9‐HA), 1.55–1.44 (m, 1H,  
9‐HB),  1.41  (s,  3H,  24‐H),  1.18  (d,  3J23/10  =  7.1  Hz,  3H,  23‐H),  1.12  (d,  3J22/6  =  7.3  Hz,  3H,  22‐H).  
13C NMR (100 MHz, CDCl3) δ 208.29 (C‐12), 153.75 (C‐20), 153.13 (C‐17), 140.79 (C‐2), 118.04 (C‐3), 




cm–1. HRMS  (ESI):  calcd  for  (C27H38O5Na)+:  465.26169,  found:  465.26100.  ሾࢻሿࡰ૛૙  =  +36.0  (c  =  0.19, CH2Cl2). 
 
   




2.10 equiv)  in  a mixture of  acetonitrile–water  (4:1,  5 mL) was  treated with  ammonium  cerium(IV) 
nitrate (234 mg, 0.43 mmol, 2.10 equiv). After 20 min, the mixture was diluted with saturated aqueous 
sodium  bicarbonate  solution  (15  mL),  water  (10  mL)  and  ethyl  acetate  (15  mL).  The  layers  were 
separated, the aqueous layer was extracted with ethyl acetate (4 x 15 mL), and the combined organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 










63.02  (C‐13),  60.37  (C‐16),  54.78  (C‐11),  50.63  (C‐7),  39.32  (C‐15),  38.46  (C‐6),  37.36  (C‐10),  32.77  
(C‐9), 32.37 (C‐8), 29.76 (C‐24), 26.47 (C‐1), 19.08 (C‐21), 18.76 (C‐22), 16.73 (C‐23). IR (Diamond‐ATR, 
neat) ṽmax: 3383 (br), 2927 (s), 2872 (s), 1705 (s), 1451 (m), 1376 (m), 1109 (m), 1047 (m), 975 (m)  
cm–1. HRMS  (ESI):  calcd  for  (C20H32O4Na)+:  359.21983,  found:  359.21898.  ሾࢻሿࡰ૛૙  =  +29.1  (c  =  0.09, CH2Cl2). 
   


































sodium  bicarbonate  (1.16  mg,  13.9  µmol,  4.40  equiv)  and  Dess‐Martin  periodinane  (2.94  mg,  
6.93 µmol, 2.20 equiv) at 23 °C. After 2.5 h, the mixture was diluted with saturated aqueous sodium 
thiosulfate  solution  (3  mL),  saturated  aqueous  sodium  bicarbonate  solution  (3  mL)  and 






3‐H),  5.13  (app  t,  3J16/15  =  2.1  Hz,  1H,  16‐H),  4.49  (d,  3J4/3  =  9.6  Hz,  1H,  4‐H),  2.88  (s,  1H,  12‐OH),  
2.38–2.26 (m, 1H, 8‐HA), 2.26–2.16 (m, 1H, 10‐H), 2.11 (s, 1H, 13‐H), 2.10–2.04 (m, 1H, 7‐H), 2.04–2.01 
(m, 2H, 15‐H), 1.98–1.90 (m, 2H, 6‐H, 11‐H), 1.77 (d, 4J1/3 = 1.4 Hz, 3H, 1‐H), 1.79–1.74 (m, 2H, 8‐HB,  
9‐HA),  1.73  (d,  4J21/3  =  1.4  Hz,  3H,  21‐H),  1.71–1.61  (m,  1H,  9‐HB),  1.55  (s,  3H,  24‐H),  1.35  (d,  
3J23/10 = 7.2 Hz, 3H, 23‐H), 0.99 (d, 3J22/6 = 7.5 Hz, 3H, 22‐H). 13C NMR (100 MHz, CDCl3) δ 139.14 (C‐2), 
119.75  (C‐3),  98.98  (C‐12),  90.96  (C‐16),  87.43  (C‐5),  77.37  (C‐14),  76.92  (C‐4),  50.84  (C‐7),  49.56  
(C‐11), 46.82 (C‐13), 45.48 (C‐15), 37.84 (C‐10), 33.45 (C‐6), 32.55 (C‐9), 30.64 (C‐8), 27.14 (C‐24), 26.52 
(C‐1),  18.72  (C‐21),  18.38  (C‐22),  18.07  (C‐23).  IR  (Diamond‐ATR,  neat)  ṽmax:  3482  (br),  2930  (s),  
2872 (m), 1450 (w), 1377 (m), 1343 (w), 1234 (w), 1158 (m), 1107 (s), 1089 (m), 1000 (s) cm–1. HRMS 
(EI): calcd for (C20H30O4)+: 334.2144, found: 334.2148. ሾࢻሿࡰ૛૙ = +87.4 (c = 0.04, CH2Cl2).    









layers  were  separated,  the  aqueous  layer  was  extracted  with  ethyl  acetate  (3  x  15  mL),  and  the 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered and the 




sodium sulfate. The dried solution was  filtered and  the  filtrate was concentrated. The  residue was 
purified  by  flash‐column  chromatography  (20%    35%  ethyl  acetate  in  hexanes)  to  provide  












3H,  7‐H,  8‐HB,  10‐H),  2.02  (d,  2J15B/15A  =  13.5  Hz,  1H,  15‐HB),  1.89  (ddd,  2J15A/15B  =  13.5  Hz,  
3J15A/16 = 3.5 Hz, 4J15A/13 = 1.2 Hz, 1H, 15‐HA), 1.86–1.71 (m, 3H, 6‐H, 8‐HA, 9‐HB), 1.72 (d, 4J1/3 = 1.4 Hz, 
3H,  1‐H),  1.69  (d,  4J21/3  =  1.3  Hz,  3H,  21‐H),  1.68–1.57  (m,  1H,  9‐HA),  1.46  (s,  3H,  24‐H),  1.20  (d,  
3J23/10 = 7.2 Hz, 3H, 23‐H), 1.05 (d, J22/6 = 7.6 Hz, 3H, 22‐H). 13C NMR (100 MHz, Acetone‐d6) δ 137.29  
(C‐2),  121.98  (C‐3),  99.38  (C‐12),  91.46  (C‐16),  88.33  (C‐5),  83.10  (C‐11),  77.36  (C‐14),  77.17(C‐4),  
55.88 (C‐7), 47.52 (C‐10), 46.26 (C‐15), 44.51 (C‐13), 34.42 (C‐6), 31.37 (C‐9), 29.54 (C‐8), 27.45 (C‐24), 
26.28 (C‐1), 18.98 (C‐22), 18.54 (C‐21), 15.84 (C‐23). IR (Diamond‐ATR, neat) ṽmax: 3448 (br), 2968 (s), 
2932  (s),  2877  (m),  1455  (m),  1378  (m),  1263  (m),  1111  (s),  1004  (s)  cm–1. HRMS  (ESI):  calcd  for 
(C20H29O5)‒: 349.20205, found: 349.20155. ሾࢻሿࡰ૛૙ = +51.4° (c = 0.29, MeOH).    
                                                 
10 S.‐H. Luo, J. Hua, C.‐H. Li, S.‐X. Jing, Y. Liu, X.‐N. Li, X. Zhao, S.‐H. Li, Org. Lett. 2012, 14, 5768. 
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(‒)‐Norleucosceptroid  B  (2):  TLC  (5%  methanol  in  dichloromethane):  Rf  =  0.20  (CAM).  1H  NMR  
(600 MHz, Acetone‐d6) δ 5.54–5.51 (m, 1H, 3‐H), 5.45 (app td, 3J16/16OH = 6.6 Hz, 3J16/15 = 5.0 Hz, 1H,  
16‐H),  5.37  (d,  3J16OH/16  =  6.6 Hz,  1H,  16‐OH),  4.50  (d,  3J4/3  =  8.8 Hz,  1H,  4‐H),  4.21  (s,  1H,  11‐OH),  
2.65 (app d, J = 1.9 Hz, 1H), 2.19–2.10 (m, 3H, 8‐HB, 9‐HB, 10‐H), 2.08–2.06 (m, 1H, 6‐H), 1.95–1.90  
(m,  1H,  15‐HB),  1.84–1.78  (m,  1H,  7‐H),  1.74  (d,  4J21/3  =  1.2 Hz,  3H,  21‐H),  1.75–1.69  (m,  2H,  8‐HA,  
15‐HA),  1.66  (d,  4J1/3  =  1.5  Hz,  3H,  1‐H),  1.58  (s,  3H,  24‐H),  1.47–1.40  (m,  1H,  9‐HA),  0.98  (d,  
J22/6 = 6.8 Hz, 3H, 22‐H), 0.95 (d, 3J23/10 = 7.3 Hz, 3H, 23‐H). 13C NMR (100 MHz, Acetone‐d6) δ 210.78  













(‒)‐norleucosceptroid  B  (2)  (4.50 mg,  12.8  µmol,  1  equiv)  in  tetrahydrofuran  (0.4 mL)  was  added 













6‐H),  1.76–1.73  (m,  6H,  1‐H,  21‐H),  1.73–1.67  (m,  1H,  8‐HA),  1.44–1.38  (m,  1H,  9‐HA),  1.25  (s,  3H,  
24‐H), 0.98 (d, 3J22/6 = 6.9 Hz, 3H, 22‐H), 0.80 (d, 3J23/10 = 7.4 Hz, 3H, 23‐H). 13C NMR (150 MHz, acetone) 
δ 212.40 (C‐12), 169.51 (C‐20), 156.20 (C‐18), 152.63 (C‐17), 137.17 (C‐2), 122.50 (C‐3), 116.61 (C‐19), 
109.46  (C‐16),  85.62  (C‐11),  84.52  (C‐5),  83.35  (C‐14),  77.30  (C‐4),  71.70  (C‐13),  50.45  (C‐7),  46.25  
(C‐10),  42.27  (C‐6),  41.63  (C‐15),  31.04  (C‐9),  30.62  (C‐8),  26.17  (C‐21),  24.32  (C‐24),  18.84  (C‐1),  
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6.1.2  X‐Ray Crystallographic Data 
The data  collections were performed either on an Oxford Diffraction Xcalibur diffractometer,  on  a 
Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoKα‐radiation  
(λ  =  0.71073 Å,  graphite monochromator).  The  CrysAlisPro  software  (version  1.171.33.41)[S8] was 
applied for the integration, scaling and multi‐scan absorption correction of the data. The structures 
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6.1.3  Computational Details 















C    -5.947000   -4.245000    5.735000 
C    -3.549000   -2.575000    3.399000 
C    -2.520000   -3.716000    3.497000 
C    -4.114000   -2.786000    2.001000 
O    -3.361000   -3.661000    1.300000 
C    -2.136000   -3.895000    2.001000 
C     1.028000   -5.779000    4.160000 
O    -0.132000   -5.514000    3.489000 
C    -0.195000   -5.631000    2.076000 
C    -4.595000   -3.480000    5.649000 
C    -4.106000   -5.695000    6.488000 
C    -5.607000   -5.704000    6.135000 
C    -3.436000   -7.067000    6.353000 
C     2.129000   -5.898000    6.322000 
C     0.992000   -5.648000    5.550000 
C    -3.506000   -4.572000    5.608000 
O    -5.108000   -2.277000    1.541000 
C    -1.607000   -5.283000    1.594000 
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C    -4.588000   -2.456000    4.514000 
C     4.529000   -6.437000    7.797000 
O     4.486000   -6.549000    6.383000 
C     2.224000   -6.166000    3.548000 
C     3.361000   -6.415000    4.321000 
C     3.326000   -6.284000    5.711000 
C    -1.148000   -2.808000    1.541000 
O    -5.377000   -1.536000    4.529000 
C    -3.143000   -4.942000    4.172000 
O    -4.318000   -5.286000    3.454000 
H    -6.483000   -4.230000    4.759000 
H    -6.616000   -3.772000    6.490000 
H    -2.998000   -1.604000    3.383000 
H    -1.630000   -3.386000    4.083000 
H     0.549000   -4.957000    1.601000 
H     0.049000   -6.674000    1.774000 
H    -4.466000   -2.913000    6.604000 
H    -4.012000   -5.371000    7.555000 
H    -5.810000   -6.395000    5.287000 
H    -6.223000   -6.046000    6.997000 
H    -3.555000   -7.498000    5.336000 
H    -2.345000   -7.008000    6.567000 
H    -3.872000   -7.799000    7.069000 
H     2.062000   -5.784000    7.415000 
H     0.054000   -5.344000    6.044000 
H    -2.581000   -4.193000    6.108000 
H    -1.610000   -5.346000    0.481000 
H    -2.315000   -6.074000    1.927000 
H     3.817000   -7.145000    8.271000 
H     4.303000   -5.397000    8.117000 
H     5.550000   -6.690000    8.150000 
H     2.293000   -6.280000    2.456000 
H     4.300000   -6.720000    3.830000 
H    -1.559000   -1.780000    1.645000 
H    -0.204000   -2.832000    2.127000 
H    -0.874000   -2.932000    0.469000 
H    -2.421000   -5.785000    4.179000 










O   -15.664000  -19.101000   13.485000 
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C   -14.707000  -11.856000   11.608000 
O   -14.341000  -17.141000   13.286000 
C   -16.502000   -7.475000   13.481000 
O   -15.728000   -7.869000   12.359000 
C   -14.298000  -10.820000   10.763000 
C   -14.656000   -9.499000   11.043000 
C   -15.426000   -9.188000   12.165000 
C   -15.835000  -10.224000   13.011000 
C   -15.477000  -11.545000   12.731000 
O   -14.405000  -13.175000   11.414000 
O   -15.338000  -19.286000   10.591000 
C   -15.682000  -15.563000    9.190000 
C   -13.454000  -15.096000   10.298000 
C   -13.638000  -13.576000   10.288000 
C   -15.103000  -15.218000   15.577000 
C   -16.173000  -17.364000   15.761000 
C   -13.818000  -14.382000   15.570000 
C   -15.507000  -15.892000   11.699000 
C   -15.273000  -18.095000   10.779000 
O   -14.384000  -17.301000   10.156000 
C   -14.743000  -15.931000   10.350000 
C   -14.921000  -16.603000   16.219000 
C   -16.069000  -17.325000   11.813000 
C   -16.412000  -16.910000   14.300000 
C   -15.632000  -17.716000   13.236000 
C   -14.714000  -15.794000   13.030000 
C   -15.713000  -15.515000   14.179000 
H   -14.978000  -19.495000   12.959000 
H   -16.636000   -6.374000   13.460000 
H   -17.509000   -7.944000   13.449000 
H   -15.987000   -7.741000   14.428000 
H   -13.689000  -11.022000    9.868000 
H   -14.328000   -8.689000   10.370000 
H   -16.442000  -10.019000   13.906000 
H   -15.805000  -12.351000   13.406000 
H   -16.075000  -14.528000    9.286000 
H   -15.167000  -15.631000    8.206000 
H   -16.567000  -16.235000    9.140000 
H   -12.788000  -15.384000   11.142000 
H   -12.891000  -15.375000    9.376000 
H   -12.641000  -13.085000   10.318000 
H   -14.144000  -13.261000    9.350000 
H   -15.873000  -14.665000   16.169000 
H   -16.053000  -18.465000   15.858000 
H   -17.042000  -17.064000   16.390000 
H   -12.971000  -14.917000   15.086000 
H   -13.961000  -13.419000   15.033000 
H   -13.494000  -14.137000   16.606000 
H   -16.316000  -15.128000   11.668000 
H   -14.000000  -17.100000   15.842000 
H   -14.852000  -16.544000   17.328000 
H   -17.165000  -17.394000   11.640000 
H   -17.499000  -16.869000   14.062000 
H   -13.857000  -15.097000   13.006000 





112  EXPERIMENTAL SECTION 
Computed free energy: ‐1306.051948 hartree 
Cartesian coordinates: 
C    -1.227000    2.085000    4.550000 
C    -1.697000    0.728000    5.104000 
C    -0.817000    0.619000    6.365000 
C    -0.618000    2.083000    6.721000 
C    -3.143000    0.507000    5.625000 
C    -2.910000   -0.637000    6.637000 
C    -1.627000   -0.222000    7.388000 
C    -2.302000    1.954000    2.241000 
C    -2.157000    2.757000    3.540000 
C    -2.607000    3.030000    1.223000 
O    -2.390000    4.257000    1.737000 
C    -1.710000    4.143000    2.993000 
C    -3.823000    1.680000    6.358000 
O    -3.025000    2.843000    0.107000 
C    -2.207000    5.274000    3.902000 
C    -0.199000    4.248000    2.725000 
C     0.230000    5.509000    1.969000 
O    -0.199000    2.505000    7.771000 
O    -1.045000    2.884000    5.717000 
O     1.634000    5.442000    1.760000 
C     2.280000    6.452000    1.102000 
C     3.663000    6.321000    0.954000 
C     4.409000    7.301000    0.296000 
C     3.778000    8.435000   -0.227000 
C     2.396000    8.566000   -0.078000 
C     1.650000    7.585000    0.580000 
O     4.425000    9.444000   -0.885000 
C     5.829000    9.376000   -1.083000 
H    -0.233000    1.935000    4.070000 
H    -1.441000   -0.089000    4.387000 
H     0.166000    0.148000    6.134000 
H    -3.803000    0.165000    4.794000 
H    -2.739000   -1.595000    6.094000 
H    -3.771000   -0.786000    7.325000 
H    -1.877000    0.382000    8.289000 
H    -1.055000   -1.114000    7.727000 
H    -3.116000    1.199000    2.310000 
H    -1.358000    1.430000    1.971000 
H    -3.172000    2.871000    3.978000 
H    -4.030000    2.543000    5.694000 
H    -4.808000    1.370000    6.773000 
H    -3.225000    2.061000    7.213000 
H    -1.680000    5.280000    4.881000 
H    -2.057000    6.275000    3.443000 
H    -3.295000    5.185000    4.115000 
H     0.349000    4.213000    3.695000 
H     0.137000    3.360000    2.142000 
H    -0.295000    5.566000    0.991000 
H    -0.016000    6.416000    2.562000 
H     4.169000    5.430000    1.362000 
H     5.496000    7.162000    0.199000 
H     1.890000    9.456000   -0.487000 
H     0.562000    7.726000    0.675000 
H     6.161000   10.280000   -1.634000 
H     6.364000    9.352000   -0.110000 
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6.1.4  Comparison of 1H and 13C NMR Data for Natural15 and Synthetic Norleucosceptroid A 
 
1H Position  Natural (400 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.69 (s, 3H)  1.69 (d, 1.3)  0 
3  5.26 (d, 9.4)  5.29‒5.23 (m)   
4  4.46 (d, 9.4)  4.46 (d, 9.4)  0 
6  1.77 (m)  1.86‒1.71 (m)   
7  2.15 (m)  2.23‒2.09 (m)   
8α  1.80 (m)  1.86‒1.71 (m)   
8β  2.16 (m)  2.23‒2.09 (m)   
9α  1.62 (m)  1.68‒1.57 (m)   
9β  1.73 (m)  1.86‒1.71 (m)   
10  2.13 (m)  2.23‒2.09 (m)   
11‐OH  3.60 (s)  3.58 (br s)  0.02 
12‐OH  3.95 (s)  3.93 (br s)  0.02 
13  2.59 (s)  2.60 (d, 1.2)  0.1 
15a  1.89 (dd, 3.4, 13.6)  1.89 (ddd, 13.5, 3.5, 1.2)  0 
15b  2.02, overlapped  2.02 (d, 13.5)  0 
16  5.09 (d, 3.3)  5.09 (d, 3.5)  0 
21  1.72 (s, 3H)  1.72 (d, 1.4)  0 
22  1.04 (d, 7.6, 3H)  1.05 (d, 7.6)  0.01 
23  1.19 (d, 7.2, 3H)  1.20 (d, 7.2)  0.01 
24  1.45 (s, 3H)  1.46 (s)  0.01 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (100 MHz, acetone‐d6)  Δδ (ppm) 
1  18.5, q  18.5  0 
2  137.2, s  137.3  0.1 
3  121.9, d  122.0  0.1 
4  77.1, d  77.2  0.1 
5  88.3, s  88.3  0 
6  34.4, d  34.4  0 
7  55.8, d  55.9  0.1 
8  29.5, t  29.5  0 
9  31.3, t  31.4  0.1 
10  47.5, d  47.5  0 
11  83.0, s  83.1  0.1 
12  99.3, s  99.4  0.1 
13  44.5, d  44.5  0 
14  77.3, s  77.4  0.1 
15  46.2, t  46.3  0.1 
16  91.4, d  91.5  0.1 
21  26.2, q  26.3  0.1 
22  18.9, q  19.0  0.1 
23  15.8, q  15.8  0 
24  27.4, q  27.5  0.1 
                                                 
15 S.‐H. Luo, J. Hua, C.‐H. Li, S.‐X. Jing, Y. Liu, X.‐N. Li, X. Zhao, S.‐H. Li, Org. Lett. 2012, 14, 5768. 
114  EXPERIMENTAL SECTION 
natural (‒)-norleucosceptroid A 
synthetic (+)-norleucosceptroid A 
natural (‒)-norleucosceptroid A 
synthetic (+)-norleucosceptroid A 
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6.1.5  Comparison of 1H and 13C NMR Data for Natural16 and Synthetic Norleucosceptroid B 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.65 (s, 3H)  1.66 (d, 1.3, 3H)  0.1 
3  5.51 (d, 8.5)  5.53 (d, 8.8)  0.2 
4  4.49 (d, 8.5)  4.50 (d, 8.6)  0.1 
6  2.06 (m)  2.07–2.03 (m)   
7  1.79 (m)  1.83–1.78 (m)   
8α  1.71 (m)  1.75–1.71 (m)   
8β  2.13 (m)  2.16–2.11 (m)   
9α  1.43 (m)  1.46–1.41 (m)   
9β  2.13 (m)  2.16–2.11 (m)   
10  2.14 (m)  2.16–2.13 (m)   
11‐OH  4.25 (s)  4.24 (s)  0.1 
13  2.63 (s)  2.64 (s)  0.1 
15a  1.69 (m)  1.73–1.68 (m)   
15b  1.91 (m)  1.95–1.88 (m)   
16  5.43 (d, 3.5)  5.47–5.42 (m)   
16‐OH  5.44 (s)  5.41 (d, 6.4)  0.3 
21  1.72 (s, 3H)  1.73 (d, 3H)  0.1 
22  0.97 (d, 7.0, 3H)  0.98 (d, 6.8, 3H)  0.1 
23  0.94 (d, 7.5, 3H)  0.95 (d, 7.2, 3H)  0.1 
24  1.56 (s, 3H)  1.57 (s, 3H)  0.1 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (100 MHz, acetone‐d6)  Δδ (ppm) 
1  18.6, q  18.7  0.1 
2  138.7, s  138.7  0 
3  122.1, d  122.1  0 
4  77.8, d  77.9  0.1 
5  87.0, s  87.0  0 
6  40.6, d  40.6  0 
7  52.5, d  52.5  0 
8  30.5, t  30.5  0 
9  31.6, t  31.6  0 
10  48.4, d  48.4  0 
11  86.9, s  86.9  0 
12  210.8, s  210.8  0 
13  64.0, d  64.1  0.1 
14  80.7, s  80.7  0 
15  50.1, t  50.1  0 
16  92.1, d  92.2  0.1 
21  26.1, q  26.1  0 
22  14.6, q  14.6  0 
23  18.5, q  18.5  0 
24  23.9, q  24.0  0.1 
   
                                                 
16 S.‐H. Luo, J. Hua, C.‐H. Li, S.‐X. Jing, Y. Liu, X.‐N. Li, X. Zhao, S.‐H. Li, Org. Lett. 2012, 14, 5768. 
116  EXPERIMENTAL SECTION 
synthetic (‒)-norleucosceptroid B 
natural (+)-norleucosceptroid B 
natural (+)-norleucosceptroid B
synthetic (‒)-norleucosceptroid B 
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6.1.6  Comparison of 1H and 13C NMR Data for Natural17 and Synthetic Leucosceptroid K 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.73 (d, 1.0)  1.76‒1.73 (m)   
3  5.57 (d, 8.9)  5.60‒5.57 (m)   
4  4.72 (d, 9.0)  4.74 (d, 8.9)  0.02 
5‐OH  3.91 (s)  3.89 (br s)  0.02 
6  1.76 (m)  1.83‒1.76 (m)   
7  2.02 (m)  2.15‒2.02 (m)   
8α  1.68 (m)  1.73‒1.67 (m)   
8β  2.10 (m)  2.15‒2.02 (m)   
9α  1.39 (m)  1.44‒1.38 (m)   
9β  2.03 (m)  2.15‒2.02 (m)   
10  2.26 (m)  2.31‒2.24 (m)   
11‐OH  4.19 (s)  4.17 (br s)  0.02 





16  5.76 (2H, t, 7.6)  5.76 (t, 7.6)  0 
19  6.01 (s)  6.01 (s)  0 
21  1.73 (s)  1.76‒1.73 (m)   
22  0.96 (d, 6.8)  0.98 (d, 6.9)  0.02 
23  0.78 (d, 7.4)  0.80 (d, 7.4)  0.02 
24  1.23 (s)  1.25 (s)  0.02 
25  2.19 (s)  2.20 (d, 1.4)  0.01 
 
   
                                                 
17 S.‐H. Luo, J. Hua, X.‐M. Niu, Y. Liu, C.‐H. Li, Y.‐Y. Zhou, S.‐X. Jing, X. Zhao, S.‐H. Li, Phytochemistry 2013, 86, 29. 
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13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (150 MHz, acetone‐d6)  Δδ (ppm) 
1  18.8  18.8  0 
2  137.1  137.2  0.1 
3  122.4  122.5  0.1 
4  77.2  77.3  0.1 
5  84.4  84.5  0.1 
6  42.2  42.3  0.1 
7  50.3  50.5  0.2 
8  30.6  30.6  0 
9  30.9  31.0  0.1 
10  46.1  46.3  0.2 
11  85.5  85.6  0.1 
12  212.4  212.4  0 
13  71.6  71.7  0.1 
14  83.3  83.4  0.1 
15  41.6  41.6  0 
16  109.4  109.5  0.1 
17  152.5  152.6  0.1 
18  156.2  156.2  0 
19  116.6  116.6  0 
20  169.5  169.5  0 
21  26.1  26.2  0.1 
22  14.0  14.0  0 
23  16.9  17.0  0.1 
24  24.3  24.3  0 
25  11.7  11.7  0 
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(+)-norleucosceptroid A 
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(‒)-norleucosceptroid B 
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6.2.1  Natural Product Isolation 























solvent mixtures  of  various  polarities  starting with  petroleum  ether  and  progressing  to  petroleum 
ether/chloroform (from 10:0 to 0:10, v/v), and then chloroform/acetone (from 10:0 to 0:10, v/v) to 
give nine fractions A‐I. Fraction E (14.2 g) was further chromatographed on a silica gel column using a 
solvent  mixture  of  petroleum  ether/ethyl  acetate  (19:1,  v/v)  to  give  four  sub‐fractions  E1‐E4. 





preparative  HPLC  with  75%  MeOH/water  (flow  rate:  3  mL/min,  column:  ZORBAX  SB‐C18,  5  m,  
9.4  ×  250 mm,  detection: UV  238  nm,  retention  time:  t  =  12.4  and  14.1 min)  to  yield  compounds  
1 (117.8 mg) and 5 (27.5 mg) as colorless oils. Crystallization of 1 with a mixture of MeOH/water (8:1) 
gave colorless blocks. Subfraction F3 (3.7 g) was repeatedly chromatographed on a silica gel column 
using  petroleum  ether/acetone  (8:1,  v/v)  as  eluent  and  finally  purified  by  reversed‐phase  semi‐







The  leaves  of  L.  canum  (12.5  kg)  were  air‐dried,  powdered,  and  then  soaked  in  petroleum  ether  
(3    20 L)  at  room  temperature  for  24  h.  The  extract  was  evaporated  to  dryness  under  reduced 
pressure  to yield 203 g of an oily  residue. This petroleum ether extract was separated by silica gel 
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column chromatography using solvent mixtures of various polarities starting with petroleum ether and 
progressing to petroleum ether/chloroform (from 10:0 to 0:10, v/v), chloroform/acetone (from 10:0 
to  0:10,  v/v)  to  give  nine  fractions  A‐I.  Fraction  F  (40.0  g)  was  subjected  to  silica  gel  column 
chromatography with petroleum ether/ethyl acetate (15:1, v/v) as eluent to afford five subfractions 
F1‐F5. Subfraction F3 (2.9 g) was further subjected to silica gel column chromatography with petroleum 
ether/acetone  (8:1,  v/v)  as  eluent  and purified by  reversed‐phase  semipreparative HPLC with 63% 
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1.79  (s)  were  clearly  visible.  In  the  low‐field  region,  a  pair  of  AB  doublets  at  δH  5.20  and  
5.53 (J = 9.8 Hz) were also observed. Twenty‐one carbon resonances were displayed in the 13C NMR 
spectrum (Table S2 and Figure S7), and were further classified by DEPT experiments as five methyls, 
four  methylenes,  six  methines,  including  an  oxymethine  (δC  79.6)  and  an  olefinic  methine  
(δC 123.8), and six quaternary carbons, including an oxygenated (δC 87.7) and three olefinic (δC 138.4, 
139.0, and 165.7) quaternary carbons, a carboxylic acid  (δC 174.9), and an ,‐unsaturated ketone  
(δC  197.2).  The  above  data  revealed  various  similarities with  those  of  leucosceptroids  B18  and  E19, 
although the furan or lactone moieties in the C‐14 side chains were absent and instead a carboxylic 




spectra,  including  1H‐1H COSY, HSQC and HMBC  (Figures S8‐S11).  Especially  the HMBC correlations 
(Figure  S1)  from  the  protons  of  the  –CH2CH2– moiety  (C‐15  and  C‐16)  to  the  carboxylic  carbon  at  
δC 174.9 (C‐17) confirmed that 1 was a C‐17‐C‐18 cleavage product of the C25 leucosceptroids. In the 
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ROESY spectrum (Figure S11) of 1, the correlations of Me‐22 with H‐4 and H‐7, and of Me‐23 with H‐6, 
indicated  that  Me‐22,  H‐4,  and  H‐7  were  all  β‐oriented  while  Me‐23  and  H‐6  were  α‐oriented. 
However, due to overlapping of H‐10, H‐11, and H‐15b (δH 2.08‐2.11), the configuration of C‐11 was 
difficult  to  determine  by  ROESY  experiment.  Therefore,  a  single  crystal  of 1  was  obtained  from  a 








1,  suggesting  that 2 was  also  a  tetranorsesterterpenoid.  The NMR  spectra  of 2  (Tables  S1  and  S2) 
closely resembled those of 1 except that an oxygenated quaternary carbon at δC 86.1 in 2 replaced the 
methine at δC 61.5 (C‐11) in 1, indicating that C‐11 of 2 was hydroxylated. This was further confirmed 










was  confirmed  by  the  COSY  coupling  relationship  of  H2‐15/H2‐16/16‐OH  (Figure  S20)  and  HMBC 
correlations from Me‐24 to C‐15 and H2‐16 to C‐14 (Figures S3 and S22). The ROESY spectrum of 3 
(Figure S23) displayed the same correlation pattern as that of 2, and its C‐11 chemical shift was also 
close to that of 2,  indicating  the same relative configurations  for  the two compounds. Thus, 3 was 
identified as shown in Figure 1, and was named norleucosceptroid F. 
For  compound 4  the molecular  formula of C20H28O4,  as  indicated  from  its HR‐EI‐MS  (observed m/z 




correlations  from H2‐15  to C‐13, C‐14, C‐24, and  the aldehyde carbon. Compound 4 was  therefore 
identified as shown in Figure 1, and was named norleucosceptroid G. 
The EI‐MS and HR‐EI‐MS of 5 indicated a molecular formula of C20H28O4. The NMR data (Tables S1 and 
S2,  Figures  S30‐S35)  of 5 were  very  similar  to  those  of 4, with  the major  differences  arising  from 
additional oxygenation at C‐16 and deoxygenation at C‐11. Comparison of the NMR spectra of 5 with 
those  of  1  showed  a  close  resemblance,  except  for  one  missing  methylene  group  in  the  former 
compound.  In  the  HMBC  spectrum  of  5,  the  correlations  from H2‐15  to  C‐13,  C‐14,  C‐24,  and  the 
carboxylic carbon δC 171.6 also indicated that C‐16 of 5 was carboxylated. Therefore, compound 5 was 
identified as shown in Figure 1, and was named norleucosceptroid H.  
Compounds 6  and 7 were  separately  isolated  as  colorless  oils  by  reversed‐phase  semi‐preparative 
HPLC,  and  the  molecular  formulas  of  C25H36O7  (m/zobsd  448.2435,  m/zcalcd  448.2461)  and  C25H36O6 
(m/zobsd 431.2424, m/zcalcd 431.2433), respectively, were deduced from the HR‐ESI‐MS and 13C NMR 
                                                 
20 Luo, S. H.; Weng, L. H.; Xie, M. J.; Li, X. N.; Hua, J.; Zhao, X.; Li, S. H. Org. Lett. 2011, 13, 18641867. 
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spectra.  Strikingly,  the  same  unsaturation  degree  and  a  similarity  of  the  NMR  spectra  of 6  and 7  
(Tables  S1  and  S2)  with  those  of  leucosceptroids  G  and  J,19  respectively,  was  found.  The  major 
difference was that a hemiketal carbon in 6 (δC 108.9) and 7 (δC 109.1) replaced an oxygenated methine 
group  in  leucosceptroids G and  J,  respectively,  suggesting  that either C‐4 or C‐17 of 6  and 7 were 













No.  1  2b  3c  4d 5 6e  7f










(10.0)  5.73 d (9.8)  5.53 d (9.9)  4.69 d (8.9)  4.42 d (8.5) 
6  2.42 m  2.33 m  2.32 m 2.39 m 2.31 m 1.77 m  1.87 m
7  1.88 m  2.13 m  2.13 m 2.17 m 1.88 m 2.03 m  1.81 m
8α  1.46 m  1.67 m  1.67 m 1.71 m 1.46 m 1.69 m  1.29 m
8β  1.90 m  2.12 m  2.12 m 2.18 m 1.90 m 2.09 m  1.81 m
9α  1.31 m  1.40 m  1.41 m 1.44 m 1.33 m 1.40 m   1.30 m
9β  1.95 m  2.14 m  2.14 m 2.19 m 1.97 m 2.00 m  1.93 m
10  2.08 m  2.17 m  2.16 m 2.19 m 2.10 m 2.27 m  2.04 overlap
11  2.11 m  ‐  ‐  ‐ 2.05 m ‐  1.78 m
13  ‐  ‐  ‐  ‐ ‐ 2.63 s  2.73 s
15a  1.83 m  2.01 m  2.00 m (2H)  2.69 dd (15.4, 3.2)  2.57 d (14.2)  1.64 m  1.64 m 
15b  2.10 m  2.08 m  ‐  2.76 dd (15.4, 2.7)  2.82 d (14.2)  1.81 m  1.79 m 
16a  2.05 m  2.16 m  3.57 m 9.75 s ‐ 2.18 m  1.96 m
16b  2.33 m  2.39 m  3.62 m ‐ ‐ 2.30 m  2.19 m
19  ‐  ‐  ‐  ‐ ‐ 5.80 s  5.79 brs
21g  1.77 s   1.76 s   1.76 s  1.79 s 1.71 s  1.72 s   1.71 d (1.5)
22g  1.05 d (7.0)  1.11 d (7.0)  1.12 d (7.0)  1.16 d (7.0)  1.04 d (7.1)  0.96 d (6.8)  0.94 d (7.0) 
23g  1.11 d (6.0)  0.92 d (7.0)  0.92 d (7.0)  0.89 d (6.6)  1.11 d (6.3)  0.82 d (7.4)  1.12 d (7.0) 
24g  1.34 s   1.04 s  1.36 s 1.49 s 1.39 s 1.18 s  1.10 s
25g  ‐  ‐  ‐  ‐ ‐ 2.04 s  2.03 brs
a 1H NMR of compounds 1‐3, 5‐7 were recorded at 500 MHz; 1H NMR of compound 4 was recorded at 400 MHz. 
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13C NMR Data of Compounds 17 in Acetone‐d6 
Table S2. 13C NMR Data of Compounds 17 in Acetone‐d6 (125 MHz, δ in ppm) 
No.  1  2  3  4 5 6 7 
1  18.2 q  18.3 q  18.3 q  18.4 q 18.2 q 18.7 q  18.7 q 
2  138.4 s  139.0 s  139.3 s 139.6 s 137.5 s 137.0 s  136.9 s 
3  123.8 d  123.3 d  123.3 d 122.9 d 124.4 d 122.5 d  122.5 d 
4  79.6 d  80.5 d  80.6 d  81.2 d 80.1 d 77.0 d  77.0 d 
5  165.7 s  166.6 s  165.7 s 166.8 s 163.5 s 84.2 s 86.2 s 
6  37.7 d  33.0 d  33.1 d  33.1 d 37.9 d 42.0 d  47.2 d 
7  54.5 d  56.1 d  56.0 d  56.2 d 54.1 d 50.2 d  46.4, d 
8  28.6 t  29.3 t 29.4 t  29.7 t 28.6 t 30.5 t 29.0 t 
9  32.8 t  32.3 t 32.3 t  32.4 t 32.9 t 30.9 t 32.9 t 
10  33.5 d  47.4 d  47.7 d  47.6 d 33.5 d 46.2 d  33.8 d 
11  61.5 d  86.1 s 86.0 s  86.1 s 61.6 d 85.5 s 65.1 d 
12  197.2 s  197.7 s  197.7 s 197.8 s 197.3 s 212.6 s  210.8 s 
13  139.0 s  138.0 s  138.6 s 137.8 s 139.3 s 72.1 d  72.4 d 
14  87.7 s  88.3 s 89.0 s  86.7 s 86.5 s 83.2 s 82.2 s 
15  34.2 t  34.8 t 42.4 t  52.9 t 43.9 t 38.4 t 37.4 t 
16  30.0 t  29.9 t 59.4 t  201.9 d 171.6 s 31.7 t 31.2 t 
17  174.9 s  174.9 s  ‐  ‐ ‐ 108.9 s  109.1 s 
18  ‐  ‐  ‐  ‐ ‐ 168.4 s   168.3 s 
19  ‐  ‐  ‐  ‐ ‐ 118.4 d  118.3 d 
20  ‐  ‐  ‐  ‐ ‐ 170.9 s  170.7 s 
21  26.0 q  25.9 q  25.9 q  26.0 q 26.0 q 26.1 q  26.1 q 
22  15.9 q  18.1 q  18.3 q  18.1 q 16.0 q 13.9 q  14.0 q 
23  21.3 q  19.2 q  19.1 q  19.3 q 21.4 q 17.1 q  22.0 q 
24  27.4 q  26.3 q  26.5 q  27.1 q 27.9 q 23.7 q  22.8 q 
25  ‐  ‐  ‐  ‐ ‐ 12.5 q  12.6 q 
 
   
SUPPORTING INFORMATION FOR CHAPTER 2.2.2  157 
Physical‐Chemical Properties of Compounds 1–7 
 








Norleucosceptroid  F  (3):  colorless  oil;  [α]D26  =  +  10.8  (c  =  0.2,  MeOH);  UV  (MeOH)  λmax  (log  ε  ):  
246 (3.41), 202 (3.39), 191 (3.27) nm; IR (KBr) νmax: 3441, 2963, 2932, 2875, 1665, 1461, 1379, 1285, 
1046 cm–1; EI‐MS m/z  (%): 334  (50)  [M]+, 316  (61), 301  (82), 253  (87) 175  (100); HR‐EI‐MS: m/zobsd 
334.2134 [M]+ (m/zcalcd [C20H30O4]+ = 334.2144). 
Norleucosceptroid G (4): colorless oil; [α]D17 = ‐ 16.6 (c = 0.2, MeOH); UV (MeOH) λmax (log ε ): 248 (3.49) 
nm;  IR  (KBr)  νmax:  3434,  2965,  2934,  2875,  1724,  1666,  1452,  1379,  1286,  1126,  1073,  1044,  
1010 cm–1; EI‐MS m/z (%): 332 (31) [M]+, 317 (34), 290 (35), 289 (100), 288 (27), 191 (42), 163 (51),  
83 (93), 55 (78); HR‐EI‐MS: m/zobsd 332.1991 [M]+ (m/zcalcd [C20H28O4]+ = 332.1988). 
Norleucosceptroid  H  (5):  colorless  oil;  [α]D20  =  +  12.5  (c  =  0.2,  MeOH);  UV  (MeOH)  λmax  (log  ε  ):  
241 (3.20), 202 (3.10), 196 (2.97) nm; IR (KBr) νmax: 3432, 2953, 2933, 2869, 1711, 1680, 1640, 1451, 




EI‐MS m/z  (%):  448  (8)  [M]+,  412  (24),  397  (12),  364  (27),  290  (53),  289  (100),  271  (55),  270  (32);  
HR‐ESI‐MS: m/zobsd 448.2435 [M]+ (m/zcalcd [C25H36O7]+ = 448.2461). 
Leucosceptroid Q (7): colorless oil; [α]D26 = + 56.3 (c = 0.4, MeOH); UV (MeOH) λmax (log ε ): 204 (3.98), 
195  (3.47)  nm;  IR  (KBr)  νmax:  3441,  2962,  2935,  2870,  1746,  1701,  1451,  1377,  1279,  1079,  939,  
926 cm–1; negative FAB‐MS m/z  (%): 431 (100)  [M‐H]‐; HR‐ESI‐MS: m/zobsd 431.2424 [M‐H]‐  (m/zcalcd 
[C25H35O6]‐ = 431.2433). 
   






3893.6  (15)  Å3, T =  ‐173  °C,  Z =  4, d  =1.182  g  cm‐3,  μ(Mo‐Kα)  =  0.71073  Å,  F(000)  =  1504,  38753 
reflections in h(‐13/13), k(‐13/13), l(‐44/48), measured in the range 1.11° ≤  ≤28.31°, completeness 
max  =  99.7%,  9656  independent  reflections, Rint  =  0.1738,  5125  reflections  with  Fo  >  4σ(Fo),  461 
parameters, 0 restraint, R1obs = 0.0657, wR2obs = 0.1122, R1all = 0.1577, wR2all = 0.1487, GOF = 0.981, 
Absolute structure parameter 0.0(13), largest difference peak and hole = 0.259 and ‐ 0.316 e Å‐3. The 
crystal  structure of 1 was  solved by direct method using  the program SHELXS‐97  (G. M.  Sheldrick, 
SHELXS97 and SHELXL97, University of Gottingen, Germany, 1997) and subsequent Fourier difference 
techniques,  and  refined  anisotropically  by  fullmatrix  least‐squares  on  F2  using  SHELXL‐97  (G.  M. 
Sheldrick, SHELXTL, Version 6.10, Bruker AXS Inc., Madison, Wisconsin, USA, 2000). 
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 Figure S8.  1H‐1H COSY spectrum of norleucosceptroid D (1) recorded in acetone‐d6. 
 Figure S9. HSQC spectrum of norleucosceptroid D (1) recorded in acetone‐d6. 
162  EXPERIMENTAL SECTION 
 Figure S10. HMBC spectrum of norleucosceptroid D (1) recorded in acetone‐d6. 
 Figure S11. ROESY spectrum of norleucosceptroid D (1) recorded in acetone‐d6. 
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 Figure S38. 1H‐1H COSY spectrum of leucosceptroid P (6) recorded in acetone‐d6. 
 Figure S39. HSQC spectrum of leucosceptroid P (6) recorded in acetone‐d6. 



































                                                 
21 Hugelshofer, C. L.; Magauer, T. Angew. Chem. Int. Ed. 2014, 53, 1135111355. 







dichromate  (7.92  g,  21.0  mmol,  2.00  equiv)  was  added  in  three  large  portions  and  stirring  was 
continued at 23 °C. After 10 min, the mixture was filtered through a pad of silica gel (4 cm) and the 









86.34  (C‐14),  83.73  (C‐6),  81.70  (C‐12),  64.19  (C‐16),  56.10  (C‐11),  55.89  (C‐21),  51.83  (C‐5),  51.45  
(C‐13),  48.69  (C‐7),  42.53  (C‐15),  39.78  (C‐10),  35.86  (C‐9),  30.87  (C‐8),  22.56  (C‐24),  19.56  (C‐23).  


































(45 mL)  was  treated  with  methylmagnesium  bromide  solution  (3.0  M  in  diethyl  ether,  9.12  mL, 
27.4 mmol, 6.00 equiv). After 5 min, the cooling bath was removed and the mixture was allowed to 








































1H,  8‐HB),  1.03  (d,  3J23/10  =  6.5  Hz,  3H,  23‐H),  0.99–0.89  (m,  1H,  9‐HB).  13C NMR  (100 MHz,  CDCl3)  
δ 137.29 (C‐2), 124.60 (C‐3), 85.00 (C‐14), 81.55 (C‐6), 80.92 (C‐12), 77.21 (C‐4), 59.61 (C‐16), 58.18  
(C‐5), 57.55 (C‐13), 57.18 (C‐11), 48.57 (C‐7), 44.18 (C‐15), 39.53 (C‐10), 36.38 (C‐9), 30.96 (C‐8), 26.00 
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Synthesis of aldehyde 46 
 
A  solution  of  oxalylchloride  (2  M  in  dichloromethane,  1.71  mL,  3.43  mmol,  3.00  equiv)  in 
dichloromethane  (8  mL)  was  treated  with  a  solution  of  dimethyl  sulfoxide  (0.49  mL,  6.85  mmol, 
6.00 equiv)  in  dichloromethane  (1 mL)  at  –78  °C.  After  15 min,  a  solution  of  alcohol 33  (350 mg, 






column  chromatography  (20%  ethyl  acetate  in  hexanes)  on  silica  gel  to  provide  aldehyde 46  as  a 
yellowish oil (316 mg, 91%). 
TLC (20% ethyl acetate in hexanes): Rf = 0.45 (CAM). 1H NMR (400 MHz, CDCl3) δ 9.84 (t, 3J16/15 = 2.4 Hz, 
1H,  16‐H),  5.22–5.18  (m,  1H,  3‐H),  4.34–4.29  (m,  1H,  4‐H),  4.19  (s,  1H,  12‐H),  3.92  (s,  1H,  6‐H),  
2.74–2.59 (m, 2H, 15‐H), 2.20–2.10 (m, 3H, 5‐H, 7‐H, 13‐H), 1.92–1.83 (m, 1H, 8‐HA), 1.77 (s, 3H, 1‐H), 
1.76 (s, 3H, 21‐H), 1.75–1.70 (m, 1H, 9‐HA), 1.67–1.58 (m, 1H, 10‐H), 1.56–1.50 (m, 1H, 11‐H), 1.41 (s, 
3H,  24‐H),  1.29–1.19  (m,  1H,  8‐HB),  1.06  (d,  3J23/10  =  6.6  Hz,  3H,  23‐H),  1.04–0.94  (m,  1H,  9‐HB).  
13C  NMR  (100 MHz,  CDCl3)  δ  202.59  (C‐16),  137.76  (C‐2),  124.41  (C‐3),  81.97  (C‐14),  81.66  (C‐6),  









tetrahydrofuran  (4  mL)  was  treated  with  n‐butyllithium  (2.30  M  in  hexanes,  161  L,  0.37  mmol, 


































an  additional  1  h  was  diluted  with  saturated  aqueous  ammonium  chloride  solution  (7  mL)  and 




1.5  h,  the  mixture  was  diluted  with  water  (5  mL)  and  dichloromethane  (5  mL).  The  layers  were 















layers  were  separated,  the  aqueous  layer  was  extracted  with  diethyl  ether  (3  x  12  mL),  and  the 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered and the 





                                                 
22 Bestmann, H. J.; Roth K.; Ettlinger, M. Chem. Ber. 1982, 115, 161171. 
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Synthesis of furan 36 
 
A  solution of  crude ethoxy  acetal 48  (19.0 mg,  45.6 mol,  1  equiv)  in  tetrahydrofuran  (1 mL) was 
treated with aqueous 1 M hydrogen chloride solution (1 mL) and the resulting mixture was heated to 
40 °C. After 30 min, the mixture was cooled to 23 °C, and then was diluted with saturated aqueous 
sodium  chloride  solution  (15  mL)  and  dichloromethane  (10  mL).  The  layers  were  separated,  the 
aqueous layer was extracted with dichloromethane (3 x 7 mL), and the combined organic extracts were 
dried  over  sodium  sulfate.  The  dried  solution was  filtered  and  the  filtrate  was  concentrated.  The 
residue was purified by flash‐column chromatography (15% ethyl acetate in hexanes) on silica gel to 
provide furan 36 as a colourless oil (14 mg, 36% over four steps). 
TLC  (20%  ethyl  acetate  in  hexanes):  Rf  =  0.59  (CAM).  1H  NMR  (400  MHz,  CDCl3)  δ  7.24  (d,  





(100 MHz,  CDCl3)  δ  150.92  (C‐17),  139.78  (C‐20),  136.78  (C‐2),  125.20  (C‐3),  113.65  (C‐18),  113.07  
(C‐19), 83.53 (C‐14), 81.75 (C‐6), 81.29 (C‐12), 76.64 (C‐4), 58.25 (C‐5), 57.17 (C‐11, C‐13), 57.12 (C‐11, 












of Rose Bengal (tip of a spatula)  in methanol  (2.5 mL) at –78 °C. The mixture was  irradiated with a 
Replux Belgium RL 160W (225‐235 Volts) lamp, and after 5 min, sparging with oxygen and irradiation 
was discontinued. Dimethyl sulfide (26.0 L, 351 mol, 10.0 equiv) was added and the mixture was then 
warmed to 23  °C. After 45 min,  triethylamine  (14.6 L, 105 mol, 3.00 equiv) was added, and after 
further  3  h,  the  mixture  was  concentrated  in  vacuo.  The  residue  was  purified  by  flash‐column 
chromatography  (30%  ethyl  acetate  in  hexanes)  on  silica  gel  to  provide  a  mixture  of  hydroxy 
cyclopentenones 40 and 41 (40:41 = 1:1) as a colourless oil (12.5 mg, 92%). Analytically pure samples 





CDCl3)  δ  7.22–7.19  (m,  1H,  19‐H),  5.22–5.17  (m,  1H,  3‐H), 4.46–4.41  (m,  1H,  20‐H),  4.31  (app  t,  
3J4/3,4/5 = 8.4 Hz, 1H, 4‐H), 4.15 (d, 3J20‐OH/20 = 2.0 Hz, 1H, 20‐OH), 4.11 (s, 1H, 12‐H), 3.87 (s, 1H, 6‐H), 




1H,  9‐HB).  13C  NMR  (100 MHz,  CDCl3)  δ  207.21  (C‐17),  155.79  (C‐19),  142.34  (C‐17),  141.37  (C‐2),  
122.66  (C‐3),  84.01  (C‐14),  81.47  (C‐6),  81.11  (C‐12),  77.36  (C‐20),  76.90  (C‐4),  58.36  (C‐5),  57.02  
(C‐11), 55.74 (C‐13), 53.75 (C‐16), 48.64 (C‐7), 41.24 (C‐15), 39.66 (C‐10), 36.45 (C‐9), 30.98 (C‐8), 26.09 
(C‐1), 23.08 (C‐24), 19.63 (C‐23), 18.85 (C‐21), 10.43 (C‐25). IR  (Diamond‐ATR, neat) ṽmax: 3486 (br), 
2950  (s),  2865  (m),  1712  (s),  1450  (w),  1379  (w),  1329  (w),  1228  (w)  cm–1. HRMS  (EI):  calcd  for 
(C24H34O4)+: 386.2457, found: 386.2461. 	ሾࢻሿࡰ૛૙ = 19.5 (c = 0.24, CH2Cl2).  
Hydroxy cyclopentenone 41: TLC (25% ethyl acetate in hexanes): Rf = 0.25 (CAM). 1H NMR (400 MHz, 
CDCl3)  δ  7.23–7.16  (m,  1H,  19‐H),  5.20–5.15  (m,  1H,  3‐H),  4.52–4.47  (m,  1H,  20‐H),  4.38  (d,  
3J20‐OH/20 = 2.5 Hz, 1H, 20‐OH), 4.31 (app t, 3J4/3,4/5 = 8.4 Hz, 1H, 4‐H), 4.14 (s, 1H, 12‐H), 3.90 (s, 1H, 6‐H), 
2.48–2.42 (m, 1H, 16‐H), 2.31 (dd, 2J15A/15B = 14.2, 3J15B/16 = 1.7 Hz, 1H, 15‐HA), 2.24–2.02 (m, 3H, 5‐H,  
7‐H,  13‐H),  1.90–1.83  (m,  1H,  8‐HA),  1.82–1.79  (m,  3H,  25‐H),  1.78–1.69  (m,  7H,  1‐H,  9‐HA,  21‐H),  
1.65–1.55  (m,  1H,  10‐H),  1.54–1.45  (m,  1H,  11‐H),  1.45–1.36  (m,  1H,  15‐HB),  1.35  (s,  3H,  24‐H),  
1.28–1.15 (m, 1H, 8‐HB), 1.04 (d, 3J23/10 = 6.6 Hz, 3H, 23‐H), 1.01–0.90 (m, 1H, 9‐HB).13C NMR (100 MHz, 
CDCl3) δ 206.86 (C‐17), 155.82 (C‐19), 141.98 (C‐17), 137.79 (C‐2), 124.32 (C‐3), 84.02 (C‐14), 81.49  
(C‐6),  80.93  (C‐12),  77.36  (C‐4),  76.50  (C‐20),  60.58  (C‐13),  58.09  (C‐5),  57.17  (C‐11),  54.74  (C‐16),  
48.68 (C‐7), 42.68 (C‐15), 39.60 (C‐10), 36.44 (C‐9), 31.03 (C‐8), 26.07 (C‐1), 19.56 (C‐23), 19.06 (C‐24), 
18.72  (C‐21),  10.37  (C‐25).  IR  (Diamond‐ATR,  neat)  ṽmax:  3468  (br),  2951  (s),  2867  (m),  1711  (s),  
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2.57–2.39  (m,  2H,  15‐H),  2.34–2.19  (m,  2H,  7‐H,  10‐H),  2.04–1.79  (m,  3H,  6‐H,  8‐H),  1.78  (d,  
4J1/3 = 1.4 Hz, 3H, 1‐H), 1.75 (d, 4J21/3 = 1.4 Hz, 3H, 21‐H), 1.68–1.55 (m, 1H, 9‐HA), 1.55–1.44 (m, 1H, 
9‐HB), 1.41 (s, 3H, 24‐H), 1.18 (d, 3J23/10 = 7.1 Hz, 3H, 23‐H), 1.12 (d, 3J22/6 = 7.3 Hz, 3H, 22‐H). 13C NMR 







                                                 
23 C. L. Hugelshofer, T. Magauer, Angew. Chem., Int. Ed. 2014, 53, 11351. 
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Synthesis of triol 2, (+)‐norleucosceptroid F (3), and tetraol 25 
 
A  solution of  ketone 1  (710 mg, 1.60 mmol,  1 equiv)  in  tetrahydrofuran  (17 mL) was  treated with 
lithium bis(trimethylsilyl)amide solution (1 M in THF, 6.74 mL, 6.74 mmol, 4.20 equiv) at 78 °C. After 
5 min,  the mixture was warmed  to 35  °C.  After  1  h,  the mixture was  cooled  to 78  °C,  triethyl 
phosphite (1.08 mL, 6.42 mmol, 4.00 equiv) was added and the argon atmosphere was exchanged for 
oxygen. After 5 min,  the mixture was warmed  to 35  °C and stirring was continued  for 2.5 h. The 
mixture  was  diluted  with  saturated  aqueous  sodium  bicarbonate  solution  (50  mL)  and 


































(s),  1231  (m),  1098  (s),  1018  (s)  cm–1.  HRMS  (ESI):  calcd  for  (C20H32O5Na)+:  375.21474,  found: 
375.21397. ሾߙሿ஽ଶ଴ = ‒117.4 (c = 0.06, CH2Cl2).   
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Synthesis of diol 26 
 
A  solution  of  triol  2  (10.0  mg,  28.4  µmol,  1  equiv)  in  a  mixture  of  tetrahydrofuran–methanol  












22‐H), 0.89  (d,  3J23/10 = 7.1 Hz, 3H, 23‐H).  13C NMR  (100 MHz, CDCl3) δ 214.78  (C‐12), 139.56  (C‐2), 
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Synthesis of (‒)‐norleucosceptroid C (5) 
 




sodium sulfate. The dried solution was  filtered and  the  filtrate was concentrated. The  residue was 
filtered  through  a  short  pad  of  silica  gel  (30%  ethyl  acetate  in  hexanes)  and  the  filtrate  was 
concentrated. The crude product (as seen by 1H NMR analysis, this α‐H11 epimer of norleucosceptroid 
C exists in its lactol and open‐chained aldehyde form in solution, ~2:1 ratio) was dissolved in methanol 




TLC  (40%  ethyl  acetate  in  hexanes):  Rf  =  0.32  (CAM).  1H  NMR  (800  MHz,  Acetone‐d6)  δ  5.54  (d,  
3J3/4 = 8.5 Hz, 1H, 3‐H), 5.44–5.38 (m, 2H, 16‐H, 16‐OH), 4.38 (d, 3J4/3 = 8.5 Hz, 1H, 4‐H), 2.92 (s, 1H,  
13‐H), 2.25–2.16 (m, 2H, 10‐H, 11‐H), 2.16–2.10 (m, 1H, 6‐H), 1.96–1.90 (m, 1H, 9‐HA), 1.90–1.84 (m, 
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Synthesis of (‒)‐norleucosceptroid B (4) 
 




over  sodium  sulfate.  The  dried  solution  was  filtered  through  a  pad  of  Celite  and  the  filtrate  was 


























TLC  (30%  ethyl  acetate  in  hexanes):  Rf  =  0.33  (CAM).  1H  NMR  (400  MHz,  Acetone‐d6)  δ  9.73  (t,  
3J16/15 = 3.0 Hz, 1H, 16‐H), 5.70 (d, 3J4/3 = 9.8 Hz, 1H, 4‐H), 5.15 (d, 3J3/4 = 9.8 Hz, 1H, 3‐H), 4.18 (s, 1H,  
















(+)‐norleucosceptroid G  (27)  (54.0 mg,  162 µmol,  1  equiv)  in  tetrahydrofuran  (1.5 mL) was  added 
dropwise  to  the  dark  red  mixture  at  0  °C.  The  transfer  was  quantitated  with  tetrahydrofuran  
(3 x 0.5 mL). After 5 min, the cooling bath was removed and the mixture was allowed to warm to 23 
°C. After 20 min, the mixture was diluted with saturated aqueous sodium bicarbonate solution (15 mL) 
and  dichloromethane  (10  mL).  The  layers  were  separated,  the  aqueous  layer  was  extracted  with 
dichloromethane (4 x 10 mL), and the combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash‐column 
chromatography  (45%  ethyl  acetate  in  hexanes)  on  silica  gel  to  provide  a  2:1  mixture  of  
(‒)‐leucosceptroid L (7) and (‒)‐leucosceptroid M (8) as a colourless oil  (62.0 mg, 93%). Analytically 
pure samples of (‒)‐leucosceptroid L (7) and (‒)‐leucosceptroid M (8) were obtained by reversed‐phase 




Acetone‐d6)  δ  6.00  (s,  1H,  19‐H),  5.66  (dd,  3J4/3  =  9.6  Hz,  4J4/6  =  1.3  Hz,  1H,  4‐H),  5.44  (app  t,  









(m), 1769  (s), 1666  (s), 1445 (w), 1378 (m), 1260  (s), 1070  (s), 1024 (s) cm–1. HRMS  (ESI): calcd for 
(C25H32O5Na)+: 435.21474, found: 435.21443. ሾߙሿ஽ଶ଴ = ‒102.4 (c = 0.09, CH2Cl2).  
   
                                                 
24 Prepared according to: a) D. C. Harrowven, J. D. Wilden, M. J. Tyte, M. B. Hursthouse, S. J. Coles, Tetrahedron Letters 
2001, 42, 6, 1193. b) C. L. Hugelshofer, T. Magauer, Angew. Chem., Int. Ed. 2014, 53, 11351. 











18.06  (C‐22),  15.54  (C‐25).  IR  (Diamond‐ATR,  neat)  ṽmax:  3440  (br),  2964  (s),  2929  (m),  2877  (w),  
1760  (s),  1661  (s),  1452  (w),  1378  (w),  1260  (s),  1079  (s),  1020  (s)  cm–1.  HRMS  (ESI):  calcd  for 
(C25H32O5Na)+: 435.21474, found: 435.21444. ሾߙሿ஽ଶ଴ = ‒42.5 (c = 0.07, CH2Cl2).   





(‒)‐norleucosceptroid  B  (4)  (57.0  mg,  163  µmol,  1  equiv)  in  tetrahydrofuran  (1.5  mL)  was  added 
dropwise  to  the  dark  red  mixture  at  0  °C.  The  transfer  was  quantitated  with  tetrahydrofuran  
(3  x 0.5 mL). After 5 min,  the cooling bath was  removed and  the mixture was allowed  to warm to  
23 °C. After 1 h, the mixture was diluted with saturated aqueous sodium bicarbonate solution (15 mL) 
and  dichloromethane  (10  mL).  The  layers  were  separated,  the  aqueous  layer  was  extracted  with 
dichloromethane (4 x 10 mL), and the combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was purified by flash‐column 
chromatography  (45%  ethyl  acetate  in  hexanes)  on  silica  gel  to  provide  a  5:1  mixture  of  
(‒)‐leucosceptroid K  (9) and the corresponding E‐isomer as a colourless oil  (63.5 mg, 91%). Further 












(m),  1451  (m),  1381  (m),  1286  (m),  1102  (w),  1029  (m)  cm–1. HRMS  (ESI):  calcd  for  (C25H34O6Na)+: 
453.22531, found: 453.22462. ሾࢻሿࡰ૛૙ = ‒70.4 (c = 0.13, MeOH).    
                                                 
25 Prepared according to: a) D. C. Harrowven, J. D. Wilden, M. J. Tyte, M. B. Hursthouse, S. J. Coles, Tetrahedron Letters 
2001, 42, 6, 1193. b) C. L. Hugelshofer, T. Magauer, Angew. Chem., Int. Ed. 2014, 53, 11351. 









separated,  the aqueous  layer was extracted with dichloromethane  (3  x 10 mL),  and  the  combined 
organic extracts were dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The residue was dissolved in dichloromethane (2.2 mL) and cinchona alkaloid catalyst 
1126  (6.1  mg,  18.6  µmol,  0.20  equiv)  was  added  at  0  °C.  Stirring  was  continued  at  0  °C  for  8  h, 
whereupon the mixture was concentrated (23 °C waterbath). The residue was purified by flash‐column 











22‐H),  0.82  (d,  3J23/10  =  7.4 Hz,  3H,  23‐H).  13C NMR  (100 MHz, Acetone‐d6)  δ  212.76  (C‐12),  173.20  
(C‐20), 170.39 (C‐18), 136.87 (C‐2), 122.64 (C‐3), 117.16 (C‐19), 85.54 (C‐11), 85.05 (C‐17), 84.22 (C‐5), 
83.44 (C‐14), 76.94 (C‐4), 72.09 (C‐13), 50.19 (C‐7), 46.22 (C‐10), 42.09 (C‐6), 39.30 (C‐15), 30.94 (C‐9), 






                                                 
26 Cinchona alkaloid catalyst 11 was prepared starting from hydroquinine according to: Y. Wu, R. P. Singh, L. Deng, J. Am. 
Chem. Soc. 2011, 133, 12458. 




methanol  (3:1,  0.8  mL)  was  treated  with  samarium(II)  iodide  solution  (0.1  M  in  THF,  0.49  mL,  
48.5 µmol, 10 equiv) at 23 °C. The resulting dark blue mixture turned nearly colourless within 1 min. 
After 15 min, the mixture was diluted with saturated aqueous sodium bicarbonate solution (5 mL) and 
































29.05  (C‐8),  27.31  (C‐16),  26.15  (C‐1),  22.86  (C‐24),  22.02  (C‐23),  18.74  (C‐21),  14.05  (C‐22),  13.85  
(C‐25). IR (Diamond‐ATR, neat) ṽmax: 3484 (br), 2931 (s), 2870 (m), 1736 (s), 1697 (m), 1640 (m), 1452 
(m),  1266  (s),  1164  (m),  1038  (w)  cm–1.  HRMS  (ESI):  calcd  for  (C25H40O5N)+:  434.29010,  found: 
434.29039. 
216  EXPERIMENTAL SECTION 
   








layers were separated,  the aqueous  layer was extracted with dichloromethane  (3 x 5 mL), and the 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered and the 
filtrate  was  concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (20%  ethyl 
acetate  in hexanes) on silica gel to provide (‒)‐leucosceptroid A (15) as a colourless solid (14.2 mg, 
75%). 

















methanol  (4:1,  0.9  mL)  was  treated  with  samarium(II)  iodide  solution  (0.1  M  in  THF,  0.72  mL,  
72.0 µmol, 15 equiv) at 23 °C. The resulting dark blue mixture turned nearly colourless within 2 min. 
After 15 min, the mixture was diluted with saturated aqueous sodium bicarbonate solution (5 mL) and 
dichloromethane  (3  mL).  The  layers  were  separated,  the  aqueous  layer  was  extracted  with 
dichloromethane (3 x 5 mL), and the combined organic extracts were dried over sodium sulfate. The 
dried solution was filtered and the filtrate was concentrated. The residue was dissolved in methanol 
(0.8 mL) and  triethylamine  (80 µL) was  added at 23  °C. After 4.5 h,  the mixture was  concentrated  
(23 °C waterbath) and the residue was filtered through a short pad of silica gel (20% ethyl acetate in 
hexanes)  to  provide  a  5:2  mixture  of  ketone  16  and  (‒)‐leucosceptroid  B  (17)  as  a  colourless  oil  
(1.2 mg, 62%). Analytically pure samples of ketone 16 and (‒)‐leucosceptroid B (17) were obtained by 
reversed‐phase semi‐preparative HPLC using methanol‒water (72:28 to 80:20 gradient over 30 min) 
as  eluent  (flow  rate:  4.5  mL/min;  column:  Nucleosil  100‐7  C18,  10x250  mm;  detection:  230  nm; 
retention times: 14.2 min for 16 and 19.1 min for 17). 
Ketone 16: TLC (20% ethyl acetate in hexanes): Rf = 0.42 (CAM). 1H NMR (800 MHz, CDCl3) δ 7.20 (d, 
3J20/19  =  1.8  Hz,  1H,  20‐H),  6.14  (d,  3J19/20  =  1.8  Hz,  1H,  19‐H),  5.47–5.43  (m,  1H,  3‐H),  4.71  (d,  
3J4/3 = 8.9 Hz, 1H, 4‐H), 2.81–2.75 (m, 2H, 11‐H, 16‐HA), 2.74 (s, 1H, 13‐H), 2.73–2.67 (m, 1H, 16‐HB), 
2.55–2.49  (m,  1H,  10‐H),  2.25–2.20  (m,  1H,  7‐H),  2.19  (s,  1H,  5‐OH),  2.11–2.06  (m,  1H,  15‐HA),  





(C‐8),  26.49  (C‐1),  21.90  (C‐24),  20.86  (C‐16),  19.17  (C‐21),  16.77  (C‐23),  13.45  (C‐22),  9.98  (C‐25). 
IR (Diamond‐ATR, neat) ṽmax: 3470 (br), 2926 (s), 2848 (m), 1691 (s), 1456 (s), 1377 (m), 1265 (m), 1149 
(m),  1054  (m)  cm–1. HRMS  (EI):  calcd  for  (C25H36O4)+:  400.2614,  found:  400.2616.  ሾࢻሿࡰ૛૙  =  ‒101.5  (c = 0.09, CHCl3). 
 
(‒)‐leucosceptroid B (17): TLC  (20% ethyl acetate  in hexanes): Rf = 0.40 (CAM). 1H NMR  (800 MHz, 
CDCl3) δ 7.20 (d, 3J20/19 = 1.8 Hz, 1H, 20‐H), 6.13 (d, 3J19/20 = 1.8 Hz, 1H, 19‐H), 5.49–5.46 (m, 1H, 3‐H), 
4.38  (d,  3J4/3  =  8.6  Hz,  1H,  4‐H),  2.76  (s,  1H,  13‐H),  2.75–2.71  (m,  2H,  16‐H),  2.31  (s,  1H,  5‐OH),  
2.15–2.10 (m, 1H, 10‐H), 2.10–2.06 (m, 2H, 15‐H), 1.98–1.93 (m, 4H, 9‐HA, 25‐H), 1.92–1.87 (m, 1H, 6‐
H),  1.85–1.80  (m,  1H,  8‐HA),  1.79  (d,  4J1/3  =  1.4  Hz,  3H,  1‐H),  1.78–1.75  (m,  1H,  11‐H),  1.74  (d,  
4J21/3 = 1.4 Hz, 3H, 21‐H), 1.66–1.59 (m, 1H, 7‐H), 1.37–1.29 (m, 2H, 8‐HB, 9‐HB), 1.22 (s, 3H, 24‐H), 1.16 
(d, 3J23/10 = 6.7 Hz, 3H, 23‐H), 0.96 (d, 3J22/6 = 7.1 Hz, 3H, 22‐H). 13C NMR (200 MHz, CDCl3) δ 209.61  












with a Replux Belgium RL 160W  (225–235 Volts)  lamp, and after 5 min,  sparging with oxygen and 
irradiation  was  discontinued.  The  cooling  bath  was  removed,  and  after  15  min  the  mixture  was 












(C‐20), 168.27, 168.21*  (C‐18), 137.00  (C‐2), 122.52, 122.49* (C‐3), 118.41, 118.38*  (C‐19), 108.93, 
108.85*  (C‐17),  85.53  (C‐11),  84.19  (C‐5),  83.30,  83.24*  (C‐14),  77.02,  77.00*  (C‐4),  72.16,  72.06*  

















1:1  mixture  of  (‒)‐leucosceptroid  C  (19)  and  cyclopentenone  28,  while  the  more  polar  fraction  
(Rf  =  0.07,  40%  ethyl  acetate  in  hexanes)  contained  the  corresponding  γ‐keto  aldehyde  (the  aldol 
reaction  precursor).  The  residue  from  the  more  polar  fraction  was  dissolved  in  dichloromethane  
(1.5 mL)  and  triethylamine  (40 L)  was  added  at  23  °C.  After  1  h,  the mixture was  concentrated  
(23 °C waterbath) and the residue was purified by flash‐column chromatography (40%  50% ethyl 






Acetone‐d6)  δ  7.21–7.19  (m,  1H,  19‐H),  5.62–5.59  (m,  1H,  3‐H),  4.80  (d,  3J4/3  =  8.8  Hz,  1H,  4‐H),  
4.65–4.62 (m, 1H, 20‐H), 4.34 (d, 3J20OH/20 = 3.7 Hz, 1H, 20‐OH), 4.26 (s, 1H, 11‐OH), 4.12 (s, 1H, 5‐OH), 
2.77  (s,  1H,  13‐H),  2.43  (app  dt,  3J16/15B  =  11.2  Hz,  3J16/15A  =  3J16/20  =  2.3  Hz,  1H,  16‐H),  2.32  (dd,  
2J15A/15B  =  14.2  Hz,  3J15A/16  =  2.3  Hz,  1H,  15‐HA),  2.30–2.27  (m,  1H,  10‐H),  2.15–2.09  (m,  1H,  8‐HA),  
2.09–2.04 (m, 2H, 7‐H, 9‐HA), 1.90 (dd, 2J15B/15A = 14.2 Hz, 3J15B/16 = 11.2 Hz, 1H, 15‐HB), 1.83–1.79 (m, 
1H,  6‐H),  1.76  (s,  6H,  1‐H,  21‐H),  1.73  (app  t,  4J25/19  =  1.8  Hz,  3H,  25‐H),  1.72–1.67  (m,  1H,  8‐HB),  
1.44–1.40 (m, 1H, 9‐HB), 1.30 (s, 3H, 24‐H), 0.98 (d, 3J22/6 = 6.8 Hz, 3H, 22‐H), 0.83 (d, 3J23/10 = 7.3 Hz, 3H, 
23‐H). 13C NMR (200 MHz, Acetone‐d6) δ 212.21 (C‐12), 206.87 (C‐17), 156.80 (C‐19), 141.83 (C‐18), 
138.12  (C‐2),  121.85  (C‐3),  85.57  (C‐11),  84.20  (C‐5),  83.73  (C‐14),  77.49  (C‐4),  76.79  (C‐20),  73.53  
(C‐13), 54.02 (C‐16) 50.32 (C‐7), 46.23 (C‐10), 44.29 (C‐15), 41.93 (C‐6), 30.98 (C‐9), 30.51 (C‐8), 26.14 
(C‐21), 23.54 (C‐24), 18.84 (C‐1), 17.21 (C‐23), 13.93 (C‐22), 10.14 (C‐25). IR (Diamond‐ATR, neat) ṽmax: 
3443  (br), 2965  (s), 2935  (s), 1699  (s), 1449  (m), 1381  (m), 1331  (m), 1234  (m), 1104  (m), 1023  (s)  
cm–1. HRMS  (ESI):  calcd  for  (C25H36O6Na)+:  455.24096,  found:  455.24091.  ሾࢻሿࡰ૛૙  =  ‒128.0  (c  =  0.06, MeOH). 
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Cyclopentenone 28:  TLC  (5% methanol  in  dichloromethane):  Rf  =  0.28  (CAM).  1H NMR  (800 MHz, 





24‐H),  0.98  (d,  3J22/6  =  6.8  Hz,  3H,  22‐H),  0.83  (d,  3J23/10  =  7.5  Hz,  3H,  23‐H).  13C  NMR  (200 MHz,  
Acetone‐d6) δ 213.72 (C‐12), 207.83 (C‐17), 157.67 (C‐19), 141.79 (C‐18), 137.84 (C‐2), 121.79 (C‐3), 













sparging  with  oxygen  and  irradiation  was  discontinued.  The  cooling  bath  was  removed,  and  the 




5.00  equiv)  were  added.  After  15  min,  the  mixture  was  diluted  with  saturated  aqueous  sodium 
bicarbonate solution (5 mL) and dichloromethane (3 mL). The layers were separated, the aqueous layer 
was extracted with dichloromethane (3 x 5 mL), and the combined organic extracts were dried over 
sodium sulfate. The dried solution was  filtered and  the  filtrate was concentrated. The  residue was 
purified  by  flash‐column  chromatography  (35%  ethyl  acetate  in  hexanes)  on  silica  gel  to  provide  
(‒)‐leucosceptroid  O  (23)  (1.3  mg,  26%)  and  (‒)‐leucosceptroid  K  (9)  (1.7  mg,  34%).  The 
characterization  data  for  (‒)‐leucosceptroid  K  (9) were  in  full  agreement with  the  values  reported 
above. 
(‒)‐leucosceptroid O (23): TLC  (40% ethyl acetate  in hexanes): Rf = 0.31 (CAM). 1H NMR  (800 MHz, 
Acetone‐d6) δ 5.84 (q, 4J19/25 = 1.6 Hz, 1H, 19‐H), 5.62–5.60 (m, 1H, 3‐H), 5.24 (d, 3J4/3 = 9.0 Hz, 1H, 4‐H), 
4.45 (s, 1H, 11‐OH), 3.50 (s, 1H, 13‐H), 2.47 (ddd, 2J16A/16B = 14.5 Hz, 3J16A/15A = 12.7 Hz, 3J16A/15B = 4.7 Hz, 
1H,  16‐HA),  2.33–2.29  (m,  1H,  10‐H),  2.25  (d,  4J25/19  =  1.6  Hz,  3H,  25‐H),  2.14–2.10  (m,  1H,  8‐HA),  




















20‐H) and 6.10 ppm (s, 1H, 19‐H)]. The ensuing spectra  (recorded  in approximate 20 min  intervals) 
show  a  gradual  intensity  decline  of  endo‐peroxide  18  while  the  intensity  of  hydroperoxide  21  
[8.09 ppm (s, 1H, 20‐OOH), 5.53 ppm (s, 1H, 20‐H), 4.92 ppm (d 3J4/3 = 8.9 Hz, 1H, 4‐H) and 3.80 ppm 
(s,  1H,  13‐H)]  and  hydroperoxide  22  (1.1:1.0  mixture  of  diastereomers  at  C20)  [9.47  ppm  (s,  1H,  
20‐OOH), 9.22* ppm  (s, 1H, 20‐OOH),  6.25 ppm  (s, 1H, 20‐H), 6.21* ppm  (s,  1H, 20‐H, minor) and  
4.80 ppm (t, 3J16/15 = 8.0 Hz, 1H ,16‐H, diastereomers overlap)] increase. Spectrum 9 (recorded after 
approximately 3 h reaction time) shows essentially full consumption of endo‐peroxide 18. 
The  approximate  1:1:1.3  ratio  of  formed  hydroperoxides  is  consistent  with  the  isolated  yields  of 
leucosceptroid  K  (9)  and  leucosceptroid  O  (23).  Hydroperoxide  22  is  visibly  a  1:1  mixture  of 
diastereomers at C‐20 (the ‒OOH resonances of the two diastereomers occur at 9.47 and 9.22 ppm in 
the  1H  NMR  spectrum).  While  21  appears  as  a  single  compound  by  1H  NMR  analysis,  the 




T = 10 min 
T = 3 h 
18, 19-H 21, 4-H 
22, 16-H 
22*, 16-H 22, 20-OOH 21, 20-H 
18, 20-H
22, 20-H 21, 20-OOH 
22*, 20-OOH 22*, 20-H 
21, 13-H 
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6.3.3  Computational Details 
Conformational  Search.  Conformational  searches  were  performed  with  Spartan’10  (Spartan’10, 












C 0   -1.345000    0.303100   -0.499900 
C 0   -0.536500   -0.405400    0.653400 
C 0   -1.162600   -1.683100    1.157900 
C 0   -1.789100   -2.655700    0.139300 
C 0   -2.452400   -1.947100   -1.088600 
C 0   -2.661200   -0.421200   -0.880900 
C 0   -0.698500   -3.605000   -0.488800 
C 0   -0.308300   -2.945800   -1.816700 
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C 0   -1.630600   -2.366200   -2.343900 
C 0   -1.497400    1.750300    0.067700 
O 0   -0.320600    1.916800    0.890800 
C 0   -0.197900    0.720800    1.686600 
C 0    0.461000   -4.018200    0.419900 
C 0   -3.828900   -0.191300    0.098100 
O 0   -2.759900   -3.416100    0.847100 
C 0   -1.584100    2.835800   -0.965600 
C 0   -2.000800    4.091400   -0.740100 
C 0   -2.061700    5.097800   -1.863400 
C 0   -2.422900    4.618600    0.609200 
C 0    1.242600    0.666400    2.251000 
C 0   -1.164500    0.805600    2.885200 
O 0   -1.154100   -2.016300    2.336900 
O 0   -0.565800    0.325600   -1.693100 
C 0    2.381500    1.290000    1.419200 
C 0    4.815000   -0.382800   -0.768700 
C 0    3.581600   -1.252800   -0.720700 
O 0    2.617500   -0.669700   -1.650200 
O 0    2.242200    0.567900   -0.938100 
C 0    4.460300    0.736900   -0.125000 
C 0    3.014800    0.460900    0.324200 
O 0    3.000300   -0.941700    0.533500 
C 0    5.151600    2.054400   -0.010200 
H 0    0.403300   -0.735100    0.195100 
H 0   -3.452900   -2.384300   -1.163200 
H 0   -2.956200    0.002300   -1.849700 
H 0   -1.285400   -4.505900   -0.715700 
H 0    0.145400   -3.665400   -2.509400 
H 0    0.421100   -2.143200   -1.664100 
H 0   -1.472700   -1.533500   -3.030900 
H 0   -2.182300   -3.146200   -2.883700 
H 0   -2.370100    1.793200    0.725800 
H 0    1.062500   -4.795800   -0.066100 
H 0    0.098500   -4.424900    1.370700 
H 0    1.128800   -3.178600    0.649000 
H 0   -4.128900    0.859800    0.146400 
H 0   -4.700100   -0.765000   -0.235200 
H 0   -3.604000   -0.530200    1.116400 
H 0   -2.459200   -3.407900    1.776700 
H 0   -1.271800    2.553100   -1.967300 
H 0   -1.410300    5.959000   -1.658300 
H 0   -1.758500    4.660600   -2.819400 
H 0   -3.078700    5.499100   -1.977400 
H 0   -2.310400    3.884000    1.408900 
H 0   -1.819000    5.495500    0.880200 
H 0   -3.468100    4.958200    0.587700 
H 0    1.478400   -0.371000    2.509500 
H 0    1.237800    1.221400    3.196200 
H 0   -1.030500    1.784500    3.358900 
H 0   -2.213800    0.706800    2.594400 
H 0   -0.955700    0.020300    3.613100 
H 0    0.334900    0.617100   -1.458500 
H 0    2.045100    2.233900    0.979100 
H 0    3.194400    1.536000    2.112700 
H 0    5.697900   -0.574400   -1.366100 
H 0    3.622200   -2.322100   -0.917800 
H 0    5.271500    2.363900    1.035600 
H 0    6.143000    2.017700   -0.471000 
H 0    4.572800    2.840300   -0.512900 
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C 0   -1.288500    0.401400   -0.497500 
C 0   -0.563100   -0.380900    0.663500 
C 0   -1.319500   -1.589400    1.163700 
C 0   -2.016200   -2.503800    0.136500 
C 0   -2.570900   -1.744700   -1.113800 
C 0   -2.650700   -0.206700   -0.914000 
C 0   -1.015400   -3.568000   -0.454300 
C 0   -0.513100   -2.957300   -1.767900 
C 0   -1.746000   -2.239000   -2.339800 
C 0   -1.332300    1.849900    0.082900 
O 0   -0.144100    1.916200    0.903400 
C 0   -0.122000    0.711700    1.696800 
C 0    0.064400   -4.097600    0.490700 
C 0   -3.817000    0.130300    0.035400 
O 0   -3.080200   -3.150200    0.823900 
C 0   -1.337400    2.949100   -0.939200 
C 0   -1.683100    4.225100   -0.708200 
C 0   -1.663400    5.243600   -1.822000 
C 0   -2.097500    4.765400    0.638300 
C 0    1.311200    0.528700    2.253600 
C 0   -1.071300    0.880800    2.900400 
O 0   -1.369200   -1.912800    2.344000 
O 0   -0.477100    0.377100   -1.671300 
C 0    2.498500    1.080700    1.436600 
O 0    2.869000   -1.674800   -0.923100 
C 0    3.055800   -0.460500   -1.703300 
C 0    4.474300    0.001300   -1.472100 
C 0    4.474600    0.478100   -0.220800 
O 0    2.871400   -1.143000    0.455100 
C 0    3.016800    0.300900    0.246500 
O 0    2.285400    0.480600   -0.970100 
C 0    5.607800    0.897400    0.655200 
H 0    0.342500   -0.806600    0.214500 
H 0   -3.602700   -2.092700   -1.223700 
228  EXPERIMENTAL SECTION 
H 0   -2.881500    0.239100   -1.890100 
H 0   -1.689100   -4.400200   -0.702000 
H 0   -0.113900   -3.722700   -2.444500 
H 0    0.297100   -2.244700   -1.580000 
H 0   -1.477000   -1.422500   -3.011900 
H 0   -2.352800   -2.953600   -2.909900 
H 0   -2.198400    1.952300    0.743100 
H 0   -0.368600   -4.449800    1.433600 
H 0    0.817200   -3.336500    0.726000 
H 0    0.589600   -4.941400    0.028400 
H 0   -4.025100    1.204000    0.068700 
H 0   -4.726500   -0.369100   -0.314000 
H 0   -3.644600   -0.217500    1.060900 
H 0   -2.797700   -3.178400    1.758700 
H 0   -1.024300    2.659100   -1.938600 
H 0   -1.368300    4.798200   -2.776800 
H 0   -2.652600    5.705300   -1.950600 
H 0   -0.966500    6.062900   -1.596100 
H 0   -2.053300    4.016900    1.432000 
H 0   -1.440900    5.595900    0.932200 
H 0   -3.116300    5.175900    0.599100 
H 0    1.460000   -0.530000    2.488000 
H 0    1.354500    1.060700    3.211100 
H 0   -2.127300    0.868900    2.616800 
H 0   -0.925800    0.083300    3.630300 
H 0   -0.852200    1.846600    3.369200 
H 0    0.425100    0.635800   -1.403400 
H 0    2.261600    2.084900    1.071700 
H 0    3.341000    1.183300    2.129300 
H 0    2.664500   -0.643900   -2.702000 
H 0    5.315100   -0.200100   -2.124400 
H 0    5.473900    1.918500    1.034100 
H 0    6.556600    0.856300    0.112500 
H 0    5.689800    0.237300    1.528800 
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1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.65 (s, 3H)  1.66 (d, 1.3, 3H)  0.01 
3  5.51 (d, 8.5)  5.53 (d, 8.8)  0.02 
4  4.49 (d, 8.5)  4.50 (d, 8.6)  0.01 
6  2.06 (m)  2.07–2.03 (m)   
7  1.79 (m)  1.83–1.78 (m)   
8α  1.71 (m)  1.75–1.71 (m)   
8β  2.13 (m)  2.16–2.11 (m)   
9α  1.43 (m)  1.46–1.41 (m)   
9β  2.13 (m)  2.16–2.11 (m)   
10  2.14 (m)  2.16–2.13 (m)   
11‐OH  4.25 (s)  4.24 (s)  0.01 
13  2.63 (s)  2.64 (s)  0.01 
15a  1.69 (m)  1.73–1.68 (m)   
15b  1.91 (m)  1.95–1.88 (m)   
16  5.43 (d, 3.5)  5.47–5.42 (m)   
16‐OH  5.44 (s)  5.41 (d, 6.4)  0.03 
21  1.72 (s, 3H)  1.73 (d, 3H)  0.01 
22  0.97 (d, 7.0, 3H)  0.98 (d, 6.8, 3H)  0.01 
23  0.94 (d, 7.5, 3H)  0.95 (d, 7.2, 3H)  0.01 
24  1.56 (s, 3H)  1.57 (s, 3H)  0.01 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (100 MHz, acetone‐d6)  Δδ (ppm) 
1  18.6  18.7  0.1 
2  138.7  138.7  0 
3  122.1  122.1  0 
4  77.8  77.9  0.1 
5  87.0  87.0  0 
6  40.6  40.6  0 
7  52.5  52.5  0 
8  30.5  30.5  0 
9  31.6  31.6  0 
10  48.4  48.4  0 
11  86.9  86.9  0 
12  210.8  210.8  0 
13  64.0  64.1  0.1 
14  80.7  80.7  0 
15  50.1  50.1  0 
16  92.1  92.2  0.1 
21  26.1  26.1  0 
22  14.6  14.6  0 
23  18.5  18.5  0 
24  23.9  24.0  0.1 
                                                 
30 S.‐H. Luo, J. Hua, C.‐H. Li, S.‐X. Jing, Y. Liu, X.‐N. Li, X. Zhao, S.‐H. Li, Org. Lett. 2012, 14, 5768. 





232  EXPERIMENTAL SECTION 
Natural31 and synthetic norleucosceptroid C 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (800 MHz, acetone‐d6)  Δδ (ppm) 
1  1.63 (s, 3H)  1.63 (s, 3H)  0 
3  5.53, (br d, 8.4)  5.54 (d, 8.5)  0.01 
4  4.38 (d, 8.4)  4.38 (d, 8.5)  0 
6  2.12 (m)  2.16–2.10 (m)   
7  1.48 (m)  1.52–1.45 (m)   
8α  1.37 (m)  1.41–1.35 (m)   
8β  1.86 (m)  1.90–1.84 (m)   
9α  1.26 (m)  1.30–1.23 (m)   
9β  1.92 (m)  1.96–1.60 (m)   
10  2.19 (m)  2.25–2.16 (m)   
11  2.21 (m)  2.25–2.16 (m)   
13  2.92 (s)  2.92 (s)  0 
15a  1.52 (m)  1.57–1.54 (m)   
15b  1.82 (m)  1.84–1.80 (m)   
16  5.42 (d, 4.0)  5.44–5.38 (m)   
16‐OH  5.40 (s)  5.44–5.38 (m)   
21  1.71 (s, 3H)  1.71 (s, 3H)  0 
22  0.90 (d, 7.1, 3H)  0.91 (d, 7.1, 3H)  0.01 
23  0.96 (d, 6.2, 3H)  0.96 (d, 6.4, 3H)  0 
24  1.61 (s, 3H)  1.61 (s, 3H)  0 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (200 MHz, acetone‐d6)  Δδ (ppm) 
1  18.7  18.7  0 
2  138.5  138.5  0 
3  122.2  122.2  0 
4  76.5  76.5  0 
5  91.4  91.4  0 
6  44.5  44.5  0 
7  51.3  51.4  0.1 
8  30.1  30.1  0 
9  31.7  31.7  0 
10  32.5  32.5  0 
11  64.6  64.6  0 
12  205.9  205.9  0 
13  65.2  65.3  0.1 
14  79.3  79.3  0 
15  49.7  49.7  0 
16  92.2  92.3  0.1 
21  26.1  26.1  0 
22  14.2  14.2  0 
23  19.9  20.0  0.1 
24  22.2  22.3  0.1 
                                                 
31 S.‐H. Luo, J. Hua, C.‐H. Li, S.‐X. Jing, Y. Liu, X.‐N. Li, X. Zhao, S.‐H. Li, Org. Lett. 2012, 14, 5768. 






234  EXPERIMENTAL SECTION 
Natural32 and synthetic norleucosceptroid G 
 
1H Position  Natural (400 MHz, acetone‐d6)  Synthetic (400 MHz, acetone‐d6)  Δδ (ppm) 
1  1.84 (s, 3H)  1.82 (s, 3H)  0.02 
3  5.18 (d, 9.7)  5.15 (d, 9.8)  0.03 
4  5.73 (d, 9.8)  5.70 (d, 9.8)  0.03 
6  2.39 (m)  2.41–2.32 (m)   
7  2.17 (m)  2.22–2.08 (m)   
8α  1.71 (m)  1.75–1.64 (m)   
8β  2.18 (m)  2.22–2.08 (m)   
9α  1.44 (m)  1.45–1.35 (m)   
9β  2.19 (m)  2.22–2.08 (m)   
10  2.19 (m)  2.22–2.08 (m)   
11‐OH  4.25 (s)  4.18 (s)  0.07 
15a  2.69 (dd, 15.4, 3.2)  2.69 (dd, 15.4, 3.2)  0 
15b  2.76 (dd, 15.4, 2.7)  2.76 (dd, 15.4, 2.6)  0 
16  9.75 (s)  9.73 (t, 3.0)  0.02 
21  1.79 (s, 3H)  1.77 (s, 3H)  0.02 
22  1.16 (d, 7.0, 3H)  1.14 (d, 6.9, 3H)  0.02 
23  0.86 (d, 6.6, 3H)  0.87 (d, 6.7, 3H)  0.01 
24  1.49 (s, 3H)  1.47 (s, 3H)  0.02 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (100 MHz, acetone‐d6)  Δδ (ppm) 
1  18.4  18.3  0.1 
2  139.6  139.5  0.1 
3  122.9  122.8  0.1 
4  81.2  81.2  0 
5  166.8  166.7  0.1 
6  33.1  33.1  0 
7  56.2  56.2  0 
8  29.7  29.4  0.3 
9  32.4  32.3  0.1 
10  47.6  47.6  0 
11  86.1  86.1  0 
12  197.8  197.7  0.1 
13  137.8  137.8  0 
14  86.7  86.7  0 
15  52.9  52.8  0.1 
16  201.9  201.7  0.2 
21  26.0  25.9  0.1 
22  18.1  18.1  0 
23  19.3  19.2  0.1 
24  27.1  27.0  0.1 
   
                                                 
32 S.H. Luo, C. L. Hugelshofer, J. Hua, S.‐X. Jing, C.‐H. Li, Y. Liu, X.‐N. Li, X. Zhao, T. Magauer, S.H. Li, Org. Lett. 2014, 16, 16, 
6416. 





























1H Position  Natural (500 MHz, CDCl3)  Synthetic (400 MHz, CDCl3)  Δδ (ppm) 
1  1.76 (s, 3H)  1.76 (s, 3H)  0 
3  5.42 (d, 8.7)  5.41 (d, 8.4)  0.01 
4  4.60 (d, 8.7)  4.60 (d, 8.4)  0 
5‐OH  2.47 (s)  2.39 (s)  0.08 
6  1.87 (m)  1.93–1.81 (m)   
7  2.11 (m)  2.27–1.98 (m)   
8α  1.82 (m)  1.93–1.81 (m)   
8β  2.16 (m)  2.27–1.98 (m)   
9α  1.50 (m)  1.55–1.44 (m)   
9β  2.01 (m)  2.27–1.98 (m)   
10  2.22 (m)  2.27–1.98 (m)   
11‐OH  2.79 (s)  2.67 (s)  0.12 
13  2.69 (s)  2.69 (s)  0 
15  2.06 (dd, 8.1, 8.5)  2.27–1.98 (m)   
16  2.74 (dd, 8.1, 8.5)  2.74 (app t, 9.2)  0 
19  6.15 (d, 1.2)  6.15 (d, 1.7)  0 
20  7.21 (d, 1.2)  7.21 (d, 1.7)  0 
21  1.80 (s, 3H)  1.80 (s, 3H)  0 
22  0.96 (d, 6.9, 3H)  0.96 (d, 6.9, 3H)  0 
23  0.86 (d, 7.3, 3H)  0.86 (d, 7.3, 3H)  0 
24  1.31 (s, 3H)  1.31 (s, 3H)  0 
25  1.97 (s, 3H)  1.96 (s, 3H)  0.01 
 
13C Position  Natural (125 MHz, CDCl3)  Synthetic (100 MHz, CDCl3)  Δδ (ppm) 
1  19.0  19.2  0.2 
2  140.0  140.3  0.3 
3  119.1  119.2  0.1 
4  76.3  76.5  0.2 
5  84.8  85.0  0.2 
6  38.9  39.0  0.1 
7  49.7  49.9  0.2 
8  29.8  30.0  0.2 
9  30.6  30.9  0.03 
10  47.1  47.4  0.03 
11  85.8  86.0  0.2 
12  213.1  213.2  0.1 
13  69.3  69.3  0 
14  82.8  82.9  0.1 
15  42.2  42.4  0.2 
16  20.9  21.1  0.2 
17  150.3  150.5  0.2 
18  113.6  113.8  0.2 
19  112.8  112.9  0.1 
20  139.8  139.9  0.1 
21  26.3  26.5  0.2 
22  14.2  14.5  0.3 
23  16.6  16.8  0.2 
24  22.7  22.9  0.2 
25  9.8  10.0  0.2 
                                                 
33 S.‐H. Luo, Q. Luo, X.‐M. Niu, M.‐J. Xie, X. Zhao, B. Schneider, J. Gershenzon, S.‐H. Li, Angew. Chem. Int. Ed. 2010, 49, 4471. 
236  EXPERIMENTAL SECTION 
Natural34 and synthetic leucosceptroid B 
 
1H Position  Natural (500 MHz, CDCl3)  Synthetic (800 MHz, CDCl3)  Δδ (ppm) 
1  1.72 (s, 3H)  1.74 (d, 1.4)  0.02 
3  5.46 (d, 9.0)  5.49–5.46 (m)   
4  4.35 (d, 9.0)  4.38 (d, 8.6)  0.03 
5‐OH  ‐  2.31 (s)   
6  1.87 (m)  1.92–1.87 (m)   
7  1.61 (m)  1.66–1.59 (m)   
8α  1.28 (m)  1.37–1.29 (m)   
8β  1.81 (m)  1.85–1.80 (m)   
9α  1.31 (m)  1.37–1.29 (m)   
9β  1.93 (m)  1.98–1.93 (m)   
10  2.11 (m)  2.15–2.10 (m)   
11  1.76 (m)  1.78–1.75 (m)   
13  2.74 (s)  2.76 (s)  0.02 
15  2.07 (t, 8.6)  2.10–2.06 (m)   
16  2.71 (t, 8.6)  2.75–2.71 (m)   
19  6.10 (d, 1.5)  6.13 (d, 1.8)  0.03 
20  7.16 (d, 1.5)  7.20 (d, 1.8)  0.04 
21  1.77 (s, 3H)  1.79 (d, 1.4)  0.02 
22  0.94 (d, 7.0, 3H)  0.96 (d, 7.1, 3H)  0.02 
23  1.14 (d, 6.5, 3H)  1.16 (d, 6.7, 3H)  0.02 
24  1.20 (s, 3H)  1.22 (s, 3H)  0.02 
25  1.93 (s, 3H)  1.95 (s, 3H)  0.02 
 
13C Position  Natural (125 MHz, CDCl3)  Synthetic (200 MHz, CDCl3)  Δδ (ppm) 
1  18.8  19.1  0.3 
2  138.8  139.2  0.4 
3  119.9  120.1  0.2 
4  75.8  76.1  0.3 
5  86.2  86.5  0.3 
6  44.8  45.0  0.2 
7  45.8  46.1  0.3 
8  28.5  28.8  0.3 
9  32.1  32.4  0.3 
10  32.8  33.1  0.3 
11  64.6  64.9  0.3 
12  209.4  209.6  0.2 
13  70.7  70.9  0.2 
14  81.9  82.1  0.2 
15  41.4  41.6  0.2 
16  20.6  20.9  0.3 
17  150.5  150.7  0.2 
18  133.4  113.7  0.3 
19  112.7  113.0  0.3 
20  139.6  139.8  0.2 
21  26.1  26.4  0.3 
22  13.8  14.1  0.3 
23  21.6  21.9  0.3 
24  22.6  23.0  0.4 
25  9.7  10.0  0.3 
                                                 
34 S.‐H. Luo, Q. Luo, X.‐M. Niu, M.‐J. Xie, X. Zhao, B. Schneider, J. Gershenzon, S.‐H. Li, Angew. Chem. Int. Ed. 2010, 49, 4471. 





238  EXPERIMENTAL SECTION 
Natural35 and synthetic leucosceptroid C 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (800 MHz, acetone‐d6)  Δδ (ppm) 
1  1.72 (s, 3H)  1.76 (s, 3H)  0.04 
3  5.57 (d, 8.8)  5.62–5.59 (m)   
4  4.76 (d, 8.8)  4.80 (d, 8.8)  0.04 
5‐OH  4.46 (s)  4.12 (s)  0.34 
6  1.78 (m)  1.83–1.79 (m)   
7  2.00 (m)  2.09–2.04 (m)   
8α  1.64 (m)  1.72–1.67 (m)   
8β  2.08 (m)  2.15–2.09 (m)   
9α  1.38 (m)  1.44–1.40 (m)   
9β  2.03 (m)  2.09–2.04 (m)   
10  2.25 (m)  2.30–2.27 (m)   
11‐OH  4.58 (s)  4.26 (s)  0.32 
13  2.76 (s)  2.77 (s)  0.01 
15a  2.28 (dd, 14.0, 2.5)  2.32 (dd, 14.2, 2.3)  0.04 
15b  1.89 (dd, 14.0, 10.5)  1.90 (dd, 14.2, 11.2)  0.01 
16  2.43 (dt, 10.5, 2.5)  2.43 (app dt, 11.2, 2.3)  0 
19  7.20 (br s)  7.21–7.19 (m)   
20  4.63 (br s)  4.65–4.62 (m)   
20‐OH  4.68 (d, 2.8)  4.34 (d, 3.7)  0.34 
21  1.72 (s, 3H)  1.76 (s, 3H)  0.04 
22  0.94 (d, 6.8, 3H)  0.98 (d, 6.8, 3H)  0.04 
23  0.79 (d, 7.4, 3H)  0.83 (d, 7.3, 3H)  0.04 
24  1.27 (s, 3H)  1.30 (s, 3H)  0.03 
25  1.70 (br s, 3H)  1.73 (app t, 1.8, 3H)  0.03 
 
   
                                                 
35 S.‐H. Luo, L.‐H. Weng, M.‐J. Xie, X.‐N. Li, J. Hua, X. Zhao, S.‐H. Li, Org. Lett. 2011, 13, 1864. 
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13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (200 MHz, acetone‐d6)  Δδ (ppm) 
1  18.8  18.8  0 
2  138.0  138.1  0.1 
3  121.8  121.9  0.1 
4  77.4  77.5  0.1 
5  84.1  84.2  0.1 
6  41.8  41.9  0.1 
7  50.2  50.3  0.1 
8  30.4  30.5  0.1 
9  30.9  31.0  0.1 
10  46.0  46.2  0.2 
11  85.5  85.6  0.1 
12  212.5  212.2  0.3 
13  73.3  73.5  0.2 
14  83.7  83.7  0 
15  44.2  44.3  0.1 
16  53.8  54.0  0.2 
17  207.4  206.9  0.5 
18  141.8  141.8  0 
19  157.0  156.8  0.2 
20  76.7  76.8  0.1 
21  26.0  26.1  0.1 
22  13.8  13.9  0.1 
23  17.2  17.2  0 
24  23.6  23.5  0.1 
25  10.0  10.1  0.1 
 
   
240  EXPERIMENTAL SECTION 
synthetic (‒)-leucosceptroid C 
natural (+)-leucosceptroid C 
natural (+)-leucosceptroid C 
synthetic (‒)-leucosceptroid C 
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Natural36 and synthetic leucosceptroid G 
 
1H Position  Natural (400 MHz, acetone‐d6)  Synthetic (400 MHz, acetone‐d6)  Δδ (ppm) 
1  1.71 (s, 3H)  1.72 (s, 3H)  0.01 
3  5.54 (d, 8.8)  5.54 (d, 8.9)  0 
4  4.68 (d, 8.8)  4.69 (d, 8.9)  0.01 
5‐OH  3.73 (s)  3.87 (s)  0.14 
6  1.78 (m)  1.83–1.74 (m)   
7  2.01 (m)  2.06–1.98 (m)   
8α  1.69 (m)  1.69–1.59 (m)   
8β  2.09 (m)  2.14–2.09 (m)   
9α  1.40 (m)  1.46–1.35 (m)   
9β  2.03 (m)  2.06–1.98 (m)   
10  2.27 (m)  2.32–2.18 (m)   
11‐OH  4.02 (s)  4.16 (s)  0.14 
13  2.65 (s)  2.65 (s)  0 
15a  1.76 (m)  1.83–1.74 (m)   
15b  ‐  1.83–1.74 (m)   
16a  1.63 (m)  1.69–1.59 (m)   
16b  2.20 (m)  2.32–2.18 (m)   
17  5.00 (br s)  5.05–4.99 (m)   
19  5.78 (br s)  5.83–5.80 (m)   
21  1.71 (s, 3H)  1.72 (s, 3H)  0.01 
22  0.96 (d, 6.8, 3H)  0.96 (d, 6.8, 3H)  0 
23  0.82 (d, 7.3, 3H)  0.82 (d, 7.4, 3H)  0 
24  1.20 (s, 3H)  1.19 (s, 3H)  0.01 
25  2.11 (br s, 3H)  2.11 (br s, 3H)  0 
 
   
                                                 
36 S.‐H. Luo, J. Hua, X.‐M. Niu, Y. Liu, C.‐H. Li, Y.‐Y. Zhou, S.‐X. Jing, X. Zhao, S.‐H. Li, Phytochemistry 2013, 86, 29. 
242  EXPERIMENTAL SECTION 
13C Position  Natural (100 MHz, acetone‐d6)  Synthetic (100 MHz, acetone‐d6)  Δδ (ppm) 
1  18.8  18.8  0 
2  137.1  136.9  0.2 
3  122.6  122.6  0 
4  77.1  76.9  0.2 
5  84.5  84.2  0.3 
6  42.0  42.1  0.1 
7  50.5  50.2  0.3 
8  30.5  30.5  0 
9  31.1  30.9  0.2 
10  46.5  46.2  0.3 
11  85.8  85.5  0.3 
12  212.8  212.8  0 
13  72.1  72.1  0 
14  83.6  83.4  0.2 
15  39.4  39.3  0.1 
16  27.7  27.6  0.1 
17  85.2  85.1  0.1 
18  170.3  170.4  0.1 
19  117.3  117.2  0.1 
20  173.2  173.2  0 
21  26.1  26.1  0 
22  14.0  13.9  0.1 
23  17.3  17.2  0.1 
24  23.8  23.7  0.1 
25  13.8  13.9  0.1 
 
   





244  EXPERIMENTAL SECTION 
Natural37 and synthetic leucosceptroid I 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (800 MHz, acetone‐d6)  Δδ (ppm) 
1  1.72 (d, 1.0, 3H)  1.72 (d, 1.3, 3H)  0 
3  5.56 (d, 9.0)  5.59–5.56 (m)   
4  4.72 (d, 9.0)  4.74 (d, 8.8)  0.02 
5‐OH  3.93 (s)  3.92 (s)  0.01 
6  1.58 (m)  1.64–1.51 (m)   
7  2.38 (m)  2.42–2.36 (m)   
8α  1.53 (m)  1.64–1.51 (m)   
8β  2.01 (m)  2.04–2.01 (m)   
9α  1.47 (m)  1.51–1.46 (m)   
9β  1.60 (m)  1.64–1.51 (m)   
10  2.42 (m)  2.47–2.42 (m)   
11  2.87 (dd, 11.0, 7.0)  2.88 (dd, 10.9, 7.0)  0.01 
13  2.65 (s)  2.66 (s)  0.01 
15a  1.77 (m)  1.81–1.75 (m)   
15b  ‐  1.75–1.71 (m)   
16a  1.57 (m)  1.64–1.51 (m)   
16b  2.22 (m)  2.26–2.20 (m)   
17  5.00 (br s)  5.02–4.99 (m)   
19  5.80 (br s)  5.83–5.81 (m)   
21  1.71 (d, 1.5, 3H)  1.73 (d, 1.3, 3H)  0.02 
22  0.94 (d, 7.0, 3H)  0.96 (d, 6.8, 3H)  0.02 
23  0.89 (d, 7.5, 3H)  0.90 (d, 7.2, 3H)  0.01 
24  1.12 (s, 3H)  1.13 (s, 3H)  0.01 
25  2.10 (br s, 3H)  2.11 (br s, 3H)  0.01 
 
   
                                                 
37 S.‐H. Luo, J. Hua, X.‐M. Niu, Y. Liu, C.‐H. Li, Y.‐Y. Zhou, S.‐X. Jing, X. Zhao, S.‐H. Li, Phytochemistry 2013, 86, 29. 
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13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (200 MHz, acetone‐d6)  Δδ (ppm) 
1  18.7  18.8  0.1 
2  136.6  136.6  0 
3  122.9  122.9  0 
4  77.0  77.0  0 
5  85.6  85.7  0.1 
6  46.2  46.3  0.1 
7  41.5  41.6  0.1 
8  31.4  31.4  0 
9  33.4  33.5  0.1 
10  37.0  37.1  0.1 
11  56.3  56.4  0.1 
12  213.2  213.2  0 
13  73.8  73.9  0.1 
14  82.6  82.6  0 
15  38.6  38.7  0.1 
16  27.2  27.3  0.1 
17  85.0  85.1  0.1 
18  170.4  170.4  0 
19  117.1  117.1  0 
20  173.2  173.2  0 
21  26.1  26.2  0.1 
22  13.8  13.9  0.1 
23  16.9  16.9  0 
24  22.1  22.1  0 
25  13.7  13.8  0.1 
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Natural38 and synthetic leucosceptroid J 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.68 (d, 1.5, 3H)  1.70 (s, 3H)  0.02 
3  5.59 (d, 8.5)  5.62–5.59 (m)   
4  4.40 (d, 8.5)  4.42 (d, 8.5)  0.02 
5‐OH  3.99 (s)  3.98 (s)  0.01 
6  1.86 (m)  1.90–1.86 (m)   
7  1.76 (m)  1.84–1.76 (m)   
8α  1.29 (overlap)  1.34–1.26 (m)   
8β  1.78 (m)  1.84–1.76 (m)   
9α  1.29 (overlap)  1.34–1.26 (m)   
9β  1.93 (m)  1.96–1.91 (m)   
10  2.04 (m)  2.08–2.05 (m)   
11  1.77 (m)  1.84–1.76 (m)   
13  2.73 (s)  2.74 (s)  0.01 
15a  1.79 (m, 2H)  1.84–1.76 (m)   
15b  ‐  1.84–1.76 (m)   
16a  1.57 (m)  1.62–1.55 (m)   
16b  2.17 (m)  2.22–2.16 (m)   
17  4.98 (br s)  5.01–4.96 (m)   
19  5.79 (br s)  5.83–5.79 (m)   
21  1.70 (d, 1.5, 3H)  1.72 (s, 3H)  0.02 
22  0.94 (d, 7.0, 3H)  0.96 (d, 7.0, 3H)  0.02 
23  1.23 (d, 7.0, 3H)  1.13 (d, 6.7, 3H)  0.1 
24  1.10 (s, 3H)  1.11 (s, 3H)  0.01 
25  2.08 (br s, 3H)  2.10 (s, 3H)  0.02 
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248  EXPERIMENTAL SECTION 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (150 MHz, acetone‐d6)  Δδ (ppm) 
1  18.7  18.7  0 
2  136.7  136.7  0 
3  122.6  122.7  0.1 
4  76.8  76.9  0.1 
5  86.2  86.2  0 
6  47.1  47.2  0.1 
7  46.4  46.4  0 
8  29.0  29.1  0.1 
9  32.9  33.0  0.1 
10  33.8  33.8  0 
11  65.1  65.2  0.1 
12  210.8  210.7  0.1 
13  72.3  72.4  0.1 
14  82.4  82.4  0 
15  38.5  38.6  0.1 
16  27.2  27.3  0.1 
17  85.2  85.2  0 
18  170.5  170.5  0 
19  117.0  117.1  0.1 
20  173.3  173.2  0.1 
21  26.2  26.2  0 
22  14.0  14.1  0.1 
23  22.0  22.0  0 
24  22.8  22.9  0.1 
25  13.8  13.9  0.1 
 
   





250  EXPERIMENTAL SECTION 
Natural39 and synthetic leucosceptroid K 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.73 (d, 1.0, 3H)  1.76‒1.73 (m, 3H)   
3  5.57 (d, 8.9)  5.60‒5.57 (m)   
4  4.72 (d, 9.0)  4.74 (d, 8.9)  0.02 
5‐OH  3.91 (s)  3.89 (br s)  0.02 
6  1.76 (m)  1.83‒1.76 (m)   
7  2.02 (m)  2.15‒2.02 (m)   
8α  1.68 (m)  1.73‒1.67 (m)   
8β  2.10 (m)  2.15‒2.02 (m)   
9α  1.39 (m)  1.44‒1.38 (m)   
9β  2.03 (m)  2.15‒2.02 (m)   
10  2.26 (m)  2.31‒2.24 (m)   
11‐OH  4.19 (s)  4.17 (br s)  0.02 
13  2.71 (s)  2.72 (s)  0.01 
15  2.77 (dd, 4.7, 7.5)  2.82‒2.74 (m)   
16  5.76 (2H, t, 7.6)  5.76 (t, 7.6)  0 
19  6.01 (s)  6.01 (s)  0 
21  1.73 (s, 3H)  1.76‒1.73 (m, 3H)   
22  0.96 (d, 6.8, 3H)  0.98 (d, 6.9, 3H)  0.02 
23  0.78 (d, 7.4, 3H)  0.80 (d, 7.4, 3H)  0.02 
24  1.23 (s, 3H)  1.25 (s, 3H)  0.02 
25  2.19 (s, 3H)  2.20 (d, 1.4, 3H)  0.01 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (150 MHz, acetone‐d6)  Δδ (ppm) 
1  18.8  18.8  0 
2  137.1  137.2  0.1 
3  122.4  122.5  0.1 
4  77.2  77.3  0.1 
5  84.4  84.5  0.1 
6  42.2  42.3  0.1 
7  50.3  50.5  0.2 
8  30.6  30.6  0 
9  30.9  31.0  0.1 
10  46.1  46.3  0.2 
11  85.5  85.6  0.1 
12  212.4  212.4  0 
13  71.6  71.7  0.1 
14  83.3  83.4  0.1 
15  41.6  41.6  0 
16  109.4  109.5  0.1 
17  152.5  152.6  0.1 
18  156.2  156.2  0 
19  116.6  116.6  0 
20  169.5  169.5  0 
21  26.1  26.2  0.1 
22  14.0  14.0  0 
23  16.9  17.0  0.1 
24  24.3  24.3  0 
25  11.7  11.7  0 
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Natural40 and synthetic leucosceptroid L 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.81 (s, 3H)  1.82 (d, 1.2, 3H)  0.1 
3  5.15 (d, 9.6)  5.16 (d, 9.7)  0.1 
4  5.66 (d, 9.6)  5.66 (dd, 9.7, 0.9)  0 
6  2.34 (m)  2.83–2.32 (m)   
7  2.14 (m)  2.15–2.10 (m)   
8α  1.64 (m)  1.67–1.63 (m)   
8β  2.11 (m)  2.15–2.10 (m)   
9α  1.34 (m)  1.37–1.33 (m)   
9β  2.12 (m)  2.15–2.10 (m)   
10  2.13 (m)  2.15–2.10 (m)   
11‐OH  4.15 (s)  4.13 (s)  0.2 
15a  2.72 (dd, 15.4, 7.2)  2.73 (dd, 15.4, 7.1)  0.1 
15b  2.89 (dd, 15.4, 8.0)  2.90 (dd, 15.4, 8.0)  0.1 
16  5.44 (t, 7.5)  5.44 (t, 7.5)  0 
19  6.00 (s)  6.00 (s)  0 
21  1.77 (s, 3H)  1.78 (d, 1.0, 3H)  0.1 
22  1.13 (d, 7.0, 3H)  1.14 (d, 7.0, 3H)  0.1 
23  0.83 (d, 7.0, 3H)  0.84 (d, 7.0, 3H)  0.1 
24  1.41 (s, 3H)  1.42 (s, 3H)  0.1 
25  2.14 (s, 3H)  2.16 (d, 1.3, 3H)  0.2 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (150 MHz, acetone‐d6)  Δδ (ppm) 
1  18.3  18.4  0.1 
2  139.2  139.3  0.1 
3  123.3  123.4  0.1 
4  80.8  80.9  0.1 
5  166.5  166.6  0.1 
6  33.0  33.0  0 
7  56.0  56.0  0 
8  29.5  29.5  0 
9  32.2  32.2  0 
10  47.5  47.5  0 
11  86.0  86.0  0 
12  197.4  197.5  0.1 
13  137.7  137.8  0.1 
14  88.6  88.7  0.1 
15  36.8  36.8  0 
16  109.0  109.1  0.1 
17  152.4  152.4  0 
18  155.7  155.8  0.1 
19  116.7  116.8  0.1 
20  169.3  169.4  0.1 
21  26.0  26.1  0.1 
22  18.2  18.2  0 
23  18.7  18.9  0.2 
24  26.7  26.8  0.1 
25  11.5  11.6  0.1 
                                                 
40 S.‐H. Luo, J. Hua, X.‐M. Niu, Y. Liu, C.‐H. Li, Y.‐Y. Zhou, S.‐X. Jing, X. Zhao, S.‐H. Li, Phytochemistry 2013, 86, 29. 
252  EXPERIMENTAL SECTION 
Natural41 and synthetic leucosceptroid M 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (600 MHz, acetone‐d6)  Δδ (ppm) 
1  1.81 (s, 3H)  1.82 (d, 1.2, 3H)  0.1 
3  5.11 (d, 9.6)  5.11 (d, 9.7)  0 
4  5.66 (d, 8.7)  5.67 (dd, 9.6, 1.2)  0.1 
6  2.35 (m)  2.39–3.44 (m)   
7  2.14 (m)  2.17–2.08 (m)   
8α  1.65 (m)  1.66–1.63 (m)   
8β  2.12 (m)  2.17–2.08 (m)   
9α  1.34 (m)  1.37–1.32   
9β  2.10 (m)  2.17–2.08 (m)   
10  2.11 (m)  2.17–2.08 (m)   
11‐OH  4.14 (s)  4.13 (s)  0.1 
15a  2.72 (dd, 15.1, 7.4)  2.73 (dd, 15.2, 7.4)  0.1 
15b  3.07 (dd, 15.3, 9.8)  3.08 (dd, 15.2, 9.7)  0.1 
16  5.64 (t, 9.4)  5.66‐5.64 (m)   
19  6.05 (s)  6.06 (s)  0.1 
21  1.75 (s, 3H)  1.76 (d, 1.1, 3H)  0.1 
22  1.13 (d, 7.0, 3H)  1.13 (d, 7.0, 3H)  0 
23  0.80 (d, 7.0, 3H)  0.81 (d, 7.0, 3H)  0.1 
24  1.42 (s, 3H)  1.42 (s, 3H)  0 
25  2.39 (s, 3H)  2.40 (d, 1.3, 3H)  0.1 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (150 MHz, acetone‐d6)  Δδ (ppm) 
1  18.4  18.3  0.1 
2  139.7  139.6  0.1 
3  123.0  122.9  0.1 
4  80.8  80.7  0.1 
5  167.4  167.4  0 
6  33.0  33.0  0 
7  56.2  56.1  0.1 
8  29.4  29.4  0 
9  32.2  32.2  0 
10  47.3  47.3  0 
11  86.0  86.0  0 
12  197.9  197.8  0.1 
13  137.3  137.3  0 
14  89.0  89.0  0 
15  35.8  35.8  0 
16  113.4  113.3  0.1 
17  151.8  151.7  0.1 
18  155.9  155.8  0.1 
19  120.1  120.0  0.1 
20  169.1  169.0  0.1 
21  26.1  26.0  0.1 
22  18.1  18.1  0 
23  19.0  18.9  0.1 
24  27.3  27.3  0 
25  15.6  15.5  0.1 
                                                 
41 S.‐H. Luo, J. Hua, X.‐M. Niu, Y. Liu, C.‐H. Li, Y.‐Y. Zhou, S.‐X. Jing, X. Zhao, S.‐H. Li, Phytochemistry 2013, 86, 29. 
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Natural42 and synthetic leucosceptroid O 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (800 MHz, acetone‐d6)  Δδ (ppm) 
1  1.74 (s, 3H)  1.75 (d, 1.3, 3H)  0.01 
3  5.60 (d, 9.0)  5.62–5.60 (m)   
4  5.23 (d, 9.0)  5.24 (d, 9.0)  0.01 
6  1.71 (m)  1.74–1.68 (m)   
7  1.97 (m)  2.02–1.95 (m)   
8α  1.56 (m)  1.59–1.52 (m)   
8β  2.12 (m)  2.14–2.10 (m)   
9α  1.39 (m)  1.42–1.36 (m)   
9β  1.99 (m)  2.02–1.95 (m)   
10  2.30 (m)  2.33–2.29 (m)   
11‐OH  4.46 (s)  4.45 (s)  0.01 
13  3.49 (s)  3.50 (s)  0.01 
15a  1.70 (m)  1.74–1.68 (m)   
15b  1.90 (m)  1.94–1.87 (m)   
16a  1.78 (m)  1.80–1.76 (m)   
16b  2.46 (m)  2.47 (ddd, 14.5, 12.7, 4.7)  0.01 
19  5.84 (s)  5.84 (q, 1.6)  0 
21  1.77 (s, 3H)  1.78 (d, 1.3, 3H)  0.01 
22  0.92 (d, 6.7, 3H)  0.93 (d, 6.7, 3H)  0.01 
23  0.84 (d, 7.3, 3H)  0.85 (d, 7.3, 3H)  0.01 
24  1.31 (s, 3H)  1.32 (s, 3H)  0.01 
25  2.24 (s, 3H)  2.25 (d, 1.6, 3H)  0.01 
 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (200 MHz, acetone‐d6)  Δδ (ppm) 
1  18.9  19.0  0.1 
2  137.9  138.0  0.1 
3  122.1  122.2  0.1 
4  78.9  79.0  0.1 
5  91.1  91.2  0.1 
6  44.0  44.0  0 
7  51.3  51.3  0 
8  31.4  31.4  0 
9  30.9  31.0  0.1 
10  45.8  45.8  0 
11  85.1  85.1  0 
12  208.0  208.0  0 
13  65.3  65.4  0.1 
14  84.1  84.1  0.1 
15  38.9  39.0  0.1 
16  31.1  31.2  0.1 
17  110.3  110.3  0 
18  170.7  170.8  0.1 
19  116.3  116.3  0 
20  170.4  170.4  0 
21  26.2  26.2  0 
22  14.3  14.3  0 
23  16.8  16.8  0 
24  27.0  27.0  0 
25  13.1  13.2  0.1 
                                                 
42 S.‐H. Luo, J. Hua, C.‐H. Li, Y. Liu, X.‐N. Li, X. Zhao, S.‐H. Li, Tetrahedron Lett. 2013, 54, 235. 
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Natural43 and synthetic leucosceptroid P 
 
1H Position  Natural (500 MHz, acetone‐d6)  Synthetic (400 MHz, acetone‐d6)  Δδ (ppm) 
1  1.71 (s, 3H)  1.72 (s, 3H)  0.01 
3  5.55 (d, 8.9)  5.58–5.51 (m)   
4  4.69 (d, 8.9)  4.70 (d, 8.9)  0.01 
5‐OH  3.90 (m)  3.93 (s)  0.03 
6  1.77 (m)  1.97–1.75 (m)   
7  2.03 (m)  2.22–1.97 (m)   
8α  1.69 (m)  1.69–1.54 (m)   
8β  2.09 (m)  2.22–1.97 (m)   
9α  1.40 (m)  1.45–1.35 (m)   
9β  2.00 (m)  2.22–1.97 (m)   
10  2.27 (m)  2.32–2.22 (m)   
11‐OH  4.16 (s)  4.18 (s)  0.02 
13  2.63 (s)  2.63 (s)  0 
15a  1.64 (m)  1.69–1.54 (m)   
15b  1.81 (m)  1.97–1.75 (m)   
16a  2.18 (m)  2.22–1.97 (m)   
16b  2.30 (m)  2.32–2.22 (m)   
17‐OH  ‐  6.34 (s)   
19  5.80 (s)  5.81 (br s)  0.01 
21  1.72 (s, 3H)  1.72 (s, 3H)  0 
22  0.96 (d, 6.8, 3H)  0.96 (d, 6.8, 3H)  0 
23  0.82 (d, 7.4, 3H)  0.82 (d, 7.3, 3H)  0 
24  1.18 (s, 3H)  1.19 (s, 3H)  0.01 
25  2.04 (s, 3H)  2.05 (overlapped, 3H)  0.01 
 
   
                                                 
43 S.H. Luo, C. L. Hugelshofer, J. Hua, S.‐X. Jing, C.‐H. Li, Y. Liu, X.‐N. Li, X. Zhao, T. Magauer, S.H. Li, Org. Lett. 2014, 16, 16, 
6416. 
256  EXPERIMENTAL SECTION 
13C Position  Natural (125 MHz, acetone‐d6)  Synthetic (100 MHz, acetone‐d6)  Δδ (ppm) 
1  18.7  18.8  0.1 
2  137.0  137.0  0 
3  122.5  122.5  0 
4  77.0  77.0  0 
5  84.2  84.2  0 
6  42.0  42.2  0.2 
7  50.2  50.2  0 
8  30.5  30.5  0 
9  30.9  30.9  0 
10  46.2  46.2  0 
11  85.5  85.5  0 
12  212.6  212.7  0.1 
13  72.1  72.2  0.1 
14  83.2  83.3  0.1 
15  38.4  38.4  0 
16  31.7  31.8  0.1 
17  108.9  108.9  0 
18  168.4  168.3  0.1 
19  118.4  118.4  0 
20  170.9  170.7  0.2 
21  26.1  26.1  0 
22  13.9  13.9  0 
23  17.1  17.2  0.1 
24  23.7  23.7  0 
25  12.5  12.6  0.1 
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Based  on  the  known  preparation  of  enone  31,44  a  round‐bottomed  flask  was  charged  with  







further  2 days,  the mixture was  cooled  to 0  °C,  and a  solution of  acetic  acid  (22.3 mL,  389 mmol,  
1.50 equiv) in water (30 mL) was added. The resulting biphasic mixture was warmed to 23 °C and stirred 















concentrated. The  residue was purified by  flash‐column chromatography on  silica gel  (20% → 30% 
ethyl acetate in hexanes) to provide enone 31 (19.0 g, 49%) as an orange oil. The characterization data 
for 31 were in agreement with values previously reported.44a,45 The absolute configuration (R) of enone 
31  was  derived  from  the  sign  of  the  optical  rotation,  and  31  was  estimated  to  be  of  
≥80%  ee  by  comparison  with  the  literature  values  (Lit.:44a  	ሾࢻሿࡰ૛૙  =  –108°  (c  =  3.50,  EtOH);  Lit.:45 
ሾࢻሿࡰ૛૙ = –94° (c = 1.00, EtOH)). TLC (20% ethyl acetate in hexanes): Rf = 0.32 (UV/CAM). 1H NMR (400 MHz, CDCl3) δ 5.78–5.76 (m, 1H, 




ATR,  neat)  vm̃ax:  2960  (m),  2928  (m),  2861  (m),  1667  (s),  1454  (w),  1421  (w),  1296  (w),  1222  (w),  
1202  (w)  cm–1.  HRMS  (EI):  calcd  for  ([M],  C10H14O)+:  150.1045,  found:  150.1044.  ሾࢻሿࡰ૛૙  =  –94.8°  (c = 2.00, EtOH).    












sodium hydrogen  carbonate  solution  (150 mL).  The  layers were  separated,  the  aqueous  layer was 




































δ 109.24 (C‐1),  80.23  (C‐3),  76.67  (C‐4),  64.50  (C‐10),  64.27  (C‐10’),  42.45  (C‐7),  40.25  (C‐2),  34.02  
(C‐6),  32.54  (C‐8),  30.45  (C‐9),  28.82  (C‐5),  21.58  (C‐18).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3460  (br),  
2954  (m), 1465 (m), 1428  (m), 1341  (m), 1265  (s), 1122  (m), 1091  (s), 1069  (s), 1032  (s), 1012  (m)  
cm–1.  HRMS  (ESI):  calcd  for  ([M+Na],  C12H20O4Na)+:  251.12593,  found:  251.12550.  ሾࢻሿࡰ૛૙  =  –61.8°  (c = 0.33, CH2Cl2). 
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Synthesis of hydrindanone 34 
 
Based  on  the  literature  procedure,47  a  suspension  of  triphenylphosphine  (17.3  g,  66.1  mmol,  
2.20 equiv) in acetonitrile (200 mL) was treated with hexachloroethane (15.7 g, 66.1 mmol, 2.20 equiv) 
at 0 °C. After 5 min, the cooling bath was removed and the mixture was warmed to 23 °C. After 30 min, 





sodium sulfate. The dried solution was  filtered and  the  filtrate was concentrated. The  residue was 
purified  by  flash‐column  chromatography  on  silica  gel  (30%  ethyl  acetate  in  hexanes)  to  provide 
hydrindanone  34  (6.32  g,  ≥99%)  as  a  yellowish  oil  which  solidified  upon  standing.  The  1H  NMR,  
13C  NMR,  IR  and  HMRS  data  for  hydrindanone  34  were  in  full  agreement  with  values  previously 
reported for the racemic compound.47 
TLC (30% ethyl acetate in hexanes): Rf = 0.38 (CAM). 1H NMR (400 MHz, CDCl3) δ 4.02–3.85 (m, 4H,  




2882  (m),  1737  (s),  1459  (m),  1354  (m),  1287  (m),  1194  (m),  1110  (s),  1080  (m),  1016  (m)  cm–1.  
HRMS  (ESI):  calcd  for  ([M+H],  C12H19O3)+:  211.13342,  found:  211.13297.  ሾࢻሿࡰ૛૙  =  –92.6°  (c  =  1.00, CH2Cl2). 
 
   










































1.95–1.75  (m,  5H,  2‐H,  3‐H,  5‐HB,  9‐HA),  1.66–1.53  (m,  3H,  6‐HA,  8‐HA,  9‐HB),  1.41  (app  td,  2J8B/8A  =  
3J8B/9A  =  13.4  Hz,  3J8B/9B  =  4.5  Hz,  1H,  8‐HB),  1.20–1.09  (m,  1H,  6‐HB),  1.07  (s,  3H,  18‐H),  0.97  (d,  
3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.95 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 13C NMR (100 MHz, CDCl3) δ 140.34 
(Ph), 128.23 (Ph), 126.79 (Ph), 126.68 (Ph), 111.05 (C‐1), 87.58 (C‐4), 64.40 (C‐10), 64.28 (C‐10’), 62.43 
(Bn),  48.33  (C‐3),  41.86  (C‐7),  40.17  (C‐6),  36.87  (C‐8),  34.43  (C‐5),  33.75  (C‐2),  33.01  (C‐15),  31.74  
(C‐9),  18.48  (C‐16,  C‐17),  18.19  (C‐18),  18.15  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  2955  (s),  
2877  (m),  1454  (m),  1385  (m),  1263  (m),  1198  (m),  1143  (m),  1085  (s),  1061  (s),  1040  (s)  cm–1.  
HRMS (EI): calcd for ([M], C22H32O3)+: 344.2351, found: 344.2338. ሾࢻሿࡰ૛૙ = +32.2° (c = 1.06, CH2Cl2).  
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Synthesis of ketone 11 
 




combined  organic  extracts  were  washed  sequentially  with  saturated  aqueous  sodium  hydrogen 
carbonate  solution  (50 mL)  and  saturated  aqueous  sodium  chloride  solution  (50 mL).  The washed 
solution  was  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 











vm̃ax:  2958  (m),  2876  (m),  1706  (s),  1454  (m),  1387  (m),  1220  (w),  1111  (m),  1085  (m),  1056  (s),  
1028  (m)  cm–1.  HRMS  (ESI):  calcd  for  ([M+NH4],  C20H32O2N)+:  318.24330,  found:  318.24334. 
ሾࢻሿࡰ૛૙ = +15.6° (c = 1.05, CH2Cl2).  
   





78  °C  (addition  to  the  inner wall  of  the  reaction  flask,  such  that  the  solution was  cooled  before 
reaching  the  reaction  mixture).  After  45  min,  a  solution  of  acetaldehyde  (0.29  mL,  5.11  mmol,  
1.20 equiv) in tetrahydrofuran (4 mL) was added dropwise over a period of 5 min. After 40 min, TLC 
analysis indicated incomplete conversion of ketone 11, and therefore a further portion of acetaldehyde 
(71.7 µL, 1.28 mmol, 0.30 equiv)  in  tetrahydrofuran  (0.5 mL) was added dropwise over a period of  






A  solution  of  the  crude  aldol  product  (assuming  4.26 mmol)  in  dimethyl  formamide  (8.5 mL) was 
treated  sequentially  with  imidazole  (0.93  g,  13.6  mmol,  3.20  equiv),  4‐dimethylaminopyridine  
(52.0 mg, 0.43 mmol, 0.10 equiv) and tert‐butyldimethylchlorosilane (0.90 g, 5.96 mmol, 1.40 equiv) 
at 0 °C. After 5 min, the cooling bath was removed and the mixture was allowed to warm to 23 °C. 
After  13  h,  the mixture was  diluted with  saturated  aqueous  sodium  hydrogen  carbonate  solution  
(40 mL), water (20 mL) and diethyl ether (20 mL). The layers were separated, the aqueous layer was 
extracted  with  diethyl  ether  (3  x  30  mL)  and  the  combined  organic  extracts  were  washed  with 
saturated  aqueous  sodium  chloride  solution  (40 mL).  The washed  solution was  dried  over  sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by 







(dd,  2J2B/2A = 15.5 Hz,  3J2B/3 = 3.9 Hz, 1H, 2‐HB), 2.09  (dd,  2J8A/8B = 12.6 Hz,  3J8A/9 = 6.5 Hz, 1H, 8‐HA),  
2.05–1.99 (m, 1H, 5‐HA), 1.84 (h, 3J15/16‐17 = 6.9 Hz, 1H, 15‐H), 1.67 (dd, 3J3/2A = 14.3 Hz, 3J3/2B = 3.9 Hz, 
1H,  3‐H),  1.57–1.49  (m,  2H,  5‐HB,  6‐HA),  1.43  (app  t,  2J8B/8A  =  3J8B/9  =  12.6  Hz,  1H,  8‐HB),  1.25  (d,  
3J11/10  =  6.2  Hz,  3H,  11‐H),  1.11  (s,  3H,  18‐H),  1.08–1.02  (m,  1H,  6‐HB),  0.99  (s,  9H,  SiR),  0.78  (d,  
3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.68 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.10 (s, 6H, SiR). 13C NMR (200 MHz, 
C6D6) δ 210.42 (C‐1), 140.13 (Ph), 128.57 (Ph), 127.33 (Ph), 127.17 (Ph), 87.58 (C‐4), 67.51 (C‐10), 62.84 
(Bn),  52.95  (C‐9),  50.46 (C‐3),  41.94  (C‐7),  41.90  (C‐2),  40.38  (C‐6),  38.07  (C‐8),  34.86  (C‐5),  32.90  
(C‐15),  26.15  (SiR),  19.85 (C‐11),  18.85  (C‐18),  18.32  (SiR),  18.10  (C‐16,  C‐17),  17.72  (C‐16,  C‐17),  
–4.36 (SiR), –4.76 (SiR). IR (Diamond‐ATR, neat) vm̃ax: 2955 (s), 2930 (s), 2857 (m), 1700 (s), 1471 (m), 
1387  (m),  1254  (s),  1109  (s),  1066  (s),  1043  (s),  1006  (m)  cm–1.  HRMS  (EI):  calcd  for  ([M–tBu], 
C24H37O3Si)+: 401.2512, found: 401.2516. ሾࢻሿࡰ૛૙ = +26.4° (c = 0.33, CH2Cl2).    




was  treated  with  lanthanum(III)  chloride  bis(lithium  chloride)  complex  solution  (0.46  M  in  THF,  
7.39  mL,  3.40 mmol,  1.00  equiv)  at  23  °C.  After  1  h,  the  brownish  solution  was  cooled  to  0  °C, 
whereupon isopropenylmagnesium bromide solution (0.5 M in THF, 20.4 mL, 10.2 mmol, 3.00 equiv) 
was added dropwise over a period of 20 min  (syringe pump). After complete addition, stirring was 
continued  for  5 min,  before  the mixture was  diluted with  pH  7  buffer  solution  (50 mL),  saturated 
aqueous sodium chloride solution (20 mL) and diethyl ether (40 mL). The layers were separated, the 
aqueous layer was extracted with diethyl ether (5 x 40 mL) and the combined organic extracts were 













IR  (Diamond‐ATR,  neat)  vm̃ax:  3461  (br),  2954  (s),  2930  (s),  2858  (m),  1454  (m),  1386  (s),  1254  (s),  
1118  (m),  1060  (s),  1028  (m)  cm–1. HRMS  (ESI):  calcd  for  ([M+H],  C31H53O3Si)+:  501.37640,  found: 
501.37617. ሾࢻሿࡰ૛૙ = +20.0°(c = 0.20, CH2Cl2).   
   




tetrabutylammonium fluoride solution  (1 M  in THF, 4.70 mL, 4.70 mmol, 1.50 equiv) at 0  °C. After  
1.5 h, the cooling bath was removed and the mixture was allowed to warm to 23 °C. After 30 min, the 
mixture was diluted with saturated aqueous sodium hydrogen carbonate solution (80 mL) and diethyl 






tetrapropylammonium perruthenate  (77.0 mg,  0.21 mmol,  0.07  equiv)  at  23  °C. After  45 min,  the 
mixture was concentrated to a small volume and the black oily residue was purified by flash‐column 
chromatography  on  silica  gel  (10%  ethyl  acetate  in  hexanes)  to  provide  β‐hydroxyketone  13 
(1.05 g, 87% over two steps) as a yellowish oil which solidified upon standing. 
TLC (10% ethyl acetate in hexanes): Rf = 0.33 (CAM). 1H NMR (400 MHz, C6D6) δ 7.38–7.33 (m, 2H, Ph), 
7.24–7.18  (m,  2H,  Ph),  7.13–7.06  (m,  1H,  Ph),  5.21–5.18  (m,  1H,  21‐HA),  4.91  (br  s,  1H,  1‐OH),  
4.83–4.80 (m, 1H, 21‐HB), 4.30–4.20 (m, 2H, Bn), 2.97 (dd,  3J9/8A = 12.7 Hz,  3J9/8B = 3.8 Hz, 1H, 9‐H),  
2.43–2.35  (m,  1H,  3‐H),  2.09–1.99  (m,  2H,  5‐HA,  15‐H),  1.98–1.93  (m,  2H,  2‐H),  1.69–1.67  (m,  3H,  




77.24  (C‐1),  63.56  (Bn),  50.80  (C‐9),  45.54  (C‐3),  42.21  (C‐7),  40.81  (C‐6),  40.34  (C‐8),  36.02  (C‐2),  

































(C‐21),  88.78  (C‐4),  79.82  (C‐1),  77.52  (C‐10),  63.17  (Bn),  44.92  (C‐3),  42.41  (C‐6,  C‐7,  C‐9,  C‐11),  
42.18 (C‐6, C‐7, C‐9, C‐11), 41.35 (C‐6, C‐7, C‐9, C‐11), 41.18 (C‐6, C‐7, C‐9, C‐11), 39.48 (C‐2), 38.18  















vacuo.  The  residue was  purified  by  flash‐column  chromatography  on  silica  gel  (25% →  30%  ethyl 
acetate  in  hexanes)  to  provide  recovered  diene  37  (106 mg,  25%)  as  a  yellow  oil  and  tricycle  14  
(0.22 g, 55%, 74% brsm) as an off‐white foam. 
TLC (20% ethyl acetate in hexanes): Rf = 0.15 (CAM). 1H NMR (800 MHz, C6D6) δ 7.38–7.32 (m, 2H, Ph), 
7.22–7.18  (m,  2H,  Ph),  7.11–7.07  (m,  1H,  Ph),  5.60–5.56  (m,  1H,  13‐H),  4.30–4.23  (m,  2H,  Bn),  
2.37–2.30 (m, 1H, 12‐HA), 2.24 (dd, 3J9/8B = 12.6 Hz, 3J9/8A = 3.8 Hz, 1H, 9‐H), 2.16 (d, 2J2A/2B = 12.5 Hz, 1H, 
2‐HA), 2.08–2.01 (m, 3H, 5‐HA, 8‐HA, 15‐H), 1.93–1.85 (m, 2H, 2‐HB, 3‐H), 1.74–1.57 (m, 9H, 5‐HB, 6‐HA,  





21.39  (C‐20),  18.61  (C‐16,  C‐17),  18.53  (C‐18),  18.36  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  
3462 (br), 2955 (s), 2873 (m), 1453 (m), 1386 (m), 1306 (m), 1090 (m), 1063 (m) cm–1. HRMS (ESI): calcd 
for ([M+CH3COO], C29H43O5)–: 471.31105, found: 471.31184. ሾࢻሿࡰ૛૙ = +17.3° (c = 0.87, CH2Cl2).    







and  then was  concentrated.  Residual water was  removed  by  azeotropic  distillation  using  benzene 





(m,  2H,  Ph),  7.15–7.13  (m,  2H,  Ph),  7.07–7.03  (m,  1H,  Ph),  4.31–4.24  (m,  2H,  Bn),  2.90  (dd, 
3J13/12A = 8.4 Hz, 3J13/12B = 3.9 Hz, 1H, 13‐H), 2.49 (app t, 2J2A/2B = 3J2A/3 = 14.1 Hz, 1H, 2‐HA), 2.12 (dd, 
3J9/8B = 12.7 Hz, 3J9/8A = 4.3 Hz, 1H, 9‐H), 2.06–1.99 (m, 4H, 2‐HB, 5‐HA, 8‐HA, 15‐H), 1.95–1.89 (m, 1H,  
12‐HA),  1.72–1.67  (m,  1H,  11‐HA),  1.66–1.54  (m,  4H,  3‐H,  5‐HB,  6‐HA,  12‐HB),  1.46  (app  t, 
2J8B/8A = 3J8B/9 = 12.7 Hz, 1H, 8‐HB), 1.40–1.36 (m, 1H, 11‐HB), 1.23 (s, 3H, 19‐H), 1.17 (s, 6H, 18‐H, 20‐H), 






(ESI):  calcd  for  ([M+CH3COO],  C29H43O6)–:  487.30596,  found:  487.30672.  ሾࢻሿࡰ૛૙  =  –16.6°  (c  =  0.18, CH2Cl2). 
 
Tetrahyodrofuran 39: TLC (30% ethyl acetate in hexanes): Rf = 0.42 (CAM). 1H NMR (800 MHz, C6D6) 
δ 7.40–7.36  (m, 2H, Ph), 7.25–7.22  (m, 2H, Ph), 7.12–7.08  (m, 1H, Ph), 4.31–4.27  (m, 2H, Bn), 3.73  
(d, 3J13/12B = 7.6 Hz, 1H, 13‐H), 2.56–2.51 (m, 2H, 11‐HA, 14‐OH), 2.44–2.38 (m, 1H, 12‐HA), 2.33 (dd, 










                                                 
48 Epoxidation of tricycle 14 with m‐CPBA (CH2Cl2, 0 °C) gave an unfavourable 2:3 mixture of epoxide 15 and tetrahydrofuran 
39. 














1.86–1.77  (m, 3H, 2‐HB, 3‐H, 11‐HA), 1.74–1.65  (m, 1H, 12‐HA), 1.65–1.51  (m, 3H, 5‐HB, 6‐HA, 8‐HB),  
1.47 (s, 3H, 20‐H), 1.44–1.35 (m, 2H, 11‐HB, 12‐HB), 1.27 (s, 3H, 19‐H), 1.23–1.14 (m, 1H, 6‐HB), 1.12 (s, 
3H, 18‐H), 0.98 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.85 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 13C NMR (100 MHz, 
C6D6)  δ  140.55  (Ph),  128.54  (Ph),  127.24  (Ph),  127.19  (Ph),  88.26  (C‐4),  76.33  (C‐13),  74.70  (C‐10),  
67.17 (C‐14), 66.39 (C‐1), 63.03 (Bn), 48.63 (C‐3), 46.83 (C‐9), 41.83 (C‐7, C‐8), 41.55 (C‐7, C‐8), 41.19 
(C‐6),  36.95  (C‐11),  34.40  (C‐5),  33.57  (C‐2),  33.09  (C‐15),  27.67  (C‐12),  25.53  (C‐19),  23.19  (C‐20), 
18.85 (C‐18), 18.33 (C‐16, C‐17), 17.99 (C‐16, C‐17). IR (Diamond‐ATR, neat) vm̃ax: 3383 (br), 2954 (s), 
2929  (s),  1451 (m),  1382  (m),  1346  (w),  1091  (s),  1059  (s),  1030  (s)  cm–1.  HRMS  (ESI):  calcd  for 
([M+CH3COO], C29H43O6)–: 487.30596, found: 487.30682. ሾࢻሿࡰ૛૙ = +35.0° (c = 0.20, CH2Cl2).  
   











TLC  (9%  methanol  in  dichloromethane):  Rf  =  0.15  (CAM).  1H  NMR  (800 MHz,  CD2Cl2)  δ  4.21  (dd, 
3J13/12B  = 4.8 Hz,  3J13/12A  =  2.5 Hz, 1H, 13‐H),  2.17–2.13  (m, 2H, 8‐HA, 9‐H),  2.04–2.00  (m, 1H, 5‐HA), 
1.87–1.80  (m,  2H,  2‐HA,  11‐HA),  1.76–1.61  (m,  5H,  5‐HB,  6‐HA,  12‐H,  15‐H),  1.53–1.48  (m,  5H,  3‐H,  
11‐HB, 20‐H), 1.46 (dd, 2J2B/2A = 14.0 Hz, 3J2B/3 = 3.2 Hz, 1H, 2‐HB), 1.41 (app t, 2J8B/8A = 3J8B/9 = 13.3 Hz, 1H, 
8‐HB), 1.20  (s, 3H, 19‐H), 1.18–1.11  (m, 1H, 6‐HB), 1.05 (s, 3H, 18‐H), 0.91  (d,  3J = 6.8 Hz, 3H, 16‐H,  
17‐H), 0.88 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 13C NMR  (200 MHz, CD2Cl2) δ 83.97 (C‐4), 76.79 (C‐13), 
75.36 (C‐10), 67.30 (C‐14), 66.40 (C‐1), 51.39 (C‐3), 46.85 (C‐9), 42.09 (C‐8), 41.33 (C‐7), 40.40 (C‐6), 
37.94  (C‐15),  37.21  (C‐11),  37.15  (C‐5),  31.69  (C‐2),  27.76  (C‐12),  25.34  (C‐19),  23.15  (C‐20),  18.90  
(C‐18),  18.55  (C‐16,  C‐17),  17.78  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3424  (br),  2957  (s),  
2924  (s),  2867  (m),  1455  (m),  1382  (m),  1261  (m),  1095  (s),  1005  (s)  cm–1. HRMS  (ESI):  calcd  for 
([M+CH3COO], C22H37O6)–: 397.25901, found: 397.26046. ሾࢻሿࡰ૛૙ = +9.4° (c = 0.11, MeOH).    











with  palladium  on  carbon  (10 wt.%,  24.9 mg,  23.4  µmol,  2.00  equiv)  at  23  °C.  An  atmosphere  of 
hydrogen was maintained by sparging the mixture with a stream of hydrogen gas using a stainless steel 
needle  for  5  min  and  vigorous  stirring  of  the  suspension  was  then  continued  under  hydrogen 
atmosphere at 23 °C. After 1 h, the mixture was diluted with ethyl acetate (10 mL) and filtered through 
a  short  pad  of  Celite.  The  filtrate was  concentrated  and  the  residue was  purified  by  flash‐column 
chromatography  on  silica  gel  (35%  ethyl  acetate  in  hexanes)  to  provide  1,10,13,14‐tetra‐epi 
dictyoxetane (epi‐1) (2.3 mg, 60% over two steps) as a colourless solid. 
Recrystallization (ethyl acetate/hexanes) of the product gave crystals suitable for X‐ray diffraction. 





3H,  16‐H,  17‐H),  0.69  (br  s,  1H,  4‐OH).  13C NMR  (100 MHz,  C6D6)  δ  96.98  (C‐1),  82.90  (C‐4),  82.37  
(C‐14), 81.52 (C‐13), 81.15 (C‐10), 51.95 (C‐9), 50.37 (C‐3), 41.47 (C‐7), 41.15 (C‐8), 39.80 (C‐6), 37.65 






                                                 
49  This  intermediate  could  also  be  obtained  via  the  dyotropic  rearrangement  of  epoxide‐oxetane  22,  see  “Synthesis  of 
dioxatricycle 17” for characterization of this product. 
298  EXPERIMENTAL SECTION 
Synthesis of bromohydrin 20 
 
A  solution  of  epoxide  15  (25.0  mg,  58.3  µmol,  1  equiv)  in  dichloromethane  (3  mL)  was  treated 
sequentially  with  magnesium  bromide  ethyl  etherate  (90.4  mg,  350  µmol,  6.00  equiv)  and 
tetrabutylammonium bromide (113 mg, 350 µmol, 6.00 equiv) at 0 °C. After 10 min, the mixture was 
warmed to 23 °C.50 After 2.5 h, the mixture was diluted with pH 7 buffer solution (15 mL) and diethyl 



















                                                 
50 Reaction monitoring by TLC analysis (30% ethyl acetate in hexanes) showed gradual conversion of epoxide 15 (Rf = 0.15) to 
a putative bromo‐triol intermediate (Rf = 0.30), which then reacted further to bromohydrin 20 (Rf = 0.80). 




with  palladium  on  carbon  (10  wt.%,  8.7  mg,  8.14  µmol,  1.00  equiv)  at  23  °C.  An  atmosphere  of 
hydrogen was maintained by sparging the mixture with a stream of hydrogen gas using a stainless steel 
needle  for  5 min  and  vigorous  stirring  of  the  suspension  was  then  continued  under  hydrogen 
atmosphere at 23 °C. After 1 h, the mixture was diluted with ethyl acetate (10 mL) and filtered through 




TLC  (30%  ethyl  acetate  in  hexanes):  Rf  =  0.35  (CAM).  1H  NMR  (400  MHz,  C6D6)  δ  4.68  (dd, 
3J13/12A = 13.2 Hz, 3J13/12B =2.0 Hz, 1H, 13‐H), 2.47–2.33 (m, 1H, 12‐HA), 2.33–2.23 (m, 2H, 2‐HA, 9‐H), 






17.66  (2C, C‐16, C‐17, C‐20).  IR  (Diamond‐ATR, neat) vm̃ax: 3460  (br), 2954  (s), 2869  (m), 1468  (m),  
1447 (m), 1374 (m), 1129 (m), 1094 (m), 1074 (m), 986 (m) cm–1. HRMS (ESI): calcd for ([M+CH3COO], 
C22H3679BrO5)–:  459.17461,  found:  459.17549;  calcd  for  ([M+CH3COO],  C22H3681BrO5)–:  461.17257, 
found: 461.17345. ሾࢻሿࡰ૛૙ = –52.5° (c = 0.35, CH2Cl2).  
   












3J13/12B  =  7.8  Hz,  3J13/12A  =  3.1  Hz,  1H,  13‐H),  2.45  (dd,  2J2A/2B  =  14.8  Hz,  3J2A/3  =  13.0  Hz,  1H,  2‐HA),  
2.08–1.95 (m, 4H, 3‐H, 5‐HA, 12‐HA, 15‐H), 1.93–1.80 (m, 3H, 2‐HB, 11‐HA, 12‐HB), 1.72–1.62 (m, 3H,  
















mixture was diluted with pH 7 buffer  solution  (15 mL) and diethyl  ether  (10 mL).  The  layers were 
separated, the aqueous layer was extracted with diethyl ether (3 x 10 mL) and the combined organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 
concentrated. The  residue was purified by  flash‐column chromatography on  silica gel  (10% → 20% 
ethyl  acetate  in hexanes)  to provide dioxatricycle 17  (2.5 mg,  36%)  as  a  colourless  solid,  olefin 41  
(1.4 mg, 20%) as a colourless oil, and enol ether 42 (2.6 mg, 37%) as a yellowish oil. 
Dioxatricycle  17:  TLC  (20%  ethyl  acetate  in  hexanes):  Rf  =  0.45  (CAM).  1H  NMR  (400  MHz,  C6D6) 
δ 7.40–7.34 (m, 2H, Ph), 7.24–7.18 (m, 2H, Ph), 7.14–7.08 (m, 1H, Ph), 4.31–4.17 (m, 3H, 13‐H, Bn), 
2.49–2.38 (m, 2H, 2‐H), 2.10–1.91 (m, 4H, 5‐HA, 9‐H, 11‐HA, 15‐H), 1.87–1.79 (m, 1H, 12‐HA), 1.76–1.62 
(m,  2H,  11‐HB,  12‐HB),  1.62–1.50  (m,  2H,  5‐HB,  8‐HA),  1.48–1.39  (m,  1H,  6‐HA),  1.38  (s,  3H,  20‐H),  
1.24–1.17 (m, 4H, 3‐H, 19‐H), 1.05 (s, 3H, 18‐H), 1.02–0.92 (m, 5H, 6‐HB, 8‐HB, 16‐H, 17‐H), 0.77 (d,  
3J  =  6.7  Hz,  3H,  16‐H,  17‐H).  13C  NMR  (100  MHz,  C6D6)  δ  140.43  (Ph),  128.58  (Ph),  127.15  (Ph), 
126.96 (Ph), 97.31 (C‐1), 87.70 (C‐4), 82.52 (C‐14), 81.38 (C‐13), 81.21 (C‐10), 62.76 (Bn), 52.00 (C‐9), 
47.78 (C‐3), 41.83 (C‐7), 40.73 (C‐6, C‐8), 40.63 (C‐6, C‐8), 34.86 (C‐5), 33.17 (C‐11, C‐15), 33.14 (C‐11, 






Bn),  2.85–2.76  (m,  2H,  9‐H,  13‐H),  2.50–2.36  (m,  2H,  2‐HA,  12‐HA),  2.33  (dd,  2J2B/2A  =  14.1  Hz,  
3J2B/3 = 3.2 Hz, 1H, 2‐HB), 2.16–1.97 (m, 4H, 3‐H, 5‐HA, 12‐HB, 15‐H), 1.77 (app t, 2J8A/8B = 3J8A/9 = 12.5 Hz, 




63.49  (C‐14),  63.18  (Bn),  44.91  (C‐3),  41.95  (C‐7),  41.19  (C‐6),  40.94  (C‐8),  37.88  (C‐9),  34.25  (C‐5),  
33.33  (C‐15), 32.69  (C‐2), 27.47  (C‐12), 22.33  (C‐19), 19.95  (C‐20), 18.56  (C‐16, C‐17), 18.50  (C‐18), 
18.33  (C‐16, C‐17).  IR  (Diamond‐ATR, neat) vm̃ax:  3474  (br),  2958  (s),  2933  (s),  2857  (m), 1453  (m),  
1385 (m), 1198 (w), 1087 (m), 1055 (s), 1027 (m), 1000 (m) cm–1. HRMS (ESI): calcd for ([M+CH3COO], 
C29H41O5)–: 469.2954, found: 469.2962. ሾࢻሿࡰ૛૙ = –19.6° (c = 0.21, CH2Cl2).    
302  EXPERIMENTAL SECTION 
Enol  ether  42:  TLC  (20%  ethyl  acetate  in  hexanes):  Rf  =  0.28  (CAM).  1H  NMR  (400  MHz,  C6D6)  
δ  7.45–7.39  (m,  2H, Ph),  7.26–7.21  (m,  2H, Ph),  7.14–7.08  (m,  1H, Ph),  4.57–4.55  (m,  1H,  20‐HA),  





























δ  140.42  (Ph),  128.55  (Ph),  127.39  (Ph),  127.26  (Ph),  88.37  (C‐4),  85.99  (C‐13),  83.99  (C‐10,  C‐14),  
83.89  (C‐10, C‐14),  76.48  (C‐1),  63.27  (Bn),  47.53  (C‐9),  44.58  (C‐3),  42.74  (C‐7),  40.65  (C‐6),  38.14  
(C‐8),  34.01  (C‐2),  33.89 (C‐5),  32.97  (C‐15),  31.87  (C‐11),  30.28  (C‐12),  28.93  (C‐20),  25.54  (C‐19),  
19.69  (C‐18),  18.67  (2C,  16‐C,  17‐C).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3547  (m),  2937  (s),  2869  (m),  
1452  (m),  1377  (m),  1276  (m),  1195  (m),  1117  (m),  1056  (s),  1018  (s)  cm–1. HRMS  (ESI):  calcd  for 


















2H,  6‐HA,  8‐HA),  1.39  (br  s,  1H,  1‐OH),  1.38  (s,  3H,  20‐H),  1.31–1.24  (m,  1H,  11‐HB),  1.22  (dd,  
2J8B/8A = 11.8 Hz, 3J8B/9 = 3.3 Hz, 1H, 8‐HB), 1.15 (s, 3H, 19‐H), 1.12–1.05 (m, 1H, 6‐HB), 1.00 (s, 3H, 18‐H), 
0.92 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.87 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 13C NMR  (100 MHz, C6D6)  
δ  140.29  (Ph),  128.57  (Ph),  127.48  (Ph),  127.36  (Ph),  92.15  (C‐14),  88.21  (C‐4),  83.26  (C‐10),  79.65  
(C‐13),  76.77  (C‐1),  63.18  (Bn),  47.12  (C‐9),  44.34  (C‐3),  42.30  (C‐7),  40.57  (C‐6),  36.92  (C‐8),  33.79  
(C‐5), 32.97  (C‐15), 32.44  (C‐11), 32.36  (C‐2), 28.17  (C‐12), 25.27  (C‐19), 20.28  (C‐20), 19.51  (C‐18), 
18.60  (C‐16, C‐17), 18.56  (C‐16, C‐17).  IR  (Diamond‐ATR, neat) vm̃ax: 3603  (w), 2937  (m), 2865  (m),  




SUPPORTING INFORMATION FOR CHAPTER 3.2.1  305 
Synthesis of mesylate 43 
 
A  solution  of  epoxide 16  (18.0 mg,  42.0  µmol,  1  equiv)  in  dichloromethane  (1.2 mL) was  treated 
sequentially with triethylamine (23.3 µL, 0.17 mmol, 4.00 equiv) and methanesulfonyl chloride (6.5 µL, 
84.0 µmol, 2.00 equiv) at –78 °C. After 30 min, the cooling bath was removed and the mixture was 
immediately diluted with pH 7 buffer  solution  (10 mL) and ethyl  acetate  (15 mL).  The  layers were 
separated, the aqueous layer was extracted with ethyl acetate (3 x 15 mL) and the combined organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 
concentrated.  The  residue  was  purified  by  flash‐column  chromatography  on  silica  gel  (50%  ethyl 
acetate in hexanes) to provide mesylate 43 (15.3 mg, 72%) as a colourless oil. 
TLC (50% ethyl acetate in hexanes): Rf = 0.25 (CAM). 1H NMR (800 MHz, C6D6) δ 7.33–7.30 (m, 2H, Ph), 
7.21–7.18  (m, 2H, Ph), 7.11–7.07  (m, 1H, Ph), 5.06  (dd,  3J13/12A = 5.8 Hz,  3J13/12B =1.5 Hz, 1H, 13‐H),  
4.23–4.16 (m, 2H, Bn), 2.41 (dd, 2J8A/8B = 12.8 Hz, 3J8A/9 = 4.8 Hz, 1H, 8‐HA), 2.29–2.22 (m, 2H, 2‐HA, 9‐H), 







(C‐15), 25.43  (C‐12), 23.90  (C‐19), 22.36  (C‐20), 18.50  (C‐18), 18.26  (C‐16, C‐17), 17.84  (C16, C‐17).  
IR  (Diamond‐ATR,  neat)  vm̃ax:  3517  (br),  2957  (s),  2929  (s),  1454  (m),  1353  (s),  1173  (s),  1087  (m), 
1064 (m), 970 (w), 898 (s) cm–1. HRMS (ESI): calcd for ([M+CH3COO], C30H45O8S)–: 565.28351, found: 
565.28434. ሾࢻሿࡰ૛૙ = –9.4° (c = 0.23, CH2Cl2).    
306  EXPERIMENTAL SECTION 
Synthesis of epoxide‐tetrahydrofuran 25 
 










7.30–7.27  (m,  2H, Ph),  7.16–7.15  (m,  1H, Ph),  4.27–4.21  (m,  2H, Bn),  4.17  (d,  3J13/12B  =  6.4 Hz,  1H,  
13‐H), 2.16–2.08 (m, 3H, 9‐H, 11‐HA, 12‐HA), 2.05–1.96 (m, 4H, 2‐HA, 3‐H, 5‐HA, 15‐H), 1.76–1.68 (m, 
1H, 12‐HB), 1.65–1.62 (m, 1H, 2‐HB), 1.61–1.57 (m, 1H, 5‐HB), 1.54 (dd, 2J6A/6B = 11.6 Hz, 3J6A/5A = 7.8 Hz, 
1H, 6‐HA), 1.46 (dd,  2J8A/8B = 11.8 Hz,  3J8A/9 = 3.5 Hz, 1H, 8‐HA), 1.35–1.30  (m, 1H, 8‐HB), 1.28  (s, 3H,  
19‐H), 1.20–1.15 (m, 5H, 6‐HB, 11‐HB, 20‐H), 1.10 (s, 3H, 18‐H), 0.96 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.91 
(d,  3J  = 6.8 Hz, 3H, 16‐H,  17‐H).  13C NMR  (200 MHz, C6D6) δ 140.56  (Ph),  128.50  (Ph),  127.19  (Ph), 
127.13 (Ph), 87.68 (C‐4), 80.71 (C‐10), 80.05 (C‐13), 68.36 (C‐14), 67.23 (C‐1), 62.85 (Bn), 49.16 (C‐3), 
45.26 (C‐9), 43.14 (C‐7), 40.82 (C‐6), 39.38 (C‐8), 33.97 (C‐5), 33.08 (C‐15), 30.91 (C‐11), 29.67 (C‐12), 
29.14  (C‐2),  26.36  (C‐19),  19.74  (C‐18),  18.39  (C‐16,  C‐17),  18.16  (C‐16,  C‐17),  17.77  (C‐20).  























1H,  13‐H),  3.29–3.25  (m,  1H,  9‐H),  1.91  (s,  3H,  20‐H),  1.85–1.77  (m,  2H,  5‐HA,  11‐HA),  1.69  (dd,  
2J8A/8B = 12.8 Hz, 3J8A/9 = 10.4 Hz, 1H, 8‐HA), 1.63–1.56 (m, 3H, 2‐HA, 12‐H), 1.50–1.44 (m, 2H, 5‐HB, 6‐HA), 
1.43–1.38 (m, 1H, 15‐H), 1.38–1.35 (m, 1H, 2‐HB), 1.34 (s, 3H, 19‐H), 1.17–1.08 (m, 2H, 3‐H, 11‐HB), 
1.00 (s, 3H, 18‐H), 0.94–0.88  (m, 1H, 6‐HB), 0.84  (d,  3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.83–0.80  (m, 1H,  
8‐HB), 0.78 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.52 (br s, 1H, 4‐OH). 13C NMR (200 MHz, C6D6) δ 206.79  
(C‐14), 88.78 (C‐10), 82.99 (C‐13), 82.69 (C‐4), 59.57 (C‐1), 49.25 (C‐3), 41.92 (C‐7), 41.15 (C‐9), 40.50 
(C‐6),  38.96  (C‐8),  37.90  (C‐15),  37.64  (C‐5),  30.51  (C‐11),  26.02  (C‐12),  24.86  (C‐20),  23.86  (C‐2),  
20.89  (C‐19),  19.69  (C‐18),  18.40  (C‐16,  C‐17),  17.80  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  
3499  (br),  2958  (s),  2872  (m),  1705  (s),  1469  (m),  1382  (m),  1281  (w),  1197  (m),  998  (m)  cm–1.  
HRMS  (ESI):  calcd  for  ([M+H],  C20H33O3)+:  321.24297,  found:  321.24329.  ሾࢻሿࡰ૛૙  =  –29.1°  (c  =  0.12, CH2Cl2). 
 
   



















34.25 (C‐5),  33.21  (C‐15),  28.43  (C‐19),  22.42  (C‐12),  21.39  (C‐20),  18.70  (C‐18),  18.63  (C‐16, C‐17), 
18.39 (C‐16, C‐17), 2.86 (SiR).  IR  (Diamond‐ATR, neat) vm̃ax: 3464 (br), 2955 (s), 2857 (m), 1453 (m), 
1379 (m),  1249  (m),  1151  (w),  1105  (m),  1086  (m),  1027  (s)  cm–1. HRMS  (EI):  calcd  for  ([M–H2O], 
C30H46O2Si)+: 466.3267, found: 466.3249. ሾࢻሿࡰ૛૙ = +12.8° (c = 0.86, CH2Cl2).  
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Synthesis of allylic alcohol 28 
 
A  stream of  pure  oxygen  gas was  bubbled  below  the  liquid  surface  of  a  solution  of  silyl  ether 44  
(75.0  mg,  155  µmol,  1  equiv)  in  dichloroethane  (20  mL)  containing  a  catalytic  amount  of 
tetraphenylporphyrin  (TPP,  tip of a spatula) at 0 °C. After 3 min,  the mixture was  irradiated with a 
Replux Belgium RL 160W (225–235 Volts) lamp. After 5 h, TLC analysis (20% ethyl acetate in hexanes) 
indicated  complete  conversion  of  silyl  ether  44  (Rf  =  0.80)  to  the  hydroperoxide  intermediate  
(Rf  =  0.29).  Sparging  with  oxygen  and  irradiation  was  discontinued,  triphenylphosphine  (81.2 mg,  
309 µmol, 2.00 equiv) was added and the mixture was then allowed to warm to 23 °C. After 5 min,  













37.85  (C‐8),  34.08  (C‐5),  33.23  (C‐15),  29.82  (C‐12),  26.99  (C‐18),  19.42  (C‐19),  18.72  (C‐16,  C‐17), 
18.59 (C‐16, C‐17), 2.91 (SiR).  IR  (Diamond‐ATR, neat) vm̃ax: 3463 (br), 2953 (s), 2869 (m), 1453 (m), 































4.35–4.26  (m,  2H,  Bn),  2.33  (dd,  J  =  14.1  Hz,  3.2  Hz,  1H),  2.26–2.17  (m,  1H),  2.14–2.04  (m,  4H),  




neat) vm̃ax: 2955  (s), 1454  (m), 1374  (m), 1349  (m), 1248  (s), 1159  (w), 1110  (s), 1084  (s), 1057  (s),  
















An  analytically  pure  sample  of  iodide  30  could  be  obtained  by  rapid  purification  by  flash‐column 
chromatography on silica gel (10% ethyl acetate in hexanes) in the dark. 
TLC (10% ethyl acetate in hexanes): Rf = 0.43 (CAM). 1H NMR (800 MHz, C6D6) δ 7.42–7.38 (m, 2H, Ph), 




9‐H, 12‐H), 1.56–1.53  (m, 1H, 8‐HA), 1.50  (dd,  3J6A/5A = 11.7 Hz,  2J6A/6B = 7.9 Hz, 1H, 6‐HA), 1.35  (dd, 
2J11B/11A = 13.0 Hz, 3J11B/12A = 8.0 Hz, 1H, 11‐HB), 1.24–1.22 (m, 1H, 8‐HB), 1.21 (s, 3H, 19‐H), 1.19–1.14 













with  palladium  on  carbon  (10 wt.%,  97.1 mg,  91.2  µmol,  2.00  equiv)  at  23  °C.  An  atmosphere  of 
hydrogen was maintained by sparging the mixture with a stream of hydrogen gas using a stainless steel 
needle  for  5  min  and  vigorous  stirring  of  the  suspension  was  then  continued  under  hydrogen 
atmosphere  at  23  °C.51 After  5 h,  the mixture was  diluted with  ethyl  acetate  (20 mL)  and  filtered 
through  a  short  pad  of  Celite.  The  filtrate  was  concentrated  and  the  residue  was  purified  by  
flash‐column  chromatography  on  silica  gel  (30%  ethyl  acetate  in  hexanes)  to  provide  
(+)‐dictyoxetane (1) (11.7 mg, 80% over two steps) as a colourless oil. 
TLC  (40%  ethyl  acetate  in  hexanes):  Rf  =  0.43  (CAM).  1H  NMR  (400  MHz,  C6D6)  δ  4.25  (br  d, 
3J13/12A = 3.9 Hz, 1H, 13‐H), 2.04 (dd, 3J3/2B = 12.9 Hz, 3J3/2A = 2.8 Hz, 1H, 3‐H), 1.94–1.86 (m, 1H, 5‐HA), 





(C‐8),  28.00  (C‐2),  27.06  (C‐19),  25.13  (C‐11),  24.03  (C‐12),  20.05  (C‐18),  18.58  (C‐16,  C‐17),  17.68  
(C‐16,  C‐17),  16.49  (C‐20).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3484  (br),  2956  (s),  2928  (s),  2862  (m),  
1452 (m), 1388 (m), 1375 (m), 1292 (w), 1148 (m), 1067 (m), 1019 (m) cm–1. HRMS (EI): calcd for ([M], 
C20H32O3)+:  320.2351,  found:  320.2349.  ሾࢻሿࡰ૛૙  =  +29.1°  (c  =  1.00,  CHCl3).  (Lit.:52  	ሾࢻሿࡰ૛૙  =  +35.0°  (c = 3.00, CHCl3). 
 
1H  NMR  (800  MHz,  CDCl3)  δ  4.38  (br  d,  3J13/12A  =  3.3  Hz,  1H,  13‐H),  2.04  (ddd,  2J5A/5B  =  14.5  Hz, 
3J5A/6B = 9.6 Hz, 3J5A/6A = 1.1 Hz, 1H, 5‐HA), 1.86–1.79 (m, 4H, 2‐HA, 3‐H, 11‐HA, 12‐HA), 1.77–1.71 (m, 2H, 



























3  2.03 (dd, 13.0, 2.5) 2.04 (dd, 12.9, 2.6)  0.01 
5a  1.90 (dd, 14.0, 9.5) 1.90 (dd, 14.0, 9.5)  0 
13  4.25 (br d)  4.25 (br d)  0 
16  0.95 (d, 6.5)  0.95 (d, 6.8)  0 
17  0.88 (d, 6.5)  0.89 (d, 6.8)  0.01 
18  1.11 (s, 3H)  1.12 (s, 3H)  0.01 
19  1.27 (s, 3H)  1.28 (s, 3H)  0.01 








1  97.2  97.4  0.2 
2  27.6  27.8  0.2 
3  48.0  48.1  0.1 
4  82.7  82.9  0.2 
5  35.9  36.0  0.1 
6  39.1  39.2  0.2 
7  42.5  42.6  0.1 
8  34.6  34.7  0.1 
9  52.6  52.8  0.2 
10  80.1  80.2  0.1 
11  24.6  24.8  0.2 
12  23.4  23.5  0.1 
13  81.3  81.4  0.1 
14  80.6  80.8  0.2 
15  36.6  36.7  0.1 
16  17.5  17.6  0.1 
17  18.5  18.7  0.2 
18  20.0  20.1  0.1 
19  26.7  26.9  0.2 
20  16.1  16.3  0.1 
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6.4.3  X‐Ray Crystallographic Data 
The data  collections were performed either on an Oxford Diffraction Xcalibur diffractometer,  on  a 
Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoKα‐radiation  
(λ  =  0.71073 Å,  graphite monochromator).  The  CrysAlisPro  software  (version  1.171.33.41)[S8] was 
applied for the integration, scaling and multi‐scan absorption correction of the data. The structures 





CCDC  1473419  contains  the  supplementary  crystallographic  data  for  triol  40.  These  data  can  be 




























































































CCDC  1473421  contains  the  supplementary  crystallographic  data  for  diol  21.  These  data  can  be 
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to  known alcohol 9056  (29.5  g,  157 mmol,  1  equiv)  at  0  °C.  Pyridinium p‐toluenesulfonate  (3.94  g,  
15.7 mmol, 0.1 equiv) was added, and after 10 min, the mixture was allowed to warm to 23 °C. After 
16 h, the suspension was filtered through a pad of Celite and the filtrate was concentrated to afford a 
thick  slurry.  Saturated  aqueous  sodium  bicarbonate  solution  (150  mL)  and  diethyl  ether/hexanes  
(1:1, 100 mL) were added and the layers were separated. The aqueous layer was extracted with diethyl 
ether/hexanes (1:1, 2 x 100 mL), and the combined organic extracts were dried over sodium sulfate, 
the  dried  solution  was  filtered  and  the  filtrate  was  concentrated.  The  residue  was  purified  by  
flash‐column chromatography (10% ethyl acetate in hexanes) on silica gel to provide benzyl ether 91 
as a colourless oil (37.2 g, 77%). 
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Synthesis of allylic alcohol 92 
 
A  solution of  benzyl  ether 91  (37.0  g,  120 mmol,  1  equiv)  in methanol  (300 mL) was  treated with 
potassium carbonate  (2.82 g, 20.4 mmol, 0.17 equiv) at 0  °C. After 5 min,  the  cloudy mixture was 
allowed to warm to 23 °C. After 2.5 h, the mixture was concentrated to a volume of ca. 70 mL, and was 
diluted with saturated aqueous ammonium chloride solution (150 mL) and ethyl acetate (100 mL). The 
layers  were  separated,  the  aqueous  layer  was  extracted  with  ethyl  acetate  (3  x  50  mL),  and  the 
combined organic extracts were dried over sodium sulfate. The dried solution was filtered and the 
filtrate  was  concentrated  to  afford  spectroscopically  pure  allylic  alcohol  92  (30.4  g,  ≥99%)  as  a 
yellowish oil. 




1H, 8‐OH).  13C NMR  (100 MHz, CDCl3) δ 159.24  (C‐18), 139.47  (C‐10), 130.76  (C‐15), 129.42  (C‐16), 
123.66  (C‐9),  113.87  (C‐17),  72.69  (C‐14),  69.64  (C‐13),  59.51  (C‐8),  55.42  (C‐20),  36.13  (C‐11),  









with  triphenylphosphine  (7.54 g, 28.8 mmol, 1.20 equiv),  followed by N‐bromosuccinimide  (5.12 g, 
28.8 mmol, 1.20 equiv) at 0 °C. After 15 min, the orange mixture was diluted with water (100 mL) and 
the layers were separated. The aqueous layer was extracted with dichloromethane (2 x 50 mL). The 





A  suspension  of  sodium  hydride  (60  wt.%  in  mineral  oil,  1.15  g,  28.8  mmol,  1.20  equiv)  in 
dimethylformamide  (50  mL)  was  treated  portionwise  with  2‐methyl‐1,3‐cyclopentanedione  (18)  
(3.22 g, 28.8 mmol, 1.20 equiv) at 0 °C. The mixture was warmed to 23 °C for 15 min before being 
cooled  to  0  °C,  whereupon  a  solution  of  the  crude  allylic  bromide  19  (assuming  24.0  mmol)  in 
dimethylformamide  (10  mL)  was  added.  The  transfer  was  quantitated  with  dimethylformamide  
(2 x 4 mL). The resulting mixture was allowed to warm to 23 °C over a period of 2 h, and then was 
diluted with saturated aqueous ammonium chloride solution (250 mL) and ethyl acetate (70 mL). The 
layers  were  separated  and  the  aqueous  layer  was  extracted  with  ethylacetate  (3  x  50  mL).  The 
combined organic extracts were dried over  sodium sulfate,  the dried solution was  filtered and  the 
filtrate  was  concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (30%  ethyl 
acetate  in  hexanes)  on  silica  gel  to  provide  diketone 93  as  a  yellowish  oil  (6.18  g,  60%). Note:  As 
determined  by  analysis  of  the  crude  1H  NMR,  an  approximate  3:1  mixture  of  C‐  and  O‐alkylated 
products was formed in this reaction. 
TLC  (20%  ethyl  acetate  in  hexanes):  Rf  =  0.14  (CAM).  1H  NMR  (400  MHz,  CDCl3)  δ  7.27  (d,  
3J16/17 = 8.4 Hz, 2H, 16‐H), 6.90 (d, 3J17/16 = 8.4 Hz, 2H, 17‐H), 4.96 (t, 3J9/8 = 7.9 Hz, 1H, 9‐H), 4.43 (s, 2H, 
14‐H),  3.83  (s,  3H,  20‐H),  3.40  (t,  3J13/12  =  6.5  Hz,  2H,  13‐H),  2.79–2.58  (m,  4H,  5‐H),  2.35  (d,  
3J8/9 = 7.9 Hz, 2H, 8‐H), 2.03 (t, 3J11/12 = 7.6 Hz, 2H, 11‐H), 1.71–1.61 (m, 2H, 12‐H), 1.59 (s, 3H, 19‐H), 






















filtered and  the  filtrate was concentrated.  The  residue was  filtered  (40% ethyl acetate  in hexanes) 
through  a  short  pad of  silica  gel  and  the  filtrate was  concentrated  to  provide  the  hydroxy  ketone  
(4.27 g), which was used in the next step without further purification. 
A solution of this hydroxy ketone (4.27 g, 12.3 mmol, 1 equiv) in dichloromethane (30 mL) was treated 





sodium sulfate,  the dried  solution was  filtered and  the  filtrate was  concentrated.  The  residue was 
filtered  (20%  ethyl  acetate  in  hexanes)  through  a  short  pad  of  silica  gel  and  the  filtrate  was 
concentrated  to  provide  the  crude  thioate,  which  was  used  in  the  next  step  without  further 
purification. 






A  mixture  of  crude  ketone  20  (assuming  12.3  mmol)  in  dichloromethane  (30  mL)  and  aqueous  








treated with  imidazole  (1.72  g,  25.2 mmol,  3.00  equiv),  followed by  tert‐butyldiphenylchlorosilane 
(3.27 mL, 12.6 mmol, 1.50 equiv) at 0 °C. After 5 min, the mixture was allowed to warm to 23 °C. After 
4 h, the mixture was diluted with water (40 mL). The layers were separated and the aqueous layer was 




































1J2/F  =  320  Hz,  C‐2),  113.37  (C‐4),  63.70  (C‐13),  47.17  (C‐7),  36.47  (C‐8,  C‐11),  36.29  (C‐8,  C‐11),  
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Synthesis of epoxide 22 
 
A solution of  triflate 94  (220 mg, 0.38 mmol, 1 equiv)  in dichloromethane  (4 mL) was treated with 








a double  set  of  signals,  the  signal of  the  second diastereomer  is marked with an asterisk.  1H NMR  
(400 MHz, CDCl3) δ 7.69–7.63 (m, 4H, Ph), 7.46–7.34 (m, 6H, Ph), 5.67 (t, 3J4/5 = 2.6 Hz, 1H, 4‐H), 5.62* 





60.12*  (C‐10),  60.06  (C‐9),  59.85*  (C‐9),  46.26  (C‐7),  45.71*  (C‐7),  37.22  (C‐8),  36.72*  (C‐8),  35.24  
(C‐11), 35.12* (C‐11), 34.46 (C‐6), 34.03* (C‐6), 28.31 (C‐12), 28.29* (C‐12), 26.97 (C‐15), 25.75 (C‐5), 














a  flame‐dried  flask,  and  the molarity of  the organozinc  reagent 23  solution was determined  to be 
1.10 M by iodometric titration. 
A  solution  of  epoxide  22  (1:1  d.r.,  218  mg,  0.37  mmol,  1  equiv)  in  tetrahydrofuran  and 
dimethylacetamide  (1:1  v/v,  2 mL)  was  treated  with  SPhos  (15.0 mg,  36.5  µmol,  0.10  equiv)  and  
SPhos  Pd  G2  (26.3  mg,  36.5 µmol,  0.10  equiv).  Freshly  prepared  organozinc  reagent  23  solution  
(1.10 M in THF, 1.33 mL, 1.46 mmol, 4.00 equiv) was then added and the resulting mixture was warmed 




chromatography  (8%  ethyl  acetate  in  hexanes)  on  silica  gel  to  provide  esters  24a  and  24b  as  a 
colourless oil (1:1 d.r., 80 mg, 41%). Analytically pure samples of the diastereomers 24a and 24b could 
be  obtained  by  further  careful  purification  by  flash‐column  chromatography  (3%  ethyl  acetate  in 












4H,  Ph),  7.45–7.34  (m,  6H,  Ph),  5.33–5.26  (m,  1H,  4‐H),  3.72–3.59  (m,  5H,  13‐H,  15‐H),  2.66  (t,  
3J9/8 = 6.5 Hz, 1H, 9‐H), 2.57–2.51 (m, 2H, 1‐H), 2.29–2.18 (m, 4H, 2‐H, 5‐H), 1.95–1.86 (m, 1H, 6‐HA), 
1.70–1.48  (m, 7H, 6‐HB,  8‐H, 11‐H, 12‐H),  1.22  (s,  3H, 19‐H),  1.05  (s,  3H, 18‐H),  1.04  (s,  9H, 17‐H).  
13C  NMR  (100  MHz,  CDCl3)  δ  174.04  (C‐14),  148.97  (C‐3),  135.69  (Ph),  134.04  (Ph),  129.72  (Ph),  
127.76 (Ph), 122.76 (C‐4), 63.88 (C‐13), 61.11 (C‐9), 60.55 (C‐10), 51.75 (C‐15), 48.71 (C‐7), 37.53 (C‐8), 
37.12 (C‐6), 35.32 (C‐11), 32.58 (C‐1), 29.78 (C‐5), 28.41 (C‐12), 27.00 (C‐17), 25.70 (C‐18), 21.92 (C‐2), 





















washed  sequentially with  aqueous 1 M hydrogen  chloride  solution  (50 mL)  and  saturated  aqueous 











concentrated.  The  residue  was  purified  by  flash‐column  chromatography  on  silica  gel  (20%  to  
30% ethyl acetate in hexanes) to provide enone 95 (19.0 g, 49%) as an orange oil. The characterization 
data for 95 were in agreement with values previously reported.44a,58 The absolute configuration (R) of 
enone  95  was  derived  from  the  sign  of  the  optical  rotation,  and  95  was  estimated  to  be  of  
≥80%  ee  by  comparison  with  the  literature  values  (Lit.:44a  	ሾࢻሿࡰ૛૙  =  –108°  (c  =  3.50,  EtOH);  Lit.:45 
ሾࢻሿࡰ૛૙ = –94° (c = 1.00, EtOH)). TLC (20% ethyl acetate in hexanes): Rf = 0.32 (UV/CAM). 1H NMR (400 MHz, CDCl3) δ 5.78–5.76 (m, 1H, 




ATR,  neat)  vm̃ax:  2960  (m),  2928  (m),  2861  (m),  1667  (s),  1454  (w),  1421  (w),  1296  (w),  1222  (w),  
1202  (w)  cm–1.  HRMS  (EI):  calcd  for  ([M],  C10H14O)+:  150.1039,  found:  150.1044.  ሾࢻሿࡰ૛૙  =  –94.8°  (c = 2.00, EtOH).    




SUPPORTING INFORMATION FOR CHAPTER 3.2.2  367 
Synthesis of ketal 9659 
 
A  round‐bottomed  flask was  charged with  enone 95  (9.21 g,  61.3 mmol,  1  equiv),  ethylene  glycol  
(20.5 mL, 368 mmol, 6.00 equiv), p‐toluenesulfonic acid monohydrate (1.17 g, 6.13 mmol, 0.10 equiv) 
and benzene  (150 mL).  The  flask was  equipped with  a Dean‐Stark  apparatus  and  the mixture was 
heated to 80 °C. After 5 h, the removal of water was judged to be complete and the mixture was cooled 
to  23  °C.  The  mixture  was  diluted  with  saturated  aqueous  sodium  hydrogen  carbonate  solution  
(150 mL). The layers were separated, the aqueous layer was extracted with diethyl ether (3 x 70 mL) 









(C‐3),  122.63  (C‐4),  109.87  (C‐1),  64.65  (C‐10),  64.51  (C‐10’),  45.14  (C‐7),  40.31  (C‐6),  37.72  (C‐8),  
36.25 (C‐2), 31.86 (C‐9), 30.51 (C‐5), 22.36 (C‐18).  IR  (Diamond‐ATR, neat) vm̃ax: 2944  (s), 2880  (m),  
1455 (w), 1353 (w), 1306 (w), 1257 (w), 1177 (w), 1115 (m), 1090 (s), 1020 (m) cm–1. HRMS (EI): calcd 
for ([M], C12H18O2)+: 194.1301, found: 194.1293. ሾࢻሿࡰ૛૙ = –18.7° (c = 0.83, CH2Cl2).    








water  (12  mL)  and  acetone  (12  mL)  was  treated  sequentially  with  4‐methylmorpholine  N‐oxide  
(5.86 g, 50.0 mmol, 1.20 equiv) and osmium tetroxide  solution  (2.5 wt.%  in  t‐BuOH, 10.2 mL, 1.04 
mmol,  0.03 equiv)  at  23  °C. After  3  days,  sodium  sulfite  (15.8 g,  125 mmol,  3.00 equiv)  and water  
(20 mL) were added. After 15 min, the mixture was diluted with more water (100 mL) and ethyl acetate 
(100 mL). The layers were separated, the aqueous layer was extracted with ethyl acetate (6 x 100 mL) 
and  the combined organic extracts were washed with  saturated aqueous  sodium chloride  solution  
(100 mL). The washed solution was dried over sodium sulfate. The dried solution was filtered and the 







δ  109.24  (C‐1),  80.23  (C‐3),  76.67  (C‐4),  64.50  (C‐10),  64.27  (C‐10’),  42.45  (C‐7),  40.25  (C‐2),  34.02  
(C‐6),  32.54 (C‐8),  30.45  (C‐9),  28.82  (C‐5),  21.58  (C‐18).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3460  (br),  
2954  (m), 1465 (m), 1428  (m), 1341  (m), 1265  (s), 1122  (m), 1091  (s), 1069  (s), 1032  (s), 1012  (m)  
cm–1.  HRMS  (ESI):  calcd  for  ([M+Na],  C12H20O4Na)+:  251.12593,  found:  251.12550.  ሾࢻሿࡰ૛૙  =  –61.8°  (c = 0.33, CH2Cl2). 
 
   
SUPPORTING INFORMATION FOR CHAPTER 3.2.2  369 
Synthesis of hydrindanone 9847 
 






allowed  to  cool  to 23 °C,  and  then was diluted with diethyl  ether  (300 mL).  The organic  layer was 
washed with water (2 x 100 mL). The washed solution was dried over sodium sulfate. The dried solution 
was  filtered  and  the  filtrate  was  concentrated.  The  residue  was  purified  by  flash‐column 
chromatography on silica gel (30% ethyl acetate in hexanes) to provide hydrindanone 98 (6.32 g, ≥99%) 
as  a  yellowish  oil  which  solidified  upon  standing.  The  1H  NMR,  13C  NMR,  IR  and  HMRS  data  for 
hydrindanone 98 were in full agreement with values previously reported for the racemic compound.47 
TLC (30% ethyl acetate in hexanes): Rf = 0.38 (CAM). 1H NMR (400 MHz, CDCl3) δ 4.02–3.85 (m, 4H,  




2882  (m),  1737  (s),  1459  (m),  1354  (m),  1287  (m),  1194  (m),  1110  (s),  1080  (m),  1016  (m)  cm–1.  
HRMS  (ESI):  calcd  for  ([M+H],  C12H19O3)+:  211.13342,  found:  211.13297.  ሾࢻሿࡰ૛૙  =  –92.6°  (c  =  1.00, CH2Cl2). 
 
   




















13C  NMR  (100 MHz,  CDCl3)  δ  110.81  (C‐1),  83.30  (C‐4),  64.47  (C‐10),  64.29  (C‐10’),  51.09  (C‐3),  
41.56 (C‐7), 39.42 (C‐6), 37.47 (C‐15), 37.29 (C‐8), 36.73 (C‐5), 31.61 (C‐2, C‐9), 31.56 (C‐2, C‐9), 18.47 
(C‐16,  C‐17),  18.31  (C‐18),  17.65  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3508  (br),  2953  (s),  
2877  (s),  1459  (m),  1348 (m),  1292  (m),  1254  (m),  1192  (m),  1145  (s),  1089  (s),  1020  (m)  cm–1.  
HRMS (EI): calcd for ([M], C15H26O3)+: 254.1877, found: 254.1876. ሾࢻሿࡰ૛૙ = –12.6° (c = 1.00, CH2Cl2).  
   
















1.95–1.75  (m,  5H,  2‐H,  3‐H,  5‐HB,  9‐HA),  1.66–1.53  (m,  3H,  6‐HA,  8‐HA,  9‐HB),  1.41  (app  td,  2J8B/8A  =  
3J8B/9A  =  13.4  Hz,  3J8B/9B  =  4.5  Hz,  1H,  8‐HB),  1.20–1.09  (m,  1H,  6‐HB),  1.07  (s,  3H,  18‐H),  0.97  (d,  
3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.95 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 13C NMR (100 MHz, CDCl3) δ 140.34 
(Ph), 128.23 (Ph), 126.79 (Ph), 126.68 (Ph), 111.05 (C‐1), 87.58 (C‐4), 64.40 (C‐10), 64.28 (C‐10’), 62.43 
(Bn),  48.33  (C‐3),  41.86  (C‐7),  40.17  (C‐6),  36.87  (C‐8),  34.43  (C‐5),  33.75  (C‐2),  33.01  (C‐15),  31.74  
(C‐9),  18.48  (C‐16,  C‐17),  18.19  (C‐18),  18.15  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  2955  (s),  
2877  (m),  1454 (m),  1385  (m),  1263  (m),  1198  (m),  1143  (m),  1085  (s),  1061  (s),  1040  (s)  cm–1.  
HRMS (EI): calcd for ([M], C22H32O3)+: 344.2346, found: 344.2338. ሾࢻሿࡰ૛૙ = +32.2° (c = 1.06, CH2Cl2).  
   
372  EXPERIMENTAL SECTION 
Synthesis of ketone 28 
 




combined  organic  extracts  were  washed  sequentially  with  saturated  aqueous  sodium  hydrogen 
carbonate  solution  (50 mL)  and  saturated  aqueous  sodium  chloride  solution  (50 mL).  The washed 
solution  was  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 





























pad  of  Celite.  The  filtrate  was  washed  sequentially  with  saturated  aqueous  sodium  hydrogen 
carbonate  solution  (50 mL)  and  saturated  aqueous  sodium  chloride  solution  (50 mL).  The washed 
solution  was  dried  over  sodium  sulfate,  the  dried  solution  was  filtered  and  the  filtrate  was 
concentrated. The residue was filtered through a pad of silica gel (50% diethyl ether in pentane) to 
provide epoxide 101  (1.85 g, 80%) as a  colourless  liquid, which was used  in  the next  step without 
further purification. 
   
                                                 
61 W. Ma, J. Fang, J. Ren, Z. Wang, Org. Lett. 2015, 17, 4180. 




















sulfoxide  (6 mL) was  treated sequentially with  triethylamine  (2.02 mL, 14.5 mmol, 5.00 equiv) and 
sulfur trioxide pyridine complex (1.39 g, 8.71 mmol, 3.00 equiv) at 23 °C. After 30 min, the mixture was 
diluted with water  (50 mL)  and  the  layers were  separated.  The  aqueous  layer was  extracted with 
diethyl ether  (2 x 20 mL) and the combined organic extracts were washed with saturated aqueous 






SUPPORTING INFORMATION FOR CHAPTER 3.2.2  375 
Synthesis of enone 104 
 
A  solution  of  aldehyde  103  (118  mg,  0.69  mmol,  1  equiv)  in  toluene  (1.4  mL)  was  treated  with  




concentrated  in  vacuo.  The  residue  was  purified  by  flash‐column  chromatography  on  silica  gel  
(20% to 30% ethyl acetate in hexanes) to provide enone 104 (87.0 mg, 60%) as a yellowish oil. 










376  EXPERIMENTAL SECTION 
Synthesis of triene 27 
 
A  solution  of  enone  104  (25.0  mg,  0.12  mmol,  1  equiv)  in  tetrahydrofuran  (0.5  mL)  was  treated 







TLC  (10%  ethyl  acetate  in  hexanes):  Rf  =  0.50  (UV/CAM).  1H  NMR  (400  MHz,  C6D6)  δ  6.28  (d,  
3J2/3 = 15.3 Hz, 1H, 2‐H), 6.20 (d, 3J3/2 = 15.3 Hz, 1H, 3‐H), 4.80 (br s, 1H, 8‐HA), 4.77 (br s, 1H, 8‐HB),  
4.38  (s,  1H,  9‐HA),  4.36 (s,  1H,  9‐HB),  2.18–1.99  (m,  2H,  6‐H),  1.75–1.58  (m,  6H,  5‐H,  15‐H,  18‐H),  
1.01 (s, 9H, SiR), 0.92–0.86 (m, 6H, 16‐H, 17‐H), 0.16 (s, 3H, SiR), 0.15 (s, 3H, SiR). 13C NMR (100 MHz, 
C6D6) δ 155.40 (C‐1), 146.45 (C‐7), 135.06 (C‐3), 127.50 (C‐2), 110.17 (C‐8), 95.68 (C‐9), 77.28 (C‐4), 
37.49  (C‐15),  37.32  (C‐5),  32.17  (C‐6),  26.00  (SiR),  22.76  (C‐18),  18.51  (SiR),  17.87  (C‐16,  C‐17),  
16.86 (C‐16, C‐17), –3.36 (SiR), –4.43 (SiR). IR (Diamond‐ATR, neat) vm̃ax: 3480 (br), 2958 (s), 2931 (s), 










–78  °C  (addition  to  the  inner  edge of  the  reaction  flask,  such  that  the  solution was  cooled before 


















Ph), 7.26–7.21  (m, 1H, Ph), 5.72–5.68  (m, 1H, 1‐H), 5.59–5.55  (m, 1H, 9‐H), 4.47–4.41  (m, 2H, Bn),  




13C NMR  (150 MHz, CDCl3)  δ  140.52  (Ph),  128.26  (Ph),  128.15  (C‐1),  126.82  (2C, Ph),  125.89  (C‐9),  
87.65 (C‐4), 62.61 (Bn), 46.42 (C‐3), 41.93 (C‐8), 40.59 (2C, C‐6, C‐7), 34.36 (C‐5), 33.36 (C‐15), 25.97 
(C‐2),  18.84  (C‐18),  18.28  (C‐16,  C‐17),  17.72  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  2958  (s),  
2924  (s),  2886  (m),  1496  (m),  1453  (s),  1385  (s),  1226  (m),  1150  (m),  1085  (m),  1063  (s)  cm–1.  
HRMS (ESI and EI): mass not found. ሾࢻሿࡰ૛૙ = –38.0° (c = 0.70, CH2Cl2).  
   




0.36 mmol,  1  equiv)  and  N,N‐diisopropylethylamine  (0.19  mL,  1.09  mmol,  3.00  equiv)  in 
dichloromethane (0.3 mL) was treated dropwise with trimethylaluminium solution (2 M in toluene, 





















1266 (m),  1062  (s)  cm–1.  HRMS  (EI):  calcd  for  ([M],  C31H38O2)+:  442.2866,  found:  442.2859. 
ሾࢻሿࡰ૛૙ = +50.4° (c = 0.90, CH2Cl2).  
   




SUPPORTING INFORMATION FOR CHAPTER 3.2.2  379 
Synthesis of α‐methylated cyclobutanone 33 
 
A  solution  of  cyclobutanone  32  (18.0  mg,  40.7  µmol,  1  equiv)  in  tetrahydrofuran  (0.7  mL)  and  
tert‐butanol (0.05 mL) was treated sequentially with iodomethane (10.1 µL, 163 µmol, 4.00 equiv) and 
potassium tert‐butoxide (5.0 mg, 44.7 µmol, 1.10 equiv) at –60 °C. The resulting bright yellow solution 







10H,  Ph),  6.05–6.03  (m,  1H,  11‐H),  4.39–4.33  (m,  2H,  Bn),  3.57–3.52  (m,  1H,  9‐H),  2.57  (app  t,  









C‐17),  17.57  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  2956  (s),  2924  (s),  2857  (m),  1766  (s),  
1495  (m),  1454  (s),  1379  (m),  1193  (w),  1084  (m),  1053  (s),  1026  (s)  cm–1. HRMS  (ESI):  calcd  for  
([M–H], C32H39O2)–: 455.29555, found: 455.29615. ሾࢻሿࡰ૛૙ = –35.4° (c = 1.00, CH2Cl2).  
   
                                                 
64 TLC analysis at this stage indicated that product formation as well as considerable decomposition of the starting material 
had occurred. 
380  EXPERIMENTAL SECTION 
Synthesis of dichlorocyclobutanone 105 
 
A vigorously  stirred  suspension of olefin 29  (60.0 mg, 0.21 mmol, 1 equiv) and  zinc‐copper  couple 
(92.5 mg, 0.72 mmol, 3.40 equiv)  in diethyl ether  (0.7 mL) was treated dropwise with a solution of 
trichloroacetyl  chloride  (37.7 µL, 0.34 mmol, 1.60 equiv)  in diethyl ether  (0.4 mL) over a period of  
45 min (syringe pump) at 23 °C. After complete addition, stirring was continued for 15 min, before the 
mixture was diluted with diethyl ether (4 mL) and filtered through a pad of Celite. The filtrate was 
washed with  saturated  aqueous  sodium  hydrogen  carbonate  solution  (2  x  5 mL)  and  the washed 








(Ph), 128.52  (Ph), 127.33  (Ph), 127.11  (Ph), 88.53 (C‐10), 87.44  (C‐4), 62.92  (Bn), 54.34  (C‐1), 46.82  






SUPPORTING INFORMATION FOR CHAPTER 3.2.2  381 
Synthesis of cyclobutanone 35 
 






chromatography  (10% ethyl  acetate  in  hexanes)  to  provide  cyclobutanone 35  (20.3 mg,  87%)  as  a 
yellowish oil which solidified upon standing. 
TLC (10% ethyl acetate in hexanes): Rf = 0.35 (UV/CAM). 1H NMR (400 MHz, CDCl3) δ 7.36–7.20 (m, 5H, 
Ph),  4.46–4.34  (m,  2H, Bn),  3.51–3.42  (m,  1H,  1‐H),  3.22  (ddd,  2J10A/10B  =  16.0  Hz,  3J10A/9  =  9.2  Hz,  
4J10A/1  =  2.3  Hz,  1H,  10‐HA),  2.71–2.59  (m,  1H,  9‐H),  2.40  (app  dt,  2J10B/10A  =  16.0  Hz,  3J10B/9  =  
4J10B/1 = 2.0 Hz, 1H, 10‐HB), 2.29–2.19 (m, 2H, 8‐HA, 15‐H), 2.14–1.99 (m, 2H, 2‐HA, 5‐HA), 1.93–1.76 (m, 






















the  alkylated  lactone  (501 mg,  41%,  yield  unoptimized), which was  used  in  the  next  step without 
further purification. 
A  round‐bottomed  flask  was  charged  with  bis(benzonitrile)palladium(II)  dichloride  (39.2  mg,  
0.10 mmol, 0.05 equiv), copper(II) chloride dihydrate (17.4 mg, 0.10 mmol, 0.05 equiv) and sodium 
nitrite (3.5 mg, 0.05 mmol, 0.03 equiv).66 The flask was flushed with oxygen for 1 min, whereupon a 
solution  of  the  lactone  (500 mg,  2.05 mmol,  1  equiv)  in  oxygen‐sparged  tert‐butanol  (22 mL)  and 
nitromethane (1.5 mL) was added. The resulting mixture was sparged with oxygen gas for 3 min, and 
stirring was then continued under oxygen atmosphere whereupon the mixture turned dark brown in 
















                                                 
65 M. Wada, M. Honna, Y. Kuramoto, N. Miyoshi, Bull. Chem. Soc. Jpn. 1997, 70, 2265. 
66 Z. K. Wickens, K. Skakuj, B. Morandi, R. H. Grubbs, J. Am. Chem. Soc. 2014, 136, 890. 
SUPPORTING INFORMATION FOR CHAPTER 3.2.2  383 
Synthesis of enol ether 108 
 
A  solution  of  aldehyde 107  (368 mg,  1.41 mmol,  1  equiv)  in  dichloromethane  (9 mL) was  treated 













residue was  purified  by  flash‐column  chromatography  (5%  ethyl  acetate  in  hexanes,  triethylamine 
pretreated silica gel) to provide a mixture of exo‐ and endo‐cyclic enol ethers. 
In order to isomerize the exo‐cyclic enol ether, the mixture was dissolved in benzene (8 mL) and the 
resulting  solution was  heated  to  80  °C.  After  3  h,  the mixture was  cooled  to  23  °C  and  then was 
concentrated to provide enol ether 108 (442 mg, 84%, 4:3 mixture of E‐/Z‐alkene isomers) as a yellow 
oil. 
TLC  (3% ethyl acetate  in hexanes): Rf = 0.23 (UV/CAM).  In cases where the proton or carbon atoms 
show a double set of signals due to the E‐/Z‐alkene isomers, the signal of the second isomer is marked 




(s,  3H, SiR).  13C NMR  (100 MHz,  C6D6)  δ  147.17  (C‐14),  147.13*  (C‐14),  142.71 (C‐12),  142.59  (Ph), 




(m),  1660  (s),  1454  (m),  1254 (s),  1169  (s),  1103  (m)  cm–1. HRMS  (EI):  calcd  for  ([M],  C23H36O2Si)+: 
372.2479, found: 372.2474. 
   
                                                 
67 J. F. Payack, D. L. Hughes, D. Cai, I. F. Cottrell, T. R. Verhoeven, Org. Synth. 2002, 79, 19. 













Alcohol  39:  TLC  (30%  ethyl  acetate  in  hexanes):  Rf  =  0.33  (UV/CAM).  1H  NMR  (400  MHz,  C6D6)  
δ 7.24–7.08 (m, 5H, 13‐H, 14‐H, 15‐H), 4.42–4.40 (m, 1H, 1‐HA), 3.64–3.62 (m, 1H, 1‐HB), 3.37–3.28 (m, 






















extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 
concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (20%  ethyl  acetate  in 
hexanes) to provide benzyl ether 109 (1.92 g, 72%) as a yellowish solid. 




(C‐19),  127.65  (C‐17,  C‐18),  121.40  (C‐9),  120.64  (C‐8),  113.92  (C‐3),  70.55  (C‐15),  30.20  (C‐20).  
IR (Diamond‐ATR, neat) vm̃ax: 3064 (w), 3032 (w), 2922 (w), 1687 (s), 1591 (s), 1558 (m), 1488 (m), 1453 





386  EXPERIMENTAL SECTION 
Synthesis of styrene 41 
 
A mixture  of  benzyl  ether 109  (2.14  g,  7.01 mmol,  1  equiv),  potassium  isopropenyltrifluoroborate  
(1.25  g,  8.41  mmol,  1.20  equiv),  triethylamine  (980  µL,  7.01  mmol,  1.00  equiv)  and  PdCl2(dppf)  





sodium sulfate,  the dried  solution was  filtered and  the  filtrate was  concentrated.  The  residue was 
purified  by  flash‐column  chromatography  (15%  ethyl  acetate  in  hexanes)  to  provide  styrene  41  
(1.59 g, 85%) as a yellow oil. 





















indicated  incomplete  conversion  of  styrene  41.  The mixture was  filtered  through  a  pad  of  Celite.  
The filtrate was concentrated and the residue was purified by flash‐column chromatography (60% to 






























borohydride  (36.8 mg, 973 µmol, 2.50 equiv) at –78  °C. After 1 h, TLC analysis  indicated complete 
conversion of  the ketone starting material  to a more polar product  (i.e. complete reduction of  the 
ketone to the corresponding alcohol). The mixture was warmed to 0 °C, whereupon nickel(II) chloride 
hexahydrate  (185 mg,  778 µmol,  2.00 equiv)  and more  sodium borohydride  (58.9 mg,  1.56 mmol,  




























i. Boc2O, DMAP, NEt3CH2Cl2, 23 °C, 4 h


































concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (30%  ethyl  acetate  in 
hexanes) to provide carbonate 44 (94.0 mg, 84% over two steps) as a colorless foam. 
TLC  (30%  ethyl  acetate  in  hexanes):  Rf  =  0.33  (UV/CAM).  1H  NMR  (600  MHz,  CDCl3)  δ  7.06  (d,  
3J2/3 = 7.9 Hz, 1H, 2‐H), 6.72 (dd, 3J3/2 = 7.9 Hz, 4J3/8 = 2.3 Hz, 1H, 3‐H), 6.56 (d, 4J8/3 = 2.3 Hz, 1H, 8‐H), 








































ferrocenecarboxylic acid, EDC, DMAP




A  solution  of  carbonate 44  (20.0 mg,  62.4  µmol,  1  equiv)  in  dichloromethane  (1 mL) was  treated 
sequentially with triethylamine (10.4 µL, 74.9 µmol, 1.20 equiv), 4‐dimethylaminopyridine (7.63 mg,  
62.4  µmol,  1.00  equiv),  ferrocenecarboxylic  acid  (17.2  mg,  74.9  µmol,  1.20  equiv),  and  
N‐(3‐dimethylaminopropyl)‐N′‐ethylcarbodiimide hydrochloride  (14.4 mg, 74.9 µmol, 1.20 equiv) at  
23  °C.  After  1.5  h,  the  mixture  was  diluted  with  saturated  aqueous  sodium  hydrogen  carbonate 
solution (15 mL) and diethyl ether (5 mL). The layers were separated, the aqueous layer was extracted 
with  diethyl  ether  (3  x  8 mL)  and  the  combined  organic  extracts were  dried  over  sodium  sulfate.  
The dried solution was filtered and the filtrate was concentrated. The residue was purified by flash‐






(s,  5H,  Cp),  1.99–1.89  (m,  2H,  11‐HA,  12‐HB),  1.63–1.60  (m,  4H,  11‐HB,  19‐H),  1.59 (s,  3H,  20‐H),  
1.48 (s, 9H, 23‐H), 0.91–0.81 (m, 1H, 12‐HB). 13C NMR (150 MHz, CDCl3) δ 170.53 (C‐24), 153.36 (C‐21), 
151.13  (C‐7),  147.52  (C‐9),  140.40  (C‐1),  122.47  (C‐2),  120.78  (C‐3),  113.17  (C‐8),  83.25  (C‐14),  
















A  mixture  of  the  known  bromide  11270  (6.00  g,  26.2  mmol,  1  equiv),  potassium 







residue  was  purified  by  flash‐column  chromatography  (20%  ethyl  acetate  in  hexanes)  to  provide 
styrene 113 (4.23 g, 85%) as a yellow oil. 
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11068  (270  mg,  0.105  mmol,  0.013  equiv)  in  dichloromethane  (90  mL)  was  cooled  to  –15  °C,  
whereupon known allenamide 4269 (2.20 g, 17.6 mmol, 1 equiv) was added. After 30 min, the cooling 









1  h,  the  yellow  cloudy  mixture  was  diluted  with  saturated  aqueous  sodium  thiosulfate  solution  
(100 mL) and diethyl ether (50 mL). The layers were separated, the aqueous layer was extracted with 
diethyl ether (3 x 50 mL) and the combined organic extracts were dried over sodium sulfate. The dried 
solution was  filtered  and  the  filtrate was  concentrated.  The  residue was  purified  by  flash‐column 
chromatography (15% ethyl acetate in hexanes) to provide ketone 115 (820 mg, 20% over two steps) 
as a colorless solid. 
TLC  (20%  ethyl  acetate  in  hexanes):  Rf  =  0.40  (UV/KMnO4).  1H  NMR  (400 MHz,  CDCl3)  δ  7.04  (d,  
3J2/3 = 8.2 Hz, 1H, 2‐H), 6.80 (dd, 3J3/2 = 8.2 Hz, 4J3/8 = 2.1 Hz, 1H, 3‐H), 6.75 (d, 4J8/3 = 2.1 Hz, 1H, 8‐H),  
3.84 (s, 3H, 6‐H), 2.42–2.27 (m, 2H, 11‐HA, 12‐HA), 2.18–2.06 (m, 1H, 12‐HB), 2.01–1.94 (m, 1H, 11‐HB),  
1.71  (s,  3H,  19‐H),  1.58  (s,  3H,  20‐H).  13C  NMR  (100  MHz,  CDCl3)  δ  204.60  (C‐13),  160.95  (C‐7),  
147.64 (C‐9), 135.23 (C‐1), 121.66 (C‐2), 112.87 (C‐3), 106.88 (C‐8), 87.67 (C‐14), 83.25 (C‐10), 55.63 




SUPPORTING INFORMATION FOR CHAPTER 3.2.2  393 
Synthesis of anisole 49 
 
A  solution  of  ketone  115  (820  mg,  3.53  mmol,  1  equiv)  in  a  mixture  of  methanol  (9  mL)  and 
dichloromethane  (9 mL) was  treated with sodium borohydride  (267 mg, 7.06 mmol, 2.00 equiv) at  
–78 °C. After 1 h, saturated aqueous ammonium chloride solution (40 mL) and ethyl acetate (50 mL) 




TLC  (40%  ethyl  acetate  in  hexanes):  Rf  =  0.24  (UV/CAM).  1H  NMR  (600  MHz,  CDCl3)  δ  7.07  (d,  
3J2/3 = 8.1 Hz, 1H, 2‐H), 6.80 (dd, 3J3/2 = 8.1 Hz, 4J3/8 = 2.4 Hz, 1H, 3‐H), 6.65 (d, 4J8/3 = 2.4 Hz, 1H, 8‐H), 
3.83 (s, 3H, 6‐H), 3.68–3.64 (m, 1H, 13‐H), 1.90–1.81 (m, 2H, 11‐HA, 12‐HA), 1.60 (s, 3H, 20‐H), 1.58 (s, 
3H,  19‐H),  1.56–1.51  (m,  1H,  11‐HB),  1.06  (br  s,  1H,  13‐OH),  0.59–0.50  (m,  1H,  12‐HB).  13C  NMR  
(150 MHz, CDCl3) δ 160.17 (C‐7), 148.07 (C‐9), 135.44 (C‐1), 121.63 (C‐2), 111.98 (C‐3), 106.36 (C‐8), 





394  EXPERIMENTAL SECTION 
Synthesis of enol ether 116 
 


























(m,  1H,  12‐HA),  1.56–1.43  (m,  2H,  11‐H),  1.34  (s,  3H,  20‐H),  1.30–1.22  (m,  1H,  12‐HB),  1.20  (s,  3H,  
19‐H). 13C NMR (100 MHz, CD2Cl2) δ 209.49 (C‐7), 137.40 (C‐1), 136.52 (C‐9), 86.26 (C‐14), 83.68 (C‐10), 















A  solution  of  the  crude  epoxide  (assuming  189  µmol)  in  methanol  (4  mL)  was  treated  with 
triethylamine  (0.25 mL) and  the resulting mixture was heated  to 45 °C. After 2 h,  the mixture was 
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Yamaguchi, N. Mizuno, Chem. Eur. J. 2004, 10, 4728. 








The  filtrate was  concentrated  to  provide  spectroscopically  pure diol 51  as  a  colourless  oil  (22 mg, 
≥99%). 
TLC  (5%  methanol  in  dichloromethane):  Rf  =  0.11  (CAM).  1H  NMR  (800  MHz,  CDCl3)  δ  3.82  (dd,  
3J13/12A  =  11.1  Hz,  3J13/12B  =  6.9  Hz,  1H,  13‐H),  2.62–2.56  (m,  1H,  3‐HA),  2.52  (app  td,  2J2A/2B  =  
3J2A/3A  =  14.4  Hz,  3J2A/3B  =  4.0  Hz,  1H,  2‐HA),  2.41  (dd,  2J8A/8B  =  15.6  Hz,  3J8A/9  =  13.9  Hz,  1H,  8‐HA),  
2.38–2.31  (m, 2H, 3‐HB, 8‐HB), 2.09  (dd,  3J9/8A = 13.9 Hz,  3J9/8B = 6.4 Hz, 1H, 9‐H), 2.01–1.96  (m, 1H,  
12‐HA), 1.85–1.81 (m, 1H, 2‐HB), 1.80 (br s, 1H, 13‐OH), 1.77–1.68 (m, 2H, 11‐HA, 12‐HB), 1.68–1.60 (m, 
2H, 1‐OH, 11‐HB),  1.41  (s,  3H, 20‐H),  1.29  (s,  3H, 19‐H).  13C NMR  (200 MHz, CDCl3) δ 212.18  (C‐7),  
86.21 (C‐14), 82.27 (C‐1), 80.33 (C‐10), 74.29 (C‐13), 58.00 (C‐9), 38.33 (C‐8), 34.20 (C‐3), 32.30 (C‐11), 
27.49 (C‐12), 26.91 (C‐19), 26.45 (C‐2), 19.84 (C‐20). IR (Diamond‐ATR, neat) ṽmax: 3426 (br), 2962 (m), 



























































A  solution  of  acetal  53  (54.0  mg,  0.20  mmol,  1  equiv)  in  dichloromethane  (2.5  mL)  was  treated 
sequentially with triethylamine (0.28 mL, 2.03 mmol, 10.0 equiv), 4‐dimethylaminopyridine (5.0 mg, 
0.04 mmol, 0.20 equiv) and di‐tert‐butyl dicarbonate (133 mg, 0.61 mmol, 3.00 equiv) at 23 °C. After 




concentrated.  The  residue  was  purified  by  flash‐column  chromatography  (25%  ethyl  acetate  in 
hexanes) to provide carbonate 54 (46.0 mg, 62%) as a colorless oil. 
TLC (30% ethyl acetate in hexanes): Rf = 0.40 (CAM). 1H NMR (400 MHz, CDCl3) δ 4.53–4.48 (m, 1H,  
13‐H),  4.04–3.95  (m,  4H,  6‐H,  6’‐H),  2.40–2.20  (m,  3H,  2‐H,  8‐HA),  2.05–1.91  (m,  2H,  8‐HB,  12‐HA),  
1.87–1.74 (m, 2H, 3‐H), 1.62–1.56 (m, 1H, 11‐HA), 1.50–1.41 (m, 11H, 11‐HB, 12‐HB, 23‐H), 1.30 (s, 3H, 
20‐H),  1.23  (s,  3H,  19‐H).  13C  NMR  (100 MHz,  CDCl3)  δ  153.52  (C‐21),  136.66  (C‐9),  135.76  (C‐1),  
108.99 (C‐7), 84.69 (C‐14), 83.97 (C‐10), 81.87 (C‐22), 75.11 (C‐13), 64.77 (C‐6, C‐6’), 64.64 (C‐6, C‐6’), 







400  EXPERIMENTAL SECTION 
Synthesis of epoxide 119 
 
A solution of acetal 53  (97.0 mg, 0.36 mmol, 1 equiv)  in dichloromethane  (2 mL) was  treated with  
meta‐chloroperoxybenzoic acid (126 mg, 0.55 mmol, 1.50 equiv) at 0 °C. After 30 min, the mixture was 



















































(C‐10),  62.58  (Bn),  52.32  (C‐9),  49.85  (C‐3),  41.82  (C‐7),  41.71  (C‐2),  40.25  (C‐6),  37.55  (C‐8),  34.78  
(C‐5), 33.00 (C‐15), 32.90 (C‐11), 31.10 (C‐12), 26.04 (SiR), 18.72 (C‐18), 18.34 (C‐16, C‐17), 18.21 (SiR),  
17.84 (C‐16, C‐17), –4.31 (SiR), –4.45 (SiR). IR (Diamond‐ATR, neat) vm̃ax: 2954 (s), 2924 (s), 2856 (m), 
1700 (s),  1471  (m),  1387  (m),  1255  (m),  1067  (s),  1046  (s)  cm–1.  HRMS  (ESI):  calcd  for  ([M+H], 
C31H51O3Si)+: 499.36075, found: 499.36045. ሾࢻሿࡰ૛૙ = +28.8° (c = 1.00, CH2Cl2).    




lanthanum(III)  chloride bis(lithium chloride) complex solution  (0.46 M  in THF, 5.01 mL, 2.31 mmol, 










7.24–7.19  (m,  2H, Ph),  7.12–7.08  (m,  1H, Ph),  5.87–5.81  (m,  1H,  13‐H),  5.30–5.27  (m,  1H,  21‐HA),  
5.12–5.08 (m, 1H, 22‐HA), 5.02–4.99 (m, 1H, 22‐HB), 4.90–4.87 (m, 1H, 21‐HB), 4.30–4.24 (m, 2H, Bn),  
3.80–3.76 (m, 1H, 10‐H), 2.70 (br s, 1H, 1‐OH), 2.27 (app t, 2J2A/2B = 3J2A/3 = 13.4 Hz, 1H, 2‐HA), 2.24–2.15 
(m,  3H,  3‐H,  11‐HA,  12‐HA),  2.13–2.00  (m,  4H,  5‐HA,  9‐H,  12‐HB,  15‐H),  1.87  (app  t,  2J8A/8B  =  









HRMS  (ESI):  calcd  for  ([M+H], C34H57O3Si)+: 541.40770,  found: 541.40760.  ሾࢻሿࡰ૛૙  = +25.0°  (c = 1.00, CH2Cl2).  
 
   




tetrabutylammonium fluoride solution  (1 M  in THF, 0.91 mL, 0.91 mmol, 1.20 equiv) at 0  °C. After  
5 min, the cooling bath was removed and the mixture was allowed to warm to 23 °C. After 25 min, the 
mixture was diluted with saturated aqueous sodium hydrogen carbonate solution (30 mL) and diethyl  




An  analytically  pure  sample  of  diol  120  was  obtained  by  flash‐column  chromatography  (7%  ethyl 
acetate in hexanes). 
TLC (10% ethyl acetate in hexanes): Rf = 0.11 (CAM). 1H NMR (800 MHz, C6D6) δ 7.37–7.35 (m, 2H, Ph), 
7.22–7.19  (m,  2H,  Ph),  7.11–7.08  (m,  1H,  Ph),  5.81  (app  ddt,  3J13/22A  =  17.0  Hz,  3J13/22B  =  10.2  Hz, 
3J13/12  =  6.7  Hz,  1H,  13‐H),  5.21–5.19  (m,  1H,  21‐HA),  5.06  (app  dq,  3J22A/13  =  17.0  Hz,  2J22A/22B  = 
4J22A/12 = 1.7 Hz, 1H, 22‐HA), 4.99–4.97 (m, 1H, 22‐HB), 4.76–4.74 (m, 1H, 21‐HB), 4.28–4.23 (m, 2H, Bn), 
3.54–3.51  (m,  1H,  10‐H),  2.65  (br  s,  1H,  1‐OH,  10‐OH),  2.26–2.16  (m,  2H,  2‐HA,  12‐HA),  2.11  (dd,  
3J3/2A = 12.9 Hz, 3J3/2B = 2.8 Hz, 1H, 3‐H), 2.10–1.99 (m, 4H, 5‐HA, 9‐H, 12‐HB, 15‐H), 1.74–1.71 (m, 3H, 
20‐H), 1.68–1.51 (m, 6H, 2‐HB, 5‐HB, 6‐HA, 8‐HA, 11‐H), 1.42 (dd, 2J8B/8A = 12.4 Hz, 3J8B/9 = 4.4 Hz, 1H,  
8‐HB),  1.22–1.16  (m,  1H,  6‐HB),  1.12  (s,  3H,  18‐H),  0.98  (d,  3J  =  6.8  Hz,  3H,  16‐H,  17‐H),  0.96  (d,  
3J = 6.8 Hz, 3H, 16‐H, 17‐H).  13C NMR  (100 MHz, C6D6) δ 155.33  (C‐14), 140.54  (Ph), 139.19  (C‐13), 
128.53  (Ph),  127.29  (Ph),  127.19  (Ph),  114.81  (C‐22),  109.27  (C‐21),  88.53  (C‐4),  78.40  (C‐1),  75.58  
(C‐10),  63.16  (Bn),  45.08  (C‐3),  42.66  (C‐9),  42.31  (C‐7),  41.72  (C‐8),  41.05  (C‐6),  38.22  (C‐2),  35.18  
(C‐11),  34.18  (C‐5),  33.21  (C‐15),  31.15 (C‐12),  20.15  (C‐20), 18.98  (C‐18),  18.57  (C‐16, C‐17),  18.35  
(C‐16, C‐17). IR (Diamond‐ATR, neat) vm̃ax: 3395 (br), 2956 (m), 2933 (m), 1639 (m), 1453 (m), 1386 (m), 
1059  (s)  cm–1.  HRMS  (ESI):  calcd  for  ([M+CH3COO],  C30H45O5)–:  485.32670,  found:  485.32744. 
ሾࢻሿࡰ૛૙ = +22.8° (c = 0.39, CH2Cl2).   
   










7.24–7.20  (m,  2H,  Ph),  7.12–7.09  (m,  1H,  Ph),  5.64  (app  ddt,  3J13/22A  =  16.6  Hz,  3J13/22B  =  10.3  Hz, 
3J13/12 = 6.4 Hz, 1H, 13‐H), 5.20–5.19 (m, 1H, 21‐HA), 4.96–4.90 (m, 3H, 1‐OH, 22‐H), 4.83–4.79 (m, 1H,  
21‐HB),  4.31–4.22  (m,  2H,  Bn),  2.98  (dd,  3J9/8A  =  12.8  Hz,  3J9/8B  =  3.8  Hz,  1H,  9‐H),  2.41  (dd,  
3J3/2A = 11.6 Hz, 3J3/2B = 3.8 Hz, 1H, 3‐H), 2.23–2.10 (m, 3H, 11‐HA, 12‐H), 2.09–2.02 (m, 3H, 5‐HA, 11‐HB, 




















diethyl  ether  (40  mL).  The  layers  were  separated,  the  aqueous  layer  was  extracted  with  diethyl  
ether (4 x 40 mL) and the combined organic extracts were dried over sodium sulfate. The dried solution 














1062  (s)  cm–1.  HRMS  (EI):  calcd  for  ([M],  C29H44O3)+:  440.3285,  found:  440.3277.  ሾࢻሿࡰ૛૙  =  +16.7°  (c = 0.23, CH2Cl2).  
 
   




to  use)  toluene  (270  mL)  was  treated  with  2,6‐dichloro‐1‐4‐benzoquinone  (9.2  mg,  52.2  µmol,  
0.20 equiv) and Stewart–Grubbs catalyst 122 (29.8 mg, 52.2 µmol, 0.20 equiv). The resulting orange 









2J6A/6B = 11.6 Hz,  3J6A/5A = 7.8 Hz, 1H, 6‐HA), 1.28–1.21  (m, 1H, 6‐HB), 1.11–1.07  (m, 6H, 16‐H, 17‐H,  
18‐H),  1.05  (s,  3H, 19‐H),  0.99  (d,  3J  =  6.8 Hz, 3H, 16‐H, 17‐H).  13C NMR  (100 MHz, C6D6) δ 144.02  
(C‐14),  140.72 (Ph),  129.04  (C‐13),  128.52  (Ph),  128.41  (Ph),  127.15  (Ph),  127.10  (Ph),  88.76  (C‐4),  
78.31 (C‐1), 76.72 (C‐10), 63.10 (Bn), 46.14 (C‐11), 44.67 (C‐3), 43.93 (C‐9), 41.59 (C‐7), 41.50 (C‐6), 
38.93  (C‐8),  37.29 (C‐2),  34.40  (C‐5),  33.27  (C‐15),  30.01  (C‐19),  23.60  (C‐12),  21.90  (C‐20),  19.20  




SUPPORTING INFORMATION FOR CHAPTER 3.2.2  407 
Synthesis of cyclic carbonate 123 
 
A  solution  of  tricycle  63a  (1.5  mg,  3.6  µmol,  1  equiv)  in  dichloromethane  (0.8  mL)  was  treated 











2J5B/5A = 13.9 Hz,  3J5B/6B = 8.4 Hz, 1H, 5‐HB), 1.49–1.42  (m, 2H, 6‐HA, 12‐HB), 1.36–1.29  (m, 2H, 8‐H),  
1.13 (ddd, 2J11B/11A = 14.9 Hz, 3J11B/12A = 5.8 Hz, 3J11B/12B = 2.9 Hz, 1H, 11‐HB), 1.09–1.03 (m, 4H, 6‐HB,  
16‐H,  17‐H),  0.98  (s,  3H,  18‐H),  0.94  (s,  3H,  19‐H),  0.92  (d,  3J  =  6.8  Hz,  3H,  16‐H,  17‐H).  13C NMR  















78  °C  (addition  to  the  inner wall  of  the  reaction  flask,  such  that  the  solution was  cooled  before 
reaching  the  reaction  mixture).  After  45  min,  a  solution  of  acetaldehyde  (0.29  mL,  5.11  mmol,  
1.20  equiv)  in  tetrahydrofuran  (4 mL)  was  added  dropwise  over  a  period  of  5 min.  After  40 min,  
TLC  analysis  indicated  incomplete  conversion  of  ketone  28,  and  therefore  a  further  portion  of 
acetaldehyde (71.7 µL, 1.28 mmol, 0.30 equiv) in tetrahydrofuran (0.5 mL) was added dropwise over a 
period of  2 min. After  further 30 min,  the mixture was diluted with  pH 7 buffer  solution  (50 mL), 
saturated  aqueous  sodium  chloride  solution  (20  mL)  and  diethyl  ether  (40  mL).  The  layers  were 
separated, the aqueous layer was extracted with diethyl ether (3 x 30 mL) and the combined organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 
concentrated  to  provide  the  aldol  product,  which  was  used  in  the  next  step  without  further 
purification. 
A  solution  of  the  crude  aldol  product  (assuming  4.26 mmol)  in  dimethyl  formamide  (8.5 mL) was 
treated  sequentially  with  imidazole  (0.93  g,  13.6  mmol,  3.20  equiv),  4‐dimethylaminopyridine  
(52.0 mg, 0.43 mmol, 0.10 equiv) and tert‐butyldimethylchlorosilane (0.90 g, 5.96 mmol, 1.40 equiv) 
at 0 °C. After 5 min, the cooling bath was removed and the mixture was allowed to warm to 23 °C. 
After  13  h,  the mixture was  diluted with  saturated  aqueous  sodium  hydrogen  carbonate  solution  
(40 mL), water (20 mL) and diethyl ether (20 mL). The layers were separated, the aqueous layer was 
extracted  with  diethyl  ether  (3  x  30  mL)  and  the  combined  organic  extracts  were  washed  with 
saturated  aqueous  sodium  chloride  solution  (40 mL).  The washed  solution was  dried  over  sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified by 






4.70–4.67  (m,  1H,  10‐H),  4.17–4.09  (m,  2H, Bn),  2.75–2.69  (m,  1H,  2‐HA),  2.66–2.61  (m,  1H,  9‐H),  
2.60 (dd, 2J2B/2A = 15.5 Hz, 3J2B/3 = 3.9 Hz, 1H, 2‐HB), 2.09 (dd, 2J8A/8B = 12.6 Hz, 3J8A/9 = 6.5 Hz, 1H, 8‐HA), 
2.05–1.99 (m, 1H, 5‐HA), 1.84 (h, 3J15/16‐17 = 6.9 Hz, 1H, 15‐H), 1.67 (dd, 3J3/2A = 14.3 Hz, 3J3/2B = 3.9 Hz, 
1H,  3‐H),  1.57–1.49  (m,  2H,  5‐HB,  6‐HA),  1.43  (app  t,  2J8B/8A  =  3J8B/9  =  12.6  Hz,  1H,  8‐HB),  1.25  (d,  
3J11/10  =  6.2  Hz,  3H,  11‐H),  1.11  (s,  3H,  18‐H),  1.08–1.02  (m,  1H,  6‐HB),  0.99  (s,  9H,  SiR),  0.78  (d,  
3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.68 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.10 (s, 6H, SiR). 13C NMR (200 MHz, 
C6D6)  δ  210.42  (C‐1),  140.13 (Ph),  128.57  (Ph),  127.33  (Ph),  127.17  (Ph),  87.58  (C‐4),  67.51  (C‐10),  
62.84  (Bn),  52.95  (C‐9),  50.46 (C‐3),  41.94  (C‐7),  41.90  (C‐2),  40.38  (C‐6),  38.07  (C‐8),  34.86  (C‐5),  
32.90 (C‐15), 26.15 (SiR), 19.85 (C‐11), 18.85 (C‐18), 18.32 (SiR), 18.10 (C‐16, C‐17), 17.72 (C‐16, C‐17), 
–4.36 (SiR), –4.76 (SiR). IR (Diamond‐ATR, neat) vm̃ax: 2955 (s), 2930 (s), 2857 (m), 1700 (s), 1471 (m), 
1387  (m),  1254  (s),  1109  (s),  1066  (s),  1043  (s),  1006  (m)  cm–1.  HRMS  (EI):  calcd  for  ([M–tBu], 
C24H37O3Si)+: 401.2512, found: 401.2516. ሾࢻሿࡰ૛૙ = +26.4° (c = 0.33, CH2Cl2).    




was  treated  with  lanthanum(III)  chloride  bis(lithium  chloride)  complex  solution  (0.46  M  in  THF,  
7.39  mL,  3.40 mmol,  1.00  equiv)  at  23  °C.  After  1  h,  the  brownish  solution  was  cooled  to  0  °C, 
whereupon isopropenylmagnesium bromide solution (0.5 M in THF, 20.4 mL, 10.2 mmol, 3.00 equiv) 
was added dropwise over a period of 20 min  (syringe pump). After complete addition, stirring was 
continued  for  5 min,  before  the mixture was  diluted with  pH  7  buffer  solution  (50 mL),  saturated 
aqueous sodium chloride solution (20 mL) and diethyl ether (40 mL). The layers were separated, the 
aqueous layer was extracted with diethyl ether (5 x 40 mL) and the combined organic extracts were 



































7.24–7.18  (m,  2H,  Ph),  7.13–7.06  (m,  1H,  Ph),  5.21–5.18  (m,  1H,  21‐HA),  4.91  (br  s,  1H,  1‐OH),  
4.83–4.80 (m, 1H, 21‐HB), 4.30–4.20 (m, 2H, Bn), 2.97 (dd,  3J9/8A = 12.7 Hz,  3J9/8B = 3.8 Hz, 1H, 9‐H),  
2.43–2.35  (m,  1H,  3‐H),  2.09–1.99  (m,  2H,  5‐HA,  15‐H),  1.98–1.93  (m,  2H,  2‐H),  1.69–1.67  (m,  3H,  





(C‐5),  33.47  (C‐15),  30.69  (C‐11),  20.15  (C‐20),  19.18  (C‐18),  18.87  (C‐16, C‐17),  18.62  (C‐16, C‐17).  
IR (Diamond‐ATR, neat) vm̃ax: 3462 (br), 2958 (s), 1695 (s), 1639 (w), 1453 (s), 1386 (s), 1182 (m), 1163 
(m), 1086  (m), 1058  (s),  1027  (s)  cm–1. HRMS  (ESI):  calcd  for  ([M+CH3COO], C27H39O5)–:  443.27975, 
found: 443.28067. ሾࢻሿࡰ૛૙ = +15.6° (c = 0.50, CH2Cl2).   
   











prepared  3‐butenylmagnesium  bromide  solution  (assuming  0.70  M  in  THF,  11.1  mL,  7.80  mmol,  
3.00 equiv) was added dropwise over a period of 20 min (syringe pump). After end of the addition, 
stirring was continued for 10 min, before the mixture was diluted with pH 7 buffer solution (70 mL), 
saturated  aqueous  sodium  chloride  solution  (30  mL)  and  diethyl  ether  (40  mL).  The  layers  were 
separated, the aqueous layer was extracted with diethyl ether (5 x 40 mL) and the combined organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 




























vacuo.  The  residue was  purified  by  flash‐column  chromatography  on  silica  gel  (25%  to  30%  ethyl 
acetate  in hexanes)  to provide recovered diene 125  (106 mg, 25%) as a yellow oil and tricycle 63b  
(0.22 g, 55%) as an off‐white foam. 
TLC (20% ethyl acetate in hexanes): Rf = 0.15 (CAM). 1H NMR (800 MHz, C6D6) δ 7.38–7.32 (m, 2H, Ph), 















A  solution  of  tricycle  63b  (3.0  mg,  7.3  µmol,  1  equiv)  in  dichloromethane  (1  mL)  was  treated 
sequentially  with  potassium  iodide  (2.7  mg,  16.0  µmol,  2.20  equiv)  and  (diacetoxyiodo)benzene  
(2.6 mg, 8.0 µmol, 1.10 equiv) at 0 °C. After 10 min, the mixture was warmed to 23 °C. After 3 h, the 
mixture was diluted with pH 7 buffer  solution  (10 mL) and diethyl  ether  (10 mL).  The  layers were 
separated, the aqueous layer was extracted with diethyl ether (3 x 10 mL) and the combined organic 






5‐HA, 12‐HB, 15‐H, 20‐H), 1.94  (app  t,  2J2A/2B =  3J2A/3 = 13.2 Hz, 1H, 2‐HA), 1.72  (dd,  2J2B/2A = 13.2 Hz,  




(Bn),  46.54  (C‐9),  44.53  (C‐3),  42.97  (C‐7),  40.59  (C‐6),  38.40  (C‐8),  36.21  (C‐2),  33.92  (C‐5),  33.04  
(C‐15), 32.10 (C‐20), 31.83 (C‐12), 31.63 (C‐11), 25.70 (C‐19), 19.71 (C‐18), 18.72 (C‐16, C‐17), 18.70  
(C‐16, C‐17). IR (Diamond‐ATR, neat) vm̃ax: 3527 (m), 2935 (s), 2861 (m), 1452 (s), 1376 (s), 1345 (m), 
1275  (m),  1191  (m),  1116  (m),  1061  (s),  1015  (s)  cm–1.  HRMS  (ESI):  calcd  for  ([M+CH3COO],  
C29H42IO5)–: 597.20769, found: 597.20840. ሾࢻሿࡰ૛૙ = +49.7° (c = 0.12, CH2Cl2).    
                                                 
72 Alternatively, iodide 67 could be cleanly prepared by using NIS (CH2Cl2, 0 °C). 





mixture was diluted with pH 7 buffer  solution  (15 mL) and diethyl  ether  (10 mL).  The  layers were 
separated, the aqueous layer was extracted with diethyl ether (3 x 10 mL) and the combined organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 




3.00  (app  t,  2J2A/2B =  3J2A/3 = 12.4 Hz, 1H, 2‐HA), 2.71  (dd,  2J2B/2A = 12.4 Hz,  3J2B/3 = 1.6 Hz, 1H, 2‐HB),  





51.05  (C‐3),  44.21  (C‐7,  C‐8),  44.16  (C‐7,  C‐8),  41.46  (C‐6),  40.41  (C‐2),  34.16  (C‐5),  33.57  (C‐15),  
31.51 (C‐11), 28.38 (C‐19), 26.89 (C‐12), 21.05 (C‐20), 19.10 (C‐18), 18.24 (C‐16, C‐17), 17.72 (C‐16,  
C‐17). IR (Diamond‐ATR, neat) vm̃ax: 2964 (s), 2924 (s), 2884 (m), 1686 (s), 1453 (m), 1382 (m), 1084 (s), 























dried  over  sodium  sulfate.  The  dried  solution was  filtered  and  the  filtrate  was  concentrated.  The 
residue was filtered through a pad of silica gel (20% ethyl acetate in hexanes) to provide diol 69, which 
was used in the next step without further purification. 
A  solution  of  the  crude  diol 69  (assuming  22.1  µmol)  in  tetrahydrofuran  (4 mL) was  treated with 
palladium on carbon (10 wt.%, 23.5 mg, 22.1 µmol, 1.00 equiv) at 23 °C. An atmosphere of hydrogen 
was maintained by sparging with a stream of pure hydrogen gas through a stainless steel needle for  
5 min  and  vigorous  stirring of  the  suspension was  then  continued under hydrogen atmosphere  at  
23 °C. After 5 h, the mixture was diluted with ethyl acetate (10 mL) and filtered through a short pad of 
Celite. The filtrate was concentrated and the residue was purified by flash‐column chromatography 
(50%  ethyl  acetate  in  hexanes)  to  provide  triol 70  (2.3 mg,  31%  over  three  steps)  as  a  colourless 
solid. 
Recrystallization of the product from ethyl acetate/hexanes gave crystals suitable for X‐ray diffraction. 




11‐HB),  1.20  (s,  3H,  19‐H),  1.18–1.10  (m,  2H,  2‐HB,  8‐HB),  1.08  (s,  3H,  18‐H),  1.02  (s,  3H,  20‐H),  
1.01–0.96 (m, 1H, 6‐HB), 0.90 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.76 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.50 
(br s, 1H, 1‐OH), 0.44  (br s, 1H, 4‐OH). 13C NMR  (100 MHz, C6D6) δ 84.55  (C‐13), 83.20  (C‐4), 83.06  
(C‐10), 76.46 (C‐1), 73.30 (C‐14), 47.42 (C‐3), 45.21 (C‐9), 42.06 (C‐7), 40.12 (C‐6), 37.35 (C‐8), 36.59  
(C‐15),  34.45  (C‐5),  31.65  (C‐11),  29.05  (C‐2),  27.69  (C‐12),  25.63  (C‐19),  19.93  (C‐18),  18.76  (C‐16,  
C‐17),  17.88  (C‐16,  C‐17),  16.75  (C‐20).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3474  (br),  2932  (s),  2860  (s),  
1466 (m), 1376 (m), 1344 (s), 1327 (m), 1188 (m), 1102 (m), 1037 (s), 1005 (s) cm–1. HRMS (ESI): calcd 
for ([M+CH3COO], C22H37O6)–: 397.25901, found: 397.26061. ሾࢻሿࡰ૛૙ = –41.7° (c = 0.08, CH2Cl2).
416  EXPERIMENTAL SECTION 
Synthesis of epoxide 71 
 










(m,  2H,  Ph),  7.15–7.13  (m,  2H,  Ph),  7.07–7.03  (m,  1H,  Ph),  4.31–4.24  (m,  2H,  Bn),  2.90  (dd,  
3J13/12A = 8.4 Hz, 3J13/12B = 3.9 Hz, 1H, 13‐H), 2.49 (app t, 2J2A/2B = 3J2A/3 = 14.1 Hz, 1H, 2‐HA), 2.12 (dd,  
3J9/8B = 12.7 Hz, 3J9/8A = 4.3 Hz, 1H, 9‐H), 2.06–1.99 (m, 4H, 2‐HB, 5‐HA, 8‐HA, 15‐H), 1.95–1.89 (m, 1H,  
12‐HA),  1.72–1.67  (m,  1H,  11‐HA),  1.66–1.54  (m,  4H,  3‐H,  5‐HB,  6‐HA,  12‐HB),  1.46  (app  t,  2J8B/8A  =  
3J8B/9  =  12.7  Hz,  1H,  8‐HB),  1.40–1.36  (m,  1H,  11‐HB),  1.23  (s,  3H,  19‐H),  1.17  (s,  6H,  18‐H,  20‐H),  










3J13/12B  =  7.6  Hz,  1H,  13‐H),  2.56–2.51  (m,  2H,  11‐HA,  14‐OH),  2.44–2.38  (m,  1H,  12‐HA),  2.33  (dd, 










                                                 
73 Epoxidation of tricycle 63b with m‐CPBA (CH2Cl2, 0 °C) gave an unfavourable 2:3 mixture of epoxide 71 and tetrahydrofuran 
126. 














1.86–1.77  (m, 3H, 2‐HB, 3‐H, 11‐HA), 1.74–1.65  (m, 1H, 12‐HA), 1.65–1.51  (m, 3H, 5‐HB, 6‐HA, 8‐HB),  
1.47 (s, 3H, 20‐H), 1.44–1.35 (m, 2H, 11‐HB, 12‐HB), 1.27 (s, 3H, 19‐H), 1.23–1.14 (m, 1H, 6‐HB), 1.12 (s, 
3H, 18‐H), 0.98 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.85 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 13C NMR (100 MHz, 
C6D6)  δ  140.55  (Ph),  128.54  (Ph),  127.24  (Ph),  127.19  (Ph),  88.26  (C‐4),  76.33  (C‐13),  74.70  (C‐10),  
67.17 (C‐14), 66.39 (C‐1), 63.03 (Bn), 48.63 (C‐3), 46.83 (C‐9), 41.83 (C‐7, C‐8), 41.55 (C‐7, C‐8), 41.19 
(C‐6),  36.95  (C‐11),  34.40  (C‐5),  33.57  (C‐2),  33.09  (C‐15),  27.67  (C‐12),  25.53  (C‐19),  23.19  (C‐20),  
18.85 (C‐18), 18.33 (C‐16, C‐17), 17.99 (C‐16, C‐17). IR (Diamond‐ATR, neat) vm̃ax: 3383 (br), 2954 (s), 
2929  (s),  1451 (m),  1382  (m),  1346  (w),  1091  (s),  1059  (s),  1030  (s)  cm–1.  HRMS  (ESI):  calcd  for 
([M+CH3COO], C29H43O6)–: 487.30596, found: 487.30682. ሾࢻሿࡰ૛૙ = +35.0° (c = 0.20, CH2Cl2).  
   











TLC  (9%  methanol  in  dichloromethane):  Rf  =  0.15  (CAM).  1H  NMR  (800 MHz,  CD2Cl2)  δ  4.21  (dd, 
3J13/12B  = 4.8 Hz,  3J13/12A  =  2.5 Hz, 1H, 13‐H),  2.17–2.13  (m, 2H, 8‐HA, 9‐H),  2.04–2.00  (m, 1H, 5‐HA), 
1.87–1.80  (m,  2H,  2‐HA,  11‐HA),  1.76–1.61  (m,  5H,  5‐HB,  6‐HA,  12‐H,  15‐H),  1.53–1.48  (m,  5H,  3‐H,  
11‐HB, 20‐H), 1.46 (dd, 2J2B/2A = 14.0 Hz, 3J2B/3 = 3.2 Hz, 1H, 2‐HB), 1.41 (app t, 2J8B/8A = 3J8B/9 = 13.3 Hz, 1H, 
8‐HB), 1.20  (s, 3H, 19‐H), 1.18–1.11  (m, 1H, 6‐HB), 1.05 (s, 3H, 18‐H), 0.91  (d,  3J = 6.8 Hz, 3H, 16‐H,  
17‐H), 0.88 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 13C NMR  (200 MHz, CD2Cl2) δ 83.97 (C‐4), 76.79 (C‐13),  
75.36 (C‐10), 67.30 (C‐14), 66.40 (C‐1), 51.39 (C‐3), 46.85 (C‐9), 42.09 (C‐8), 41.33 (C‐7), 40.40 (C‐6), 
37.94  (C‐15),  37.21  (C‐11),  37.15  (C‐5),  31.69  (C‐2),  27.76  (C‐12),  25.34  (C‐19),  23.15  (C‐20),  18.90  
(C‐18),  18.55  (C‐16,  C‐17),  17.78  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3424  (br),  2957  (s),  
2924  (s),  2867  (m),  1455  (m),  1382 (m),  1261  (m),  1095  (s),  1005  (s)  cm–1. HRMS  (ESI):  calcd  for 
([M+CH3COO], C22H37O6)–: 397.25901, found: 397.26046. ሾࢻሿࡰ૛૙ = +9.4° (c = 0.11, MeOH).    











with  palladium  on  carbon  (10 wt.%,  24.9 mg,  23.4  µmol,  2.00  equiv)  at  23  °C.  An  atmosphere  of 
hydrogen was maintained by sparging the mixture with a stream of hydrogen gas using a stainless steel 
needle  for  5  min  and  vigorous  stirring  of  the  suspension  was  then  continued  under  hydrogen 
atmosphere at 23 °C. After 1 h, the mixture was diluted with ethyl acetate (10 mL) and filtered through 
a  short  pad  of  Celite.  The  filtrate was  concentrated  and  the  residue was  purified  by  flash‐column 
chromatography  on  silica  gel  (35%  ethyl  acetate  in  hexanes)  to  provide  1,10,13,14‐tetra‐epi 
dictyoxetane (tetra‐epi‐3) (2.3 mg, 60% over two steps) as a colourless solid. 
Recrystallization of the product from ethyl acetate/hexanes gave crystals suitable for X‐ray diffraction. 





3H,  16‐H,  17‐H),  0.69  (br  s,  1H,  4‐OH).  13C NMR  (100 MHz,  C6D6)  δ  96.98  (C‐1),  82.90  (C‐4),  82.37  
(C‐14), 81.52 (C‐13), 81.15 (C‐10), 51.95 (C‐9), 50.37 (C‐3), 41.47 (C‐7), 41.15 (C‐8), 39.80 (C‐6), 37.65 






                                                 
74  This  intermediate  could  also  be  obtained  via  the  dyotropic  rearrangement  of  epoxide‐oxetane  78,  see  “Synthesis  of 
dioxatricycle 77” for characterization of this product. 
420  EXPERIMENTAL SECTION 
Synthesis of bromohydrin 127 
 
A  solution  of  epoxide  71  (25.0  mg,  58.3  µmol,  1  equiv)  in  dichloromethane  (3  mL)  was  treated 






















                                                 
75 Reaction monitoring by TLC analysis (30% ethyl acetate in hexanes) showed gradual conversion of epoxide 71 (Rf = 0.15) to 
a putative bromo‐triol intermediate (Rf = 0.30), which then reacted further to bromohydrin 127 (Rf = 0.80). 




with  palladium  on  carbon  (10  wt.%,  8.7  mg,  8.14  µmol,  1.00  equiv)  at  23  °C.  An  atmosphere  of 
hydrogen was maintained by sparging the mixture with a stream of hydrogen gas using a stainless steel 
needle  for  5 min  and  vigorous  stirring  of  the  suspension  was  then  continued  under  hydrogen 
atmosphere at 23 °C. After 1 h, the mixture was diluted with ethyl acetate (10 mL) and filtered through 




TLC  (30%  ethyl  acetate  in  hexanes):  Rf  =  0.35  (CAM).  1H  NMR  (400  MHz,  C6D6)  δ  4.68  (dd,  
3J13/12A = 13.2 Hz, 3J13/12B =2.0 Hz, 1H, 13‐H), 2.47–2.33 (m, 1H, 12‐HA), 2.33–2.23 (m, 2H, 2‐HA, 9‐H), 






17.66  (2C, C‐16, C‐17, C‐20).  IR  (Diamond‐ATR, neat) vm̃ax: 3460  (br), 2954  (s), 2869  (m), 1468  (m),  
1447 (m), 1374 (m), 1129 (m), 1094 (m), 1074 (m), 986 (m) cm–1. HRMS (ESI): calcd for ([M+CH3COO], 
C22H3679BrO5)–:  459.17461,  found:  459.17549;  calcd  for  ([M+CH3COO],  C22H3681BrO5)–:  461.17257, 
found: 461.17345. ሾࢻሿࡰ૛૙ = –52.5° (c = 0.35, CH2Cl2).  
   












3J13/12B  =  7.8  Hz,  3J13/12A  =  3.1  Hz,  1H,  13‐H),  2.45  (dd,  2J2A/2B  =  14.8  Hz,  3J2A/3  =  13.0  Hz,  1H,  2‐HA),  
2.08–1.95 (m, 4H, 3‐H, 5‐HA, 12‐HA, 15‐H), 1.93–1.80 (m, 3H, 2‐HB, 11‐HA, 12‐HB), 1.72–1.62 (m, 3H,  
5‐HB, 8‐H), 1.62–1.54  (m, 1H, 6‐HA), 1.29  (s, 3H, 20‐H), 1.28–1.17  (m, 2H, 6‐HB, 11‐HB), 1.11  (s, 3H,  
19‐H), 1.10 (s, 3H, 18‐H), 1.02 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.93 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H). 














mixture was diluted with pH 7 buffer  solution  (15 mL) and diethyl  ether  (10 mL).  The  layers were 
separated, the aqueous layer was extracted with diethyl ether (3 x 10 mL) and the combined organic 
extracts  were  dried  over  sodium  sulfate.  The  dried  solution  was  filtered  and  the  filtrate  was 
concentrated.  The  residue  was  purified  by  flash‐column  chromatography  on  silica  gel  (10%  to  
20% ethyl acetate in hexanes) to provide dioxatricycle 77 (2.5 mg, 36%) as a colourless solid, olefin 129 
(1.4 mg, 20%) as a colourless oil, and enol ether 83 (2.6 mg, 37%) as a yellowish oil. 
Dioxatricycle  77:  TLC  (20%  ethyl  acetate  in  hexanes):  Rf  =  0.45  (CAM).  1H  NMR  (400  MHz,  C6D6) 
δ 7.40–7.34 (m, 2H, Ph), 7.24–7.18 (m, 2H, Ph), 7.14–7.08 (m, 1H, Ph), 4.31–4.17 (m, 3H, 13‐H, Bn), 
2.49–2.38 (m, 2H, 2‐H), 2.10–1.91 (m, 4H, 5‐HA, 9‐H, 11‐HA, 15‐H), 1.87–1.79 (m, 1H, 12‐HA), 1.76–1.62 
(m,  2H,  11‐HB,  12‐HB),  1.62–1.50  (m,  2H,  5‐HB,  8‐HA),  1.48–1.39  (m,  1H,  6‐HA),  1.38  (s,  3H,  20‐H),  
1.24–1.17 (m, 4H, 3‐H, 19‐H), 1.05 (s, 3H, 18‐H), 1.02–0.92 (m, 5H, 6‐HB, 8‐HB, 16‐H, 17‐H), 0.77 (d,  
3J  =  6.7  Hz,  3H,  16‐H,  17‐H).  13C  NMR  (100  MHz,  C6D6)  δ  140.43  (Ph),  128.58  (Ph),  127.15  (Ph), 
126.96 (Ph), 97.31 (C‐1), 87.70 (C‐4), 82.52 (C‐14), 81.38 (C‐13), 81.21 (C‐10), 62.76 (Bn), 52.00 (C‐9), 
47.78 (C‐3), 41.83 (C‐7), 40.73 (C‐6, C‐8), 40.63 (C‐6, C‐8), 34.86 (C‐5), 33.17 (C‐11, C‐15), 33.14 (C‐11, 






Bn),  2.85–2.76  (m,  2H,  9‐H,  13‐H),  2.50–2.36  (m,  2H,  2‐HA,  12‐HA),  2.33  (dd,  2J2B/2A  =  14.1  Hz,  
3J2B/3 = 3.2 Hz, 1H, 2‐HB), 2.16–1.97 (m, 4H, 3‐H, 5‐HA, 12‐HB, 15‐H), 1.77 (app t, 2J8A/8B = 3J8A/9 = 12.5 Hz, 
1H,  8‐HA),  1.69–1.60  (m,  4H,  5‐HB,  19‐H),  1.60–1.53  (m,  1H,  6‐HA),  1.49  (dd,  2J8B/8A  =  12.5  Hz,  
3J8B/9 = 4.9 Hz, 1H, 8‐HB), 1.22 (s, 3H, 20‐H), 1.22–1.17 (m, 4H, 6‐HB, 18‐H), 1.08 (d,  3J = 6.8 Hz, 3H,  
16‐H,  17‐H),  0.95  (d,  3J  =  6.8  Hz,  3H,  16‐H,  17‐H).  13C  NMR  (200 MHz,  C6D6)  δ  140.53  (C‐10, Ph),  
140.48 (C‐10, Ph), 128.54 (Ph), 127.04 (Ph), 127.00 (Ph), 124.86 (C‐11), 88.59 (C‐4), 75.15 (C‐1), 65.40 
(C‐13), 63.49 (C‐14), 63.18 (Bn), 44.91 (C‐3), 41.95 (C‐7), 41.19 (C‐6), 40.94 (C‐8), 37.88 (C‐9), 34.25  
(C‐5),  33.33  (C‐15),  32.69  (C‐2),  27.47  (C‐12),  22.33  (C‐19),  19.95  (C‐20),  18.56  (C‐16,  C‐17),  18.50  
(C‐18),  18.33  (C‐16,  C‐17).  IR  (Diamond‐ATR,  neat)  vm̃ax:  3474  (br),  2958  (s),  2933  (s),  2857  (m),  
1453  (m), 1385  (m), 1198  (w),  1087  (m), 1055  (s),  1027  (m), 1000  (m)  cm–1. HRMS  (ESI):  calcd  for 
([M+CH3COO], C29H41O5)–: 469.2954, found: 469.2962. ሾࢻሿࡰ૛૙ = –19.6° (c = 0.21, CH2Cl2).  
424  EXPERIMENTAL SECTION 
Enol  ether  83:  TLC  (20%  ethyl  acetate  in  hexanes):  Rf  =  0.28  (CAM).  1H  NMR  (400  MHz,  C6D6) 
δ  7.45–7.39  (m,  2H, Ph),  7.26–7.21  (m,  2H, Ph),  7.14–7.08  (m,  1H, Ph),  4.57–4.55  (m,  1H,  20‐HA), 


















A solution of  tricycle 63a  (37.0 mg, 82.4 µmol, 1 equiv)  in dimethyl  formamide (1 mL) was treated 





dried  over  sodium  sulfate.  The  dried  solution was  filtered  and  the  filtrate  was  concentrated.  The 











(C‐16,  C‐17,  Si(i‐Pr)2),  18.40  (C‐16,  C‐17,  Si(i‐Pr)2),  18.28  (C‐16,  C‐17,  Si(i‐Pr)2),  17.83  (C‐16,  C‐17,  
Si(i‐Pr)2),  17.70  (C‐16,  C‐17,  Si(i‐Pr)2),  15.66  (C‐16,  C‐17,  Si(i‐Pr)2),  14.59  (C‐16,  C‐17,  Si(i‐Pr)2).  
IR  (Diamond‐ATR, neat) vm̃ax: 2943  (s), 2863  (s), 1463  (m), 1385  (w), 1372  (w), 1248  (w), 1148  (m),  
1116  (m),  1011  (s)  cm–1.  HRMS  (EI):  calcd  for  ([M],  C33H52O3Si)+:  524.3680,  found:  524.3686. 
ሾࢻሿࡰ૛૙ = +17.6° (c = 1.00, CH2Cl2).    





indicated  incomplete  conversion  of  siloxane  84,  and  therefore  a  further  portion  of  
N‐bromosuccinimide (33.9 mg, 191 µmol, 5.00 equiv) was added. After 1 h, the mixture was diluted 
with saturated aqueous sodium hydrogen carbonate solution (15 mL) and diethyl ether (10 mL). The 




An  analytically  pure  sample  of  allylic  bromide  85  was  obtained  by  flash‐column  chromatography  
(8% ethyl acetate in hexanes). 
TLC  (10%  ethyl  acetate  in  hexanes):  Rf  =  0.33  (CAM).  1H  NMR  (400  MHz,  C6D6)  δ  5.51  (d,  
2J20A/20B = 1.4 Hz, 1H, 20‐HA), 4.94 (d, 2J20B/20A = 1.4 Hz, 1H, 20‐HB), 4.81–4.75 (m, 1H, 13‐H), 2.89–2.80 
(m,  1H,  9‐H),  2.24–2.06  (m,  2H,  2‐HA,  12‐HA),  1.99  (dd,  3J3/2A  =  12.9  Hz,  3J3/2B  =  2.8  Hz,  1H,  3‐H),  
1.95–1.63  (m,  9H,  2‐HB,  5‐H,  6‐HA,  8‐H,  11‐H,  12‐HB),  1.62–1.53  (m,  1H,  15‐H),  1.35  (s,  3H,  18‐H),  
1.26–1.01 (m, 18H, 6‐HB, 19‐H, Si(i‐Pr)2), 0.96 (d, 3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.92 (d, 3J = 6.8 Hz, 3H, 
























sodium sulfate. The dried solution was  filtered and  the  filtrate was concentrated. The  residue was 
purified by flash‐column chromatography (25% ethyl acetate in hexanes) to provide allylic oxetane 86 
(11.5 mg, 94% over three steps) as a colourless oil. 
TLC  (30% ethyl acetate  in hexanes): Rf = 0.31 (CAM). 1H NMR  (400 MHz, C6D6) δ 4.94–4.91 (m, 1H,  
13‐H), 4.64 (app t,  2J20A/20B =  3J20A/13 = 1.6 Hz, 1H, 20‐HA), 4.40  (app t,  2J20B/20A =  3J20B/13 = 1.6 Hz, 1H,  





(C‐4),  74.11  (C‐10),  48.82  (C‐9),  47.52  (C‐3),  41.62  (C‐7),  40.65  (C‐6),  38.75  (C‐8),  38.23  (C‐5,  C‐11,  
C‐15), 38.14 (C‐5, C‐11, C‐15), 37.27 (C‐5, C‐11, C‐15), 35.38 (C‐2), 29.38 (C‐19), 28.37 (C‐12), 19.09  






















16‐H,  17‐H),  0.86  (br  s,  1H,  1‐OH),  0.17  (s,  9H,  SiR).  13C  NMR  (100  MHz,  C6D6)  δ  141.15  (C‐14),  
140.62 (Ph), 131.16 (C‐13), 128.49 (Ph), 127.11 (Ph), 127.08 (Ph), 88.69 (C‐4), 79.83 (C‐10), 76.72 (C‐1), 
63.03  (Bn),  47.81  (C‐9),  45.96  (C‐3),  45.83  (C‐11),  41.66  (C‐6,  C‐17),  41.53  (C‐6,  C‐7),  39.78  (C‐8),  
38.52  (C‐2),  34.25 (C‐5),  33.21  (C‐15),  28.43  (C‐19),  22.42  (C‐12),  21.39  (C‐20),  18.70  (C‐18),  18.63  
(C‐16, C‐17), 18.39 (C‐16, C‐17), 2.86 (SiR). IR (Diamond‐ATR, neat) vm̃ax: 3464 (br), 2955 (s), 2857 (m), 
1453  (m),  1379 (m),  1249  (m),  1151  (w),  1105  (m),  1086  (m),  1027  (s)  cm–1. HRMS  (EI):  calcd  for  
([M–H2O], C30H46O2Si)+: 466.3267, found: 466.3249. ሾࢻሿࡰ૛૙ = +12.8° (c = 0.86, CH2Cl2).  
   
SUPPORTING INFORMATION FOR CHAPTER 3.2.2  429 
Synthesis of allylic alcohol 87 
 
A  stream of pure oxygen gas was bubbled below  the  liquid  surface of a  solution of  silyl ether 130  
(75.0  mg,  155  µmol,  1  equiv)  in  dichloroethane  (20  mL)  containing  a  catalytic  amount  of 
tetraphenylporphyrin  (TPP,  tip of a spatula) at 0 °C. After 3 min,  the mixture was  irradiated with a 
Replux Belgium RL 160W (225–235 Volts) lamp. After 5 h, TLC analysis (20% ethyl acetate in hexanes) 
indicated  complete  conversion  of  silyl  ether  130  (Rf  =  0.80)  to  the  hydroperoxide  intermediate  
(Rf  =  0.29).  Sparging  with  oxygen  and  irradiation  was  discontinued,  triphenylphosphine  (81.2 mg,  
309 µmol, 2.00 equiv) was added and the mixture was then allowed to warm to 23 °C. After 5 min,  





7.22–7.18  (m,  2H,  Ph),  7.10–7.07  (m,  1H,  Ph),  5.17–5.11  (m,  1H,  20‐HA),  4.74  (br  s,  1H,  20‐HB), 
4.29–4.23 (m, 2H, Bn), 4.21–4.18 (m, 1H, 13‐H), 2.64 (br d, 3J9/8B = 12.6 Hz, 1H, 9‐H), 2.40–2.35 (m, 1H, 
2‐HA),  2.12–2.03  (m,  3H,  5‐HA,  8‐HA,  15‐H),  1.97  (dd,  3J3/2A  =  13.2  Hz,  3J3/2B  =  2.9  Hz,  1H,  3‐H),  
1.93–1.89 (m, 2H, 12‐H), 1.70–1.57 (m, 6H, 2‐HB, 5‐HB, 6‐HA, 8‐HB, 11‐H), 1.35 (s, 3H, 19‐H), 1.32 (s, 3H, 
18‐H), 1.28–1.22  (m, 1H, 6‐HB), 1.06  (br s, 1H, 1‐OH), 1.04  (d,  3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.95  (d,  
3J = 6.7 Hz, 3H, 16‐H, 17‐H), 0.80–0.77  (m, 1H, 13‐OH), 0.16  (s, 9H, SiR).  13C NMR  (200 MHz, C6D6)  
δ  160.21  (C‐14),  140.49 (Ph),  128.52  (Ph),  127.65  (Ph),  127.22  (Ph),  111.37  (C‐20),  88.65  (C‐4),  
79.35 (C‐10), 76.91 (C‐1), 75.47 (br, C‐13), 63.39 (Bn), 46.82 (2C, C‐3, C‐9), 43.68 (br, C‐2), 42.81 (C‐7), 
41.16  (C‐6),  39.29  (C‐11),  37.85  (C‐8),  34.08  (C‐5),  33.23  (C‐15),  29.82  (C‐12),  26.99  (C‐18),  19.42  
(C‐19), 18.72 (C‐16, C‐17), 18.59 (C‐16, C‐17), 2.91 (SiR). IR (Diamond‐ATR, neat) vm̃ax: 3463 (br), 2953 































4.35–4.26  (m,  2H,  Bn),  2.33  (dd,  J  =  14.1  Hz,  3.2  Hz,  1H),  2.26–2.17  (m,  1H),  2.14–2.04  (m,  4H),  
2.00–1.82  (m,  3H),  1.72–1.50  (m,  5H),  1.42  (br  s,  3H,  19‐H),  1.25–1.17  (m,  1H),  1.15  (s,  3H,  18‐H),  




















An  analytically  pure  sample of  iodide 131  could  be  obtained by  rapid  purification by  flash‐column 
chromatography on silica gel (10% ethyl acetate in hexanes) in the dark. 
TLC (10% ethyl acetate in hexanes): Rf = 0.43 (CAM). 1H NMR (800 MHz, C6D6) δ 7.42–7.38 (m, 2H, Ph), 




9‐H, 12‐H), 1.56–1.53  (m, 1H, 8‐HA), 1.50  (dd,  3J6A/5A = 11.7 Hz,  2J6A/6B = 7.9 Hz, 1H, 6‐HA), 1.35  (dd, 
2J11B/11A = 13.0 Hz, 3J11B/12A = 8.0 Hz, 1H, 11‐HB), 1.24–1.22 (m, 1H, 8‐HB), 1.21 (s, 3H, 19‐H), 1.19–1.14 
(m,  1H,  6‐HB),  1.09–1.06  (m,  6H,  16‐H,  17‐H,  18‐H),  0.96  (d,  3J  =  6.7 Hz,  3H,  16‐H,  17‐H).  13C NMR 
(200 MHz, C6D6) δ 140.42 (Ph), 128.56 (Ph), 128.29 (Ph), 127.34 (Ph), 95.57 (C‐1), 87.21 (C‐4), 82.11  
(C‐14), 81.04 (C‐13), 80.23 (C‐10), 63.03 (Bn), 53.68 (C‐9), 45.70 (C‐3), 42.99 (C‐7), 40.14 (C‐6), 35.08 










with  palladium  on  carbon  (10 wt.%,  97.1 mg,  91.2  µmol,  2.00  equiv)  at  23  °C.  An  atmosphere  of 
hydrogen was maintained by sparging the mixture with a stream of hydrogen gas using a stainless steel 
needle  for  5 min  and  vigorous  stirring  of  the  suspension  was  then  continued  under  hydrogen 
atmosphere  at  23  °C.76 After  5 h,  the mixture was  diluted with  ethyl  acetate  (20 mL)  and  filtered 
through  a  short  pad  of  Celite.  The  filtrate  was  concentrated  and  the  residue  was  purified  by  
flash‐column  chromatography  on  silica  gel  (30%  ethyl  acetate  in  hexanes)  to  provide  
(+)‐dictyoxetane (3) (11.7 mg, 80% over two steps) as a colourless oil. 




1.10–1.05  (m, 1H, 6‐HB), 0.95  (d,  3J = 6.8 Hz, 3H, 16‐H, 17‐H), 0.89  (d,  3J = 6.8 Hz, 3H, 16‐H, 17‐H),  
0.54 (br s, 1H, 4‐OH). 13C NMR (100 MHz, C6D6) δ 97.05 (C‐1), 82.45 (C‐4), 81.17 (C‐13), 80.77 (C‐14), 
79.78 (C‐10), 53.30 (C‐9), 47.89 (C‐3), 42.67 (C‐7), 39.72 (C‐6), 36.68 (C‐15), 35.43 (C‐5), 35.08 (C‐8), 
28.00  (C‐2),  27.06  (C‐19),  25.13 (C‐11),  24.03  (C‐12),  20.05  (C‐18),  18.58  (C‐16,  C‐17),  17.68  (C‐16,  
C‐17), 16.49 (C‐20). IR (Diamond‐ATR, neat) vm̃ax: 3484 (br), 2956 (s), 2928 (s), 2862 (m), 1452 (m), 1388 
(m), 1375  (m), 1292 (w), 1148  (m), 1067  (m), 1019  (m) cm–1. HRMS  (EI):  calcd  for  ([M], C20H32O3)+: 
320.2346, found: 320.2349. ሾࢻሿࡰ૛૙ = +29.1° (c = 1.00, CHCl3). (Lit.:77 	ሾࢻሿࡰ૛૙ = +35.0° (c = 3.00, CHCl3).  
1H  NMR  (800  MHz,  CDCl3)  δ  4.38  (br  d,  3J13/12A  =  3.3  Hz,  1H,  13‐H),  2.04  (ddd,  2J5A/5B  =  14.5  Hz, 
3J5A/6B = 9.6 Hz, 3J5A/6A = 1.1 Hz, 1H, 5‐HA), 1.86–1.79 (m, 4H, 2‐HA, 3‐H, 11‐HA, 12‐HA), 1.77–1.71 (m, 2H, 




























was  filtered  and  the  filtrate  was  concentrated.  The  residue  was  purified  by  flash‐column 
chromatography on silica gel  (3% ethyl acetate  in hexanes)  to provide macrocycle 89  (4.0 mg) as a 
colourless  oil. Note:  At  this  stage macrocycle  89  remained  contaminated  with minor,  unidentified 
impurities and the yield was thus determined after subsequent benzyl deprotection. 
TLC (10% ethyl acetate in hexanes): Rf = 0.47 (CAM). 1H NMR (800 MHz, C6D6) δ 7.35–7.33 (m, 2H, Ph), 
7.24–7.21  (m,  2H,  Ph),  7.12–7.08  (m,  1H,  Ph),  5.30–5.26  (m,  1H,  13‐H),  5.17–5.13  (m,  1H,  9‐H),  
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Synthesis of (+)‐dolabellane V (6) 
 




1  h,  the  mixture  was  diluted  with  more  saturated  aqueous  sodium  hydrogen  carbonate  solution  
(10 mL) and diethyl ether (10 mL). The layers were separated, the aqueous layer was extracted with 
diethyl ether (3 x 10 mL) and the combined organic extracts were dried over sodium sulfate. The dried 





3J2A/3  =  8.5  Hz,  1H,  2‐HA),  2.24–2.19  (m,  1H,  12‐HB),  2.18  (d,  2J2B/2A  =  14.7  Hz,  1H,  2‐HB),  2.12  (dd, 




(C‐9), 87.88 (C‐4), 48.12  (C‐3), 44.72  (C‐7), 43.20  (C‐8), 40.82  (C‐6), 37.92  (C‐11), 37.32  (C‐2), 34.54  
















3  2.03 (dd, 13.0 Hz, 2.5 Hz, 1H) 2.04 (dd, 12.9 Hz, 2.6 Hz, 1H)  0.01 
5a  1.90 (dd, 14.0 Hz, 9.5 Hz, 1H) 1.90 (dd, 14.0 Hz, 9.5 Hz, 1H)  0 
13  4.25 (br d, 1H)  4.25 (br d, 1H)  0 
16  0.95 (d, 6.5 Hz, 3H)  0.95 (d, 6.8 Hz, 3H)  0 
17  0.88 (d, 6.5 Hz, 3H)  0.89 (d, 6.8 Hz, 3H)  0.01 
18  1.11 (s, 3H)  1.12 (s, 3H)  0.01 
19  1.27 (s, 3H)  1.28 (s, 3H)  0.01 








1  97.2  97.4  0.2 
2  27.6  27.8  0.2 
3  48.0  48.1  0.1 
4  82.7  82.9  0.2 
5  35.9  36.0  0.1 
6  39.1  39.2  0.2 
7  42.5  42.6  0.1 
8  34.6  34.7  0.1 
9  52.6  52.8  0.2 
10  80.1  80.2  0.1 
11  24.6  24.8  0.2 
12  23.4  23.5  0.1 
13  81.3  81.4  0.1 
14  80.6  80.8  0.2 
15  36.6  36.7  0.1 
16  17.5  17.6  0.1 
17  18.5  18.7  0.2 
18  20.0  20.1  0.1 
19  26.7  26.9  0.2 
20  16.1  16.3  0.1 
 
   









2a  2.70 (dd, 15.0 Hz, 8.5 Hz, 1H)  2.71 (dd, 14.9 Hz, 8.5 Hz, 1H)  0.01 
2b  2.18 (dd, 15.0 Hz, 1.5 Hz, 1H)  2.18 (d, 14.7 Hz, 1H)  0 
8a  2.12 (dd, 13.0 Hz, 11.0 Hz, 1H)  2.12 (dd, 13.4 Hz, 10.7 Hz, 1H)  0 
9  5.02 (dd, 10.5 Hz, 5.0 Hz, 1H)  5.04–4.99 (m, 1H)  0 
12a  2.76 (m, 1H)  2.81–2.73 (m, 1H)  0 
12b  2.22 (m, 1H)  2.24–2.19 (m, 1H)  0 
13  5.58 (t, 8.5 Hz, 1H)  5.57 (app t, 8.6 Hz, 1H)  0.01 
16  1.00 (d, 7.0 Hz, 3H)  1.00 (d, 6.8 Hz, 3H)  0 
17  0.99 (d, 7.0 Hz, 3H)  0.99 (d, 6.8 Hz, 3H)  0 
18  1.11 (s, 3H)  1.11 (s, 3H)  0 
19  1.57 (br s, 3H)  1.57 (br s, 3H)  0 








1  207.4  207.5  0.1 
2  37.1  37.3  0.2 
3  47.9  48.1  0.2 
4  87.6  87.9  0.3 
5  31.0  31.3  0.3 
6  40.6  40.8  0.2 
7  44.4  44.7  0.3 
8  43.0  43.2  0.2 
9  122.2  122.5  0.3 
10  134.9  135.2  0.3 
11  37.6  37.9  0.3 
12  24.9  25.1  0.2 
13  135.6  135.8  0.2 
14  137.8  138.1  0.3 
15  34.2  34.5  0.3 
16  18.1  18.3  0.2 
17  17.4  17.6  0.2 
18  24.5  24.8  0.3 
19  17.6  17.8  0.2 
20  21.2  21.4  0.2 
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6.5.6  Computational Details 
Conformational  Search.  Conformational  searches  were  performed  with  Spartan’14  (Spartan’14, 












 C 0    -2.88789   0.64727   0.17941  
 C 0    -2.86044  -0.54898  -0.44168  
 C 0    -1.72743  -1.25598  -0.58773  
 C 0    -0.60432  -0.73556  -0.08309  
 C 0    -0.60918   0.44649   0.53017  
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 C 0    -1.73842   1.14953   0.66922  
 O 0    -4.05646   1.33375   0.29982  
 C 0     0.82146  -1.21982  -0.11766  
 C 0     1.48998  -0.68721  -1.39112  
 C 0     2.23702   0.62827  -1.14656  
 C 0     1.50563   1.54849  -0.15169  
 C 0     0.80699   0.74458   0.95548  
 O 0     1.38565  -0.54474   0.98911  
 C 0     0.90612   1.39256   2.3313  
 C 0     0.96536  -2.72547   0.06438  
 O 0     0.52531  -0.48646  -2.40046  
 H 0    -3.79852  -0.95837  -0.85338  
 H 0    -1.71842  -2.22139  -1.11617  
 H 0    -1.72611   2.12794   1.17326  
 H 0    -4.77249   0.81881  -0.10615  
 H 0     2.21235  -1.43473  -1.79661  
 H 0     2.4466    1.16127  -2.10316  
 H 0     3.23679   0.37707  -0.71304  
 H 0     0.76198   2.18507  -0.68583  
 H 0     2.25208   2.25065   0.2895  
 H 0     0.46653   2.41541   2.32844  
 H 0     0.37048   0.78886   3.099  
 H 0     1.96857   1.48069   2.65357  
 H 0     0.53126  -3.27928  -0.79841  
 H 0     2.03757  -3.0145    0.14934  
 H 0     0.44907  -3.06901   0.98965  
 H 0    -0.16624   0.10164  -2.07974  
 
   





 C 0    -2.80609   0.72783  -0.27842  
 C 0    -2.70736  -0.52479  -0.76818  
 C 0    -1.57928  -1.24847  -0.67078  
 C 0    -0.53611  -0.68254  -0.05581  
 C 0    -0.61143   0.55634   0.43311  
 C 0    -1.73497   1.27415   0.32856  
 O 0    -3.96697   1.42633  -0.40477  
 C 0     0.8601   -1.18293   0.20169  
 C 0     1.72688  -0.81281  -1.0004  
 C 0     1.66321   0.68745  -1.3153  
 C 0     1.63046   1.5409   -0.03347  
 C 0     0.73399   0.89028   1.02759  
 O 0     1.28117  -0.38428   1.28583  
 C 0     0.6683    1.69139   2.32189  
 C 0     0.94325  -2.65291   0.59523  
 O 0     1.26638  -1.52916  -2.12227  
 H 0    -3.58152  -0.97073  -1.2723  
 H 0    -1.51221  -2.26566  -1.08563  
 H 0    -1.77957   2.29874   0.72815  
 H 0    -4.62255   0.876    -0.86305  
 H 0     2.78238  -1.11876  -0.81265  
 H 0     0.73759   0.89891  -1.90314  
 H 0     2.51558   0.98871  -1.96848  
 H 0     1.26941   2.56979  -0.26827  
 H 0     2.66522   1.63893   0.37311  
 H 0     0.24911   2.70776   2.14731  
 H 0     0.02846   1.18079   3.07727  
 H 0     1.68258   1.81653   2.7644  
 H 0     0.59868  -3.32078  -0.22538  
 H 0     1.99068  -2.93741   0.8445  
 H 0     0.31237  -2.86281   1.48893  
 H 0     0.31634  -1.38605  -2.19413    
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6.5.7  X‐Ray Crystallographic Data 
The data  collections were performed either on an Oxford Diffraction Xcalibur diffractometer,  on  a 
Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoKα‐radiation  
(λ  =  0.71073 Å,  graphite monochromator).  The  CrysAlisPro  software  (version  1.171.33.41)[S8] was 
applied for the integration, scaling and multi‐scan absorption correction of the data. The structures 























































CCDC 1487774  contains  the supplementary crystallographic data  for ketone 50. These data can be 
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Triol 70 
CCDC  1487775  contains  the  supplementary  crystallographic  data  for  triol  70.  These  data  can  be 












































CCDC  1473419  contains  the  supplementary  crystallographic  data  for  triol  74.  These  data  can  be 




























































































CCDC  1473421  contains  the  supplementary  crystallographic  data  for  diol  128.  These  data  can  be 
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